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  Abstract/Resum 
Abstract 
Bacillus thuringiensis is an entomopathogenic bacterium that belongs to the Bacillus 
cereus group and produces a wide variety of insecticidal proteins along with other 
virulence factors contributing to its pathogenicity. Bacillus thuringiensis has been 
considered as the most successful bioinsecticidal agent during the last century. Currently, 
it is widely used as a microbial agent of the major insect pests. In the present doctoral 
thesis, we performed the screening for new B. thuringiensis insecticidal protein genes 
from selected B. thuringiensis isolates based on their gene content. Also, we studied in 
detail different aspects (insecticidal spectrum, cross-resistance, mode of action and cell 
death response of Spodoptera exigua intoxicated with the Vip3Ca protein) of the new 
Vip3Ca protein family. 
Regarding the mining of new insecticidal proteins, we found one new couple of binary 
Vip-like proteins (Vip2Ac-like_1-Vip4Aa-like_1), two new Vip-like proteins (Vip2Ac-
like_1 and Vip4Aa-like_2), one Sip1A-like protein (Sip1A-like_1) and eight Crystal-like 
proteins (Cry23A-like, Cry45Aa-like_1, Cry45Aa-like_2, Cry45Aa-like_3, Cry32Ea-
like, Cry32Da-like, Cry32Eb-like and Cry73Aa-like). The Vip-like proteins have been 
detected in the supernatant, marginally expressed, while the Crystal-like proteins have 
been found in the parasporal crystal (E-SE10.2: 2.5 % - 30 % ; O-V84.2: 7.0 % - 9.8 % 
Cry45-like proteins, 30.4 % - 30.5 % Cry32-like proteins and 2.8 % - 4.25 % Cry73Aa-
like), except the Cry23Aa-like protein, that has also been found in the supernatant at 24 
h and 48 h. In addition, the toxicity of the supernatant (E-SE10.2: 24 h and 48 h; O-V84.2: 
24 h and 48 h) and parasporal crystal (E-SE10.2 and O-V84.2) has been tested in S. exigua 
and Spodoptera littoralis, where the Cry23Aa-like showed some toxicity to both insect 
species. 
In the case of the Vip3Ca protein, we first extended the study of its insecticidal activity 
to ten lepidopteran pests (Cydia pomonella, Grapholita molesta, Sesamia nonagrioides, 
Galleria mellonella, Plutella xylostella, Pectinophora gossypiella, Ephestia kuehniella, 
Plodia interpunctella and Ostrinia furnacalis), one aphid (Nezara viridula) and one 
model organism (Drosophila melanogaster). Several methodologies of biossays were 
used. For the species tested by surface contamination, C. pomonella was the most 
susceptible one, followed by G. mellonella, with percentages of mortality higher than 
50%. Regarding the four species tested by diet incorporation, O. furnacalis was the most 
Mining of new insecticidal protein genes plus determination of the insecticidal spectrum and 
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susceptible one, with an LC50 value of 0.31 µg/g. For the other types of bioassays, Tuta 
absoluta showed some susceptibility to high concentrations of Vip3Ca (30 % mortality). 
Also, several Cry1A, Cry2A, Dipel, Vip3 and Vip3/Cry2Ab resistant insect colonies were 
tested against the Vip3Ca protein to determine if they presented cross-resistance. The 
results showed that the insect colonies resistant to Cry1Ac (Helicoverpa armigera, 
Trichoplusia ni, O. furnacalis and P. interpunctella) or Cry2Ab (H. armigera and T. ni) 
were not cross-resistant to Vip3 proteins (Vip3Aa and Vip3Ca). In contrast, the H. 
armigera colonies resistant to Vip3Aa or Vip3Aa/Cry2Ab showed cross-resistance to the 
Vip3Ca protein.  
We should mention that, as a secondary work arising from the search for susceptible 
species, arose the monographic study on the susceptibility of G. molesta to those 
formulated by B. thuringiensis, its toxins (Cry and Vip3) and synergies between the Cry 
and Vip3 proteins. As a result, we found that G. molesta is highly susceptible to B. 
thuringiensis, Dipel® and Xentari® formulates, and to the B. thuringiensis toxins 
Cry1Aa, Cry1Ac, Cry1C, Vip3Aa and Vip3Af. Once determined that G. molesta is 
susceptible to Cry1Aa, Cry1Ac, Cry1C and Vip3Aa toxins, the possible synergies 
between these proteins were evaluated in dose-response assays. The combinations of 
Cry1Aa-Vip3Aa and Cry1C-Vip3Aa proteins were antagonistic while the combination of 
Cry1Ac-Vip3Aa proteins shows an additive effect. It is interesting to mention that the 
antagonism detected in the Cry1Aa-Vip3Aa and Cry1C-Vip3Aa protein combinations 
increased as the amount of Vip3A protein in the mixture was higher; this fact suggests 
that, though these proteins do not compete for the same binding sites, they may interact 
in events prior to the binding, making more or less accessible the binding to the receptor. 
To study in more detail the mode of action of the Vip3Ca protein, we chose M. brassicae 
because of its relatively high susceptibility to this toxin.  
(I) Proteolysis of the Vip3Ca protein and oligomerization 
The proteolytic pattern of the Vip3Ca protein with trypsin and midgut juice showed that 
theVip3Ca protein was processed into two main fragments of ~70 kDa and ~20 kDa. The 
kinetics of Vip3Ca with the midgut juice from insect species with different susceptibility 
correlated with the susceptibility of the insect species to this toxin. To discard that the 
differences in the toxicity of the Vip3Ca protein was due to inappropriate activation of 
the protein, the Vip3Ca protein was processed with midgut juice of O. nubilalis or M. 
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brassicae and this did not significantly change its toxicity to either insect species. In an 
attempt to determine if the Vip3Ca protein makes oligomers, the size of the Vip3Ca 
digested with trypsin and midgut juice of M. brassicae was determined by size exclusion 
chromatography. As a result, we found that the Vip3Ca protein, either activated with 
trypsin or midgut juice, forms an oligomer composed of 4 units, that is stable up to two 
days in solution. Also, the toxin fragments of ~70 kDa and ~20 kDa coeluted together, 
suggesting that both protein bands are needed to form the oligomer. 
(II) Histopathological effects and in vivo / in vitro binding of Vip3Ca 
The histopathological effects of Vip3Ca were determined in midgut sections of M. 
brassicae intoxicated for different intervals with the Vip3Ca protein. The results indicated 
that the Vip3Ca protein was able to disrupt the midgut epithelium of M. brassicae. To 
know if the Vip3Ca protein binds to the midgut apical membrane, the larvae were fed 
with Vip3Ca and, after 3 h of exposure, the binding of the Vip3Ca protein to the midgut 
epithelium was detected. With the aim to demonstrate that the Vip3Ca protein bound 
specifically to the midgut epithelium of M. brassicae and compete for the same binding 
sites than Vip3Aa, binding assays were performed with biotin-labelled Vip3 proteins. The 
homologous competition showed that the Vip3Aa and Vip3Ca proteins bound specifically 
to the brush border membrane vesicles (BBMV) because the respective unlabelled Vip3 
proteins were able to displace the homolog proteins. The heterologous competition 
experiments indicated that Vip3Ca and Vip3Aa share binding sites. 
(III) Cell death response of S. exigua intoxicated with Vip3Ca2 
The election of S. exigua was due to the fact that a previous publication described a set 
of 47 S. exigua genes that responded to the intoxication by the Vip3A protein. The gene 
expression analysis indicated that the number of the S. exigua genes is dose-dependent. 
Regarding the up-regulated genes, these were involved in the immune system and 
hormone modulation, whereas the down-regulated genes were those involved in the 
digestion process and peritrophic membrane permeability. In addition, the gene encoding 
a component of the Jak-Stat pathway was found down-regulated after 24 h of exposure at 
the higher dose tested. The effect of the Vip3Aa and Vip3Ca proteins on the midgut 
epithelium indicated that the release of aminopeptidase N (APN) is higher when the larvae 
are exposed to Vip3Aa rather than Vip3Ca, at concentrations that produce growth 
inhibition > 99 %. Also, the fitness cost associated to the intoxication with the Vip3Ca 
19
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and Vip3Aa protein is affected by an increase in the time of pupation and a reduction of 
the percentage of pupation. To determine if the down-regulation of the Jak-Stat pathway 
is involved in the apoptosis, the expression level of the caspases and TUNEL staining of 
midgut sections was performed. The results showed the presence of TUNEL-positive 
cells in the S. exigua midgut sections exposed to sublethal concentrations of Vip3Ca 
protein and the Se-caspase-4 was up-regulated at all the time intervals, while the Se-
caspase-1 and Se-caspase-2 were up-regulated at 12 h. 
 
20
                                                                                                                                             Abstract/Resum 
Mining of new insecticidal protein genes plus determination of the insecticidal spectrum and 
mode of action of Bacillus thuringiensis Vip3Ca protein 
Resum 
Bacillus thuringiensis és un bacteri que pertany al grup de Bacillus cereus i produeix una 
gran varietat de proteïnes insecticides juntament amb altres factors de virulència que 
contribueixen a la seva patogenicitat. Bacillus thuringiensis s'ha considerat com el agent 
bioinsecticida amb més èxit durant el segle passat. Actualment, és àmpliament utilitzat 
com agent microbià per a les principals plagues d'insectes com a formulat (selecció de 
aïllats de B. thuringiensis escollits per la seua combinació de proteïnes insecticides 
present en el cristall parasporal) o mitjançant l’expressió de les proteïnes insecticides 
(cultius Bt) en plantes d’interès agronòmic (dacsa, cotó, soja, etc.).  
En quant al seu cicle de vida, B. thuringiensis és un bacteri gram-positiu, anaeròbic 
facultatiu, quimioorganotròfic i amb una distribució cosmopolita. El tret característic de 
B. thuringiensis es la formació de inclusions cristal·lines (proteïnes Cry) que son tòxiques 
contra insectes, especialment contra plagues que produeixen grans danys en diversos 
cultius. El mecanisme general de toxicitat de B. thuringiensis consisteix en un primer pas 
en la ingesta de les proteïnes insecticides i solubilització al tracte intestinal. Després de 
la solubilització, les proteïnes (protoxines) son activades per les proteases intestinals a la 
seua forma activa (toxines). Les toxines travessen la membrana peritrófica, s’uneixen als 
receptors específics de la vora en raspall en la membrana apical del intestí d’insectes 
susceptibles. Seguit de la unió de la proteïna al receptors específics, aquesta s’insereix, 
de manera immediata e irreversible, en la membrana cel·lular formant porus que 
provoquen la lisis cel·lular. La lisis massiva de moltes cèl·lules del intestí provoca la 
disrupció del intestí i la mort del insecte per septicèmia. A mes a més, B. thuringiensis 
també produeix altres factors de virulència que faciliten l’acció de les proteïnes 
insecticides com son: proteases (destrueixen el pèptids antimicrobians generats per part 
del insecte com a resposta a la intoxicació amb B. thuringiensis), bacteriocines i pèptids 
antibacterians (competeixen amb la microbiota resident al intestí del insecte), quitinases 
i “enhancins” (desintegren la membrana peritrófica).  
En la present tesi doctoral, s’ha realitzat la detecció de nous gens de proteïnes insecticides 
de B. thuringiensis a partir d'un conjunt d’aïllats de B. thuringiensis seleccionats basat en 
el seu contingut genètic. També vam estudiar detalladament diferents aspectes (espectre 
insecticida, resistència creuada, mode d'acció i  resposta de mort cel·lular de Spodoptera 
exigua intoxicada amb la proteïna Vip3Ca) de la nova família de proteïnes Vip3Ca. 
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La recerca de nous gens de proteïnes insecticides amb un espectre insecticida i mode 
d’acció diferent al descrit per a les diferents toxines B. thuringiensis es una aproximació 
utilitzada per incrementar l’espectre insecticida de les toxines de B. thuringiensis i 
retardar l’aparició de poblacions d’insectes resistents. Un mètode utilitzat per a la recerca 
de nous gens de proteïnes insecticides es el cribat de col·leccions de aïllats de B. 
thuringiensis de diferents localitzacions i hàbitats mitjançant la utilització de la reacció 
en cadena de la polimerasa (PCR) o, recentment, mitjançant tecnologies d’alt rendiment 
com son: la seqüenciació massiva de DNA genòmic de bacteris i la identificació de 
proteïnes mitjançant de cromatografia líquida acoplada a espectrometria de masses. 
Pel que fa a la recerca de nous gens de proteïnes insecticides, vam partir d'un conjunt 
d’aïllats de B. thuringiensis possibles portadors de nous gens vip1 i vip2. En un primer 
pas, vàrem realitzar dues PCR on, en la primera d’aquestes, determinàvem la presència 
de gens vip1 i vip2, mentre que, en la segona PCR, caracteritzàvem a quin del gens vip1 
i vip2 descrits eren més semblants les seqüencies obtingudes. Com a resultat obtinguérem 
la presència de dos nous al·lels de les parelles de gens vip2Ac1 - vip1Ca1 i vip2Bb1 - 
vip1Bb1 als aïllats B. thuringiensis V-J20.2, V-LE1.1, V-V54.26, V-V54.31, E-TE7.43, 
E-TE16.5 i E-TE18.40. També es detectaren la presència de dos seqüencies amb baix 
percentatge d’identitat als gens vip1Bb1 i vip1Da1 als aïllats de B. thuringiensis E-10.2 i 
O-V84.2.  
En un segon pas, per tal de determinar la seqüencia completa dels gens amb baix 
percentatge d’identitat a vip1Bb1 i vip1Da, es va realitzar la seqüenciació massiva de 
DNA genòmic de ambdós bacteris mitjançant la plataforma de seqüenciació Illumina 
HiSeq-PE150. A partir de les lectures netes, subministrades per Novogene S.L., varen ser 
ensamblades, anotades, i les seqüències codificants foren predites abans de realitzar una 
recerca per homologia contra una base de dades específica de toxines de B. thuringiensis, 
i posteriorment es va validar el resultat obtingut amb la recerca per homologia contra la 
base de dades “Non-Redundant database” del NCBI. Com a resultat obtinguérem la 
predicció de 24 gens de proteïnes insecticides entre els aïllats de B. thuringiensis E-10.2 
i O-V84.2. Per tal de determinar quants dels gens insecticides predits son expressats pels 
aïllats de B. thuringiensis E-10.2 i O-V84.2, es va buscar la seua presència al sobrenedant 
i en la mescla d’espores i cristalls per medi de la identificació de proteïnes amb 
cromatografia líquida acoblada a espectrometria de masses. Com a resultat, trobàrem una 
nova parella de proteïnes tipus Vip (Vip2Ac-like_1-Vip4Aa-like_1), dues noves 
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proteïnes tipus Vip (Vip2Ac-like_1 i Vip4Aa-like_2), una proteïna semblant a Sip1A 
(Sip1A-like_1) i vuit proteïnes tipus Cry (Cry23Aa-like, Cry45Aa-like_1, Cry45Aa-
like_2, Cry45Aa-like_3, Cry32Ea-like, Cry32Da-like, Cry32Eb-like i Cry73Aa-like). 
Una vegada determinada el nombre de noves proteïnes insecticides que són produïdes 
pels aïllats de B. thuringiensis E-10.2 i O-V84.2, es va procedir a determinar la seua 
localització subcel·lular i en quina quantitat eren produïdes per B. thuringiensis. Per tal 
de determinar la localització subcel·lular de les proteïnes tipus Vip i Cry es van detectar 
les proteïnes presents en el sobrenedant (24h i 48h) i en la mescla d’espores i cristalls per 
separat, en tres rèpliques independents. El resultat obtingut fou que les proteïnes tipus 
Vip es van detectar en els sobrenedants, mentre que les proteïnes tipus Cry es van trobar 
en el cristall parasporal, excepte per la proteïna Cry23Aa-like que també es troba en el 
sobrenedant del aïllat de B. thuringiensis E-SE10.2 al temps 24 h i 48 h. 
Pel que respecta a la quantificació de les proteïnes tipus Vip i Cry en tres rèpliques 
independents, es van utilitzar dues aproximacions diferents: (I) Determinar l’abundància 
relativa de les proteïnes tipus Vip i Cry en la mateixa rèplica a un temps fixe, i (II) anàlisi 
lliure de marca dels sobrenedants a 24 h i 48 h dels aïllats de B. thuringiensis E-SE10.2 i 
O-V84.2 per comparar la quantitat de les proteïnes a dos temps concrets. Pel que fa als 
resultats obtinguts de la abundància relativa, indiquen que les proteïnes tipus Vip 
s’expressen de manera marginal al sobrenedant a 24 h i 48 h en els aïllats de B. 
thuringiensis E-SE10.2 i O-V84.2. A més a més, en el cas de l’aïllat de B. thuringiensis 
E-SE10.2, la proteïna Cry23Aa-like fou la proteïna més abundant del sobrenedant a 24 h 
i 48 h, indicant que el cultiu es trobaria en l’inici de la fase d’esporulació. Per a les 
proteïnes Cry, es van detectar en la mescla d’espores i cristalls, on l’aïllat de B. 
thuringiensis E-SE10.2 expressa únicament la proteïna Cry23Aa-like, amb un 
percentatge en pes entre el 2.5% - 30%, mentre que l’aïllat de B. thuringiensis O-V84.2 
expressa set proteïnes diferents amb els següents percentatges en pes: 1.4% - 2.8% 
Cry45Aa-like_1, 2.0% - 3.3% Cry45Aa-like_1, 1.8% - 5.3% Cry45Aa-like_3, 24.3% - 
25.9% Cry32Ea-like, 4.6% - 6.1% Cry32Da-like, 4.4% - 6.2% Cry32Eb-like i 2.8% - 
4.2% Cry73Aa-like. 
En quant als resultats obtinguts de l’anàlisi lliure de marca dels sobrenedants dels aïllats 
de B. thuringiensis E-SE10.2 i O-V84.2 a 24 h i 48 h, indiquen que les proteïnes 
insecticides Vip4Aa-like_1 i Vip4Aa-like_2 de l’aïllat de B. thuringiensis O-V84.2 
mostren diferències significatives entre les 24 h i 48 h. La proteïna Vip4Aa-like_1 es 
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troba incrementada en la seua quantitat dues vegades a 48 h respecte a les 24 h, mentre 
que la proteïna Vip4Aa-like_2 es va detectar a 24 h però no es detecta a 48 h. Pel que 
respecta a la resta de proteïnes tipus Vip, es varen trobar al sobrenedant i no mostraren 
diferències significatives en la seua producció entre les 24 h i 48 h. 
Per finalitzar aquest estudi, es va comprovar la toxicitat de les proteïnes tipus Vip i Cry 
expressades pels aïllats de B. thuringiensis E-SE10.2 and O-V84.2, mitjançant la 
realització de bioassajos amb neonats de les espècies d’insectes plaga Spodoptera exigua 
i Spodoptera littoralis utilitzant el sobrenedant concentrat dels aïllats de B. thuringiensis 
E-SE10.2 and O-V84.2 (autoclavats i no autoclavats) i les proteïnes solubilitzades de la 
mescla d’espores i cristalls. El resultat dels bioassajos amb les proteïnes solubilitzades de 
la mescla d’espores i cristalls de l’aïllat de B. thuringiensis E-SE10.2 indica que la 
proteïna Cry23Aa-like mostra certa toxicitat a S. exigua i S. littoralis, mentre que no 
s’observa cap efecte en les proteïnes solubilitzades de la mescla d’espores i cristalls de 
l’aïllat de B. thuringiensis O-V84.2. En quant a les proteïnes tipus Vip, el sobrenedant 
concentrat, autoclavat i no autoclavat, dels aïllats de B. thuringiensis E-SE10.2 i O-V84.2 
no mostraren toxicitat front a cap de les dues espècies d’ insectes provades. 
********** 
Les proteïnes Vip3 son proteïnes insecticides produïdes per B. thuringiensis durant la fase 
vegetativa i secretades al medi extracel·lular. En el moment d’escriptura d’aquesta tesi, 
les proteïnes Vip3 es troben agrupades en tres famílies proteiques: Vip3A, Vip3B i 
Vip3C. Les proteïnes Vip3A son les més abundants i, per tant, amb les que s’ha dut a 
terme la majoria dels estudis publicats i sobre les que més informació es troba disponible 
sobre el seu espectre insecticida i mode de acció. Pel que respecta a les proteïnes Vip3B 
i Vip3C, són menys abundants i pocs estudis s’han realitzat amb aquestes proteïnes. 
La proteïna Vip3A té una mida al voltant de ~85-90 kDa quant és secretada al medi, 
mentre que al ser activada per les proteases intestinals genera dos fragments, un de 20 
kDa (N-terminal) i l’altre de 60 kDa (C-terminal). La toxina activada mostra toxicitat 
contra un ampli rang d’espècies de lepidòpters, amb alguns d’aquests que fins i tot 
mostren una baixa susceptibilitat a les proteïnes Cry, com ara pot ser Agrotis ipsilon, S. 
exigua i Spodoptera frugiperda. Pel que respecta al mode d’acció de les proteïnes Vip3, 
principalment Vip3Aa, aquest segueix la mateixa seqüencia d’esdeveniments descrits per 
a les proteïnes Cry: (I) Ingesta de les proteïnes Vip3A per l’insecte, (II) activació de la 
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proteïna Vip3A per part de les proteases intestinals i migració a través de la membrana 
peritròfica, (III) unió de la proteïna Vip3A activada al receptors específics de membrana 
de la vora en raspall de les cèl·lules intestinals, i (IV) formació del porus i lisi cel·lular. 
Pel que respecta a la informació disponible sobre la Vip3Ca, prèvia a la realització de la 
present tesi doctoral, fou un treball conjunt del grup d’investigació “Control 
Biotecnològic de Plagues”, de la Universitat de València, i el grup d’investigació 
“Protección de Cultivos”, de la “Universidad Pública de Navarra”. En aquest treball, 
publicat en una nota curta, es descriu per primera vegada la proteïna Vip3Ca i demostren 
que és moderadament tòxica contra Mamestra brassicae, Trichoplusia ni i Crysodeixis 
chalcites. Donat que ja teníem informació prèvia sobre l’espectre insecticida de la 
proteïna Vip3Ca, en un primer pas vam ampliar l’estudi sobre el seu espectre insecticida 
en deu espècies més de lepidòpters plaga (Cydia pomonella, Grapholita molesta, Sesamia 
nonagrioides, Galleria mellonella, Plutella xylostella, Pectinophora gossypiella, 
Ephestia kuehniella, Plodia interpunctella i Ostrinia furnacalis), una espècie d’àfid 
(Nezara viridula) i un organisme model (Drosophila melanogaster). Es van utilitzar 
diverses metodologies de bioassaig. Per a les espècies que es va provar la proteïna per 
contaminació superficial, C. pomonella va ser la més susceptible, seguida de G. 
mellonella, amb percentatges de mortalitat superiors al 50%. Pel que fa a les quatre 
espècies on la proteïna es va provar incorporada en la dieta, O. furnacalis va ser la més 
susceptible, amb un valor LC50 de 0.31 μg/g. Pel que respecta a la resta dels bioassaigs, 
Tuta absoluta va mostrar certa susceptibilitat a altes concentracions de Vip3Ca (30% de 
mortalitat). 
En un segon pas, avaluàrem la proteïna Vip3Ca en colònies d’insectes resistents a les 
proteïnes Cry1A, Cry2A iVip3. Pel que respecta a la proteïna Vip3A, es troba descrit que 
les colònies d’insectes resistents a les proteïnes Cry1A o Cry2A no mostren resistència 
creuada a la Vip3A i vice versa. Per tal de dur a terme aquest objectiu, es varen provar 
diferents colònies d'insectes resistents a les proteïnes Cry1A (H. armigera, T. ni, O. 
furnacalis i P. interpunctella), Cry2A (H. armigera i T. ni) i Vip3 i Vip3/Cry2Ab (H. 
armigera) per a la seua susceptibilitat front a la proteïna Vip3Ca, per determinar si 
presentaven resistència creuada. Els resultats van mostrar que les colònies d'insectes 
resistents a Cry1A (H. armigera, T. ni, O. furnacalis i P. interpunctella) o Cry2Ab (H. 
armigera i T. ni) no mostraren resistència creuada a les proteïnes Vip3 (Vip3Aa i 
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Vip3Ca). Per contra, les colònies de H. armigera resistents a les proteïnes Vip3Aa o 
Vip3Aa/Cry2Ab van mostrar resistència creuada a la proteïna Vip3Ca. 
Hem de mencionar que, com un treball secundari sorgit a partir de la recerca d’espècies 
susceptibles, fou l’estudi monogràfic sobre la susceptibilitat de G. molesta als formulats 
de B. thuringiensis, les seues toxines i sinergies entre les proteïnes Cry i Vip3. Com a 
resultat obtinguérem que G. molesta és altament susceptible al formulats de B. 
thuringiensis, Dipel® i Xentari®, i a les toxines de B. thuringiensis Cry1Aa, Cry1Ac, 
Cry1C, Vip3Aa i Vip3Af. Una vegada determinat que G. molesta és susceptible a les 
toxines Cry1Aa, Cry1Ac, Cry1C i Vip3Aa, es va determinar les possibles sinergies entre 
aquestes proteïnes. Les combinacions de proteïnes Cry1Aa-Vip3Aa i Cry1C-Vip3Aa 
foren antagòniques mentre que la combinació de proteïnes Cry1Ac-Vip3Aa va mostrar 
un efecte additiu. És interesant mencionar que el antagonisme detectat en les 
combinacions de proteïnes Cry1Aa-Vip3Aa i Cry1C-Vip3Aa augmentava segons era 
major la quantitat de proteïna Vip3A en la mescla; aquest fet suggereix que encara que 
aquestes no competeixen llocs d’unió potser interactuen en esdeveniments anteriors a la 
unió fent més o menys accessible la unió al receptor.  
Per aprofundir en el mode d'acció de la proteïna Vip3Ca i comprovar si és similar al 
descrit per a la proteïna Vip3A, escollirem M. brassicae degut a la seua relativament alta 
susceptibilitat a la proteïna Vip3C i Vip3A. Els experiments duts a terme per estudiar el 
mode d’acció de la proteïna Vip3Ca foren els següents: (I) Proteòlisi i oligomerització de 
la proteïna Vip3Ca, (II) efectes histopatològics i unió in vivo / in vitro de Vip3Ca, i (III) 
resposta de la mort cel·lular de S. exigua intoxicada amb Vip3Ca2. 
(I) Proteòlisi i oligomerització de la proteïna Vip3Ca
En un primer pas volguérem demostrar si la proteïna Vip3Ca mostrava un patró 
d’activació similar a la proteïna Vip3Aa. S’ha descrit que, per a la proteïna Vip3A, 
l’activació amb proteases (tripsina o suc intestinal) genera dos fragments de 20 kDa i 60 
kDa. Pel que respecta a la proteïna Vip3Ca, primer es va determinar el seu patró 
proteolític amb tripsina i suc intestinal, mostrant que la proteïna Vip3Ca es processava a 
dos fragments majoritaris de ~ 70 kDa i ~ 20 kDa, tant si utilitzàvem tripsina com suc 
intestinal. Hem de fer notar que pel que respecta a la cinètica d’activació de la proteïna 
Vip3Ca amb el suc intestinal d'espècies d'insectes que mostren diferent susceptibilitat, es 
correlacionava amb la susceptibilitat d’aquestes espècies d'insectes a la proteïna Vip3Ca. 
Mining of new insecticidal protein genes plus determination of the insecticidal spectrum and 
mode of action of Bacillus thuringiensis Vip3Ca protein 
26
  Abstract/Resum 
Donat que la cinètica d’activació de la proteïna Vip3Ca amb el suc intestinal de diferents 
espècies d'insectes es correlaciona amb la susceptibilitat d’aquestes per a la Vip3Ca, 
volguérem determinar si això es devia a una incorrecta activació de la proteïna. En el cas 
de la Vip3Aa s’ha demostrat que la diferent susceptibilitat mostrada per part de les 
diferents espècies d’insectes no es deu a una inapropiada activació de la proteïna. En 
quant a la proteïna Vip3Ca, per descartar que les diferències en la toxicitat de la proteïna 
Vip3Ca es devien a una activació inapropiada de la proteïna, la proteïna Vip3Ca es va 
processar amb suc intestinal de O. nubilalis o M. Brassicae i això no va modificar 
significativament la seva toxicitat a cap espècie d'insecte.  
Per finalitzar aquest punt volguérem demostrar si la proteïna Vip3Ca forma oligòmers 
(tetràmers) com ja s’ha demostrar per a la proteïna Vip3Aa. Per determinar si la proteïna 
Vip3Ca forma oligòmers, la mida de la Vip3Ca digerida amb tripsina i suc intestinal de 
M. brassicae es va determinar per cromatografia d’exclusió molecular. Com a resultat, 
vam trobar que la proteïna Vip3Ca activada, tant amb tripsina com amb suc intestinal, 
forma un oligòmer de 4 unitats que és estable fins a dos dies en solució. A més, els 
fragments de la toxina de ~ 70 kDa i ~ 20 kDa elueixen junts, el que suggereix que ambdós 
fragments de proteïnes són necessaris per formar l'oligòmer, com ja s’ha demostrat per a 
la proteïna Vip3Aa.
(II) Efectes histopatològics i unió in vivo / in vitro de Vip3Ca
En un primer pas volguérem demostrar si la proteïna Vip3Ca és capaç de causar danys en 
l’intestí d’espècies d’insectes susceptibles i si s’uneix la proteïna de manera específica a 
receptors de membrana i competeix pels mateixos llocs d’unió que la Vip3Aa.  
Els efectes histopatològics de la proteïna Vip3Ca es van determinar en talls histològics 
de l’intestí de M .brassicae intoxicat a diferents temps amb la proteïna Vip3Ca. Els 
resultats van indicar que la proteïna Vip3Ca pot causar grans danys en l'epiteli intestinal 
de M. brassicae, però quan es va comparar amb la Vip3Aa (control positiu de toxicitat), 
es va veure que la proteïna Vip3Ca necessita més temps per a mostrar els mateixos efectes 
histopatològics que la proteïna Vip3Aa. Per determinar si els danys observat a l’epiteli 
intestinal de M. brassicae es devien a la unió de la proteïna Vip3Ca a les cèl·lules de 
l’epiteli intestinal, les larves de M .brassicae es van alimentar amb Vip3Ca durant 3 h. El 
resultat va ser que la Vip3Ca s’unia a l’epiteli de M. brassicae, observat mitjançant 
tècniques immunofluorecents. 
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Amb l'objectiu de demostrar que la unió observada de la proteïna Vip3Ca a l’epiteli 
intestinal de M. brassicae és específica i que la proteïna Vip3Ca competeix pels mateixos 
llocs d'unió que la proteïna Vip3Aa, es van realitzar assaigs d’unió amb les proteïnes Vip3 
marcades amb biotina. La competència homòloga va mostrar que les proteïnes Vip3Aa i 
Vip3Ca s’uneixen de manera específica a les vesícules de membrana de vora en raspall 
(BBMV) perquè les respectives proteïnes Vip3 no marcades poden desplaçar les proteïnes 
homòlogues. Els experiment de competència heteròloga van indicar que Vip3Ca i Vip3Aa 
comparteixen llocs d'unió indicant per primera vegada que diferents famílies de proteïnes 
Vip3 competeixen pels mateixos llocs d’unió.  
El fet que les proteïnes Vip3Aa i Vip3Ca competeixen pels mateixos llocs d’unió té 
importants implicacions en la gestió del control de plagues. La combinació de les 
proteïnes Vip3Aa i Vip3Ca no seria optima per al control d’espècies d’insectes plaga, 
perquè l’aparició de resistència a la Vip3Aa (per modificació del receptor) provocaria al 
mateix temps la presencia de resistència creuada cap a la Vip3Ca. 
(III) Resposta de la mort cel·lular de S. exigua intoxicada amb Vip3Ca2
L'elecció de S. exigua es va deure al fet que publicacions anteriors descrivien un conjunt 
de 47 gens en S. exigua que responien a la intoxicació de la proteïna Vip3A. L'anàlisi 
d'expressió gènica dels 47 gens candidats indica que el nombre de gens de S. exigua que 
responen és dependent de la dosi, on el nombre màxim de gens que responien es trobaren 
a la dosi de 10.000 ng/cm2. En quant als gens sobre-expressats a les diferents dosis 
provades, els resultats indiquen que es troben implicats en el sistema immune i la 
modulació hormonal, mentre que els gens reprimits participen en el procés de digestió i 
la permeabilitat a la membrana . A més, el gen que codifica un component de la ruta Jak-
Stat es va trobar reprimit després de 24 hores d'exposició a la dosi més alta provada. 
Pel que respecta a l’efecte de les proteïnes Vip3Ca i Vip3Aa a les dosis utilitzades en 
l’epiteli intestinal, els resultats indiquen que la presència de dany (medit com 
l'alliberament d'aminopeptidasa N) és major quan les larves són exposades a la proteïna 
Vip3Aa més que quan són exposades a concentracions que produeixen una inhibició del 
creixement > 99% de la proteïna Vip3Ca. Hem de fer notar que també es mesura el cost 
biològic associat a la intoxicació amb les proteïna Vip3Ca i Vip3Aa on les larves de S. 
exigua mostraren un augment en el temps de pupació i una reducció del percentatge de 
pupació. 
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Per determinar si la repressió de la via Jak-Stat està implicada en l'apoptosi, es va mesurar 
el nivell d'expressió de les caspases de S. exigua (Se-caspasa-1, Se-caspasa-2, Se-
caspasa-3, Se-caspasa-4, Se-caspasa-5 i Se-caspasa-6) i es realitzaren talls histològics 
de l’intestí de S. exigua que es tenyiren amb la tècnica del TUNEL. Els resultats obtinguts 
indicaren que Se-caspasa-4 estava sobre-expressada en tots els intervals temporals (3h, 
6h, 12h i 24h) mentre que la Se-caspasa-1 i Se-caspase-2 sols estaven sobre-expressades 
a les 12 h. En quant als resultats obtinguts en els talls histològics tenyits per la tècnica del 
TUNEL, mostraren la presència de cèl·lules positives per a la Vip3Ca a la dosi de 10.000 
ng/cm2 mentre que per a la Vip3Aa es detectaren presència de cèl·lules positives per a les 
dosis entre 1-100 ng/cm2 però no a la màxima dosi, degut a que el dany fou tan gran que 
probablement participen altres vies de mort cel·lular que no involucren l’apoptosi. 
********** 
En resum, en la present tesi doctoral hem detectat la presència d’una sèrie de nous gens 
tipus Vip i Cry a partir de dos aïllats de B. thuringiensis i, per primera vegada, hem 
aprofundit en el mode d’acció de la proteïna Vip3Ca. El resultats obtinguts sobre 
l’espectre insecticida de la proteïna i el mode d’acció de la proteïna Vip3Ca suposen una 
gran font d’informació sobre el comportament d’aquesta proteïna tant poc estudiada fins 
al moment de la realització de la present tesi doctoral. Pel que respecta a les conclusions 
específiques obtingudes a partir del treball realitzat, durant les ultimes cinc anualitats, han 
sigut les següents: 
1.- En els aïllats de B. thuringiensis E-SE10.2 i O-V84.2 es van identificar 13 proteïnes 
insecticides noves a partir de dos aïllaments seleccionats pel seu contingut gènic. Les 
proteïnes tipus Vip i Sip (Vip2Ac-like_1-Vip4Aa-like_1, Vip2Ac-like_1, Vip4Aa-like_2 
i Sip1A-like_1) s’expressaven de manera marginal en el sobrenedant mentre que les 
proteïnes tipus Cry (Cry23Aa-like, Cry45Aa-like_1, Cry45Aa-like_2, Cry45Aa-like_3, 
Cry32Ea-like, Cry32Da-like, Cry32Eb-like i Cry73Aa-like) es localitzaven en el cristall 
parasporal  
2.- L'estudi de l’espectre insecticida de la proteïna Vip3Ca es va ampliar a 12 noves 
espècies d'insectes, on O. furnacalis fou la més susceptible. Pel que fa a l'anàlisi de la 
resistència creuada a les plagues de lepidòpters, indiquen que la resistència deguda a la 
selecció amb proteïnes Cry no confereix resistència creuada a Vip3Ca, mentre que les 
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poblacions d'insectes resistents a Vip3A mostren resistència creuada a la proteïna 
Vip3Ca 
3.- Grapholita molesta és altament susceptible als formulats de B. thuringiensis i les seves 
toxines individuals (Cry i Vip3). Pel que fa a les interaccions entre les proteïnes Cry i 
Vip3, es va trobar l'antagonisme en les combinacions Cry1Aa-Vip3Aa i Cry1C-Vip3Aa 
4.- La proteïna Vip3Ca es processa en dos fragments de ~ 70 kDa i ~ 20 kDa, tant 
utilitzant tripsina com suc intestinal. La proteïna Vip3Ca activada amb tripsina i suc de 
midgut de M. brassicae forma un oligòmer de 4 subunitats. La proteïna Vip3Ca és capaç 
d'unir-se a l'epiteli produint la lisi cel·lular. A més, els assaigs d'unió van mostrar que 
Vip3Ca s’uneix específicament i competeix pels mateixos llocs d'unió que la proteïna 
Vip3Aa 
5.- L'exposició de les larves de S. exigua a les concentracions subletals de la proteïna 
Vip3Ca activa diferents vies de resposta d'insectes que desencadenen la regulació 
d'alguns gens pertanyents al grup de resposta a patògens, indueixen l’alliberament d'APN 














2.1. - General aspects of Bacillus thuringiensis 
The control of insect pests in agriculture is mainly achieved using chemical insecticides. 
However, the use of these chemical pesticides has led to several problems, including 
environmental pollution and increase in human health effects, such as cancer and several 
immune system disorders. The selection of insect resistant populations has also caused 
significant and major outbreaks of secondary pests (1). The entomopathogenic bacteria, 
viruses and fungi have been proposed as biological control agents for pest control, due to 
the fact that these control agents are specific for one or few range of insect pest without 
affecting the non-target insects and don’t produce environmental pollution in field 
applications (2). However, they show some disadvantages such as the following: [1] A 
narrow spectrum of activity that enables them to kill only certain insect species, [2] low 
environmental persistence in the field, [3] they require precise application practices, since 
many of these pathogens are specific to young insect larval stages or are sensitive to 
irradiation (1). 
Bacillus thuringiensis is an aerobic, spore-forming, gram-positive and entomopathogenic 
bacterium that belong to the Bacillus cereus group and produces a wide variety of 
insecticidal proteins, such as Cry, Cyt, Mtx-like, Bin-like,Vip and Sip proteins, along 
with other virulence factors contributing to its pathogenicity (Figure 1).  
B. thuringiensis has been considered as the most successful bioinsecticide during the last
century. Currently, it is widely used as a microbial agent of the major insect pests (which
represents ~2% of the total insecticidal market) (1,5). In the market, there can be found
more than 98 formulated sprayable bacterial pesticides (6). Moreover, recent studies
confirmed new applications of the B. thuringiensis strains. These new features include
plant growth promoting bioremediation of heavy metals and other chemicals, anticancer
activities, polymer production, and antagonistic effects against plant and animal
pathogenic microorganisms (Figure 1) (4).
2.1.1.-Life cycle of Bacillus thuringiensis 
B. thuringiensis is a widespread bacteria with a complex life cycle (Figure 2) which is
commonly found in soil, water, plants, stored cereals and dead insects. Due to the





Figure 1. Bacillus thuringiensis cell factory potentials. ACC: 1-aminocyclopropane-1-
carboxylate (ACC) deaminase, PSE: phosphate solubilization enzymes, IAA: indole-3-
acetic acid, PB: proteins involved in bioremediation. This figure has been adapted from 
Palma et al., 2014 (3) and Jouzani et al., 2017 (4). 
direct effects against insect pests relevant to agriculture. However, studies focusing 
purely on the ecology of B. thuringiensis, including its interactions with a diverse range 
of organisms that occupy the same niches are scarce (7). The ecology and lifestyle of B. 
thuringiensis have been a target of many as yet unanswered questions. Two theories try 
to explain the life cycle of B. thuringiensis: [1] B. thuringiensis is a soil-dwelling 
microorganism that obtains nutrition for its survival and reproduction in nature from 
decaying organic matter or root exudates, reaching the aerial parts of plants when these 
germinate and emerge from soil (Figure 2) (7–9). [2] B. thuringiensis is a specialized 
pathogen that, by colonizing and killing its hosts, and multiplying in their cadavers, is 




2.1.1.1. - Niches occupied by Bacillus thuringiensis in the environment 
Soil Environment 
The soil has been considered the main storage of B. thuringiensis spores. The authors that 
consider B. thuringiensis as a soil microorganism propose that B. thuringiensis could 
germinate in the soil and is a natural soil inhabitant. However, the authors that consider a 
B. thuringiensis as a specialized pathogen consider that the soil act as a storage milieu for
the spores, as they do not germinate in these places, requiring specific nutrients and pH
conditions for that (7).
The researchers who argue that B. thuringiensis is a soil microorganism generally believe 
in its saprophytic lifestyle (14–16). However, recent reports demonstrated that B. 
thuringiensis in the colonization of insect cadavers is in fact necrotrophic, which appears 
to be an important feature to ensure bacterial proliferation and dispersion in the 
environment. Naryanan et al. (17) demonstrated that an infected dead insect on a leaf 
surface caused the death of one third of the larvae around. Dubois et al. (18) showed that 
the necrotrophic stage is part of a complex life cycle of B. thuringiensis that involves the 
activation and regulation of several genes that alter its metabolism after the host death. 
Such changes are required for survival and colonization of the host cadaver, involving the 
production of enzymes (proteases, lipases, esterases and chitinases) that allow the use of 
host contents and the cuticle breakage for the release of toxins and spores. 
Epiphytic Environment - Phylloplane 
B. thuringiensis has been isolated from the phylloplane (the surface of a leaf considered
as a habitat for the microorganisms) in natural or artificial ways. It has been shown that
B. thuringiensis can reach this niche by rain splash from the soil to lower leaves, from
soil as a result of being carried by germinating seeds, from animal feces such as those
from insects or birds, and from dead insects (7). The variation in  the  B. thuringiensis
survival rates in the phylloplane seems to be linked to the plant species (9,19). In addition,
some reports indicate that B. thuringiensis is a poor leaf colonizer, being found mostly as
spores in these habitats. Even with nutritionally rich leaf surface that leads to spore
germination, vegetative B. thuringiensis cells sporulate again after a few rounds of
division, which confers a survival ability for long periods, even under stress conditions,
such as desiccation (20). In addition, the leaf exudates can also affect B. thuringiensis





mortality rates of B. thuringiensis in this environment (21,22). So the leaves have been 
suggested to work as a secondary reservoir that participate in the recycling process of the 
bacterium by returning cells and spores to the soil (7). 
Epiphytic Environment - Rhizosphere 
Some reports indicate that B. thuringiensis is able to colonize the rhizosphere of the 
plants, for instance, a B. thuringiensis strain highly toxic against Simulium trifasciatum 
has been isolated from the rhizosphere of Ficus doliaria (23). Moreover, Hendricksen 
and Hansen (8) reported that the population of B. thuringiensis var kurstaki was found 
260 times higher in the rhizosphere than in the phylloplane of the same plants. These 
results suggest that the B. thuringiensis is more effective in the colonization of the 
rhizosphere and roots than in the phylloplane due to a richer nutrient availability in these 
environments that favours the microbial growth (7). 
Endophytic Environment 
Few studies in cotton, soybean, corn, sugar cane, cabbage, ricebean, gahat and lentil have 
reported that B. thuringiensis was successful in endophytic colonization, even with 
concomitant production of Cry toxins. The efficient B. thuringiensis colonization of 
cabbage seedlings roots suggests that this might be in fact the main route of its penetration 
in the plant. After this event, vegetative cells, spores and crystals were found in several 
parts of the seedlings, which characterized a complete B. thuringiensis colonization (24–
27). Similarly, B. thuringiensis was able to colonize the roots of certain legumes, passion 
fruit and cacao (28,29). B. thuringiensis can reach the interior of the plant through the 
roots, stomata and wounds, or through the action of hydrolytic enzymes (30,31). It is 
known that Cry toxins are inactivated by UV radiation and can be washed out from the 
leaves by rain or irrigation; when B. thuringiensis grows endophytically, these adverse 
conditions do not occur (7). 
Aquatic Environment 
The adaptation of B. thuringiensis to the aquatic environment has been assessed by few 
reports. Ichimatsu et al. (14) isolated a great variety of B. thuringiensis serovars from 
50% of running (river, stream, and ditch) and still water (pond) samples in Japan. They 
found that 26.7% of isolates exhibited larvicidal activities against Culex pipiens and 





kurstaki remains in water for large periods: 40 days in sea water and 70 days in lake water. 
Konecka et al. (33)isolated a B. thuringiensis strain from a forest creek sample that 
appeared to be 24× more toxic than HD1 against Cydia pomonella (Lepidoptera) larvae. 
Taken together, these data suggest that B. thuringiensis is also ubiquitous in aquatic 
environments. Since most part of water-isolated serovars were also isolated from soil and 
phylloplane, it is likely that they reach the water bodies through rain, percolation, 
floodings, wind, animal excrements, etc (7). 
Paratenic Behavior 
The intake of contaminated nutrients is the main access route of B. thuringiensis to  
invertebrate or vertebrate animals. For the vertebrate animals, some studies report the 
colonization of the whole or part of the intestinal tract. Wilcks et al. (34) demonstrated 
that B. thuringiensis colonize the intestinal tract of germ-free rats where the cells grew 
vegetatively for various generations before sporulation and elimination by the feces. 
Ammons et al. reported the presence of B. thuringiensis in rectal samples from milk cows, 
with indication that multiplication of B. thuringiensis cells were done in the digestive 
tract of the cows. Zhang et al. (35) showed the presence of B. thuringiensis in the intestinal 
tract of chickens, with the duodenum being the main portion colonized and the chickens 
kept releasing the bacterium through their feces for a certain time, even after removal of 
B. thuringiensis from the diet. Regarding the invertebrate animals, B. thuringiensis has
also been isolated from fecal pellets of non-susceptible caterpillars from forests of
conservation areas (36). In addition, the germination of B. thuringiensis in the alimentary
tract was demonstrated in different invertebrates with sporulation occurring after
defecation (8). If we assume that intestinal colonization does not occur, the fact that the
B. thuringiensis spores are able to cross the digestive tract of these animals and reach their
feces does provide a nutrient-rich environment for their multiplication (9,14,16). This
ecological feature of survival, proliferation and sporulation in paratenic hosts warrants to
B. thuringiensis a wide dispersion in the environment through animals migration and
defecation (7).
Pathogenic Behavior 
The pathogenic behaviour of B. thuringiensis is the aspect most studied because it can 
infect economically important pest that produce damages in several crops. Following the 







tract. After solubilisation, the proteins (protoxins) must be activated through proteolytic 
cleavage by the insect midgut proteases to generate active toxins. The activated toxins 
pass through the peritrophic membrane, and bind to specific receptors on the apical brush 
border of the midgut microvilli in susceptible insects. Following binding, the toxin 
rapidly, and irreversibly, inserts into the cell membrane. Insertion results in the formation 
of pores, which leads to epithelial cell lysis (Figure 2) (3,13).  
Moreover, B. thuringiensis produce other virulence factors in the midgut that facilitate 
the action of the B. thuringiensis toxins such as: proteases (destroy insect-produced 
antimicrobial peptides), bacteriocins and antibacterial peptides target (competing gut 
microbiota), chitinases and enhancins (disrupt the peritrophic membrane). In addition, 
when B. thuringiensis crosses the midgut epithelium, it produces immune inhibitors and 
cytolisins (help to evade haemocytes), antibiotics and quorum quenchers (domination of 
the host), degradative enzymes and iron uptake systems (nutrient acquisition from the 
host) (Figure 2) (13). 
2.1.1.2. - Bacillus thuringiensis is a bona fide insect pathogen 
Despite the hypothesis that support that B. thuringiensis might only be an opportunistic 
pathogen and might even be incapable of full virulence without the aid of other bacteria, 
it appears to express a sufficiently wide range of virulence factors to equip it well for a 
pathogenic lifestyle (13). The ingested spores are able to germinate in the gut and 
synthesize a modified cell surface that help protect them from antimicrobial peptides 
(AMPs) synthesized by the host or competing bacteria. To be able to compete with other 
gut bacteria, B. thuringiensis produces its own AMPs, bacteriocins and express a number 
of drug efflux transporters to combat antibiotics produced by competitors (Figure 2). The 
viable B. thuringiensis cells in the gut environment attack the host producing specific 
toxins secreted in the vegetative growth phase (Vip, Sip, etc.) and in the sporulation phase 
as crystalline inclusions (Cry, Cyt, Mtx-like, etc.). These toxins target, and cause the 
destruction of, the epithelial cells of the midgut. In addition, the germination of the spore 
allows the expression and production of other virulence factors involved in the destruction 
of the midgut tissues, which include an array of phospholipases, enterotoxins and 
proteases (Figure 2) (3,13). 
To invade the insect, B. thuringiensis must cross the peritrophic matrix, a largely 





been breached by the action of the Cry, Cyt and Vip proteins, the B. thuringiensis cells or 
spores can enter into the haemocoel. Within the haemolymph, the bacteria must avoid 
destruction by the innate humoral immune system and circulating haemocytes. 
Production of the metalloproteases might help to protect B. thuringiensis from the innate 
immune system through cleavage of AMPs or by facilitating its escape from haemocytes. 
The expression of enterotoxins by B. thuringiensis during septicaemia and iron 
acquisition systems has been reported, and these might play an active role in colonization. 
The increased reproduction of B. thuringiensis within the haemolymph results in acute 
septicaemia. Furthermore, B. thuringiensis has been shown to reproduce in insect 
cadavers at the expense of intestinal enterococci that were otherwise found to rapidly 
exploit hosts killed in the absence of B. thuringiensis. This ability to compete might be 




Figure 2 Life cycle B. thuringiensis. A) Simplified view of complex lifestyle of B. thuringiensis (Argôlo-Filho et al., 2014). The numbers indicate 
the possible steps followed by B. thuringiensis from the soil reservoir to the insect gut. The different colors of the arrows indicate different strategies 
used by B. thuringiensis to occupy different niches and disperse in environment with or without causing diseases. B) Life cycle of B. thuringiensis 





2.1.1.3. - Transmission of infection 
The process of transmission of infection is an important part of the ecology of every 
pathogen. In the case of B. thuringiensis, the horizontal transmission fits with the biology 
of a highly virulent bacterium that needs to kill its host in order to proliferate. There are 
two possible routes of horizontal transmission for a B. thuringiensis strain active against 
a leaf-eating insect (13): 
1. Indirect transmission via a reservoir in which the spores released from a cadaver 
are quickly deposited in soil. The bacteria must recolonize plant material to infect 
hosts at a later date. This could be done by co-migration of B. thuringiensis with 
the growing plant, transfer by biotic or abiotic means or even through endophytic 
transport
2. Direct transmission, in which new infections are produced by larvae feeding on 
spores and crystals recently released onto leaf material from a B. thuringiensis 
killed cadaver 
The possible routes of transmission above suggested that the toxin production takes place 
only in two places: (1) within the host or (2) on/within the plants. The contact with the 
host occurs periodically. The vegetative growth of B. thuringiensis on leaves is not only 
poor but also periodic and might be linked to fluctuation in leaf chemistry or ambient 
humidity. If transmission occurs indirectly, then Cry toxin production must take place in 
situ on the leaf surface in a relatively dry environment, protected probably by microsites. 
Sporulation occurs after replication within host cadavers when limiting resources are 
exhausted. Again, this is a relatively dry environment, and spores and crystals might be 
protected from rain and UV radiation when associated with the insect cuticle and other 
tissue fragments (13). 
2.1.2. - Classification and Taxonomy of Bacillus thuringiensis 
The placement of B. thuringiensis as a separate species within the genus Bacillus spp has 
been controversial since the publication of “The Genus Bacillus” in 1973 and “Bergey’s 
Manual of Determinative Bacteriology” in 1974. The genus Bacillus spp is one of the 
most diverse genera in the Bacilli class and includes aerobic and facultative anaerobic, 





eight genera in the class Bacilli have been proposed: Bacillus, Alicyclobacillus, 
Paenibacillus, Brevibacillus, Aneurinibacillus, Virgibacillus, Salibacillus and 
Gracilibacillus. In the “The Genus Bacillus”, B. thuringiensis is considered a variety of 
B. cereus along with Bacillus anthracis and Bacillus mycoides. Certainly, B. 
thuringiensis, B. anthracis and B. cereus share many common phenotypic and genotypic 
properties to the extent that the three species have been placed under one group called the 
Bacillus cereus (BC) group (37). 
The most widely used method for classification of B. thuringiensis isolates has been H 
serotyping, the immunological reaction to the bacterial flagellar antigen. The hag gene 
encodes flagellin, which is responsible for eliciting the immunological reaction in H 
serotyping. Specific flagellin amino acid sequences have been correlated to specific B. 
thuringiensis H serotypes and at least 69 H serotypes and 82 serological varieties 
(serovars) of B. thuringiensis have been characterized. H serotyping, however, is limited 
in its capability to distinguish strains from the same H serotype or from the same serovar 
(38). With the continuously increasing number of B. thuringiensis strains, additional 
procedures have been implemented to continue with a systematic characterization of 
novel B. thuringiensis strains. Widespread use of DNA sequencing technologies in 
clinical, public health, and research laboratories has resulted in rapid and accurate 
molecular diagnostic methods. A bacterial isolate can now be identified more rapidly by 
16S rRNA sequence analysis than by conventional methods. In the second edition of 
Bergey’s manual of systematic bacteriology, the phenotypic characteristics and the 
laborious task of DNA-DNA hybridization procedures have been replaced by 16S rRNA 
sequence analysis as the basis for taxonomic classification (Ludwig et al., 2001). 
However, the differentiation between closely related species using 16S rRNA gene 
sequences can be difficult. For example, in some bacteria, the sequences may appear to 
be identical, as has been reported for strains of B. anthracis, B. cereus, and B. 
thuringiensis (39).  
Due to the economic importance of B. thuringiensis, alternative methods have been 
developed to classify the members of the BC group, such as multi-locus sequence typing 
(MLST) (40,41), PCR amplified fragment polymorphisms of flagellin genes (PCR-
AFPF) (42), Rep-PCR fingerprinting patterns (43), and plasmid patterns (44). Certainly 
none of the several methods (H serotyping, 16 RNA gene sequences, MLST, PCR-AFPF, 





members of BC group are able to identify, individually, a novel B. thuringiensis strain 
with 100% of confidence. Thus, the need to use combination of some of them to properly 
characterize a novel B. thuringiensis strain. 
2.1.3. - Economic impact of the Bacillus thuringiensis products present in the market 
The use of B. thuringiensis in biological control can be done by three strategies: classical, 
conservative and augmentative. The most common way for pest control is the 
augmentative-inundative application of B. thuringiensis. The success of B. thuringiensis 
as microbial control agent (MCA) is due to the practical similarity to conventional 
pesticides: B. thuringiensis-based products are relatively cheap and easy to formulate, 
have long shelf life and can be applied using conventional application equipment. In 
addition, the use of B. thuringiensis is compatible with other strategies for crop 
management such as agricultural practices, biological control using natural enemies and 
chemical treatments. B. thuringiensis formulations are by far the MCA most used at a 
global scale and account for almost 98% of the bacterial MCA (Figure 3) (6). 
Regarding the transgenic Bt crops, the rapid adoption, 1996 to 2016, confirm that biotech 
crops have delivered substantial agronomic, environmental, economic and health benefits 
(5). A total of 24 countries, 19 developing and 5 industrialized countries, planted biotech 
crops in 2017. The top ten countries were led by the USA which grew 75 million hectares 
(40% of global total), Brazil with 50.2 million hectares (26%), Argentina with 23.6 
million hectares (12%), Canada with 13.1 million hectares (7%), India with 11.4 million 
hectares (6%), Paraguay with 3.0 million hectares (2%), Pakistan with 3 million hectares 
(2%), China with 2.8 million hectares (1%), South Africa with 2.7 million hectares (1%) 
and Bolivia with 1.3 million hectares (1%). Regarding the EU countries, Spain and 
Portugal continued to plant biotech crops in 2017 at 131,535 hectares, indicating a slight 
decrease of 4% from 136,363 hectares in 2016 (Figure 3) (5). 
The four major biotech crops in 2017 are soybeans, maize, cotton, and canola. These 
crops occupied most (99%) of the global biotech crop area. The adoption trend show 
alarge increase for soybeans, cotton, and canola and a slight decrease in biotech maize 
(Figure 3). In addition, the Bt crops suppose an important percentage of the crops seeding 
market in 2017. For cotton, soybean, maize, and canola, the global adoption rates (%) for 






Figure 3 Economic impact and global status of the Bacillus thuringiensis products 
present in the market. A) Estimated world biopesticide sales by type in 2010 and 
entomopathogenic bacteria used for control of insect pests of major crops, forest, turf, 
humans and domesticated animals (6). B) Distribution of biotech crops (B. thuringiensis 
crops) by country and crops from 1996 to 2017 (5). This figure has been adapted from 
Lacey et al., 2015 (6) and ISAA Brief 53 2017 (5). 
The economic benefits of the biotech crops of the six principal countries during the first 
21 years of commercialization of biotech crops, 1996 to 2016 were, in descending order 
of magnitude, the USA (US$80.3 billion), Argentina (US$23.7 billion), India (US$21.1 
billion, Brazil (US$19.8 billion), China (US$19.6 billion), Canada (US$8 billion), and 
others (US$13.6 billion) for a total of US$186.1 billion. In 2016, the six countries that 
gained the most economically from biotech crops were: the USA (US$7.3 billion), Brazil 
(US$3.8 billion), India (US$1.5 billion), Argentina (US$2.1 billion), China (US$1 
billion), Canada (US$0.82 billion), and others (US1.8 billion) for a total of US$18.2 
billion. The global economic benefits of US$18.2 billion were divided between the 






2.2. - Mining of new insecticidal protein genes of Bacillus thuringiensis 
Regardless of whether we consider B. thuringiensis a soil-dwelling microorganism or a 
specialized pathogen, B. thuringiensis shows a high genetic plasticity. Different series of 
approaches have been used for isolating novel insecticidal protein genes from B. 
thuringiensis, such as the construction of B. thuringiensis DNA libraries, followed by 
screening by Western Blotting and PCR. Currently, the next generation sequencing 
(NGS) allows rapid sequencing of entire genomes and the number of B. thuringiensis 
whole genomes that have been sequenced has increased quickly in the recent years 
(Figure 4). Consequently, the number of putative insecticidal protein genes predicted 
based on the genome data available have increased exponentially. 
2.2.1 - PCR approach used in the mining of new insecticidal protein genes 
The mining of new insecticidal proteins is a tool that helps researchers to cope with the 
problem of the eventual appearance of resistance in the field against currently used B. 
thuringiensis toxins. Thus, it is necessary to explore the potential of new insecticidal 
proteins in new B. thuringiensis isolates for pest control. One of the first approach 
developed was the construction of B. thuringiensis DNA libraries, followed by screening 
by Western Blotting or a hybridization-based method (45,46). With the invention of the 
polymerase chain reaction (PCR), specific applications to mining new insecticidal genes 
quickly started to be developed, such as PCR hybridization, PCR-RFLP, E-PCR, PCR-
SSCP, Multiplex-PCR, etc. (47–51). With the combination of the specific PCR 
applications, there have been identified more than 800 B. thuringiensis quaternary rank 
toxins (52) (Figure 4). Although the PCR approach has demonstrated to be a great 
technique in the mining of new insecticidal protein genes, it is limited to finding new 
insecticidal protein genes with enough homology to the primers used. These new 
insecticidal protein genes should display a small number of synonymous or non-
synonymous substitutions and encoded identical or slightly different proteins compared 
to previously described alleles. In addition, since these techniques yield only a part of the 
gene sequence, time-consuming PCR walking strategies or construction of genomic 






2.2.2 - Novel insecticidal protein genes and high-throughput technologies (NGS 
and LC/MSMS) 
Currently, the next-generation sequencing (NGS) technologies are a useful tool to 
discover new insecticidal protein genes that would otherwise be difficult to identify by 
the PCR approach. NGS technologies provide a fast and reliable framework to obtain 
complete genomic sequences, and offer excellent cost-benefit ratios. This cost may be 
reduced only if raw sequence production is outsourced and the researcher completes the 
assembly steps. The cleaning, assemble, mapping and annotation of the data generated by 
the high-throughput technologies can be done using a regular desktop computer or in a 
cluster of the Spanish Supercomputing Network (RES). Regarding the tools to manage 
the data generated by the NGS technologies, they can be done with private bioinformatics 
software, such as CLC Genomics Workbench or Geneious Pro, or using open source 
softwares that are freely available in the BioLinux distribution, among other alternatives. 
Several reports have been published that use the high-throughput technologies to assess 
the mining of new insecticidal protein genes and can be grouped in the following 
strategies: 
1. Whole genome sequencing, assembly and annotation of the B. thurinigensis 
standards such as B. thuringiensis serovar morrisoni (BGSC 4AA1), B. 
thuringiensis serovar kurstaki (HD1 and HD73), B. thuringiensis serovar 
galleriae (HD29), B. thuringiensis serovar tolworthi (BGSC 4L1-4L3), etc 
(https://www.ncbi.nlm.nih.gov/genome/microbes/)
2. Whole genome sequencing of a B. thuringiensis isolate that shows a wide 
insecticidal spectrum or insecticidal activity against pests that  are  difficult  to 
control (54–58)
3. Mining, expression and insecticidal spectrum of new insecticidal protein genes 
detected by whole genome sequencing (53,55,59,60)
4. Screening of the B. thuringiensis toxin gene content in a B. thuringiensis 
collection by pool deconvolution approach (61) 
The emergence of mass sequencing programs offers huge potential for the discovery of 
new toxin sequences and suppose a challenge to the B. thuringiensis toxin nomenclature 





overwhelm the system, as well as nomenclature difficulties within the present system 
(62). 
2.2.3. - Bacillus thuringiensis Toxin Nomenclature 
Since the identification of the Cry1Aa protein in 1985 (46), the number of insecticidal 
protein genes and whole genome sequences of B. thuringiensis has been growing every 
year, generating the need to develop a nomenclature system (Figure 4). A first 
nomenclature system was developed where the names of the Cry toxins included a Roman 
numeral (primary rank distinction) depending on the insecticidal activity of the crystal 
protein: CryI for proteins toxic to lepidopterans, CryII for proteins with toxicity against 
both lepidopterans and dipterans, CryIII for proteins toxic to coleopterans, and CryIV for 
proteins toxic exclusively for dipterans (63). However, this system exhibited important 
complications, such as the following: [1] the activity of new toxins had to be assayed 
against a big set of insects before the toxin could be named, [2] some novel homologous 
proteins were in fact non-toxic as expected and others exhibited dual toxicity against 
dipteran and lepidopteran species (64).  
To avoid the problems of the old toxin nomenclature, the B. thuringiensis Toxin 
Nomenclature Committee developed a novel system of classification where a novel toxin 
received a four-rank name depending on its degree of pairwise amino acid identity to 
previously named toxins (64) as follows (Figure 4): 
1. Proteins  with  % of  similarity  < 45%  are  assigned  to  a different  primary rank 
(protein name and arabic number, eg, Vip1 and Vip3)
2. Proteins with % of similarity < 78% are assigned to a different secondary rank (a 
capital letter, eg, Vip3A and Vip3C)
3. Proteins with % of similarity < 95 % are assigned to a different terciary rank (a 
lowercase letter, eg, Vip3Aa and Vip3Ab)
4. Proteins with % of similarity > 95 % are assigned to a different quaternary rank 
(an arabic number, e.g., Vip3Aa1 and Vip3Aa2) 
The advantages of the novel nomenclature system developed by the B. thuringiensis 
Toxin Nomenclature Committee consist in grouping the proteins according to the 
sequence identity, which does not imply a similar protein structure, host range or even 






Figure 4 Schematic overview of the current nomenclature system used by the B. 
thuringiensis Toxin Nomenclature Committee. A: The system consists of four ranks 
based on amino acid sequence identity. The primary, secondary, and tertiary ranks 
distinguish proteins with less than > 45, 78, and 95 % sequence identities, respectively. 
The quaternary rank distinguishes proteins sharing > 95 % sequence identity (65). B: 
Number of Cry, Cyt and Vip from 1989 to 2013, listed in the B. thuringiensis Toxin 
Nomenclature website at either tertiary (holotype) or quaternary (allelic) rank (52). C: 
Number of whole genome sequences of Bacillus thuringiensis from 1989 to 2018, listed 




2.3. - Insecticidal proteins of Bacillus thuringiensis 
B. thuringiensis strains synthesize δ-endotoxins (crystal and cytolytic toxins) at 
the  beginning of the stationary growth phase as parasporal crystalline inclusions. 
Once ingested by the insect, the crystal is solubilized in the midgut and then the 
toxins are processed by the midgut proteases to a toxic core. After the activation, the 
toxic core crosses the peritrophic membrane and binds to specific receptors located 
in the brush border membrane of the midgut epithelium, leading to cell disruption and 
insect death. Additionally, B. thuringiensis isolates can produce other insecticidal 
proteins during the vegetative growth phase that are secreted into the culture medium, 
Vip and Sip proteins. These insecticidal proteins show a similar mode of action with 
the Cry proteins but do not compete for their binding sites (3). 
2.3.1 - Crystal Toxins (δ-endotoxins) 
Cry toxins are defined as proteins that have significant sequence similarity to existing 
toxins within the nomenclature or be a B. thuringiensis parasporal inclusion protein that 
exhibits pesticide activity, or toxic effect, to a target organism (64). Currently, the 
different kinds of Cry proteins (Three-domain proteins, Bin-like proteins, Etx_Mtx-like 
proteins and Unclassified Cry proteins) constitute the largest group of insecticidal 
proteins by B. thuringiensis and show toxicity against lepidopterans, coleopterans, 
hemipterans, dipterans, Gastropoda and human-cancer cells of various origins (Table 1 








Figure 5 Insecticidal proteins produced by B. thuringiensis. A: Schematic representation 
of the different kinds of insecticidal proteins produced by B. thuringiensis. B: Overview 
of the insecticidal spectrum of the Cry proteins with their target pest in each class. Cry1A-
C (separated by hyphen) indicates a group of Cry1A, Cry1B and Cry1C toxins. Cry1B 
and Cry1I (separated by colon) indicates different Cry1B and Cry1I toxins. Semicolons 
separate groups or individual toxins. Cyt toxins are in red. This figure has been adapted 




Tabla 1.  The summary of B. thuringiensis toxin proteins, structure and their activities. 
Lep: Lepidoptera; Dip: Diptera; Col: Coleoptera; Rha: Rhabditia; Hem: Hemiptera AT: antitumoral activity; AB: antibacterial activity and ND: no 
known invertebrate target. Blue: Three-domain, Green: Unclassified Cry, Orange: Etx-Mtx-like, Pink: Bin-like, Parasporin: Toxins named with 























Cry1(A–N) 275 Lep and Col Cry23(A) 1 Col Cry45(A–B) 2 AT Cry67(A) 2 ND 
Cry2(A–B) 82 Dip and Lep Cry24(A–C) 3 Dip Cry46(A) 3 AT Cry68(A) 1 ND 
Cry3(A–C) 19 Col Cry25(A) 1 Dip Cry47(A) 1 Dip Cry69(A) 3 ND 
Cry4(A–C) 17 Dip  Cry26(A) 1 Col Cry48(A)  5 Dip Cry70(A) 3 ND 
Cry5(A–E) 13 Rha Cry27(A) 1 Dip Cry49(A)  5 Dip Cry71(A) 1 ND 
Cry6(A–C) 4 Rha and Hem Cry28(A) 2 Col Cry50(A–B) 3 ND Cry72(A) 1 ND 
Cry7(A–L) 37 Col Cry29(A–B) 2 Dip Cry51(A) 2 Lep Cry73(A) 1 ND 
Cry8(A–T) 59 Col Cry30(A–G) 13 Dip Cry52(A–B) 2 Dip Cry74(A) 1 ND 
Cry9(A–G) 37 Lep  Cry31(A) 12 ND Cry53(A) 2 ND Cry75(A) 1 Col 
Cry10(A) 5 Dip Cry32(A–W) 31 Dip Cry54(A–B) 5 Lep 
Cry11(A–B) 8 Dip Cry33(A) 1 ND Cry55(A) 3 Col and Rha 
Cry12(A) 1 Rha Cry34(A–B) 11 Col Cry56(A) 4 ND Cry78Aa 1 Hem 
Cry13(A) 1 Rha Cry35(A–B)  11 Col Cry57(A) 2 ND 
Cry14(A) 2 Col and Rha Cry36(A) 1 Col Cry58(A) 1 ND 
Cry15(A) 1 Lep Cry37(A) 1 Col Cry59(A–B) 2 Lep 
Cry16(A) 1 Dip Cry38(A) 1 Col Cry60(A–B) 6 ND 
Cry17(A) 1 Dip Cry39(A) 1 Dip Cry61(A) 3 ND 
Cry18(A–C) 3 Col Cry40(A–D) 4 Dip Cry62(A) 1 ND 
Cry19(A–C) 3 Dip and Lep Cry41(A–C) 5 AT Cry63(A) 1 AT 
Cry20(A–B) 4 Lep Cry42(A) 1 ND Cry64(A–C) 3 AT 
Cry21(A–H) 10 Rha and Dip Cry43(A–C) 7 Col Cry65(A) 2 AT and AB 





2.3.1.1 - Three domain Cry proteins 
Sequence alignments of different Cry toxins show that the majority of the Cry proteins 
contain five typical conserved blocks located in the N-terminal part of the protoxins 
(domains I, II and III) and three additional conserved blocks are located in the C-terminal 
end of the protoxins (Figure 6). The C-terminal extension found in the large protoxins is 
not part of the active core but is believed that participate in the crystal formation and 
putuative mechanism to generate new specificities in the nature. Also other three-domain 
protoxins lack the extended C-terminal region and are, instead, synthesized as shorter 
protoxins of approximately 70-kDa (3,69). 
 
 
Figure 6 Primary and tertiary structure of the Cry proteins. A: Amino acid conserved 
blocks (1 to 8) among different three-domain Cry proteins (colored boxes). Green boxes 
represent the five conserved amino acid blocks of the N-terminal while the red boxes 
indicate the three additional conserved amino acid blocks of the C-terminal part. Three-
dimensional structure of Cry1Ac protoxin with the toxic core comprising the domains I, 
II and III. B: Relative lengths of Cry protoxins and position of the five conserved blocks 
and C-terminal region. This figure has been adapted from Palma et al., 2014 (3) and Ruud 





The domain I or perforating domain is located in the N-terminal region. This domain 
consists of seven α-helices, six amphipathic α-helices around a central core helix (Figure 
6). The domain I may be involved in the toxin membrane insertion and pore formation. 
Domain II or β-prism consists of three antiparallel β-sheets and plays an important role 
in toxin-receptor interactions. The domain III or galactose-binding domain consist in two 
antiparallel β-sheet sandwich and is involved in receptor binding and pore formation 
(3,69). 
2.3.1.2 - Mode of action of the three domain Cry proteins 
The mode of action of the three-domain crystal proteins has been mainly studied in 
lepidopteran pests. Two different models have been proposed to explain the mode of 
action of the three-domain Cry proteins: the sequential binding model and the signalling 
pathway model (Figure 7). The crystal inclusion, after the ingestion by the insect, is 
dissolved in the alkaline midgut lumen and the native proteins (protoxin) present in the 
crystal composition are activated to the protease-resistant toxic core, N-terminal region, 
by the action of the midgut proteases (Figure 6). The toxic core of the Cry proteins crosses 
the peritrophic membrane and enter in the extracellular media. The sequential binding 
model suggests that the toxic core of the Cry toxins bind to cadherin-like proteins 
(transmembrane protein that function as toxin receptors) and undergo a conformational 
change that facilitate the proteolytic removal of the α-1 helix from domain I and formation 
of the oligomeric pre-pore structure. Later, binding to a secondary receptor, such as an 
aminopeptidase or alkaline phosphatase, facilitates the insertion of the pre-pore structure 
into the membrane, leading to cell death (3,70). In contrast, the signalling-pathway model 
suggests that the toxic activity of the three-domain Cry proteins is mediated by the 
specific binding to cadherin receptors, leading to the activation of an Mg2+-dependent 
signal-transduction pathway which, in subsequent steps, activates the G protein (Gα), 
adenylyl cyclase (AC), and protein kinase A (PKA). The activation of the Mg2+-
dependent signal-transduction pathway increased the exocytosis of the intracellular 
cadherin receptors into the membrane and the PKA modifies downstream molecules that 




2.3.1.3 - Non-Three-Domain Cry Toxins  
Epsilon toxin_ Metaxin 2 (Etx_Mtx2)-like Cry toxins 
The Etx_Mtx2-like Cry proteins such as Cry15, Cry23, Cry33, Cry38, Cry45, Cry46, 
Cry51, Cry60, Cry64 and Mtx3 and Mtx2 share features of the ETX_MTX2 family that 
include the Mtx proteins from Lysinbacillus sphearicus and the Clostridium perfringens 
epsilon toxin. The latter toxin has an extended beta sheet structure related to aerolysin, a 
pore-forming toxin produced by the Aeromonas hydrophila, which forms beta-barrel 
pores in target cells. A similar mode of action is also likely for the Etx_Mtx2-like Cry 
toxins above (3,66). 
Binary (Bin)-like Cry toxins 
The Bin-like Cry toxins such as Cry34, Cry35, Cry36, Cry37, Cry49, BinA and BinB 
belong to the Toxin_10 family of proteins and show an aerolysin-like fold that is very 
similar of the Etx_Mtx2-like Cry proteins. Cry35 contains a QxW motif, which is 
structurally very similar to carbohydrate-binding domains of ricin and Mtx1. It is 
interesting to note that some of the above toxins are able to act alone to cause toxicity 
(e.g., Cry36), whereas others require a second protein to act as binary toxins (e.g., 
BinA/BinB, Cry23/Cry37, Cry34/Cry35 and Cry48/Cry49). Cry34 is a member of the 
aerolysin family, where the structure of the protein (PBD accession number 4JOX) shows 
a single domain protein with a beta-sandwich conformation and a hydrophobic core. 
Although there is no obvious homology at the level of their amino acid sequences, the 
Cry34/Cry35 pair show structural similarity to another binary toxin, Cry23/Cry37 (3). 
Unclassified Cry toxins 
In few years, new crystal proteins  have been reported, such as  the 42 kDa protein, 
sphaericolysins, alveolysins, enhancin-like proteins and P19 and P20 helper proteins. The 
42-kDa protein exhibited high similarity to BinA and BinB and no toxicity has been 
reported yet. Sphaericolysin, a protein with a unique N-terminal sequence and 
cholesterol-dependent cytolysins motif, is very effective to control Blattella germanica 
and Spodoptera litura. The enhancin-like proteins show similarity to viral enhancin 
proteins; for the Bel enhancin, it has been reported to be effective in enhancing the 
toxicity of Cry1Ac against Helicoverpa armigera but not when it is combined with 








Figure 7 Mode of action of the three-domain Cry proteins. A: Schematic representation 
of the mechanism of toxicity of the three-domain Cry proteins. B: The two different 
models that explain the mode of action Cry proteins: the sequence binding model and the 
signalling-pathway model. Steps of the sequence binding model: (1) Toxin solubilisation 
in the midgut lumen, (2) Activation by midgut proteases, (3 and 4) Binding to primary 
receptor (cadherin, ABCC2, etc.) and cleavage of helix α-1 and trigger the toxin 
oligomerization, (5) The toxin oligomer then binds to a secondary receptor, such as 
aminopeptidase or alkaline phosphatase, (6) Toxin insertion into the membrane of the 
insect cells. Regarding the signalling-pathway model proposes that the interaction of the 
Cry toxin (monomer or oligomer) with the primary receptor activate an intracellular 
signalling pathway that is mediated by activation of protein G (4a) which, in a subsequent 
step, activates adenylyl cyclase. This signal then increases the levels of cyclic adenosine 
monophosphate, which activates protein kinase A and leads to cell death (5a). This figure 
has been adapted Pardo-López et al., 2013 (71) and Bravo et al., 2011 (1). 
P20 have a role in the production of the stable parasporal crystal for those Cry proteins 
without C-terminal region such as Cry11A. Also the helper proteins improve the 
production of Cry proteins in acrystalliferous Bt strains and E.coli strains. P20 also 
synergizes with the toxicity of Cry11A against third-instar larvae of Aedes aegypti (3). In 
addition, few unclassified B. thuringiensis toxins, such as Cry6, Cry22, Cry55 and Cry46, 
have been reported. The Cry22 is reported to show four cadherin-like domains and a C-
terminal region with structural similarities to domain III of the three-domain toxins. No 





family within their central regions. The Cry55 and Cry46 proteins have no known 
structural homolog and show no conserved domains (3). 
2.3.2 - Secretable proteins 
Apart from the production of the δ-endotoxins in the parasporal crystal, screening 
programs have been performed with the aim to evaluate active insecticidal components 
in culture supernatants. Different Bacillus spp isolates (B. cereus strain AB78, B. 
thuringiensis strain AB88) were identified that produce a proteinaceous active component 
that causes mortality to Diabrotica virgifera, Agrotis ipsilon and other lepidopteran 
larvae. The proteinaceous active components of the respective Bacillus spp isolates were 
identified as three proteins of 85, 45 and 88 kDa respectively. The B. thuringiensis toxin 
nomenclature named these active components as Vip1, Vip2 and Vip3 (65). It should be 
mentioned that another insecticidal protein has been later reported: the Sip1A protein 
(72). Currently the Sip1A protein is not included in the B. thuringiensis toxin 
nomenclature but can be consider as a vegetative insecticidal protein. 
2.3.2.1 - Vip1 and Vip2 proteins 
The Vip1 and Vip2 proteins act as a binary toxin. The vip1 and vip2 genes are present in 
B. cereus, B. thuringiensis, L. sphaericus and Brevibacillus laterosporus. These two
genes are located in an operon of ~4-kb with two open reading frames separated by an
intergenic space of 4 to 16 bp in the genome sequence or in a megaplasmid (3,65). The
Vip1 and Vip2 proteins are expressed concomitantly and encode an approximately ~100
and ~50-kDa proteins, respectively. They are produced during the vegetative growth
phase of B. thuringiensis, and their levels remain high until after the sporulation stage.
Vip1 and Vip2 contain and N-terminal signal peptide sequences, which for the Vip1
protein is processed after secretion into a smaller ~80-kDa mature protein.
The protein pairs Vip1/Vip2 show toxic activity against some coleopteran larvae and 
Aphis gossypii, but they do not show toxicity against lepidopteran larvae (Table 2). Their 
homology to other bacterial binary toxins suggests that Vip1 and Vip2 form a A+B type 
of binary toxin, where Vip2 is the cytotoxic A-domain and Vip1 the receptor-binding 
domain responsible of the translocation of the cytotoxic Vip2 into the host cell. Vip2 
exhibits sequence and structural homology with the enzymatic domain of toxin CdtA 





possessing ADP-ribosyltransferase activity that targets actin, inducing cytoskeletal 
disorders and cell death (57,65). The mode of action of the Vip1/Vip2 proteins is not 
totally understood (Figure 8). The intoxication process start with the ingestion of the 
toxins by the larva, followed by the proteolytic activation in the midgut. The activated 
Vip1 proteins forms oligomers of seven units of Vip1 molecules. These oligomers 
recognize specific receptors in the midgut brush border membrane, where the toxin is 
then inserted into the membrane. The mechanism by which Vip2 enters the cell is still 
unknown but based on its homology with the C2-I component of the C2 clostridial binary 
toxin, it seems likely that Vip2 enters the cell via receptor-mediated endocytosis (65). 
Leuber et al., 2006 (73) proposed a second possibility, in which the proton gradient across 
the midgut brush border membrane of insect cells could promote the directly delivered 
into the cytoplasm of the Vip2Ac monomers via the channel formed by Vip1Ac. 
Table 2 Insecticidal spectrum of different Vip1/Vip2 protein combinations on different 




Insect species Activity Reference 
Vip1Aa+Vip2Aa Coleoptera 
Diabrotica virgifera +++ 




Vip1Aa+Vip2Ab Coleoptera Diabrotica virgifera +++ Warren 1997 (74) 
Vip1Ac1+Vip2Ae3 Homoptera Aphis gossypii +++ Yu et al.,2011 (75) 
Vip1Ae1+Vip2Ae1 Homoptera Aphis gossypii +++ Sattar et al., 2011 (76) 
88% similarity to 
vip2Ac and vip1Ac Coleoptera Sitophilus zeamais +++ 
Shingote et al., 
2013 (77) 
Vip1Ad1-Vip2Ag1 Coleoptera 
Holotrichia oblita +++ 
Bi et al., 2014 (59) Anomala corpulenta +++ 
Holotrichia parallela +++ 
Vip1Ba1-Vip2Ba1 Coleoptera Diabrotica virgifera +++ Schnepf et al., 2005 (78) 
Vip1Da1-Vip2Ad1 Coleoptera 
Diabrotica virgifera +++ 









Anthonomus grandi +++ 
Vip1Aa2+Vip2Aa2 Coleoptera Diabrotica virgifera +++ Feitelson et al., 2003 (80) 






Figure 8 Mode of action of the binary Vip1/Vip2 toxin. The Vip1 protoxin is processed 
by midgut proteases. The activated toxin (monomer or oligomer) binds to specific 
receptors. Vip2 then binds to the oligomer Vip1 protein and enters the cell either by 
endocytosis of the whole complex or directly through the pore formed by Vip1. Once 
inside the cytosol, Vip2 catalyzes the transfer of the ADP-ribose group from NAD to the 
actin monomers, preventing their polymerization. Adapted from Chakroun et al. (65). 
2.3.2.2 - Sip proteins 
The secreted insecticidal protein, Sip protein, shows toxicity against some coleopteran 
larvae (Table 3). The Sip1Aa protein was initially isolated from the B. thurnigiensis strain 
EG2158, while the Sip1Ab protein was obtained from the B. thurnigiensis strain QZL38. 
These proteins are ~41 kDa proteins with a secretion signal of 30 amino acids. For the 
Sip1Aa protein, it was found that it was N-terminally processed in the first 43 amino acids 
by active proteases present in the culture medium to the toxic core (81). Regarding the 
structure of the Sip proteins, it shows similarity to the 36-kDa Mtx3 mosquitocidal toxin 
and suggests that the toxicity of the Sip1Aa1 protein toxicity may be caused by pore 





Table 3 Activity spectrum of different Vip1/Vip2 protoxin combinations on different 
insect species. The number of “+” symbols indicate the activity level. 
2.3.2.3 - Vip3 proteins 
The Vip3 proteins (Vip3A, Vip3B and Vip3C) are encoded by the vip3 genes that are 
present in strains of B. thuringiensis (82–84). Different strategies for screening new 
vip3 genes have been applied to several B. thuringiensis collections (51,75,76,83–91) 
and, as a result, 65 vip3Aa, 2 vip3Ab, 1 vip3Ac,4 vip3Ad, 1 vip3Ae, 4 vip3Af, 15 
vip3Ag, 2 vip3Ah, 1 vip3Ai, 2 vip3Aj,  2 vip3Ba,3 vip3Bb, 1 vip3Bc and 4 
vip3Ca genes have been reported (http://www.lifesci.sussex.ac.uk/Home/
Neil_Crickmore/Bt/). Interestingly most of the studies carried out on the Vip3 
proteins have been performed with the Vip3A proteins, and hence, little information 
is available about the insecticidal spectrum and mode of action of the Vip3B and 
Vip3C proteins. The vip3 genes (vip3A, vip3B and vip3C) encoded an 
approximately ~85-90 kDa protein that is secreted to the medium and activated by 
the insect midgut proteases to two fragments of 20 kDa and 60 kDa (82–84). The 
activated protein shows toxic activity against a wide range of lepidopteran larvae and 
certain species with less susceptibility to Cry1A proteins (e.g., Agrotis ipsilon, S. exigua 
and Spodoptera frugiperda) (Table 4). 
Several reports have focused on interactions among the Vip3 proteins and Cry proteins 
(mainly Cry1, Cry2 and Cry9). Yu et al. (92) observed synergism between the Vip3Aa 
and Cyt2Aa proteins against Chilo suppressalis and S. exigua, but this protein 
combination was slightly antagonistic against Chilo quinquefasciatus. Dong et al. (93) 
reported synergism between Vip3Aa and Cry9Ca in Plutella xylostella. Bergamasco et 
al. (94) reported synergism between Vip3A and Cry1Ia in S. frugiperda, Spdoptera 
albula, and Spodoptera cosmioides but slight antagonism in Spodoptera eridania. Lemes 
et al. (95) found antagonism for the combination of Cry1Ca and Vip3Aa, Vip3Ae, or 
Vip3Af, and for the combination of Vip3Af with either Cry1Aa or Cry1Ac in Heliothis 
Mining of new insecticidal protein genes plus determination of the insecticidal spectrum and 
mode of action of Bacillus thuringiensis Vip3Ca protein 
Protein Insect order Insect species Activity Reference 
Sip1Aa Coleoptera 
Diabrotica virgifera +++ 
Donovan et al., 2006 
(72)
Dibrotica undecimpunctata +++ 
Leptinotarsa decemlineata +++ 





virescens. Also Vip3Aa and Cry1Ca showed antagonism in S. frugiperda, whereas the 
same combination was synergistic in Diatraea saccharalis. Crialesi-Legori et al. (96) 
described that mixtures of Vip3Aa, Vip3Ae and Vip3Af with Cry1Aa, Cry1Ab, Cry1Ac, 
Cry1Ca and Cry1Ea, tested against Anticarsia gemmatalis and Chrysodeixis includes, 
showed synergistic interactions in most of them. Graser et al. (97) reported an additive 
effect among the Cry1Ab, Vip3Aa20, and Cry1F proteins for Ostrinia nubilalis and S. 
frugiperda. Also, interactions between different Bt-crops (Vip3A: COT102, COT202 and 
COT203, Cry proteins: Cotton lines 02A, 67B, 69D and MON 15985) and their offspring 
demonstrated that the combined activity of different Bt crops expressing different kinds 
of B. thuringiensis proteins produce and additive effect (98,99). The mechanisms 
underlying synergism and antagonism are unknown. For the antagonism between the 
Vip3A and Cry1C proteins, Lemes et al. (95) hypothesized that a physical interaction of 
the two proteins impairs the access of the binding epitopes to the membrane receptor. For 
the synergism, the formation of and hetero-oligomer that increased the ability for 
membrane insertion or pore formation was proposed to explain the synergism between 
Cry1Ac and Cry1Aa (100). In this sense, a recent report demonstrated that the Cry9Aa 
and Vip3A proteins show specific binding between them and that this is a primary and 















Table 4 Insecticidal spectrum of the Vip3 proteins in lepidopteran insect species reported 
in the bibliography. Adapted from Chakroun et al. (65) and Zack et al. (102). 
Protein 
family 











































Agrotis segetum Phthorimaea operculella  
Spodoptera frugiperda Chrysodeixis chalcites 
 
Chrysodeixis includes 
Spodoptera exigua Earias vitella 
Spodoptera albula Pieris brassicae 
Spodoptera eridania Prays oleae Ostrinia nubilalis  
Spodoptera cosmoides Tuta absoluta Helicoverpa armigera 
Spodoptera littoralis Ephestia kuehniella Helicoverpa punctigera 
Spodoptera littura Ectomyelois ceratoniae  
Helicoverpa armigera Chironomus tepperi  
Helicoverpa punctigera Anticarsia gemmatalis Agrotis ipsilon 
Helicoverpa zea Cydia pomonella Chrysodeixis chalcites 
Heliothis virescens Dendrolimus pini Helicoverpa armigera 
Danaus plexippus Lobestria botrana Mamestra brassicae 
Manduca sexta Mamestra brassicae Spodoptera exigua 
Scirpophaga incertulas Plutella xylostella Spodoptera frugiperda 
Bombix mori Chilo partellus Spodoptera littoralis 

















Regarding the mode of action of the Vip3 proteins (mainly Vip3Aa), although the Vip3 
proteins do not share structural homology with the Cry proteins, the toxic action follow 
the same sequence of events (3,65): [1] Ingestion of the Vip3 proteins by the susceptible 
insects. [2] Activation by the midgut proteases and crossing the peritrophic membrane. 
[3] Binding to the specific receptors in the apical membrane of the epithelial midgut cells. 
[4] Pore formation and cell lysis (Figure 9). 
 
 
Figure 9. Proposed mode of action of the Vip3A proteins. The full-length protein is 
proteolytically processed by the midgut juice proteases in the lumen. The activated Vip3 
protein (monomer or tetrameric conformation) crosses the peritrophic membrane and 
enter the extracellular media. The activated monomeric Vip3 protein could oligomerize 
in the extracellular media, binding to the receptor and insert in the cell membrane. 
Alternatively, the activated monomer of the Vip3A protein could cross the peritrophic 
membrane and interact with a binding molecule that trigger the oligomerization and 
insertion of the Vip3Aa in the membrane. Pores are then formed, which lead to the death 
of the cell. The arrows with different colours indicate possible modes of action of the 
Vip3 proteins. This figure has been adapted from Chakroun et al. (65); Kunthic et al. 





(1) Ingestion of the Vip3 proteins by susceptible insects
The behavioural effects of the insect after the ingestion of the Vip3A protein show 
similarities for the ones described for the Cry proteins: feeding cessation, loss of gut 
peristalsis and paralysis of the insect. In addition the analysis of the histopathological 
effects in midgut sections show the lysis of the epithelial cells, release of the cellular 
components to the lumen and finally the disruption of the midgut structure (65). 
(2) Activation by the midgut proteases and crossing the peritrophic membrane
The activation of the Vip3 proteins by the midgut juice produces four main fragments: 
62-66, 45, 33 and 22 kDa (108–111). The 22-kDa fragment is the N-terminal part of the 
protein (from amino acids 1 to 198) while the 62-66 kDa fragment corresponds to the C-
terminal part of the protein (from amino acid 199 to the end of protein). The 45- and 33-
kDa fragments derived from the proteolysis of the C-terminal part of the Vip3 protein 
(82,102,105). The Vip3 proteins, as opposite to the Cry proteins, do not contain a minimal 
fragment that retained the insecticidal activity, as does the N-terminal region of the Cry 
proteins (domains I, II and III). Several studies indicate that the 62-66-kDa fragment is 
the Vip3Aa active fragment, though the incubation of with commercial serine proteases 
or insect midgut juice showed the unstable nature of the 62-66 kDa fragment, which 
started to break down into the 45-, 33-kDa and other small fragments (108,110–112). 
Interestingly, the Vip3 proteins, after the activation by the midgut juice or commercial 
proteases, oligomerize in a tetrameric conformation in which the structure of the protein 
is pH sensitive: at high pH the structure of the tetramer is affected (aggregation in large 
particle size) but not at neutral or acidic pH (the tetrameric conformation is stable) (104). 
Also the 20-kDa fragment produced upon proteolytic processing co-purifies with the 62-
66 kDa fragment, suggesting that, after activation of the full-length protein, the two 
fragments remain together in the tetramer (102–106). In addition, the 22 kDa fragment is 
needed for the formation of the tetramer since the expression of the C-terminal part of the 
Vip3Ab1 and Vip3Bc1 oligomerize in a dimer conformation instead of the tetrameric 
form of the full length protein (102).
The proteolytic activation is not a critical step in the Vip3A insect toxicity and specificity 
since O. nubilalis (non-susceptible insect) midgut juice could process the Vip3 protein 
into the C-terminal and the activated Vip3 protein was toxic when fed to Spodoptera 





differences in mortality disappeared when the trypsin-activated protein was used instead 
of the full- length protein (113–115), whereas this phenomenon has not been observed in 
other insect species (85). 
(3) Binding to the specific receptors in the apical membrane of the epithelial midgut cells
The Vip3A binds to the apical microvilli of the midgut epithelial cells as demonstrated 
by the in vivo immunolocalization studies (111). To determine if the binding of the Vip3A 
protein was specific, binding assays were performed with brush border membrane 
vesicles (BBMVs) of susceptible and non-susceptible insects. The specific binding of the 
Vip3 proteins to the BBMVs from susceptible insects was first shown using biotin-
labelled Vip3A proteins (94,108,109,112,116–119). The quantitative binding analysis 
showed that the binding of the Vip3Aa protein was found to be saturable, mostly 
irreversible, differentially affected by the presence of divalent cations and showed slightly 
lower affinities but higher concentrations of binding sites than the Cry1A and Cry2A 
proteins (111). Regarding the binding of the Vip3A protein to the BBMVs, the 
homologous competition of Vip3A showed that the 62-kDa and the 20-kDa fragments of 
Vip3Aa16 bound to BBMVs, and both fragments were displaced by the addition of non-
labelled protein (111). However, Liu et al. 2011 report that the 62-kDa fragment was able 
to bind to Helicoverpa armigera BBMVs and that the 20-kDa fragment was found in the 
supernatant of the binding reaction mixture. Competition binding assays between the 
Vip3 and Cry proteins demonstrate the absence of shared binding sites. This has been 
shown for Vip3Aa with Cry1Ac, Cry1Ab, Cry1Fa, Cry2Ae, and Cry2Ab and for Vip3Af 
with Cry1Ab and Cry1F (108,110–112,116–118,120). However, a partial competition of 
CryIa for the Vip3Aa binding sites was reported for S. eridiana and for the Cry9Aa and 
Vip3A proteins, which show interaction between them that improve the binding to the 
binding sites of both proteins (94,100). Regarding the competition among proteins of the 
Vip3A family, this has been tested in S. frugiperda where the Vip3Ae, Vip3Af and 
Vip3Ad proteins competed for the Vip3Aa binding sites with no significant differences 
in their binding parameters (111). Interestingly, Pan et al., 2017 (121) reported differences 
in the dissociation constants between the Vip3Aa60 and Vip3Ad5 to S. exigua midguts. 
This fact could be due that both Vip3 proteins share a 79.1 % similarity in the C-terminus. 
With the aim to identify the BBMVs proteins that interact with the Vip3 proteins, ligand 
blot analysis was performed with different Vip3 proteins in different insect species: [1] 





65 kDa protein in Prays oleae and Agrotis segetum. [3] Vip3A bound to proteins of 55 
and 100 kDa proteins in Spodoptera littoralis. [4] Vip3Aa bound to 65 kDa proteins in 
Ephestia kuehniella, S. frugiperda, S. albula, S. cosmioides and S. eridania. [5] Vip3A 
recongized 65 and 130 kDa proteins in Diatraea flavipennella and Elasmopalpus 
lignosellus; and [6] Vip3A bound to 55 and 100 kDa proteins, Vip3Af and Vip3Ae bound 
to 65 kDa in S. littoralis (94,108–110,118,119,122,123). Regarding the identification of 
the receptor of the Vip3Aa protein in the midgut cells, very few studies have been 
performed. Two studies proposed two binding molecules as possible Vip3 receptors: a 48 
kDa protein with homology to tenascins, and the S2 ribosomal protein (124,125). 
Recently Jian et al. (107) described that the Scavenger receptor-C (SR-C) act as a receptor 
in vitro and ex vivo in Sf9 cells. In addition, they showed that downregulation of the SR-
C expression in Sf9 cells and in S. exigua larvae midgut reduced the toxicity of Vip3Aa 
to both systems. Also, the heterologous expression of SR-C in transgenic Drosophila 
melagonaster midgut enhanced the virulence of Vip3Aa to D. melanogaster larvae. 
(4) Pore formation and cell lysis
The Vip3 proteins activated with trypsin or midgut juice have a pore forming activity in 
dissected midguts of M. sexta and planar lipid bilayers, while the full-length Vip3Aa 
protein was unable to form pores (104,122). In addition, the pore-forming ability of 
activated Vip3Aa was also demonstrated by fluorescence quenching using H. armigera 
BBMVs (117). The ion channels formed by the Vip3 proteins were able to destroy the 
transmembrane potential and they were voltage independent and cation selective (122). 
A recent study demonstrated a pH dependence of the activity of the activated Vip3Aa 
protein in the permeabilization of calcein-entrapped liposomes and pore formation. For 
the permeabilization of calcein-entrapped liposomes, the maximum of the calcein release 
was observed at neutral pH. Furthermore, the calcein-release decreased at acidic pH and 
the liposome permeability was lost at pH 10. These results suggest that the membrane 
permeability caused by the activated Vip3A proteins is highly efficient at neutral pH, but 
not at acidic or alkaline pH (104). Regarding the pore formation, this was detected in the 
range of pH 5-8 but not at pH 10. At the range of pH 5-8, the current-voltage signal 
suggests the formation of stable pores, while at acidic pH the pores become unstable. The 
pore size changed as a function of the pH; while at pH 5-6 the size of the pore was 








2.4. - Insect resistance to Vip3 proteins and cross-resistance analysis 
against populations selected for resistance to Cry and Vip3 proteins 
Few cases of laboratory selection in lepidopteran pests to Vip3 proteins have been 
reported. Pickett et al. (126) reported a H. virescens colony that reached a 2,040-fold 
resistance level (Vip3-Sel) to theVip3Aa protein compared to the susceptible population 
(Vip3-Unsel). Resistance ranged from completely autosomal recessive to incompletely 
autosomal dominant depending on the dose, and the results of the bioassays on the 
offspring from the backcrosses of the F1 progeny with the Vip3-Sel indicated that the 
resistance was due to more than one locus (126). Regarding the fitness costs, survival of 
resistant insects was temperature dependent, where the Vip3-Sel colony showed reduced 
survival to adult, hatching, egg viability, mating success and lower intrinsic rate of 
population increase (127). Also the BBMVs of the Vip3-Unsel and Vip3-Sel showed 
similar binding of Vip3A, indicating that the binding alteration is not the basis of 
resistance (128). Barkhade and Thakare (129) reported a S. littura colony that, after 12 
generations, reached a resistant ratio of 285-fold compared to a susceptible colony. This 
Vip3Aa resistant colony showed the lack of two casein-degrading bands (in native 
electrophoresis) and a reduced proteolytic activity (~2- fold) with several protease
substrates.  
Regarding the presence of resistance alleles in field populations, this was addressed with 
four different populations using the F2 screen method (130–132): H. armigera and 
Helicoverpa punctigera in Australia, S. frugiperda in Brazil, and S. frugiperda in USA. 
For the H. armigera and H. punctigera populations, the results indicate that the resistance 
alleles were present in the populations as natural polymorphisms. The frequency of the 
resistance alleles (0.027 and 0.008, respectively) is above the mutation rates normally 
encountered (130). The resistance for both insect populations was due to alleles at the 
same locus, and resistance was found autosomal recessive, most probably conferred by a 
single gene. The Vip3 resistance in the populations of H. armigera and H. puntigera did 
not result in cross- resistance to Cry1Ac or Cry2Ab (Mahon et al., 2012). The Vip3 H. 
armigera resistant colony showed a reduction in the proteolytic activity of the midgut 
proteases and similar binding of Vip3A (Chakroun et al., 2016b), indicating that the 
binding alteration is not the basis of this resistance as described above for the H. virescens 





frequency of resistance alleles (0.0009) was relatively low. The resistance ratio was 
>3200-fold compared to the susceptible strain; the inheritance of Vip3Aa20 resistance 
was autosomal recessive and monogenic. Regarding the fitness cost, the Vip3-resistant 
strain showed an 11% reduction in the survival rate until adult stage and a ∼50% lower 
reproductive rate compared with susceptible strain (Bernandi et al., 2015). For the Vip3 
S. frugiperda resistant colony isolated in the USA, the frequency of resistance alleles 
(0.0048) was relatively low. The resistance ratio in diet and whole-plate bioassays was 
>632-fold relative to the susceptible population. The resistance was found monogenic, 
autosomal, recessive and it did not confer cross-resistance to Cry1F, Cry2Ab2 or Cry2Ae 
proteins. Moreover, Chen et al. (133) reported, for the Vip3 S. frugiperda resistant colony 
isolated in the USA, the presence of recessive fitness cost (reduced pupal weight and 
growth rate), at the individual level, on sorghum, but not in non B. thuringiensis corn, 
cotton and artificial diet. However, at the population level, not fitness costs were detected 
in the different non B. thuringiensis hosts.  
With the aim to improve the pest control and insect resistant management, the evaluation 
of cross-resistance between Cry and Vip3A proteins has been evaluated in several Cry 
and Vip3resistant strains. So far, no significant cross-resistance between these two classes 
of proteins has been described in the Cry or Vip3 resistant strains. Regarding the Cry 
resistant strains, several studies indicated the lack of cross-resistance of the Cry-resistant 
insect populations to the Vip3A proteins. Jackson et al. (134) described the lack of cross-
resistance in three Cry-resistant H. virescens strains (YHD2, resistant to Cry1Ac and 
CXC and KCBhyb, both resistant to Cry1Ac and Cry2Aa2) to the Vip3Aa protein. Fang 
et al. (135) showed the lack of cross-resistance, in a T. ni Cry1Ac-resitant colony, to 
Vip3Ac1 and Vip3Aa1. Anilkumar et al. (136) demonstrated, in a Helicoverpa zea 
Cry1Ac-resistant colony, the lack of cross-resistance against the Vip3Aa protein. Vélez 
et al. (137) showed, in a S. frugiperda Cry1F-resistant colony, the absence of cross-
resistance to Vip3Aa. Welch et al. showed the lack of cross-resistance to Vip3A in the H. 
zea selected against CryAc/MVP II. Qian et al. (138), in a H. armigera Cry1Ac-resistant 
colony, showed the lack of cross-resistance to Vip3A. Horikoshi et al. (139) 
demonstrated, in two colonies of S. frugiperda (Cry1A.105/Cry2Ab2- and 
Cry1A.105/Cry2Ab2/Cry1F-resistant colonies), the lack of cross-resistance to Vip3Aa.. 
Wei et al. showed the lack of cross-resistance in four H. armigera resistant colonies (two 





In the case of the Vip3A resistant strains, some recent studies show the lack of cross-
resistance of the Vip3-resistant insect populations to the Cry proteins. Mahon et al. 
showed the lack of cross-resistance in two Vip3-resistant H. armigera colonies (SP85 and 
SP477) and one Vip3-resistant H. punctigera colony to the Cry1Ac and Cry2Ab proteins. 
Chakroun et al. demonstrated the absence of cross-resistance to the Cry1Ac and Cry2Ab 
proteins in isofemale lines of a Vip3-resistant H. armigera colony derived from the SP85 
colony (Mahon et al., 2012). Horikoshi et al. (139) showed the lack of cross-resistance, 
of two Vip3-resistant S. frugiperda colonies (Vip3A- and Vip3A/Cry1Ab), to several 
Cry-resistant Bt crops (Cry1F, Cry1A.105/Cry2Ab2, Cry1A.105/Cry2Ab2/Cry1F, 
Cry2Ab/Cry1Ac, Cry1Ac/CryF, Cry1Ab/Cry2Ae). Yang et al. (132) showed, in a S. 





2.5. - Host-response to Bacillus thuringiensis proteins in non-model 
insects. 
The ingestion of B. thuringiensis, or its toxins, activates different mechanisms to reduce 
the cellular and tissue damage produced by the B. thuringiensis or its toxins. Little is 
known about the pathways and the genes involved in the response to  B. thuringiensis 
intoxication. Recent reports identified a set of genes involved in the host response to B. 
thuringiensis and its virulence factors (Figure 10): 
(1) Serine proteinases
These proteins are the main digestive enzymes in the gut of the insects. The down-
regulation of several serine proteinases has been observed after the ingestion of B. 
thuringiensis commercial products, as well as individual toxins, in S. exigua and S. 
frugiperda (140–142). Also, in other lepidopteran pests, down-regulation of serine 
proteinases has been reported: Sparks et al. (143) found down-regulation of the 
chymotrypsin-like protease after the infection of Lymantria dispar with B. thuringiensis. 
Vellichirammal et al. (144) found, in O. nubilalis, five transcripts (two coding for trypsin-
like serine proteases and three coding for chymotrypsin- like serine proteases) that were 
down-regulated after Cry1F ingestion. Zhang et al. (145) found, in a Cry1Ab-resitant 
Ostrinia furncalis strain, down-regulation of the trypsin-like and chymotrypsin-like 
proteases. Yao et al. (146) found, in a Cry1Ab-resistant O. nubilalis strain, the down-
regulation of the trypsin-like and chymotrypsin-like proteases. On the contrary, Lei et al. 
(147) found, in two Cry1Ac-resistant P. xylostella strains, the up-regulation of the 
catalytic genes and Song et al. (148) found, in S. litura, that most of the serine proteases 
were up-regulated when larvae were fed with the Vip3Aa toxin.
(2) Antimicrobial peptides
Antimicrobial peptides (AMPs) are small molecular weight proteins able to kill or block 
bacterial growth and have been grouped in four families based on their structures or 
unique sequences: the α-helical peptides (cecropin and moricin), cysteine-rich peptides 
(insect defensin and drosomycin), proline-rich peptides (apidaecin, drosocin, and 
lebocin), and glycine-rich peptides/proteins (attacin and gloverin) (149,150). Two studies 
showed a strong up-regulation of AMPs in the midgut of S. exigua larvae exposed to 







up-regulated. Because these two toxins have different modes of action, the results suggest 
that up-regulation of AMPs was probably associated to the cell damage produced by the 
toxins. In agreement with the role of AMPs in defense against B. thuringiensis, Hwang 
and Kim (152) reported that silencing of gloverin by RNAi in S. exigua increased larval 
susceptibility to B. thuringiensis. Regarding the role of the AMPs in other insect species, 
it has been reported the up-regulation of the AMPs in Galleria mellonella and Tribolium 
castaneum after the intoxication with B. thuringiensis (153–155). 
(3) REPAT proteins
REPAT proteins are midgut specific proteins that participate in the midgut response to B. 
thuringiensis and baculoviruses in Spodoptera spp (156,157). The first members 
(REPAT1 to REPAT4) were found to be strongly up-regulated in response to different B. 
thuringiensis toxins and baculoviruses (156). To date, more than 40 different members 
have been described in S. exigua (140,156,158–160) and many of them have been found 
up-regulated after larval treatment with Cry1Ca, Vip3Aa and B. thuringiensis 
formulations (140,142,159–162). The functions of REPAT proteins are still unknown, 
but their ability to translocate into the cell nucleus has suggested their possible role as 
transcription factors, regulating the response to cellular damage and/or cell differentiation 
(159). 
(4) α-arylphorin
The α-arylphorin has been considered a storage protein produced by the fat body, but 
recent reports show that it can stimulate midgut stem cell proliferation (163–165) and its 
production in the lepidopteran midgut epithelium has also been established (166,167). In 
addition, a new role of the α-arylphorin has been proposed in insect immunity (168,169). 
The increase of arylphorin levels results in midgut hyperplasia (164,170). Arylphorin was 
found to be up-regulated in response to B. thuringiensis formulations and Cry1Ca toxin 
in S. exigua (140), suggesting its possible effect in promoting repair of the midgut 
epithelium after damage produced by B. thuringiensis toxins. Increased levels of 
arylphorin were proposed to sequester Cry1Ac toxin in the gut lumen in H. armigera 
(171). Interestingly, reduction of the ABCC2 expression by RNAi also induced the up-
regulation of arylphorin in the absence of exposure to B. thuringiensis (161). In contrast, 
reduced levels of arylphorin transcripts were detected upon exposure of S. exigua to 





reported discrepancies in the regulation of arylphorin may represent differences in the 
mode of action of Cry versus Vip3Aa toxins and the effect of B. thuringiensis spores 
versus purified proteins on midgut cells. 
(5) Midgut differentiation factor (MDP)
The midgut differentiation factors (MDF1, MDF2, MDF3 and MDF4) are 30 amino acid 
peptides with high identity to the C-terminus of fetuin, isolated from conditioned media 
H. virescens culture cells (MDF1 and MDF2) and chymotryptic digestion of L. dispar
hemolymph (172–175). MDF1 and MDF2 promoted the development of stem cells to
columnar, goblet cells and newly differentiated cells to become cuboidal in shape,
respectively. MDF3 and MDF4 were active in the differentiation of the stem cells to
columnar and goblet cells (175). However, 100% differentiation of Lepidoptera stem cell
cultures has never been observed with these MDFs, suggesting the existence of additional
differentiation factors, including ecdysone, α-arylphorin and insulin-related bombyxin
(163,164,176). The MDF1 peptide has been involved in the midgut healing response to
Cry1Ac in vitro (177). The treatment of H. virescens cell culture with Cry1Ac increase
in the number of immunopositive cells and the insect species treated with  B. thuringiensis
show an up-regulation of the synthesis of an MDF1-like factor and ostensibly directing
increased stem cell differentiation.
(6) Chitin deacetylase
The peritrophic matrix is a dynamic, complex, structure that participates in the 
immobilization of digestive enzymes, actively protecting the gut from parasite invasion 
and intercepting toxins. The major proteins of the peritrophic matrix are chitin 
deacetylase-like and mucin-like proteins, the latter with multiple chitin-binding domains 
that may cross-link chitin fibrils to provide a barrier against abrasive food particles and 
parasites, one of the major functions of the matrix (178). The chitin deacetylase genes 
were found to be among the strongest down-regulated genes after intoxication of S. exigua 
larvae with the Vip3A toxin, baculoviruses and after feeding H. armigera larvae with a 
mixture of spores and crystals from B. thuringiensis (142,179,180). The down-regulation 
of the chitin deacetylase could be explained as a mechanism to decrease peritrophic 
matrix permeability and reduce the amount of toxin passing through the peritrophic 





Figure 10 Model of the response of insect epithelial cells to Bacillus thuringiensis and/or 
its toxins. In the lethal condition, the epithelial cells swell and burst and the midgut tissues 
collapse dealing to the insect death. In the nonlethal condition, the epithelial cells growth 
factors and other factors contribute to the renewal of the columnar cell layer and the 
reduction of the cellular and tissue damage, respectively. This figure has been adapted 
from Tanaka et al. (181), Catagnola et al. (182) and Herrero et al. (183). 
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Identification, quantification, toxicity and mode of action of new insecticidal protein genes 
from Bacillus thuringiensis 
Objectives: 
 
In order to carry out this Doctoral Thesis, we focussed the study mainly on the new protein 
family Vip3Ca: insecticidal spectrum, cross-resistance analysis, mode of action and cell 
death response of S. exigua intoxicated with the Vip3Ca protein. In addition, we 
performed the mining of new B. thuringiensis insecticidal protein genes from selected B. 
thuringiensis isolates based on their gene content. 
 
The study of these general objectives was performed by performing the more specific 
objectives described below: 
 
1. Mining of new insecticidal protein genes and quantification of the new toxins in the 
supernatant and the crystal based in a set of B. thuringiensis isolates selected for their 
gene content 
 
2. Increase the knowledge on the insecticidal spectrum of the Vip3Ca protein and analysis 
of cross-resistance in lepidopteran pests selected for resistance against Cry1, Cry2 and 
Vip3A 
 
3. Determine the mode of action of the Vip3Ca protein in Mamestra brassicae as a model 
susceptible insect 
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4.1. - Contributions made by the PhD student in the publications. 
In the present doctoral thesis, five research studies have been published in journals 
indexed in the main databases, three of them as first author, and the rest as a second 
author. The research studies published are the following: 
1. - Gomis-Cebolla, J.; Ricietto, A.P.S.; Ferré, J. 2018. A Genomic and Proteomic 
Approach to Identify and Quantify the Expressed Bacillus thuringiensis Proteins in the 
Supernatant and Parasporal Crystal. Toxins. Vol 10, Issue 5, p. 193 - 211. 
doi:10.3390/toxins10050193
2. - Gomis-Cebolla, J.; Wang, Y.; Quan, Y.; He, K.; Walsh, T.; James, B.; Downes, S.; 
Kain, W.; Wang, P.; Leonard, K.; Morgan, T.; Oppert, B.; Ferré, J. 2018. Analysis of 
cross-resistance to Vip3 proteins in eight insect colonies, from four insect species, 
selected for resistance to Bacillus thuringiensis insecticidal proteins. Journal of 
Invertebrate Pathology. Vol 155, p. 64 - 70, doi.org/10.1016/j.jip.2018.05.004
3. - Hernández-Martínez, P.; Gomis-Cebolla, J.; Ferré, J.; Escriche, B. 2017. Changes in 
gene expression and apoptotic response in Spodoptera exigua larvae exposed to sublethal 
concentrations of Vip3 insecticidal proteins. Scientific Reports. Vol 7, Article number 
16245, doi:10.1038/s41598-017-16406-1
4. - Gomis-Cebolla, J.; Ruiz de Escudero, I.; Vera-Velasco, N.M.; Hernández-Martínez, 
P.; Hernández-Rodríguez, C.S.; Ceballos, T.; Palma, L.; Escriche, B.; Caballero, P.; 
Ferré, J. 2017. Insecticidal spectrum and mode of action of the Bacillus thuringiensis 
Vip3Ca insecticidal protein. Journal of Invertebrate Pathology. Vol 142, p. 60 - 67, 
doi.org/10.1016/j.jip.2016.10.001
5. - Ricietto, A.P.S.; Gomis-Cebolla, J.; Ferré, J. 2016. Susceptibility of Grapholita 
molesta (Busck, 1916) to formulations of Bacillus thuringiensis, individual toxins and 
their mixtures. Journal of Invertebrate Pathology. Vol 141, p. 1 - 5, 
doi.org/10.1016/j.jip.2016.09.006 
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Regarding the research studies included in the doctoral thesis, one of them was a 
collaboration with a Spanish group from the “Universidad Pública de Navarra” (Gomis-
Cebolla et al., 2017). Regarding the rest of the articles (Ricietto et al., 2016; Hérnandez-
Martínez et al., 2017; Gomis-Cebolla et al., 2017 and Gomis-Cebolla et al., 2018) were 
international collaborations with the following institutions: Universidade Estadual de 
Londrina, Chinese Academy of Agricultural Sciences, Cornell University, 
Commonwealth Scientific and Industrial Research Organisation, and United States 
Department of Agriculture. 
Since the PhD student does not apper as the first author in all the published articles, a 
technical report is provided about the research work performed by the PhD student in the 
articles included in the doctoral thesis. 
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Chapter 1. Identification and quantification of the insecticidal protein genes in Bacillus thuringiensis 
isolates 
Article Authors Gomis-Cebolla, J Ricietto, A.P.S Ferré, J 
A Genomic and proteomic Approach 
to identify and Quantify the Expressed 
Bacillus thuringiensis Proteins in the 
Supernatant and Parasporal Crystal 
Experimental design X X X 
Experiments 
1.-Bacterial Strains and Growth Conditions for 
DNA Analysis X X - 
2.-Genomic DNA Preparation X X - 
3.-Identification of Vip1- and Vip2-Type Genes X X - 
4.-Genome Sequencing, Assembly and Annotation 
Analysis X - - 
5.-Sample Preparation for in Gel Digestion 
LC/MSMS Analysis and Insecticidal Activity of Bt 
Isolates 
X - - 
6.-In Gel Digestion LC/MSMS Analysis X - - 
Protein Identification of the in Gel Digestion 
LC/MSMS Analysis with Paragon Algorithm and 
Mascot 
X - - 
7.-Label Free Analysis of the Concentrated 
Supernatant 24 h vs. 48 h in Both Bt Isolates X - - 
Data analysis X X X 
Writing the article X X X 
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G.T Ferré, J 
Susceptibility of Grapholita 
molesta 
(Busck, 1916) to formulations of 
Bacillus thuringiensis, individual 
toxins and their 
mixtures 
Experimental design X X - X 
Experiments     
1.-Insect rearing and bioassays 
optimization X X - - 
2.-Expression of Cry and Vip3 proteins  X X - - 
3.-Susceptibility of Grapholita molesta to 
Cry and Vip proteins and Bacillus 
thuringiensis commercial products 
X - - - 
4.-Interactions of Vip3Aa with Cry1 
proteins in Grapholita molesta X X - - 
5.-Statistical analysis X X - - 
Data analysis X X - X 
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design X - - - - - - - - - - - X 
Experiments              
1.-Insect rearing of 
the respective pests - X X X X X X X X X X X - 
2.-Expression and 
purification of 
Vip3A and Vip3Ca 
proteins 
X - - - - - - - - - - - - 
3.-Dose-response 





- X X X X X X X X X X X - 
4.-Stadistical 
analysis X X X X - - - X X X X X - 
Data analysis X - - - - - - - - - - - - 
Writing the article X - - - - - - - - - - - X 
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and mode of 






Experimental design X - - X X - - X - X 
Experiments           
1.- Insect colonies X X X X - - - - - - 
2.- Expression and purification 
of Vip3 proteins X X X X - - - - - - 
3.-Insect toxicity assays X - - - - X - - - - 
4.-Midgut juice preparation and 
Vip3 proteins processing X X X X - - - - - - 
5.-Insect toxicity assays of the 
activated Vip3 proteins with 
midgut juice from Mamestra 
brassicae and Ostrinia nubilalis 
- X - - - - - - - - 
6.-Histopathological effects and 
in vivo binding of Vip3 
proteins in Mamestra brassicae 
X - - - - - - - - - 
7.-Vip3 toxins labeling, 
preparation of Mamestra 
brassicae BBMV, and binding 
analyses 
X - - - - - - - - - 
Data analysis X - - - X - X X X - 
Writing the article X - - - - - - - - X 
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Chapter 3. Mode of action of the Vip3Ca insecticidal protein from Bacillus thuringiensis 
 
 
Article   
Authors 
Hernández-Martínez, P Gomis-Cebolla, J Escriche, B Ferré, J 
Changes in gene 
expression and 
apoptotic response in 
Spodoptera exigua 





Experimental design X - X X 
Experiments   
  
1.-Insects rearing  X X - - 
2.-Expression and 
purification of Vip3Aa and 
Vip3Ca proteins 
X X - - 
3.-Growth inhibition assays. - - - - 
4.-Effects on larva 
development after Vip3 
protein exposure 
X X - - 
5.-Gene expression analysis X - - - 
6.-Measurement of 
aminopeptidase activity in the 
midgut lumen 
X - - - 
7.-Sectioning of insect tissues 
and TUNEL staining. X X - - 
Data analysis X X X X 
Writing the article X - - X 
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4.2. - Timeline and workflow of the research work carried out by the 
PhD student. 
 
4.2.1. - Timeline of the research work developed during the doctoral thesis 
 
The present doctoral thesis has been financed by two different projects of the Ministry of 
Economy and Competitiveness. In the first two annuities, the objectives of the 
BABIGEN-CYCIT project were fulfilled (Figure 11), with the following objectives: 
 
1. - Insecticidal spectrum and mode of action of Vip3Ca form B. thuringiensis 
2. - Susceptibility of Grapholita molesta to B. thuringiensis toxins and formulations 
3. - Identification of the vip1 and vip2 genes in selected B. thuringiensis isolates based on 
their gene content 
 
On the other hand, during the last two years, the objectives of the DAMBT project were 
fulfilled (Figure 11) with the following works: 
 
1. - Characterization of the cell death in S. exigua intoxicated with Vip3Aa and Vip3Ca 
proteins 
2. - Analysis of the cross-resistance to Vip3Ca protein in resistant insect colonies selected 
with Cry1, Cry2 and Vip3 proteins 
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Figure 11 Chronology of the research work carried out during the four-year duration of 
the doctoral thesis funded by two different projects of the Ministry of Economy and 
Competitively of the Spanish Government. 
 
4.2.2. - Workflow of the research work developed during the doctoral thesis 
 
The starting point of the present doctoral thesis were the articles from Hernández-
Rodríguez et al. (1) and Palma et al. (2). In Hernández-Rodríguez et al. (1), from a Spanish 
B. thuringiensis collection, a subset of isolates were selected based on their vip1 and vip2 
gene content. In Palma et al. (2), a new Vip3 protein family, Vip3Ca, was discovered in 
four isolates independently and was active against M. brassicae, A. ipsilon, T. ni, etc. (2). 
Based on the results obtained in the previous studies, the workflow of the present doctoral 
thesis used three different approaches: (1) Mining of new insecticidal protein genes, (2) 
toxicity of the Vip3Ca protein and analysis of cross-resistance, (3) mode of action of 
Vip3Ca and host-response of S. exigua intoxicated with Vip3Ca (Figure 12).  Regarding 
the structure of the present thesis, it is based on three different approaches that constitute 
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1. Chapter 1: Identification and quantification of the insecticidal protein genes
in Bacillus thuringiensis isolates
This chapter is focused in the mining of new vip1 and vip2 protein genes in a 
selected set of B. thuringiensis, selected based on their gene content. A set of new 
vip1 and vip2 alleles was discovered and the sequences were deposited in the 
GenBank. In the case of the mining of new insecticidal protein genes, two B. 
thuringiensis isolates were sequenced and their gene content was predicted with 
the Rast Server. Also the protein detection and quantification of the predicted 
insecticidal protein genes was done in the supernatant and crystal by LC-ESI-
MSMS (3). 
2. Chapter 2: Toxicity and Cross-Resistance of the Vip3 proteins to the
lepidopteran insect species
This chapter is focused on enlarging the insecticidal spectrum of Vip3Ca, after 
the report of Palma et al. in 2012, and the analysis of cross-resistance of insect 
populations selected against the Cry1, Cry2 and Vip3 proteins, respectively. The 
insecticidal spectrum of Vip3Ca was increased in 12 new insect species, among 
which O. furnacalis is a very susceptible target for the Vip3Ca protein. Regarding 
the analysis of cross-resistance of insect populations selected with the Cry1, Cry2 
and Vip3 proteins, to the Vip3Ca protein, they were performed in collaboration 
with several laboratories (4–6). For the insect species G. molesta, due the lack of 
data and worldwide distribution of the pest, we decided to write a monographic 
article about the susceptibility to B. thuringiensis. This study was done in 
collaboration with a PhD student from Brazil, in 2015-2016 (4). 
3. Chapter 3: Mode of action of the Vip3Ca protein from Bacillus thuringiensis
This chapter is focused on the determination of the mode of action of the Vip3Ca 
protein and the host-response of S. exigua intoxicated with Vip3Ca. The study of 
the mode of action of the Vip3Ca protein was determined using M. brassicae as a 
susceptible species based on publish data to date. Regarding the host response to 





susceptible species based on publish data to date. Regarding the host response to 
the Vip3Ca protein, we chose S. exigua based on previous works where S. exigua 
was intoxicated with Vip3Aa and a set of genes had been already established that 
responded to the intoxication by the Vip3 proteins (7–9).  In addition, midgut 
sections were stained to determine the presence of apoptosis as a possible 
mechanism that regulate the cell death response (10). 
Figure 12 Workflow of the research work carried out during the four-year duration of the 
PhD period in the research projects BABIGEN-CYCIT and DAMBT-CYCIT. 
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Abstract: The combined analysis of genomic and proteomic data allowed us to determine which
cry and vip genes are present in a Bacillus thuringiensis (Bt) isolate and which ones are being
expressed. Nine Bt isolates were selected from Spanish collections of Bt based on their vip1
and vip2 gene content. As a first step, nine isolates were analyzed by PCR to select those Bt
isolates that contained genes with the lowest similarity to already described vip1 and vip2 genes
(isolates E-SE10.2 and O-V84.2). Two selected isolates were subjected to a combined genomic
and proteomic analysis. The results showed that the Bt isolate E-SE10.2 codifies for two new
vegetative proteins, Vip2Ac-like_1 and Sip1Aa-like_1, that do not show expression differences at
24 h vs. 48 h and are expressed in a low amount. The Bt isolate O-V84.2 codifies for three new
vegetative proteins, Vip4Aa-like_1, Vip4Aa-like_2, and Vip2Ac-like_2, that are marginally expressed.
The Vip4Aa-like_1 protein was two-fold more abundant at 24 h vs. 48 h, while the Vip4Aa-like_2
was detected only at 24 h. For Vip2Ac-like_2, no differences in expression were found at 24 h vs.
48 h. Moreover, the parasporal crystal of the E-SE10.2 isolate contains a single type of crystal protein,
Cry23Aa-like, while the parasporal crystal from O-V84.2 contains three kinds of crystal proteins:
7.0–9.8% weight of Cry45Aa-like proteins, 35–37% weight of Cry32-like proteins and 2.8–4.3% weight
of Cry73-like protein.
Keywords: insect pest control; crop protection; vip proteins; cry proteins
Key Contribution:
• Genomic and proteomic analysis can identify insecticidal proteins genes and quantify their
expressed products.
• The Bt isolates E-SE10.2 and O-V84.2 produce five new Vip-like and Sip-like proteins and eight
new Cry-like proteins
1. Introduction
Bacillus thuringiensis (Bt) is an entomopathogenic bacterium that produces several types of
insecticidal proteins, such as Cry, Cyt, Vip, Sip, Mtx-like, and Bin-like proteins, along with other
virulence factors contributing to its pathogenicity [1,2]. The Vip proteins are a family of proteins
that are secreted during the vegetative growth phase and that have been classified into four groups
according to their sequence homology: Vip1, Vip2, Vip3, and Vip4 [2]. Because of repeated applications
of Bt sprays and the widespread adoption of Bt-crops (transgenic crops protected from insects by
the expression of cry and/or vip3 genes), some insect populations have developed resistance to Bt
Toxins 2018, 10, 193; doi:10.3390/toxins10050193 www.mdpi.com/journal/toxins
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toxins [3–6]. Therefore, in this arms race against insects, it is necessary to explore the potential of
new insecticidal proteins for pest control. A series of approaches have been used for isolating novel
insecticidal protein genes from Bt, such as PCR, which has further evolved into specific applications to
mining new insecticidal genes, such as PCR hybridization, PCR-RFLP, E-PCR and PCRSSCP [7–11].
In addition, the construction of Bt DNA libraries, followed by screening by Western Blotting or a
hybridization-based method, has also been used to detect novel insecticidal protein genes [12–14].
The PCR approaches being used to detect vip genes are based on the presence of conserved blocks
in the DNA sequence of these genes [11,15] and most of the studies have focused on genes from
the vip3 family. Therefore, the PCR approach is limited to finding vip genes with enough homology
to the primers used. An additional problem with the PCR approach is that it does not provide the
full length of the new vip genes. On the other hand, the library-based methods are time-consuming
and laborious. The next generation sequencing (NGS) allows rapid sequencing of entire genomes at
a low cost-effective ratio [16,17]. The number of Bt whole genomes that have been sequenced has
increased quickly in the past decade. To date, 459 Bt strains have been sequenced, with a mean genome
size ranging from 5.3 MB to 6.7 MB and a mean guanine-cytosine content (GC content) between 34%
and 35% (https://www.ncbi.nlm.nih.gov/genome/?term=Bacillus+thuringiensis). The combination
of the low cost NGS with the development of many freeware tools has enabled the rapid detection
of insecticidal protein genes at the genome level. On the other hand, the development of the mass
spectrometry (MS)-based proteomics has enabled the detection of proteins from complex mixtures from
different stages of a microorganism [18]. The combination of the genomic and proteomic approaches is
a very successful approach for validation and correction of predicted genomic coding information in a
wide variety of organisms [18–22].
In this study, the identity of vip genes has been determined in nine Bt isolates which were
candidates to harboring new vip1 and vip2 genes (Vip1 and Vip2 constitute a binary toxin and
their genes are normally located in an operon). Two of these isolates, which were found to carry
vip-type genes with a similarity lower than 45% to already reported genes, were subjected to whole
genome sequencing and to different kinds of proteomic analysis to determine and estimate the relative
abundance of the expressed insecticidal protein genes.
2. Results
2.1. Identification of Vip1-, Vip2-, and Vip4-Type Genes
To identify the specific genes within the vip1 and vip2 gene families, a strategy based on
PCR-Sanger Sequencing was used. A first PCR with “screening primers” was performed to confirm
the presence of vip genes. The results showed that the nine isolates were positive for the presence of a
vip1-type gene, and that seven were positive for the presence of a vip2-type gene (Table 1). Those samples
that gave positive for a determined gene type were subjected to a second PCR with “typing primers” to
narrow down the identity of the gene. The results allowed us to classify the isolates into two types of
isolates containing a vip1–vip2 gene pair: those with a gene pair with high similarity (>95%) to vip2Bb
(KR065728)–vip1Bb (KR065727) (V-J20.2 and V-LE1.1), and those with a gene pair with high similarity
to vip2Ac (KR065726)–vip1Ca (KR065725) (V-V54.26, V-V54.31, E-TE7.43, E-TE16.5 and E-TE18.40).
In addition to these two categories, two isolates were identified to contain just a single vip gene with
low similarity to all reported ones; one had the highest similarity to vip1Bb (E-SE10.2) and the other
had the highest similarity to vip1Da (O-V84.2), which was later shown to belong to the vip4Aa family
(Table 1).
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Table 1. Identification of vip1, vip2 and vip4 genes in selected isolates of Bacillus thuringiensis.
Name of Isolate
Identified with vip1 Primers Identified with vip2 Primers
Similarity (%) ‡ Coverage (%) * Closest Homolog Similarity (%) ‡ Coverage (%) * Closest Homolog
V-J20.2 100 44 vip1Bb1 97 70 vip2Bb1
V-LE1.1 100 40 vip1Bb1 99 72 vip2Bb1
V-V54.26 99 49 vip1Ca1 99 71 vip2Ac1
V-V54.31 100 49 vip1Ca1 98 73 vip2Ac1
E-SE10.2 62 30 vip1Bb3 No DNA amplification
E-TE7.43 100 49 vip1Ca1 99 64 vip2Ac1
E-TE16.5 98 43 vip1Ca1 98 73 vip2Ac1
E-TE18.40 100 30 vip1Ca1 100 45 vip2Ac1
O-V84.2 40 40 vip4Aa1 No DNA amplification
* The coverage values represent the mean of two replicates of the typing or screening PCR products to the full
sequence length of the respective vip1, vip2 and vip4 genes deposited in GenBank. ‡ The similarity values provided
by BlastX (NCBI) represent the mean value of the in silico translation of two replicates of the PCR products.
2.2. Genome Sequencing of the Bt Isolates E-SE10.2 and O-V84.2, Contig Assembly and Gene Annotation
Whole genome sequencing of the Bt isolates E-SE10.2 and O-V84.2 resulted in 10,401,436 high
quality reads for the Bt isolate E-SE10.2 and 9,210,116 high quality reads for the Bt isolate O-V84.2,
with an average length of 150 bp for both Bt isolates. For the E-SE10.2 isolate, the 97.4% of the reads
were assembled in 222 scaffolds while for the O-V84.2 isolate the 98.2% of the reads were assembled
in 249 scaffolds. For the E-SE10.2 isolate, the results of the assembled paired reads were as follows:
genome size of 6.1 Mb, N50 was 71 kb, the GC content 36%, and the longest scaffold length was
258 kb. For the O-V84.2 isolate, the genome size was 6.3 Mb, N50 was 123 kb, the GC content 36%,
and the longest scaffold length was 336 kb. Coding sequence prediction of the assembled reads showed
that the 222 scaffolds of the E-SE10.2 isolate defined 6156 coding sequences (CDS) and that the 249
scaffolds of the O-V84.2 isolate defined 6457 CDS. For both isolates, the CDS represented the 79% of
the length of the bacterial genome, and contained 71.5% of annotated genes, 28.5% of hypothetical
genes, and 60–68 tRNAs (Table 2). In addition, for both isolates, 60% of the CDS could be associated
to a subsystem category, being more abundant the ones associated with amino acids and derivatives,
carbohydrates, protein metabolism, and cofactors, prostetic groups and pigments, in decreasing order
(Figure S1).




Gene Content Length (Mb) Gene Content Length (Mb)
Genome Content * 6216 6.1 6525 6.3
Coding sequences ‡ 6156 (99%) 4.8 6457 (98.9%) 5
Annotated genes 4398 (70%) 4.05 4615 (71.4%) 4.21
Hypothetical genes 1758 (28.2%) 0.75 1842 (28.2%) 0.79
Predicted insecticidal genes § 6 0.002 18 0.4
tRNAs 60 0.004 68 0.005
* The gene content values refer the total of predicted sequences (Coding sequences and tRNAs) predicted by
the Rast server. ‡ The coding sequences values refer to the total predicted sequences (protein encoding genes
and rRNA). The annotated genes refer to the predicted sequences that were included in subsystem category,
while the hypothetical genes refer to the predicted sequences that were not included in any subsystem category.
The percentage of coding sequences was calculated by dividing the values of the coding sequences, annotated genes
and hypothetical genes, by the value of genome content. § The predicted insecticidal genes refer to the coding
sequences that report similarity to the homemade Bt database at amino acid level (BlastX).
Regarding the insecticidal protein genes present in the Bt isolates E-SE10.2 and O-V84.2, the results
indicated a total of 24 coding sequences (6 in E-SE10.2 and 18 in O-V84.2) (Table 3). For the Bt isolate
E-SE10.2, four out of the six sequences showed homology to a vip gene, one to a sip gene and one to a
cry gene (Table 3). In the case of the Bt isolate O-V84.2, 10 out of the 18 sequences showed homology to
a vip gene, one to a sip gene and seven to a cry gene (Table 3).
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Table 3. Insecticidal genes of the E-SE10.2 and O-V84.2 isolates predicted by Glimmer v2 software and
filtered against a customized Bt protein database and then with the non-redundant database (NCBI).
Sample Gene Identity ‡ Closest Homolog * Similarity (%) Coverage (%)
E-SE10.2
vip1Ad-like_1 AGC08395.1 55 24
vip1Bb-like_1 AAR40282.1 61 99
vip2Aa-like 1QS1_A 41 23
vip2Ac-like_1 AAO86513.1 30 30
sip1Aa-like_1 ABC71340.1 75 98
cry23Aa-like AAF76375.1 75 98
O-V84.2
vip1Ad-like_2 AGC08395.1 26 34
vip1Ba-like AAR40886.1 28 30
vip1Da-like CAI40767.1 37 12
vip2Ac-like_2 AAO86513.1 33 47
vip2Ac-like_3 AAO86513.1 37 41
vip2Bb-like AKI69695.1 30 43
vip4Aa1-like_1 AEB52299.1 40 80
vip4Aa1-like_2 AEB52299.1 40 83
vip4Aa-like_3 AEB52299.1 49 94
vip4Aa-like_4 AEB52299.1 52 97
sip1Aa-like_3 ABC71340.1 32 33
cry45Aa-like_1 BAD22577.1 61 100
cry45Aa-like_2 BAD22577.1 69 99
cry45Aa-like_3 BAD22577.1 68 85
cry32Ea-like ADK66923.1 47 98
cry32Eb-like AGU13828.1 51 41
cry32Da-like BAB78603.1 40 98
cry73Aa-like AEH76822.1 88 80
‡ The genes predicted by the gene prediction software were named based on the homologous gene in the database
that showed more identity and coverage in the BlastX. * Access number of the gene that showed the highest identity
in the protein database considered in the analysis.
2.3. Global Analysis of the Proteins Identified by in Gel Digestion LC/MSMS Analysis of the Bt Isolates
E-SE10.2 and O-V84.2
To determine the proteins that are being expressed in the Bt isolates E-SE10.2 and O-V84.2,
an LC/MSMS analysis was done. By this method, we first screened the protein content in the
concentrated supernatants and in the parasporal crystals at three growth phases, two during the log
phase of growth (Phase T1 at 24 h and Phase T2 at 48 h), and one in the stationary phase when the
crystal is formed (Phase T3 at 72 h). In the concentrated supernatant at Phase T1, 627 and 225 proteins
were identified for E-SE10.2 and O-V84.2, respectively, while, at Phase T2, the number of proteins
identified were 637 and 530, respectively. In the case of the proteins identified in the solubilized crystal
(Phase T3), the numbers were 512 and 185, respectively. A total of 1791 and 940, respectively, were
identified considering the three growth phases together and this represents about the 29.03% and
14.55% of the respective predicted proteins from the genomic data for the Bt isolates E-SE10.2 and
O-V84.2. The pairwise comparison of the identified proteins at the T1, T2 and T3 growth phases
showed that the shared expressed proteins of the T1-T2, T2-T3, and T1-T3 phases were 406 and 160,
221 and 73, 219 and 33, respectively, for the Bt isolates E-SE10.2 and O-V84.2. The identified proteins of
Bt isolates E-SE10.2 and O-V84.2 at the three growth phases were classified according to their gene
ontology (GO) terms (Figure S2).
2.4. Protein Identification of the Expressed Predicted Putative Insecticidal Protein Genes
To determine if the predicted insecticidal protein genes are being expressed, the protein expression
was assessed by proteomic analysis. We considered a positive identification only those proteins that
were identified with both Protein Pilot v4.5 and Mascot algorithms in at least two of the replicates.
Considering the two isolates together, we found a total of five secretable proteins (Vip-like and Sip-like)
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and eight crystal proteins (Cry-like and Mtx-like) (Table 4 and Tables S1–S3). For the E-SE10.2 isolate,
only three out of the six putative insecticidal protein genes automatically annotated were found to
be expressed (Table 3), and 10 out of 18, in the case of the O-V84.2 isolate (the seven Cry proteins,
the Vip2Ac-like_2 protein, and the two Vip4-like proteins). Regarding the Vip2Ac-like_3 protein,
it was detected just in one replicate with Mascot (Table 4 and Table S3) and the Sip1Aa-like_2 protein
was detected in two replicates, but in one of them only with Mascot (Table 4, Tables S1 and S3) and,
therefore, the Vip2Ac-like_3 and Sip1Aa-like_2 proteins were not considered a positive identification.
According to the similarity to the closest homolog, the Vip2Ac-like, Vip4Aa-like, Cry32Aa-like and
Sip1Aa-like_2 proteins could be considered new Bt-like proteins (different to Cry, Vip or Sip because of a
similarity lower than 45%). Regarding the Cry45Aa-like, Cry73Aa-like, Cry23Aa-like and Sip1Aa-like-1
proteins, according to the similarity to the closest homolog (between 45% and 75%), they could be
considered new protein families of their respective reference proteins (e.g., with a different number)
(Table 3). Regarding the subcellular localization of the putative insecticidal proteins, we performed
an LC/MSMS analysis with the concentrated culture supernatants and with the solubilized crystal
proteins (Table 4). In the supernatant of the culture broth, we could detect at 24 h and 48 h the
Vip2Ac-like_1, Sip1Aa-like_1 and Cry23Aa-like proteins in the Bt isolate E-SE10.2. For the Bt isolate
O-V84.2, we detected Vip4Aa-like_1, Vip4Aa-like_2 and Vip2Ac-like_2 proteins at 24 h, whereas,
at 48 h, we detected Vip4Aa-like_1 and Vip2Ac-like_2 proteins (Table 4). In the fraction of solubilized
crystal proteins, we detected the Cry23Aa-like protein in the Bt isolate E-SE10.2, while, for the Bt
isolate O-V84.2, we detected the Cry45Aa-like_1, Cry45Aa-like_2, Cry45Aa-like_3, Cry32Ea-like,
Cry32Eb-like, Cry32Da-like and Cry73Aa-like proteins. The putative insecticidal proteins identified in
the supernatant and solubilized crystal agree with the prediction of the SignalIP server 4.0, except for
the Cry23Aa-like protein which has been found in the supernatant and in the crystal even though it
does not contain signal peptide to be exported out of the cell (Table 4).
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Table 4. Identification of expressed proteins from the identified putative insecticidal protein genes in the concentrated supernatant and in the solubilized proteins
from the spore/crystal mixture of the Bt isolates E-SE10.2 and O-V84.2 by in gel digestion LC/MSMS analysis *.
Sample Protein Identity Mass Protein (kDa) SignalIP Server 4.1
Supernatant (LB) Spore/Crystal Mixture (CCY)
24 h 48 h 72 h
Rep. 1 Rep. 2 Rep. 3 Rep. 1 Rep. 2 Rep. 3 Rep. 1 Rep. 2 Rep. 3
E-SE10.2
Vip2Ac-like_1 51.6 Yes +/+ +/+ +/+ +/+ +/+ +/+ −/− −/− −/−
Sip1Aa-like_1 40.7 Yes +/+ +/+ +/+ +/+ +/+ +/+ −/− −/− −/−
Cry23Aa-like 29.3 No +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+ +/+
O-V84.2
Vip4Aa-like_1 97.5 Yes +/+ +/+ +/+ +/+ +/+ +/+ −/− −/− −/−
Vip2Ac-like_2 80.79 Yes +/+ +/+ +/+ −/+ +/+ +/+ −/− −/− −/−
Vip4Aa-like_2 87.5 Yes +/+ +/+ −/+ −/− −/− −/− −/− −/− −/−
Vip2Ac-like_3 23.2 Yes −/− −/+ −/− −/− −/− −/− −/− −/− −/−
Sip1Aa-like_2 38.7 Yes −/− −/+ +/+ −/− −/− −/− −/− −/− −/−
Cry45Aa-like_1 30.6 No −/− −/− −/− −/− −/− −/− +/+ +/+ +/+
Cry45Aa-like_2 29.3 No −/− −/− −/− −/− −/− −/− +/+ +/+ +/+
Cry45Aa-like_3 25.6 No −/− −/− −/− −/− −/− −/− +/+ +/+ +/+
Cry32Ea-like 151.2 No −/− −/− −/− −/− −/− −/− +/+ +/+ +/+
Cry32Da-like 153.7 No −/− −/− −/− −/− −/− −/− +/+ +/+ +/+
Cry32Eb-like 76.8 No −/− −/− −/− −/− −/− −/− +/+ +/+ +/+
Cry73Aa-like 72.2 No −/− −/− −/− −/− −/− −/− +/+ +/+ +/+
* +/+, the insecticidal protein genes were identified with Protein Pilot (Paragon algorithm) and Mascot; +/−, the insecticidal protein genes were identified with Protein Pilot (Paragon
algorithm) but not with Mascot; −/+, the insecticidal protein genes were identified with Mascot but not Protein Pilot (Paragon algorithm); −/−, the insecticidal protein genes were not
identified with either Protein Pilot (Paragon algorithm) or Mascot.
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2.5. Gene synteny, Conserved Domains and Phylogenetic Analysis of the Expressed Putative Insecticidal
Protein Genes
In the E-SE10.2 isolate, the vip2Ac-like_1 gene was found in an operon together with a
non-expressed vip1Bb-like gene, with the peculiarity that the vip1Bb-like gene was upstream of the
vip2Ac-like_1 (Figure 1), contrary to the general relative location of vip1 and vip2 genes in operons.
The cry32Aa-like gene was found in an operon with a predicted truncated cry37-like gene. In the
O-V84.2 isolate, the genes for the Vip2Ac-like_2, Vip4Aa-like_1, and Vip4Aa-like_2 proteins were
found in operons containing the pairs vip2Ac-like_2–vip4Aa-like_1 and vip2Ac-like_3–vip4Aa-like_2
(Figure 1). Regarding the cry genes of this isolate, they were found in different scaffolds with different
transcription origins (Figure 1).
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which are typical of the three-domain Cry proteins. The cry32Eb-like gene showed low similarity to the
other two cry32-like genes (61% amino acid similarity to cry32Ea-like and 64% amino acid similarity
to cry32Da-like) and did not show any conserved domains. The cry73Aa-like gene also showed the
predicted conserved domains Endotoxin_N, Endotoxin_M, and Delta_Endotoxin_C.
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2.6. Relative Abundance of the Putative Insecticidal Proteins in the Supernatant and in the Crystal of the Bt
Isolates E-SE10.2 and O-V84.2
To determine the relative abundance of the putative insecticidal protein genes in the supernatants
and crystals of th Bt isolates E-SE10.2 d O-V84.2, we perform d two ty es of analyses: first,
an emPAI analysis to de ermine the relative abundance within a same replicate at a given time (Table 5
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and Table S3); and, second, a label free analysis to compare between different times in the log phase
(T1 vs. T2) (Table 6 and Table S4). The results showed that the putative vegetative insecticidal proteins
were minimally expressed in the supernatant of both Bt isolates, being the most abundant protein
flagellin FlaA (Table 5). In the Bt isolate E-SE10.2, among the putative insecticidal proteins found in the
supernatant, the most abundant in all replicates was the Cry23Aa-like protein. In contrast, for O-V84.2,
all secretable proteins were similarly represented (Table 5). Regarding the relative abundance of the
proteins in the solubilized crystals, the crystal of E-SE10.2 contained only the Cry23Aa-like protein.
In the case of O-V84.2, the percent weight corresponding to Cry proteins was close to the 50% of the
solubilized proteins from the crystal (Table 5), being the most abundant, by far, the Cry32Ea-like protein.
To be able to compare the expression level of the proteins between 24 h and 48 h, a label free
analysis was performed (Table 6 and Table S4). Only the putative insecticidal proteins Vip4Aa-like_1
and Vip4Aa-like_2, from the Bt isolate O-V84.2, showed significant differences at the two growth
phases (Tables 5 and 6). The former increased two-fold at 48 h compared to 24 h (Table 6), and the
latter was only found at 24 h but not at 48 h (Table 5). The other proteins found in the supernatant did
not show statistical differences in their production at 24 h vs. 48 h.
Table 5. Estimation of the relative production expressed as weight percentage of the insecticidal protein
genes in the supernatant and solubilized proteins from the spore and crystal mixtures of the Bt isolates
E-SE10.2 and O-V84.2 identified with Mascot.
Supernatant
24 h (% Weight) 48 h (% Weight)
R1 R2 R3 R1 R2 R3
E-SE10.2
Non Secretable toxins 98.56 99.06 99.36 97.87 99.26 99.63
Flagellin protein FlaA 55.21 73.82 87.19 39.75 36.04 43.19
Secretable toxins 1.44 0.94 0.64 2.13 0.74 0.37
Vip2Ac-like_1 0.09 0.06 0.03 0.09 0.10 0.06
Sip1A-like_1 0.09 0.03 0.02 0.06 0.08 0.02
Cry23Aa-like * 1.26 0.85 0.59 1.98 0.56 0.29
O-V84.2
Non Secretable toxins 99.99 99.99 99.99 99.99 99.99 99.99
Flagellin protein FlaA 99.20 99.37 98.35 84.14 99.15 88.35
Secretable toxins 0.0032 0.0012 0.0030 0.0111 0.00007 0.0075
Vip4Aa-like_1 0.0014 0.0008 0.0016 0.0019 0.00004 0.0029
Vip4Aa-like_2 0.0005 0.0001 0.0002 - - -
Vip2Ac-like_2 0.0013 0.0002 0.0010 0.0092 0.00003 0.0046
Crystal
72 h (% Weight)
R1 R2 R3
E-SE10.2
Non-crystal toxins 69.52 95.26 97.51
Crystal toxins 30.48 4.74 2.49
Cry23A-like 30.48 4.74 2.49
O-V84.2
Non-crystal toxins 52.86 51.12 53.25
Crystal toxins 47.14 48.88 46.75
Cry45Aa-like_1 2.82 2.46 1.41
Cry45Aa-like_2 3.05 2.03 3.38
Cry45Aa-like_3 1.88 5.29 2.20
Cry32Ea-like 24.30 25.06 25.89
Cry32Da-like 6.10 5.40 4.60
Cry32Eb-like 6.20 4.46 5.02
Cry73Aa-like 2.79 4.18 4.25
* The Cry23Aa-like protein was detected in the supernatant and the crystal of the Bt isolate E-SE10.2, but, according
to the prediction of the SignalIP server 4.1, it is most likely not secretable.
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Table 6. Label free analysis of the putative insecticidal protein genes of the Bt isolates E-SE102 and O-V84.2 in the concentrated supernatant at 24 h versus 48 h,
identified with Protein Pilot v4.5.
Bt Isolate Proteins t-Value † p-Value φ
Mean Peaks Area Standard Deviation Peaks Area
Fold Change 24/48 § Status
24 h 48 h 24 h 48 h
E-SE10.2 Vip2Ac-like_1 0.71 0.52 307,838 266,602 54,005 84,577 1.15 No differences
Sip1Aa-like_1 0.89 0.42 110,172 76,938 47,032 44,040 1.43 No differences
Cry23Aa-like * 0.32 0.77 5,796,029 4,858,544 4,951,202 1,257,383 1.19 No differences
O-V84.2 Vip4Aa-like_1 4.07 0.04 134,357 68,825 26,801 7636 1.95 Increased
Vip2Ac-like_2 0.56 0.61 32,544 27,573 13,419 7512 1.18 No differences
† Student’s t-test statistical analysis was performed between the concentrated supernatant at 24 h versus 48 h. φ With a p value lower than 0.05, it was considered that the differences
observed between the concentrated supernatant at 24 h versus 48 h were statistically significant. § The fold change was calculated by dividing the mean value at 24 h by the mean values
at 48 h. * The Cry23Aa-like protein was detected in the supernatant and the crystal of the Bt isolate E-SE10.2, but, according to the prediction of the SignalIP server 4.1, is most likely
not secretable.
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3. Discussion
A screening of Spanish collections of Bt isolates was undertaken to search for novel members of
the Vip family. As a result, nine Bt isolates were selected for harboring new binary insecticidal protein
genes of the vip1/vip2 family [11]. As a first step, the PCR-Sanger Sequencing approach revealed
new alleles of already described vip1 and vip2 genes (vip2Ac2-vip1Ca2 and vip2Bb4-vip1Bb3) and two
sequences with low similarity to the vip1Bb1 (from the Bt isolate E-SE10.2) and vip4Aa1 (from the
Bt isolate O-V84.2) genes. In a second step, the Bt isolates E-SE10.2 and O-V84.2 were subjected to
whole genome sequencing with the Illumina HiSeq-PE150 sequencing platform. Then, the genomes of
E-SE10.2 and O-V84.2 were assembled in 222 and 249 scaffolds codifying for 6156 CDS and 6457 CDS,
respectively. The CDS predicted for both genomes represented close to the 99% of the total number
of genes predicted in the genomes. In addition, from this 99% of the predicted CDS, 28% belonged
to hypothetical genes and 72% to annotated genes by the Rast server. Moreover, the results obtained
from the automated annotation indicated that both Bt genomes had a similar subsystems category
distribution (Figure S1).
The supernatants at 24 h (growth Phase T1) and 48 h (growth Phase T2) and the crystal proteins
(growth Phase T3) of both Bt isolates were also analyzed and annotated with GO terms (Figure S2).
The quantity of the proteins expressed at the three different growth phases for the Bt isolates E-SE10.2
and O-V84.2 were 10.2–3.5% and 10.4–8.2%, 8.3–2.8%, respectively, of their genome encoded sequences.
This low percentage of expressed proteins detected indicates that, in our experimental conditions, we
only detect a small part of the predicted proteins by the genome data prediction, a phenomenon that
has also been found in other studies [21,22]. The low percentage of detected expressed proteins should
not be interpreted as that the rest of the proteins cannot be expressed, since they could do it under
different growth conditions. Considering both isolates together, the number of annotated proteins in
each growth phase, T1, T2 and T3, was 42.3%, 49.8% and 56.9%, respectively. The distribution of the
GO terms over the different growth phases is similar in the Bt isolates E-SE10.2 and O-V84.2 (Figure S2).
The most common and abundant GO terms in all the phases (cellular biosynthetic process, organic
substance biosynthetic process, cellular nitrogen compound metabolic process, and organonitrogen
compound metabolic process) indicate that both Bt isolates metabolize the carbon and nitrogen in
the media to produce all the organic and organonitrogen compounds that they need (Figure S2).
The specific GO term macromolecule metabolic process of the T3 growth phase indicates that both Bt
isolates express proteins of a relatively high molecular mass, such as the Cry-like proteins detected
(Figure S2).
Regarding the predicted insecticidal protein genes in both Bt genomes, we were able
to find some of the predicted gene products: one new couple of binary Vip-like proteins
(Vip2Ac-like_1-Vip4Aa-like_1), two new Vip-like proteins (Vip2Ac-like_1 and Vip4Aa-like_2),
one Sip1A-like protein (Sip1A-like_1), and eight Crystal-like proteins (Cry23A-like, Cry45Aa-like_1,
Cry45Aa-like_2, Cry45Aa-like_3, Cry32Ea-like, Cry32eDa-like, Cry32Eb-like and Cry73Aa-like)
(Table 4). The discrepancies of the protein identification between the replicates can be attributed
to metabolic flow changes in cells during development, resulting from enzyme-related changes
or that some proteins exist with extremely low abundances such that they cannot be detected by
MS. To determine if the detected Bt-like proteins are being secreted or that they form inclusion
bodies, we performed an LC/MSMS analysis with the supernatant (24 h and 48 h) and solubilized
crystal proteins. In the supernatant of both Bt isolates at 24 h, the Vip4Aa-like_1, Vip4Aa-like_2,
Vip2Ac-like_1, Vip2Ac-like_2, and Sip1Aa-like_1 proteins were detected, while at 48 h only
Vip4Aa-like_1, Vip2Ac-like_1, Vip2Ac-like_2, and Sip1Aa-like_1 were detected. Again, the extremely
low abundance of these proteins might be responsible for the differences found at 24 h and 48 h.
Regarding the Vip4Aa-like proteins, this is the first time that there has been demonstrated that they
are expressed and secreted to the medium in the log phase. Regarding the crystal proteins, they were
found in the crystal of both Bt isolates, except for the Cry23Aa-like, which was also found in the
supernatant at 24 h and 48 h. The detection of the Cry23Aa-like protein and sporulation factors (Stage
115
Toxins 2018, 10, 193 12 of 18
V sporulation protein, spore coat protein B, spore coat polysaccharide biosynthesis protein spsB and
spore coat polysaccharide synthesis) in the supernatant at 24 h (and also at 48 h) of the Bt isolate
E-SE10.2 indicates that the cells already started the sporulation process.
The relative abundance of the Bt-like proteins was estimated in the supernatant and the parasporal
crystal in both Bt isolates. In the supernatant (24 h and 48 h) of both Bt isolates, the Vip-like,
Sip1-like and Cry23Aa-like were marginally expressed. Regarding the crystal proteins in the Bt
isolate O-V84.2, the Cry-like proteins represent around the half of the total crystal weight, while for
the Bt isolate E-SE10.2, the Cry23Aa-like protein represents between 2.5% and 30% of the crystal
weight. The high variability observed in the amount of Cry23Aa-like could be due to the different
replicates are not in the same time point of the sporulation process. The crystal composition of the Bt
isolate O-V84.2 was also determined for those proteins with a percentage of similarity lower than 45%.
The crystal was composed by four kinds of proteins: 7.0–9.8% Cry45-like proteins (Cry45Aa-like_1,
Cry45Aa-like_2 and Cry45Aa-like_3), 30.4–30.5% Cry32-like proteins (Cry32Ea-like and Cry32Da-like),
5.0–6.2% Cry32Eb-like, and 2.8–4.25% Cry73Aa-like, while the Bt isolate E-SE10.2 only produced the
Cry23Aa-like protein.
The expression levels of the Vip-like, Sip1-like and Cry23Aa-like proteins were compared between
24 h and 48 h. The amount of Vip4Aa-like_1 protein was increased two-fold at 24 h vs. 48 h, while the
Vip4Aa-like_2 was only detected at 24 h. As regard to the rest of the proteins (Vip2Ac-like, Sip1A-like,
and Cry23A-like proteins), no differences in expression were observed. These results suggest that the
Vip4Aa-like_2, Vip2A-like and Sip1A-like proteins were expressed at the 24 h while the Vip4Aa-like_1
was expressed later at the end of the 24 h and the beginning of the 48 h periods.
4. Conclusions
In summary, the combined use of the genomic and proteomic data allowed us to determine which
of the identified insecticidal protein genes, present in the Bt isolates E-SE10.2 and O-V84.2, are being
expressed and, if so, at which relative abundance. Considering the two Bt isolates together, we were
able to identify five new insecticidal protein genes that are expressed within the first 24 h, except for
vip4Aa-like_1, which is expressed after the 24 h. In the parasporal crystals, we found nine new crystal
proteins. The spore/crystal mixture of the Bt isolate E-SE10.2 contains solely the Cry23Aa-like protein,
while the crystal of the Bt isolate O-V84.2 contains four kinds of Cry proteins: Cry45-like, Cry32-like,
Cry32Eb-like, and Cry73Aa-like.
5. Materials and Methods
5.1. Bacterial Strains and Growth Conditions for DNA Analysis
Nine Bt isolates from a Spanish collection, known to carry vip1 and vip2 genes, were selected for
this study [11]. For further gene identification of the vip1 and vip2 genes, the Bt isolates were grown
in 4 mL LB medium overnight (ON) at 29 ◦C and 200 rpm. For the whole genome sequencing, only
those Bt isolates with vip1 and vip2 genes with less than 60% similarity to already described vip1 and
vip2 genes were chosen. The isolates were grown in 10 mL LB medium until OD of 0.6 at 29 ◦C and
200 rpm.
5.2. Genomic DNA Preparation
Total genomic DNA used for gene identification (GI) was isolated from a single colony of the
Bt isolates. Cells were collected at 9000× g for 10 min at 4 ◦C and the pellet was washed in 2 mL of
TE buffer (1 M Tris-HCl, 10 mM EDTA, pH 8.0). The pellet was dissolved in 200 µL of TEL buffer
(TE buffer + 4 mg/mL lysozyme) and further incubated at 37 ◦C for 30 min. Then, 400 µL of lysis
solution (0.2 M NaOH, 1% SDS) was added. After gentle mixing, 300 µL of the neutralization buffer
(3 M KAc, pH 5.5) was added and the mixture incubated for 5 min on ice. The mixture was centrifuged
at 14,000× g for 15 min at 4 ◦C and the supernatant was transferred to a new tube. One volume of cold
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100% ethanol was added and the samples kept at −20 ◦C for 16 h. The samples were centrifuged at
14,000× g for 15 min at 4 ◦C and the supernatant was transferred to a new tube and the pellet washed
with 1 mL of cold 70% ethanol. The pellet was dried with the Eppendorf concentrator 5301 for 5 min at
42 ◦C and solubilized in 50 µL of TE buffer. Total genomic DNA, used for whole genome sequencing
(WGS), was purified as described in the manufacturer instructions of the DNeasy Blood & Tissue Kit
Qiagen. The DNA for GI was quantified using Nanodrop 2000 (Thermo Scientific, Waltham, MA,
USA), while for WGS, the DNA was measured with a Qubit Fluorimetrer. In addition, the integrity of
the DNA for GI and WGS was evaluated by agarose gel electrophoresis (1% agarose).
5.3. Identification of Vip1- and Vip2-Type Genes
Identification of vip1 and vip2 genes was performed with primer pairs designed from conserved
regions within the vip1 and vip2 gene families, respectively. A first PCR with “screening primers” [11]
was performed to confirm the presence of vip genes. With the positive samples, a second PCR
was performed with the “typing primers” [11,23] for the identification of the vip1 and vip2 genes.
PCR reactions contained, in a final volume of 25 µL, 100 ng of the DNA template, 0.25 U of Biotools
polymerase (Biotools), 2.5 µL of 10-fold reaction buffer, 10 mM of each dNTPs, and 0.3 µM of the
corresponding primers (vip1sc, vip2sc, vip2 typing [11] or vip1 typing [23]). PCR amplifications were
carried out in an Eppendorf Mastercycler thermal cycler as follows: 5 min denaturation at 95 ◦C,
35 cycles of amplification (1 min denaturation at 94 ◦C, 1 min of annealing at 45 ◦C, and 2 min of
extension at 72 ◦C), and an extra extension step of 10 min at 72 ◦C. To determine the similarity of the
amplified sequences to already described vip1 and vip2 genes, the PCR products obtained with the
“typing primers” (or with the “screening primers” for those samples that did not give amplification with
the “typing primers”) were ligated into the pGEM®-T Easy plasmid (Promega), cloned in Escherichia coli
DH10β, and sequenced. DNA sequence analysis and contig assembly was performed using DNAstar
v5 and NCBI BLAST tools (Blastx) [24].
5.4. Genome Sequencing, Assembly and Annotation Analysis
Genome Sequencing for the Bt isolates E-SE10.2 and O-V84.2 was performed with the Illumina
HiSeq-PE150 sequencing platform (Novogene S.L Hong Kong, China). From the clean reads (without
adapters, low quality, N and duplication) provided by Novogene S.L., first we evaluated the quality of
the data with FastQC software (0.11.5, Babraham Bioinformatics Institute, Cambridge, Cambridgeshire,
United Kingdom, 2016). Then, the reads were assembled with SoapdeNovo2 (kmer size 35 and genome
size 5,600,000 bp) and the gaps were closed with GapCloser (maximum read length 150, overlap 25 bp
and thread number 1) [25]. The assembled reads were annotated with Rast server (Figure S1) and
the coding sequence (CDS) prediction was performed with the Glimmer v2 [26]. First, the predicted
genes were filtered against a customized Bt protein database (https://sourceforge.net/projects/bt-
proteindatabase/files/Btdatabase/) with Blastx (genetic code bacteria and archaea, e-value 0.001 and
word size 6) to select those CDS with homology to the Bt toxins [24]. Next, the putative insecticidal
protein genes were compared against the Non-Redundant database and only the concordant results
along the customized Bt protein database and Non-Redundant database were selected as true positive.
Moreover, for the selected putative insecticidal genes, prediction of conserved domains was carried
out with CD-search [27] and the gene sinteny was determined in the assembled sequences.
5.5. Sample Preparation for in Gel Digestion LC/MSMS Analysis and Insecticidal Activity of Bt Isolates
A single colony of Bt was grown in 100 mL of LB at 29 ◦C for 24 h and 48 h for detection of the
secretable proteins, while for the detection of proteins in the parasporal crystal the culture was grown
in 100 mL of CCY at 29 ◦C until culture sporulation (72 h). The supernatant of Bt was concentrated
by trichloroacetic acid (TCA) precipitation. Briefly, the cells were collected at 6000× g for 15 min
at 4 ◦C and filtered through sterile 0.45 µm cellulose acetate filters (GE Healthcare Life Sciences).
The sample was incubated with 10% TCA (final concentration) and kept at 4 ◦C for 24 h. Then, the
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sample was centrifuged at 16,000× g for 20 min at 4 ◦C. The pellet was washed with 100 mL of
cold acetone (−18 ◦C), centrifuged at 16,000× g for 20 min at 4 ◦C, and let dry at room temperature
for 5 min. The precipitated proteins were solubilized in 50 mM carbonate buffer containing 10 mM
dithiothreitol (pH 11.3) for 48 h, with two buffer changes (Figure S3). Crystals (together with spores)
were separated by centrifugation at 6000× g for 12 min at 4 ◦C. The pellet containing the parasporal
crystals was washed three times with ice cold solution A (1 M NaCl, 5 mM EDTA, 10 mM PMSF, 1%
Triton X-100) and centrifuged at 17,000× g for 12 min at 4 ◦C between washes. The pellet was then
washed three times with ice cold solution B (10 mM KCl) and centrifuged at 24,000× g for 15 min at 4 ◦C.
The crystals in the final pellet were solubilized in 20 mL of 50 mM carbonate buffer containing 10 mM
dithiothreitol (pH 11.3) by incubation at room temperature for 2 h with continuous shaking (Figure S3).
Concentration of the proteins in the supernatant and in the solubilized crystals was estimated with the
Bradford method [28]. The purity of the expressed proteins in the supernatant and the crystal was
analyzed by SDS-PAGE and stained with Coomassie brilliant blue R-250 (Sigma-Aldrich, St. Louis,
MO, USA) (Figure S3).
5.6. In Gel Digestion LC/MSMS Analysis
The detection of the expression of the putative insecticidal proteins was done by LC/MSMS at
the proteomics facility of the SCSIE (Servei Central de Suport a la Investigació Experimental), at the
University of Valencia, Spain. First, a 1D SDS-PAGE (without resolving gel) was performed with 30 µg
of total protein in three replicates of the concentrated supernatant (24 h and 48 h) and solubilized crystal
proteins. The bands were cut out and in gel digested with 500 ng sequencing grade trypsin (Promega).
The digestion was stopped with trifluoroacetic acid (TFA, 1% final concentration). After subjecting
the samples to a double extraction with acetonitrile (ACN), all the peptide solutions were dried in a
rotatory evaporator. Samples were solubilized with 50 µL of 2% ACN, 0.1% TFA. A sample aliquot
of 5 µL was loaded onto a trap column (NanoLC Column, 3 µ C18-CL, 350 µm × 0.5 mm, Eksigent)
and desalted with 0.1% TFA at 3 µL/min for 5 min. The peptides were then loaded onto an analytical
column (LC Column, 3 µ C18-CL, 75 µm × 12 cm, Nikkyo) equilibrated in 5% ACN 0.1% formic
acid (FA). The elution was carried out with a linear gradient of 5–35% B in A for 30 min (A: 0.1%
FA; B: ACN, 0.1% FA) at a flow rate of 0.3 µL/min. Peptides were analyzed in a nanoESI qQTOF
(5600 TripleTOF, ABSCIEX) mass spectrometer. Eluted peptides were ionized applying 2.8 kV to the
spray emitter. Analysis was carried out in a data-dependent mode (DDA). Survey MS1 scans were
acquired from 350 to 1250 m/z for 250 ms. The quadrupole resolution was set to “UNIT” for MS2
experiments, which were acquired 100–1500 m/z for 50 ms in “high sensitivity” mode. The following
switch criteria were used: charge: 2+ to 5+; minimum intensity; 70 counts per second (cps). Up to 25
ions were selected for fragmentation after each survey scan and the collision energy was automatically
selected by the instrument according to the following equation: |CE| = (slope) × (m/z) + (intercept);
Charge (Unknown, 1, 2, 3, 4, 5), Slope (0.0575, 0.0575, 0.0625, 0.0625, 0.0625, 0.0625), Intercept (9, 9, −3,
−3, −6, −6)
5.7. Protein Identification of the in Gel Digestion LC/MSMS Analysis with Paragon Algorithm and Mascot
The MS/MS information of three replicates of the concentrated supernatant (24 h and 48 h) and
solubilized crystal proteins were sent to Paragon algorithm [29] via the Protein Pilot v 4.5 (ABSciex).
Protein Pilot v 4.5 default parameters were used to generate peak list directly from the 5600 TripleTof
Sciex. The Paragon algorithm of Protein Pilot v 4.5 was used to search in a homemade database that
was created combining all the coding sequences predicted by Glimmer v2 software for the Bt isolates
E-SE10.2 and O-V84.2; the new database was named Bt_combined (https://sourceforge.net/projects/
bt-combined/files/Bt_combined/). The search in the respective protein database was done with the
following parameters: trypsin specificity, cys-alkylation, and the search effort set to through. To avoid
using the same spectral evidence in more than one protein, the identified proteins were grouped
based on MS/MS spectra (proteins sharing MS/MS spectra are grouped, regardless of the peptide
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sequence assigned) by the Protein-Pilot Progroup algorithm. A protein group in a Progroup Report
is a set of proteins that share some physical evidence, the formation of protein groups in Pro Group
was guided entirely by observed peptides only and the unobserved regions of protein sequence play
no role in explaining the data (Tables S1 and S2). The protein within each group which can explain
more spectral data is that protein shown as the primary protein of the group. Only the proteins of the
group for which there is individual evidence (unique peptides with enough confidence) are also listed
(Tables S1 and S2). In addition, to support the identification of the Protein Pilot v 4.5 (ABSciex) and
estimate the relative production of the insecticidal proteins in the three replicates of the concentrated
supernatant and solubilized crystal proteins, a series of Mascot MS/MS ion searches with the output of
the 5600 TripleTof Sciex were done with the Bt_combined protein database. The following parameters
were used: MS/MS “ion search”, enzyme “trypsin”, fixed modifications “carbamidomethyl (C)”,
variable modifications “deamidated (NQ) and oxidation (M)”, mass values “monoisotopic”, protein
mass “unrestricted”, peptide mass tolerance “50 ppm”, fragment mass tolerance “0.6 Da”, max miss
cleavages “1”, instrument type “ESI-QUAD-TOF”, number of queries for E-SE10.2 “(Supernatant 24
h: R1 7468, R2 8755, R3 7682; Supernatant 48 h: R1 9, 243, R2 8602, R38,286; Crystal: R1 6779, R2
7173 R3 7790)” and for O-V84.2 “(Supernatant 24 h: R1 3708, R2 4459, R3 3536 Supernatant 48 h: R1
6016, R2 6654, R3 6123; Crystal: R1 5206 R2 5206 R3 4476)”, significance threshold “p-value < 0,05”,
max number of families “auto”, ions score or expect cut-off “20”, and preferred taxonomy “all entries”.
The Exponentially Modified Protein Abundance Index (emPAI) was expressed as molar and weight
percentage [30] (Table 5 and Table S3).
We defined as a true positive all those proteins with homology to the Bt toxins higher than 100 aa
that had been identified with Protein Pilot v4.5 and Mascot in at least two of the replicates. In addition,
for the identified proteins, the functional annotation was performed with the SwissProt Database using
the Blast2GO v5.0 software (Figure S2) [31].
5.8. Label Free Analysis of the Concentrated Supernatant 24 h vs. 48 h in Both Bt Isolates
The data obtained from the 5600 TripleTof Sciex of the concentrated supernatant and solubilized
proteins from the crystal were analyzed by Peak View 1.1 following the parameters: Unused ≥ 1.3,
confidence > 95% and with maximum 50 peptides for protein. For the protein library construction of
the global analysis, a joint search with the Bt_combined protein database was performed with the three
replicates of the concentrated supernatant (24 h and 48 h) and solubilized crystal proteins (Table S5).
In the case of the specific conditions analysis (Supernatant: E-SE10.2 24 h vs. 48 h, and O-V84.2 24 h vs.
48 h), a joint search with the Bt_combined protein database was performed with the three replicates
of the concentrated supernatant (Table S4). The search in the respective analysis was done with the
following parameters: trypsin specificity, cys-alkylation, and the search effort set to through. First,
a global analysis was done to study grouped data analysis and samples distribution. A joined search
with all the samples was performed with the Peak View 1.1 that identified 1816 proteins and the
quantitative data obtained was analyzed with Marker View 1.3. Briefly, for the grouped data analysis,
a PCA analysis was done with the non-normalized area of the peaks and with the area peaks corrected
by the total areas sum. In the case of the samples distribution, a PCA analysis was done with the area
of the peaks corrected by the total areas sum (Table S5). For the specific conditions analysis, a specific
search with Peak View 1.1 was done with the respective samples to study the statistical significant
differences. The quantitative data was analyzed with Marker View 1.3. Prior to data analysis of the
E-SE10.2 24 h vs. 48 h, and O-V84.2 24 h vs. 48 h, we applied a normalization by total areas sum,
and then a grouped data analysis with PCA analysis was done. A student’s t-test statistical analysis
with the concentrated supernatant (E-SE10.2 24 h vs. 48 h, and O-V84.2 24 h vs. 48 h) was performed to
determine the differentially expressed proteins between two experimental conditions with the Marker
View 3.1 software (Table S4).
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Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6651/10/5/193/s1,
Figure S1: Subsystem category distribution of the Bt isolates E-SE10.2 and O-V84.2 by the genome annotation
based on the Rast server. The right pie chart indicates the percentage or predicted encoding genes associated
to at least one subsystem; Figure S2: Functional annotation of the protein identification from the concentrated
supernatants at 24 h and 48 h in LB medium, and of the solubilized proteins from the crystal at 72 h in CCY
medium. The number of sequences that belong to the group are indicated in brackets; Figure S3: SDS-PAGE of
the three replicates of the concentrated supernatants and solubilized proteins from the spore/crystal mixtures
and growth curve of the Bt isolates E-SE10.2 and O-V84.2; Table S1: Protein summary of three replicates of
concentrated supernatants and solubilized proteins from spore/crystal mixtures with Protein Pilot v4.5; Table S2:
Peptide summary of three replicates of concentrated supernatants and solubilized proteins from spore/crystal
mixtures identified with Protein Pilot v4.5; Table S3: Result of the Mascot search in the three replicates of the
concentrated supernatants and solubilized proteins form spore/crystal mixtures; Table S4: Label free analysis at
24 h vs. 48 h of concentrated supernatants of the proteins identified with Protein Pilot v4; Table S5: Protein library
construction and PCA analysis of the joint search with the concentrated supernatants and solubilized proteins
from spore/crystal mixtures identified with Protein Pilot v4.5.
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a b s t r a c t
The Oriental fruit moth, Grapholita molesta (Lepidoptera: Tortricidae), is a major pest of fruit trees world-
wide, such as peach and apple. Bacillus thuringiensis has been shown to be an efficient alternative to syn-
thetic insecticides in the control of many agricultural pests. The objective of this study was to evaluate
the effectiveness of B. thuringiensis individual toxins and their mixtures for the control of G. molesta.
Bioassays were performed with Cry1Aa, Cry1Ac, Cry1Ca, Vip3Aa, Vip3Af and Vip3Ca, as well as with
the commercial products DiPel and XenTari. The most active proteins were Vip3Aa and Cry1Aa, with
LC50 values of 1.8 and 7.5 ng/cm
2, respectively. Vip3Ca was nontoxic to this insect species. Among the
commercial products, DiPel was slightly, but significantly, more toxic than XenTari, with LC50 values
of 13 and 33 ng commercial product/cm2, respectively. Since Vip3A and Cry1 proteins are expressed
together in some insect-resistant crops, we evaluated possible synergistic or antagonistic interactions
among them. The results showed moderate to high antagonism in the combinations of Vip3Aa with
Cry1Aa and Cry1Ca.
 2016 Published by Elsevier Inc.
1. Introduction
Bacillus thuringiensis is an entomopathogenic bacterium that
produces several types of insecticidal proteins, such as Cry, Cyt,
Vip, and Sip proteins, along with other virulence factors contribut-
ing to its pathogenicity. Among them, Cry and Vip3 proteins are the
ones that have been best characterized (Vilas-Bôas et al., 2012;
Palma et al., 2014). Cry proteins are produced during the sporula-
tion phase as parasporal crystals and some of them exhibit a speci-
fic toxic effect to insects belonging to different orders, mainly
Lepidoptera, Coleoptera and Diptera (Schnepf et al., 1998; Ricieto
et al., 2013; Palma et al., 2014). Vip3 proteins are produced during
the vegetative growth and are not concentrated in crystals since
they are secreted to the environment or the culture medium
(Estruch et al., 1996; Chakroun et al., 2016). Vip3 proteins are very
toxic to Lepidoptera (Chakroun et al., 2012; Hernández-Martínez
et al., 2013). The mode of action of Cry proteins involves solubiliza-
tion and activation by gut proteases, recognition and binding to
midgut receptors, pore formation, and cell lysis, finally causing
the death of the insect (Bravo et al., 2007). Vip3 proteins are also
cleaved by midgut proteases and bind to specific receptors in the
insect midgut, which are different from those of Cry proteins
(Chakroun et al., 2016).
Biopesticides based on B. thuringiensis have been used since the
middle of the last century. They are widely used in organic farming
and, compared to chemical insecticides, they have some
advantages since they lack safety periods and are harmless to
non-target organisms, including insect predators and other benefi-
cial insects. On the other hand, due to the low persistence of the
active ingredient in the environment, repeated applications is
common practice. This has led to some outbreaks of resistance to
B. thuringiensis commercial products (Ferré & Van Rie, 2002) and
more recently, to Bt-crops (transgenic crops protected from insects
by the expression of cry or/and vip3 genes) expressing a single Cry
protein (Tabashnik et al., 2009).
Grapholita molesta (Busck, 1916) (Lepidoptera: Tortricidae) is
native from Asia, although it is present in all temperate zones of
Europe, America, Africa and Australia. It is considered a pest of
economic importance around the world since it causes damage
to production of fruits like peaches, nectarines, apricots and apples,
and can be associated with attacks in others crops (Myers et al.,
2007; Piñero and Dorn, 2009; Kirk et al., 2013). Data on the insec-
ticidal activity of B. thuringiensis Cry proteins for the control of
other Tortricidae pests, such as Cydia pomonella and Lobesia
botrana, have been reported (Boncheva et al., 2006; Ruiz de
Escudero et al., 2007). However, despite the fact that formulations
http://dx.doi.org/10.1016/j.jip.2016.09.006
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of B. thuringiensis have been tested in the field and laboratory for
the control of G. molesta (Rama et al., 2001; Monteiro and Souza,
2010), there are no reports on the activity of individual
B. thuringiensis proteins on this pest.
In the present study, we show the effectiveness of B. thuringiensis
bioinsecticides for the control of G. molesta, test the insecticidal
activity of some individual Cry1A and Vip3 proteins, and show an
antagonistic effect in some of their combinations.
2. Materials and methods
2.1. Insects
A colony of G. molesta was established and maintained at the
University of Valencia (Spain), originally obtained from Entomos
AG (Switzerland). Insects were reared on semi-artificial diet
(Guennelon et al., 1981) under controlled conditions of tempera-
ture (25 ± 2 C), humidity (RH 70 ± 10%) and photoperiod (16:8 h
light:dark) (Arioli et al., 2007). The same diet and rearing
conditions were used in the bioassays.
2.2. Cry and Vip3 proteins
Escherichia coli clones carrying plasmids with cry1Aa, cry1Ac and
cry1Ca genes were kindly provided by Ruud de Maagd (Plant
Research International, Wageningen, Netherlands). The vip3Aa16
gene was kindly provided by Slim Tounsi (Centre de Biotecnologie
de Sfax) and vip3Af1 by Jeroen Van Rie (Bayer CropScience, Ghent,
Belgium). The vip3Ca2 gene was isolated from an autochthonous
B. thuringiensis strain (Palma et al., 2012).
Cry proteins were expressed, solubilized and trypsin activated
as described elsewhere (Hernández-Martínez et al., 2008) and
stored frozen in 20 mM Tris, 150 mM NaCl, pH 8.0. IPTG was
used to induce expression of Vip3A proteins from E. coli BL21
cells and Vip3Ca from E. coli WK6 cells. The cells were then cen-
trifuged and resuspended in lysis buffer (20 mM phosphate saline
buffer, pH 8.0 with 3 mg/mL lysozyme, 10 lg/mL DNAse and
100 lM PMSF) and incubated with shaking for 30 min at 37 C.
The cells were lysed by sonication and the supernatant recovered
by centrifugation at 27,000g and filtered through sterile 0.45 lm
and 0.22 lm cellulose acetate filters. The Vip3 proteins were
purified by isoelectric point precipitation (IPP) (Chakroun et al.,
2012) with 0.1 M acetic acid to reach pH 5.5 (Vip3Aa), pH 5.4
(Vip3Af) or pH 5.95 (Vip3Ca). The partially purified Vip3 proteins
were solubilized and stored frozen in 20 mM Tris, 150 mM NaCl,
pH 9.0.
The concentration of Cry1 and Vip3 proteins was estimated by
the Bradford method (Bradford, 1976). The quality of the expressed
proteins was checked by 12% SDS-PAGE with Coomassie brilliant
blue R-250 (Sigma-Aldrich) staining (Fig. 1). Cry1A activated pro-
teins were observed as bands of around 62 kDa and Vip3 protoxins
as bands of approximately 89 kDa.
2.3. Bacillus thuringiensis commercial products
DiPel DF (B. thuringiensis subsp. kurstaki) and XenTari GD
(B. thuringiensis subsp. aizawai) (formulations as wettable gran-
ules) were kindly provided by Kenogard S.A. (Barcelona, Spain).
2.4. Bioassays
Different concentrations of formulations and protein solutions
were dispensed on the diet surface. Prior to the sample application,
the surface of the diet was sterilized under UV light for 10 min. A
volume of 50 lL of each concentration was applied on the surface
of solidified diet (2 cm2 multiwell plates, Bio-Cv-16, C-D
International) and let dry in a flow hood. Once dried, one larva
was transferred to each well using 16 neonates per replicate, with
two replicates per concentration. Preliminary assays were done at
100 and 1000 ng/cm2 for DiPel, XenTari and Cry1 proteins, and
at 2500 ng/cm2 for Vip3 proteins. The larvae mortality was scored
after 7 days.
Dose-response bioassays were performed only for those pro-
teins causing a mortality higher to 90% in the preliminary assays.
At least seven serial dilutions and a control with just buffer were
tested for each protein. Bioassays were carried out in triplicate
with sixteen neonate larvae per replicate (n = 48). Mortality was
scored after 7 days. Only bioassays for which the mortality in the
controls was lower than 12% were considered.
2.5. Statistical analyses
Estimates of LC50 and LC90 were obtained using the POLO-PC
software (LeOra software, Berkeley, CA). LC50 and LC90 values were
considered significantly different if their 95% fiducial limits (FL95)
did not overlap.
Tests for possible synergistic/antagonistic interactions between
Vip3Aa and Cry1 proteins were initially performed at a single con-
centration of each protein. The expected mortality was estimated,
assuming simple independent action, by the formula:
P ¼ 1 ð1 P1Þð1 P2Þ
which is equivalent to equation 11.33 of Finney (1971). P1 and P2
represent the proportions of dead larvae for toxins 1 and 2, respec-
tively. Significance of deviations between the observed and
expected mortality values was determined using Fisher’s exact test
and Chi-square test. A second type of experiment to test for interac-
tions between Vip3Aa and Cry1 proteins was carried out with
dose-response assays in which the proportions of two proteins in
the mixture were close to the ratio between their LC50 values. The
expected LC50 value of the mixture was estimated assuming simple








Fig. 1. SDS-PAGE of Escherichia coli lysates. MM, Molecular Mass Markers ‘‘PINK
Plus Prestained Protein Ladder” (Genedirex); lane 1, Vip3Aa; lane 2, Vip3Af; lane 3
Vip3Ca; lane 4, Cry1Aa; lane 5, Cry1Ac; lane 6 Cry1Ca.
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similar action (Finney, 1971) according to the formula of Tabashnik
(1992), which derives from equation 11.8 from Finney (1971):




where a and b refer to the components the mixture, ra and rb are the
relative proportions of a and b. The ratio of the observed LC50 of the
mixture over the expected LC50(m) is a measure of the antagonism.
An antagonism factor (AF) greater than 1 indicates an antagonistic
interaction. If the ratio is equal to 1 indicates an additive toxicity,
and a value lower than 1 indicates that the interaction is a
synergistic.
3. Results
3.1. Susceptibility of G. molesta to Cry and Vip proteins and
B. thuringiensis commercial products
A first approach to determine whether G. molesta was suscepti-
ble to B. thuringiensis commercial products and their individual
insecticidal proteins consisted on performing bioassays at a high
concentration of the insecticidal samples (Table 1). The two com-
mercial products (DiPel and XenTari) produced high mortality
to G. molesta neonate larvae. Among the Cry1 and Vip3 proteins,
Cry1Aa, Cry1Ac, Cry1Ca, Vip3Aa and Vip3Af showed high toxicity
to G. molesta. In contrast, Vip3Ca was nontoxic.
Response-dose assays were carried out for those samples that
showed highest insecticidal activity. DiPel was slightly more toxic
than XenTari, with significantly lower LC50 and LC90 values
(Table 2). Among the individual proteins, all except Vip3Ca were
very active, with LC50 values between 1.8 ng/cm2 (Vip3Aa) and
57 ng/cm2 (Cry1Ca). Despite significant differences at the LC50
level, no significant differences of activity were found at the LC90
level among the active proteins.
3.2. Interactions of Vip3Aa with Cry1 proteins
Combinations between Vip3Aa and the active Cry1 proteins
were tested to check for synergistic or antagonistic interactions.
The concentrations to use in the mixture were chosen close to their
respective LC50 values. The observed mortality was compared to
the expected mortality assuming no interaction (Table 3). Signifi-
cant antagonistic interactions were found for Vip3Aa-Cry1Aa and
Vip3Aa-Cry1Ca (P < 0.001). No significant interaction was found
for Vip3Aa-Cry1Ac.
The interaction Vip3Aa-Cry1Aa and Vip3Aa-Cry1Ca was investi-
gated in dose-response assays at the 1:1 ratio and at ratios close to
their respective LC50 ratios (LC50 Cry1 to LC50 Vip3 and vice versa).
The results, at the LC50 level, confirmed the antagonism for both
Vip-Cry combinations in the different ratios tested (Table 4).
Table 1
Susceptibility of G. molesta neonates to Cry1 activated toxins, Vip3A protoxins, and B.
thuringiensis commercial products.a
Mortality (%)
100 ngb/cm2 1000 ng/cm2 2500 ng/cm2
Commercial
product
DiPel 100.00 ± 0.00 100.00 ± 0.00
XenTari 80.00 ± 0.11 100.00 ± 0.00
Toxin Cry1Aa 97.00 ± 0.03 100.00 ± 0.00
Cry1Ac 93.00 ± 0.07 96.87 ± 0.03
Cry1Ca 60.00 ± 0.07 100.00 ± 0.00
Protoxin Vip3Aa 100.00 ± 0.00
Vip3Af 94.00 ± 0.00
Vip3Ca 23.00 ± 0.03
a Bioassays were performed with 16 larvae per replicate, with two replicates
(n = 32), and the mortality was scored at 7 days.
b Nanograms of formulated product in the case of the commercial products, and
of solubilized protein in the case of individual proteins.
Table 2
Susceptibility of G. molesta neonates to Cry1 activated toxins and Vip3A protoxins in
dose-response assaysa.
Protein Slope ± SEb LC50 (FL95)c LC90 (FL95)c
Cry1Aa 0.59 ± 0.08 7.5 (2.7–29)a,b 1120 (160–154,000)a
Cry1Ac 1.21 ± 0.12 24 (11–64)b,c 252 (86–2700)a
Cry1Ca 1.13 ± 0.11 57 (30–116)c 780 (310–4000)a
Vip3Aa 0.49 ± 0.77 1.8 (0.5–4.5)a 700 (130–37,000) a
Vip3Af 0.81 ± 0.10 27 (13–86) b, c 1000 (240–20,000) a
Vip3Ca >3600
DiPel 1.75 ± 0.22 13 (9–17) 69 (46–127)
XenTari 1.40 ± 0.14 33 (18–56) 269 (137–818)
a Bioassays were performed with 16 larvae per replicate, with three replicates
(n = 48), and the mortality was scored at 7 days.
b Standard error.
c Values expressed in ng/cm2 with 95% fiducial limits. LC values followed by the
same letter (in the same column) are not significantly different based on the overlap
of FL.
Table 3
Susceptibility of G. molesta to combinations of Vip3Aa and Cry1 proteinsa.






Cry1Aa 5 32 45.8c
Cry1Ac 24 63 50c
Cry1Ca 57 64 50c
Vip3Aa 1.2 37 46.5c
Vip3Aa+Cry1Aa 1.2 + 5 12 57d <0.0001 <0.0001
Vip3Aa+Cry1Ac 1.2 + 24 69 76d 0.80 0.61
Vip3Aa+Cry1Ca 1.2 + 57 42 77d 0.0018 0.0013
a Bioassays were performed with 16 larvae per replicate, with three replicates
(n = 48), and the mortality was scored at 7 days.
b Percentage of death insects due the action the individual toxins and their
mixtures at the dose tested.
c Expected mortality according to the Probit linear regression analysis (Table 2).
d Expected mortality assuming simple independent action calculated with the
11.33 equation (Finney, 1971) using the observed mortality values for each
individual protein.
Table 4
Evaluation antagonism, at the LC50 level, of different mixtures of Vip3Aa and Cry1
proteins to G. molesta larvae.a




Cry1Aa 0:100 0.59 ± 0.08 7.5 (2.7–29.4)
Vip3Aa+Cry1Aa 25:75 1.39 ± 0.14 31 (19–47) 4.2 7.4
50:50 1.86 ± 0.20 71 (52–97) 2.9 24.5
75:25 1.73 ± 0.22 60 (42–85) 2.2 27.0
Vip3Aa 100:0 0.49 ± 0.77 1.8 (0.5–4.5)
Vip3Aa+Cry1Ca 97:3 1.38 ± 0.19 120 (48–288) 1.86 64.5
50:50 1.47 ± 0.15 62 (33–116) 3.49 17.8
3:97 1.57 ± 0.15 364 (250–536) 29.1 12.5
Cry1Ca 0:100 1.13 ± 0.11 57 (30–116)
a Bioassays were performed with 16 larvae per replicate, with three replicates
(n = 48), and the mortality was scored at 7 days.
b The ratios were expressed as percentage between Vip3 and Cry1 proteins in the
mixture.
c Slope ± standard error.
d LC values with 95% fiducial limits.
e Expected mortality considering simple similar action.
f Antagonism factor (calculated as the ratio of the observed LC50 to expected LC50).
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Moreover, the data indicate that the degree of antagonism var-
ied depending on the Vip3 to Cry ratio. For both Cry1 proteins, the
antagonismwas higher when the proportion of Vip3 in the mixture
was higher. This phenomenon is much more evident with Cry1Ca
and Vip3Aa: just a 3% of Cry1Ca in the mixture led to an
AF = 64.5, which represents a reduction in the potency of Vip3Aa
of 67-fold (LC50 of the mixture divided by the LC50 of Vip3Aa pure).
4. Discussion
Despite of B. thuringiensis being the most common biological
agent used in pest control, little has been reported about the con-
trol of G. molesta and only some commercial formulations have
been tested in field and under laboratory conditions. Some authors
have reported contradictory data in relation to field assays. Rama
et al. (2001) tested preparations of B. thuringiensis in Italian farms
and no toxic effect against G. molesta was observed. The authors
justified this result by the small short life of the tested formula-
tions. In contrast, Monteiro and Souza (2010) reported that formu-
lations of B. thuringiensis were able to control this pest to a level
not significantly different to the chemical insecticides. The results
obtained by us clearly show that DiPel and XenTari are very
effective for the control of G. molesta under laboratory conditions.
The results with individual B. thuringiensis proteins showed
that, with the exception of Vip3Ca, the rest were highly active
against this pest. For Cry1 proteins, Cry1Aa was not significantly
different to Cry1Ac at the LC50 level, but when compared to Cry1Ca,
Cry1Aa is 7.6-fold more toxic. At LC90 level, no significant
difference was found among the Cry1 proteins. For Vip3A proteins,
Vip3Aa was 15-fold more toxic than Vip3Af at LC50 level, though
this difference was not observed at the LC90 level.
Toxicity of Cry and Vip3 proteins against other pest species of
the order Tortricidae has already been reported by other authors
(Herrero et al., 2001; Boncheva et al., 2006; Sauka et al., 2007;
Ruiz de Escudero et al., 2007; Li and Bouwer, 2012; Ruiz de
Escudero et al., 2014; Baranek et al., 2015). In those cases, Cry1Aa,
Cry1Ac and Cry1C were toxic, as they are against G. molesta. For
Vip3A proteins, Vip3Aa and Vip3Af are toxic to C. pomonella and
L. botrana, as they are for G. molesta.
Studies on synergism/antagonism between insecticidal proteins
are potentially important in providing evidence of possible unex-
pected effects, not only on the target pest, but on non-target organ-
isms. This has even become a requirement by some regulatory
agencies for safety assessment of GM crops combining different
insecticidal proteins with the same or different mode of action
(Levine et al., 2015). With G. molesta, we have found antagonistic
interactions between Vip3Aa and Cry1Aa or Cry1Ca, though not
between Vip3Aa and Cry1Ac. We have considered evidence of
antagonism when the expected LC50 value did not fall within the
fiducial limits of the observed LC50 value of the mixture. The antag-
onistic effect became more evident as the proportion of Vip3Aa in
the mixture increased and this effect was especially drastic in the
97:3 Vip3Aa:Cry1Ca mixture, with an AF of 64.5 (Table 4). Interac-
tions between Vip3Aa and Cry1 proteins had also been reported in
other insect species. Combinations of Vip3Aa, Vip3Ae and Vip3Af
with Cry1Aa, Cry1Ac and Cry1Ca were found antagonistic in
Heliothis virescens. Furthermore, the combination Vip3Aa-Cry1Ca
showed different results depending on the species tested. For
H. virescens and Spodoptera frugiperda, the interaction was antago-
nistic, whereas, the same combination in Diatraea saccharalis was
synergistic (Lemes et al., 2014). Mixtures of Vip3Aa, Vip3Ae and
Vip3Af with Cry1Aa, Cry1Ab, Cry1Ac, Cry1Ca and Cry1Ea were
tested against Anticarsia gemmatalis and Chrysodeixis includens
and synergistic interactions were found in most of them, especially
the strong synergisim of the combination Vip3Af-Cry1Ab in both
insect species (Crialesi-Legori et al., 2014). A Vip3Aa and Cry1Ia
mixture resulted in a slight antagonism in Spodoptera eridania
while presenting synergism in other three Spodoptera species
(Bergamasco et al., 2013). In trying to explain antagonistic interac-
tions, some authors suggested that the two proteins could form a
complex that would lead to their inactivation (Lemes et al.,
2014). Another speculative explanation would be that antagonism
results from the interaction of both proteins with the same mem-
brane protein, even if they bind to different epitopes (Lemes et al.,
2014). In our study, being that Vip3Aa is much more toxic than
Cry1Ca to G. molesta and as little as 3% of the latter is enough to
decrease the potency of Vip3Aa so dramatically (67-fold), it seems
clear that the Cry protein is blocking some key factor for the
toxicity of Vip3Aa. Despite the fact that the phenomenon of the
antagonistic/synergistic interaction between some Vip3A and
Cry1 proteins seems quite general, the biochemical/physiological
basis have not been searched for yet. Future work is needed to find
out at which level the interactions are taking place (in the lumen,
previously to binding to the membrane, at the binding step, or
further down the toxic process) and, ideally, to pinpoint the
determinants responsible for such interactions.
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A B S T R A C T
Bacillus thuringiensis Vip3 proteins are synthesized and secreted during the vegetative growth phase. They are
activated by gut proteases, recognize and bind to midgut receptors, form pores and lyse cells. We tested the
susceptibility to Vip3Aa and Vip3Ca of Cry1A-, Cry2A-, Dipel- and Vip3-resistant insect colonies from different
species to determine whether resistance to other insecticidal proteins confers cross-resistance to Vip3 proteins.
As expected, the colonies resistant to Cry1A proteins, Dipel (Helicoverpa armigera, Trichoplusia ni, Ostrinia fur-
nacalis and Plodia interpunctella) or Cry2Ab (H. armigera and T. ni) were not cross-resistant to Vip3 proteins. In
contrast, H. armigera colonies resistant to Vip3Aa or Vip3Aa/Cry2Ab showed cross-resistance to the Vip3Ca
protein. Moreover, the Vip3Ca protein was highly toxic to O. furnacalis (LC50 not significantly different from that
of Cry1Ab), whereas the Vip3Aa protein only showed moderate growth inhibition at the highest concentration
tested (100 μg/g of diet). These results extend the cross-resistance studies between Vip3 and Cry proteins, show
for the first time cross-resistance between proteins within the Vip3 subfamily, and points to O. furnacalis as a
target for the Vip3Ca protein.
1. Introduction
Vip3 insecticidal proteins are synthesized by Bacillus thuringiensis
(Bt) during the vegetative growth phase and are active against lepi-
dopteran insects (Chakroun et al., 2016a; Estruch et al., 1996). Vip3
proteins are classified into three protein subfamilies based on their
amino acid sequence identity: Vip3A, Vip3B, and Vip3C (Crickmore
et al., 2013). Most studies on the insecticidal activity of Vip3 proteins
have been performed on the Vip3A protein subfamily, in particular,
with the Vip3Aa protein. Vip3Ca was discovered more recently and
show some toxic effect against some lepidopteran species (Palma et al.,
2012; Gomis-Cebolla et al., 2017). In contrast to Vip3Ca, Vip3A pro-
teins have a broad insecticidal spectrum against lepidopteran pests
(Chakroun et al., 2016a). The fact that the insecticidal spectrum and the
mode of action of the Vip3 proteins differ from that of the Cry1 and
Cry2 proteins, makes Vip3 proteins good candidates to be used in
combinations with Cry proteins in Insect Resistance Management (IRM)
programs.
The mode of action of Vip3 proteins (Vip3A and Vip3C) shares some
similarities to that of the Cry proteins in that they are synthesized in the
form of protoxins, which are further processed by midgut proteases
rendering the active toxin (Estruch et al., 1996; Yu et al., 1997; Lee
et al., 2003; Chakroun et al., 2012; Caccia et al., 2014; Gomis-Cebolla
et al., 2017). The activated toxins bind to specific receptors in the
midgut membrane leading to the disruption of the midgut epithelial
cells and eventual death of the larva. The Vip3 receptors are not shared
by Cry proteins (Lee et al., 2006; Abdelkefi-Mesrati et al., 2009; Sena
et al., 2009; Gouffon et al., 2011; Chakroun et al., 2014; Gomis-Cebolla
et al., 2017). However, it has been recently shown that the Vip3Aa and
Vip3Ca proteins compete for shared binding sites (Gomis-Cebolla et al.,
https://doi.org/10.1016/j.jip.2018.05.004
Received 8 January 2018; Received in revised form 10 May 2018; Accepted 14 May 2018
⁎ Corresponding author at: Departamento de Genética, Facultad de CC. Biológicas, Dr. Moliner 50, 46100-Burjassot, Valencia, Spain.
E-mail address: juan.ferre@uv.es (J. Ferré).
130
2017).
In agriculture worldwide, repeated applications of Bt sprays and
widespread adoption of Bt-crops (transgenic crops protected from in-
sects by the expression of cry or/and vip3 genes) have led to resistance
(Ferré and Van Rie, 2002; Ferré et al., 2008, Tabashnik, 2015;
Tabashnik et al., 2009). Therefore, in this arms race against insects, it is
necessary to keep exploring the potential of new insecticidal proteins
for pest control and, at the same time, to test for their compatibility in
combinations with other proteins in terms of cross-resistance. Although
cross-resistance studies have been performed with Cry1- and Cry2-re-
sistant colonies against Vip3Aa (Jackson et al., 2007; Fang et al., 2007;
Anilkumar et al., 2008; Vélez et al., 2013; Huang et al., 2014; Qian
et al., 2015; Welch et al., 2015; Horikoshi et al., 2016), and with
Vip3Aa-resistant colonies against Cry1A proteins (Mahon et al., 2012;
Chackroun et al., 2016b; Pickett et al., 2017), cross-resistance to
Vip3Ca has never been tested.
In this study, we tested the susceptibility of Cry1-, Cry2- and Dipel-
resistant colonies from four insect species (Trichoplusia ni, Plodia inter-
punctella, Helicoverpa armigera and Ostrinia furnacalis) to the Vip3Aa
and Vip3Ca proteins and compared the results to the non-selected
controls. In addition, we tested two Vip3Aa-resistant colonies from H.
armigera for cross-resistance to Vip3Ca.
2. Materials and methods
2.1. Insect colonies
2.1.1. Insect rearing of T. ni strains
Three T. ni strains were used to examine their response to Vip3Aa
and Vip3Ca. The T. ni Cornell laboratory strain (Wang et al., 2007) was
used as the susceptible control strain. The two resistant strains were a
Cry1Ac-resistant strain, GLEN-Cry1Ac-BCS (Wang et al., 2007), and a
Cry2Ab-resistant strain, GLEN-Cry2Ab-BCS (Song et al., 2015). Both of
the resistant T. ni strains were near-isogenic to the susceptible Cornell
strain and the resistance is fixed (i.e., they were homozygous for the
resistance genes). The T. ni colonies were maintained on artificial diet
without exposure to Bt toxins (Bell et al., 1981).
2.1.2. Insect rearing of H. armigera strains
Five H. armigera strains were used to determine their response to
Vip3Ca. The H. armigera susceptible colony, GR, was used as a control
(Mahon et al., 2007). The H. armigera homozygous resistant colonies
ISOC8, (Cry1Ac), Sp15 (Cry2Ab resistant) and Sp85 (Vip3A resistant)
were established from lab selection (ISOC8) and positive F2 tests in
2002 (Sp15) and 2010, (Sp85) respectively. The H. armigera Cry2Ab/
Vip3A resistant strain was established by reciprocal crosses placing
male pupae from one strain with female pupae from the other in cages
(Walsh et al., 2014). All of the resistant strains were repeatedly out-
crossed to a susceptible colony and reselected with the appropriate
toxin(s). The Cry2Ab resistant line Sp15 carries an ABCA2 transporter
mutation that confers the phenotype (Tay et al., 2015), but the me-
chanism of resistance is unknown for ISOC8 (Cry1Ac) and Sp85
(Vip3A). The rearing methods used to maintain H. armigera were
modified from those described by Teakle and Jensen (1985).
2.1.3. Insect rearing of P. interpunctella strains
Two P. interpunctella strains were used to characterize their response
to Vip3Aa. The P. interpunctella susceptible colony, EP, was obtained
from a grain storage bin and has been maintained in the laboratory on
cracked wheat diet (Oppert et al., 2010). The resistant colony EP-
Dpl500 was selected from the parental EP, with 500mg Dipel (Bt
subspecies kurstaki, strain HD-1) per kg diet, gradually increasing the
dose to 10,000mg/kg, the maintenance dose for this resistant colony.
2.1.4. Insect rearing of O. furnacalis strains
Two strains of O. furnacalis, a Bt susceptible strain and a Cry1Ab-
resistant strain were established in the laboratory. The Bt susceptible
strain was collected from the field and had been reared using standard
rearing techniques without exposure to any insecticide before bioassays
were conducted (Song et al., 1999). The Cry1Ab-resistant strain was
selected from the Bt susceptible strain by exposure to trypsin-activated
Cry1Ab. The Cry1Ab-resistant strain was initially exposed throughout
larval development to Cry1Ab in the artificial diet (2.5 ng of toxin/g
diet). The toxin concentration was increased in succeeding generations
to target 40–70% mortality in the exposed insects. After 51 generations,
larvae were reared on diet containing 400 ng of toxin/g diet. The
Cry1Ab-selected colony had developed> 100-fold resistance to Cry1Ab
after 35 generations (Xu et al., 2010).
2.2. Source and expression of Vip3 proteins for cross-resistance assays
Vip3Aa (NCBI accession No AAW65132) was overexpressed in re-
combinant Escherichia coli BL21 carrying the vip3Aa16 gene (Abdelkefi-
Mersati et al., 2009). The Vip3Ca protein (NCBI accession No
AEE98106) was prepared from recombinant E. coli WK6 carrying the
vip3Ca2 gene (Palma et al., 2012).
The Vip3Aa protein was expressed following the conditions de-
scribed by Chakroun et al., 2012. For the Vip3Ca protein, a single
colony was inoculated in 7ml of LB medium containing 100 μg/ml
ampicillin and grown overnight at 37 °C and 180 rpm. A 1/100 dilution
of the culture in 700ml LB medium containing 100 μg/ml ampicillin
was further incubated at 37 °C and 180 rpm. The culture was induced
with 1mM IPTG at an OD of 0.7 and it was grown overnight at 37 °C
and 200 rpm. Cells were collected at 6000 g for 15min at 4 °C. The
pellet was weighed and suspended in 3ml lysis buffer (PBS, pH 8.0,
containing 3mg/ml lysozyme, 10 μg/ml DNase, and 100 μM PMSF) per
gram of pellet. The sample was incubated at 37 °C for 30min and then
sonicated on ice applying two 1min pulses at 70W at a constant duty
cycle, separated by a 10-s cooling period on ice. Then, the insoluble
material was separated by centrifugation at 16,000 g for 15min at 4 °C
and the soluble cellular fraction sequentially filtered through sterile
0.45 μm and 0.22 μm cellulose acetate filters.
2.3. Purification of Vip3 proteins for cross-resistance assays
Vip3 proteins used for dose-response assays for the T. ni, H. armigera
and O. furnacalis colonies were purified by isoelectric point precipita-
tion (IPP) (Chackroun et al., 2012; Gomis-Cebolla et al., 2017). The pH
of the lysate was lowered with acetic acid to pH 5.5 for Vip3Aa and pH
5.95 for Vip3Ca. The pellets were recovered by centrifugation at
16,000 g for 10min and then dissolved in 20mM Tris, 150mM NaCl,
pH 9, and dialyzed against the same buffer overnight. The Vip3Aa
protein used for dose-response assays for the P. interpunctella colonies
was purified by immobilized metal ion absorption chromatography
(IMAC) on a Hi-Trap chelating HP column (GE Healthcare) charged
with Ni2+ (Fig. 1A) (Chackroun et al., 2012). The purified proteins
were frozen at −80 °C and then lyophilized. The concentration of the
Vip3 proteins purified by IPP was estimated by densitometry after SDS-
PAGE separation. The concentration of the Vip3Aa purified by Hi-Trap
chelating HP column was measured by the method of Bradford
(Bradford et al., 1976). In both methods, bovine serum albumin (BSA)
was used as standard. The purity of the Vip3 proteins was analyzed by
SDS-PAGE (Fig. 1).
2.4. Insect toxicity assays
2.4.1. Dose-response assays for the susceptible and resistant T. ni strains
Examination of T. ni strains for their susceptibilities to Vip3Aa and
Vip3Ca were conducted using the surface contamination method (Kain
et al., 2004). Briefly, an aliquot of 200 μl of Vip3Aa or Vip3Ca solution
was spread on the surface of diet in 30-ml cups (surface area is ap-
proximately 7 cm2) and 10 neonate larvae were placed in each cup that
J. Gomis-Cebolla et al.
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was covered with a lid and placed at 27 °C. Eight concentrations of
Vip3Aa or Vip3Ca in 2-fold serial dilutions from 800 to 6.25 μg/ml and
a non-toxin control were used for each bioassay. Five replicate cups of
larvae (50 larvae in total for each dose) were included for each con-
centration of toxin. Larval mortality and growth inhibition (larval de-
velopmental stage remaining in the first instar) were recorded after
4 days of rearing on diet. The bioassay data were subjected to Probit
analysis using the software POLO, LeOra Software to obtain the LC50
and IC50 of the Vip proteins (Russell et al., 1977).
2.4.2. Dose-response assays for the susceptible and resistant H. armigera
strains
The susceptibility of H. armigera strains to Vip3Aa and Vip3Ca was
conducted using the surface contamination method as follows.
Approximately 300 μl of standard diet was added to straight sided 96
well trays providing 0.567 cm2 of surface area. Once the diet had
cooled, 20 μl of a solution containing an appropriate concentration of
toxin was added and allowed to air dry. One neonate was placed in each
well before it was sealed with a perforated heat-sensitive lid. Trays
were incubated at 25 °C, 60% RH, and 14:10 h light: dark for 8 days. Six
concentrations of Vip3Ca in 2-fold serial dilutions from 20 to 0.625 μg/
cm2 and a non-toxin control were used for each bioassay. A minimum of
three replicate bioassays of larvae (16 larvae in total for each dose)
were included for each concentration of toxin. The numbers of dead and
alive larvae were counted and the data were subjected to Probit
analysis using the software POLO, LeOra Software to obtain the LC50 of
the Vip proteins (Russell et al., 1977). Moreover, the instars of surviving
larvae were recorded to obtain the larval development index (LDI) of
surviving larvae.
=
× + × + × + × + ×LDI nL nL nL nL nL
N
[( 1 1) ( 2 2) ( 3 3) ( 4 4) ( 5 5)]
where nL1, nL2, nL3, nL4 and nL5 are the numbers of alive larvae in
the respective larvae development stage and N refer the total number of
alive larvae. We consider as statistically significant all those LDI values
where the 95% confidence intervals of the mean did not overlap with
another LDI value for the susceptible and resistant population (Cry1Ac-,
Cry2Ab-, Vip3A- and Vip3/Cry2Ab-resistant) of H. armigera.
Confirmation of resistance in the Cry1-, Cry2-, Vip3-, and Vip3/Cry2Ab-
resistant insects at the time of Vip3 bioassays was obtained from single
dose assays at a discriminant dose (Table S1).
2.4.3. Dose-response assays for the susceptible and resistant P.
interpunctella strains
The P. interpunctella strains used in the current study are EP (Dipel-
susceptible) from which EP-Dpl500 was selected with Dipel, and the
parent strain for the Dipel-resistant strain which was selected and
maintained on 10,000mg/kg Dipel (the resistant strain used in this
study). The Dpl500 strain was moderately resistant to Cry1F (18-fold)
and Cry1Ab (over 100-fold), and very resistant to Cry1Ac (> 3000-
Fig. 1. SDS-PAGE of Vip3Aa and Vip3Ca protoxins after partial purification from E. coli extracts. (a) Vip3Aa purified by Hi-Trap chelating HP column charged with
Ni+2. (b) Vip3Aa and Vip3Ca purified by isoelectric point precipitation. M: Molecular Weight Markers (“PINK PlusPrestained Protein Ladder”, from Genedirex). The
arrowhead indicates the band corresponding to the Vip3 protein.
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fold) and Dipel (with no mortality observed at the highest dose) (Table
S2). The bioassays of P. interpunctella strains with Vip3 toxins were
conducted using 4mm round diet disks punched out from a flattened
cereal mixture (Herrero et al., 2001). Briefly, 5 μl of 11 different doses
of Vip3Aa (from 0.1 to 100 μg/4 mm diet disk for Dipel-susceptible
insects, and from 2 to 100 μg/4 mm diet disk for Dipel-resistant insects)
and Vip3Ca (from 2 to 100 μg/4 mm diet disk for Dipel-susceptible
insects, and from 2 to 100 μg/4 mm diet disk for Dipel-resistant insects)
were added to diet disks using a micropipettor, with controls of 5 μl
water only for each replicate. Treated diet disks were placed in 16-well
black assay trays (Frontier Agricultural Sciences, Newark, DE, USA),
and eggs were added to each well (n= 16 individuals per dose, three
independent biological replicates for each toxin and P. interpunctella
strain). Trays were covered with perforated adhesive plastic sheets and
incubated at 28 °C and 75% relative humidity (R.H.) in darkness.
Mortality was recorded at approximately 21 d. Data was analyzed by
Probit analysis using the software POLO, LeOra Software (Russell et al.,
1977) to obtain the LC50 of the Vip proteins, reported in mg of toxin per
4mm (15mg) diet disk.
2.4.4. Dose-response assays for the susceptible and resistant O. furnacalis
strains
The susceptibility of O. furnacalis neonates to Vip3 proteins (Vip3A
and Vip3Ca) was determined in dose-response assays in agar-free semi-
artificial diet (He et al., 2005). Briefly, a single neonate was randomly
transferred into each well of 48-well tray and then covered with a piece
of paper and the lid. Trays were held in a growth chamber for seven
days at 27 °C, 80% RH and a 16:8 h photoperiod. Number of dead larvae
and the weight of larvae surviving per tray were recorded after seven
days of exposure. If a larva had not developed beyond the first instar
and weighed±0.1mg, it would be counted as dead for calculating
practical mortality. Average larval weight of survivors would be used to
determine the larval growth inhibition rate as a function of toxin con-
centration. Bioassays were repeated on two dates with total of 96 larvae
per concentration and included 6–10 concentrations of purified toxin.
Dilutions of Vip3 toxins were prepared in 20mM Tris 150mM NaCl, pH
9. The same buffer was used as a negative control. Bioassay data were
subjected to Probit analysis using the software POLO, LeOra Software
1977 to obtain the LC50 of the Vip proteins (Russell et al., 1977).
Confirmation of resistance in the Cry1Ab-resistant insects at the time of
Vip3 bioassays was obtained from dose-response bioassays with Cry1Ab
(Table S3).
3. Results and discussion
3.1. Cry1A and Dipel-resistant colonies
We first tested the vulnerability of susceptible and Cry1A and Dipel-
resistant colonies (P. interpunctella, T. ni, H. armigera and O. furnacalis)
against Vip3 proteins (Table 1). Previously it was demonstrated in T. ni
that Cry1Ac-resistant strains were not cross-resistant to Vip3A proteins
(Fang et al., 2007), but Vip3Ca had never been tested. Our results show
that Vip3Ca is 5–10-fold less active than Vip3Aa to this insect species
and that Cry1Ac-resistance does not confer cross-resistance to either of
the two Vip3 proteins. However, growth inhibition assays showed that
Cry1Ac-resistant insects were slightly less affected by both Vip3Aa and
Vip3Ca (IC50 around 2-fold higher) compared to the susceptible insects
(Table 2).
P. interpunctella had never been tested for cross-resistance to Vip3
proteins. Although the LC50 for Vip3Aa in the Dipel-resistant strain was
approximately 5-fold higher than that of the Dipel-susceptible strain,
the fiduciary limits were overlapping. Conversely, the Dipel-susceptible
strain was approximately 5-fold less susceptible to Vip3Ca than the
Dipel-resistant strain, but again with overlapping fiduciary limits.
Therefore, cross-resistance to Vip3 proteins was not observed in the two
P. interpunctella strains. In comparing responses of the two Vip3 toxins
to Cry toxins, Dipel-susceptible insects were less susceptible to Vip3
than Cry toxins, whereas Dipel-resistant insects were more susceptible
to Vip3 toxins than Dipel, Cry1F, and Cry1Ac (Table S2).
Lack of cross-resistance to Vip3Aa in Cry1Ac-resistant H. armigera
colony has been previously shown (Mahon et al., 2012; Chackroun
et al., 2016b) and, therefore, only Vip3Ca was used in our study. The
LC50 values for the Cry1Ac-resistant versus susceptible colonies were
statistically different, indicating that resistant insects were 3.3-fold
more susceptible to Vip3Ca. This difference could reflect a cost in the
Cry1Ac-resistant insects which makes them less fit to withstand the
same doses of Vip3Ca. As with P. interpuntella, fitness costs in Cry1Ac-
resistant H. armigera may induce increased susceptibility to other
toxins, such as Vip3Ca. An assay with sublethal doses of Vip3Ca was
performed to test whether the slightly higher mortality produced by
this protein on Cry1Ac-resistant larvae was reflected in the develop-
ment time. As is indicated in Table 3, no significant differences in the
larval development index (LDI) were detected between susceptible and
Cry1Ac-resistant population.
Regarding O. furnacalis, this insect species has never been tested
before against Vip3 proteins. The results of O. furnacalis (both suscep-
tible and Cry1Ab-resistant strains) with Vip3Aa show that this species is
not susceptible to this protein (Table 1). Only at 100 μg/g diet about
50% growth inhibition was observed in the two strains. In contrast,
Vip3Ca was highly active to O. furnacalis larvae from both strains. The
LC50 value of Vip3Ca for the susceptible strain was not significantly
different from that of Cry1Ab (LC50= 0.23 μg/g, FL= 0.17–0.30)
(Table S3). However, because of the different slope values of their re-
spective regression lines (Tables 1 and S2), Vip3Ca has an LC90 value
(LC90= 0.98 μg/g, FL=0.81–1.31) lower than that of Cry1Ab
(LC90= 2.94 μg/g, FL=1.94–2.53), suggesting that the former is more
effective to control this pest than the latter. The small difference (LC50
3.12-fold and LC90 3 fold) between Vip3Ca LC values of the susceptible
and Cry1Ab-resistant insects is statistically different, suggesting that
Cry1Ab-resistance in this strain confers minimum cross-resistance to
Vip3Ca.
3.2. Cry2Ab-resistant colonies
Prior to this study, cross-resistance to Vip3 proteins was not found
in two Cry2A-resistant colonies from Heliothis virescens (Jackson et al.,
2007). In the present study, Cry2Ab-resistant colonies of T. ni and H.
armigera were tested against Vip3 proteins, and the results were com-
pared to their susceptible controls (Table 1). Cry2Ab-resistant T. ni was
not cross-resistant to either of the two Vip3 proteins as measured by
mortality (Table 1) or growth inhibition (Table 2).
Cry2Ab-resistant H. armigera had never been tested for cross-re-
sistance to Vip3 proteins, though lack of cross resistance or genetic
linkage with Cry2Ab-resistance loci had been reported for Vip3Aa-re-
sistant colonies (Mahon et al., 2007; Mahon et al., 2012; Chackroun
et al., 2016b). Similarly to Cry1Ac-resistant H. armigera colony, the
Cry2Ab-resistant insects were slightly more vulnerable (2.3-fold) than
susceptible ones (Table 1). As with Cry1Ac-resistant insects, sublethal
doses of Vip3Ca did not drive differences in larvae development
(Table 3).
3.3. Vip3Aa-resistant colonies
Cross-resistance within the Vip3 subfamily of proteins has not yet
been established. We tested the susceptibility of two Vip3-resistant H.
armigera colonies (one resistant to Vip3Aa alone and the other resistant
toVip3Aa and Cry2Ab) against the Vip3Ca protein (Table 1). The
highest Vip3Ca doses tested (20 μg/cm2 for the Vip3Aa-resistant insects
and 10 μg/cm2 for the Vip3Aa/Cry2Ab-resistant insects) only caused a
mortality of 4.7% and 6.2%, respectively. Compared to the mortality
observed in the susceptible control insects and the Cry1- and Cry2-re-
sistant insects, these results clearly indicate that resistance to Vip3Aa
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Table 1
Evaluation of the susceptibility to Vip3 proteins of susceptible and Cry1-, Cry2-, Dipel- and Vip3-resistant insect colonies from different insect species.
Insect species Protein tested Replicates Colony Slope ± SE1 LC50 (FL95)2 Resistance3 ratio
T. ni μg/cm2
Vip3Aa R14 Susceptible 4.0 ± 0.4 0.95 (0.84–1.09) a –
Cry1Ac-resistant 5.0 ± 0.6 1.41 (1.07–1.91) a 1.48
Cry2Ab-resistant 2.7 ± 0.3 1.10 (0.51–1.77) a 1.15
R24 Susceptible 4.3 ± 0.5 1.05 (0.65–1.80)5 a –
Cry1Ac-resistant 4.2 ± 0.4 2.16 (1.30–3.83)5 a 2.05
Cry2Ab-resistant 3.4 ± 0.4 1.63 (1.36–1.90) a 1.55
Vip3Ca R14,§ Susceptible 2.5 ± 0.2 8.53 (5.42–15.09) b –
Cry1Ac-resistant 2.5 ± 0.3 10.02 (6.07–18.3) b 1.17
Cry2Ab-resistant 1.6 ± 0.2 16.12 (8.33–82.09) b 1.88
R24,§ Susceptible 3.3 ± 0.4 3.02 (2.53–3.54) c –
Cry1Ac-resistant 2.9 ± 0.3 4.95 (2.82–8.33) c 1.63
Cry2Ab-resistant 3.0 ± 0.3 4.05 (3.40–4.78) c 1.33
P. interpunctella μg/15mg diet disk
Vip3Aa Susceptible 0.43 ± 0.09 15.9 (2.25 – 151) d –
Dipel-resistant 0.65 ± 0.16 78.7 (27.2–792) d 4.95
Vip3Ca Susceptible 0.58 ± 0.20 67.5 (5.87–394) e –
Dipel-resistant 0.42 ± 0.12 13.7 (1.04–76.0) e 0.20
H. armigera μg/cm2
Vip3Ca Susceptible 2.1 ± 0.20 5.34 (4.34–6.65) f –
Cry1Ac-resistant 2.1 ± 0.30 1.60 (1.11–2.11) g 0.30
Cry2Ab-resistant 1.9 ± 0.27 2.36 (1.70–3.14) g 0.44
Vip3Aa-resistant – NA6 0
Vip3Aa/Cry2Ab-resistant – NA6 0
O. furnacalis μg/g
Vip3Aa Susceptible – UD7 –
Cry1Ab-resistant – UD7 0
Vip3Ca Susceptible 2.52 ± 0.37 0.31 (0.22–0.38)h –
Cry1Ab-resistant 1.67 ± 0.15 0.97 (0.74–1.22)i 3.12
1 SE: Standard error of the slope.
2 LC50 values followed by the same letter are not significantly different from their corresponding susceptible strain based on the overlap of fiducial limits (FL).
3 Resistance Ratio was calculated dividing the LC50 value of the resistant strain by the LC50 value of the susceptible strain.
4 The dose-response assays, R1 and R2, are biological replications. Within each biological replication, three T. ni strains were assayed using the same Vip solutions
at the same time.
5 FL90, instead of FL95, was calculated and presented, as the heterogeneity of the data was above the default threshold (g > 0.5) by POLO for adequate FL95
calculation.
6 NA: Non active. The highest dose tested (20 μg/cm2 for the Vip3-resistant and 10 μg/cm2 for theVip3Aa/Cry2Ab-resistant) caused a mortality of 4.7% and 6.2%,
respectively.
7 UD: Unable to determine. The highest dose tested (100 μg/g for the susceptible and resistant O. furnacalis strains) there was not significant mortality observed.
However, it showed about 50% growth inhibition.
§ The differences observed in the Vip3 proteins were considered as variations between replicates.
Table 2
Evaluation of the growth inhibition to Vip3Aa and Vip3Ca of susceptible and Cry1-, Cry2-resistant T. ni insect colonies.
Insect species Protein tested Replication Colony Growth inhibition Resistance ratio4
Slope ± SE1 IC50 (FL95)2
T. ni μg/cm2
Vip3Aa R13 Susceptible 5.5 ± 0.7 0.33 (0.30–0.37) a –
Cry1Ac-resistant 4.3 ± 0.5 0.64 (0.44 0.86) b 1.93
Cry2Ab-resistant 4.0 ± 0.7 0.24 (0.18–0.29) a 0.72
R23 Susceptible 4.0 ± 0.5 0.30 (0.26–0.35) a –
Cry1Ac-resistant 3.6 ± 0.4 0.64 (0.55–0.73) b 2.10
Cry2Ab-resistant 5.0 ± 0.9 0.27 (0.22–0.31) a 0.88
Vip3Ca R13 Susceptible 3.4 ± 0.3 1.17 (1.00–1.35) c –
Cry1Ac-resistant 4.3 ± 0.5 2.20 (1.34–3.42) c 1.88
Cry2Ab-resistant 4.2 ± 0.5 1.38 (1.21–1.57) c 1.18
R23 Susceptible 4.2 ± 0.7 0.41 (0.33–0.47) d –
Cry1Ac-resistant 3.8 ± 0.6 0.93 (0.75–1.09) c 2.28
Cry2Ab-resistant 4.8 ± 0.7 0.54 (0.45–0.62) d 1.33
1 SE: Standard error of the slope.
2 IC values followed by the same letter are not significantly different based on the overlap of FL.
3 The dose-response assays, R1 and R2, are biological replications. Within each biological replication, three T. ni strains were assayed using the same Vip solutions
at the same time.
4 Resistance Ratio was calculated dividing the LC50 value of the resistant strain by the LC50 value of the susceptible strain.
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conferred cross-resistance to Vip3Ca. This conclusion is supported by
the results in Table 3, where Vip3Ca did not cause any delay in the
development of the two Vip3Aa-resistant colonies.
The results obtained regarding cross-resistance are in agreement
with the differences in the mode of action of Cry and Vip3 proteins.
Several studies demonstrated that Vip3Aa does not share binding sites
with Cry1 or Cry2 proteins (Lee et al., 2006; Abdelkefi-Mesrati et al.,
2009; Sena et al., 2009; Gouffon et al., 2011; Chakroun et al., 2014) and
recent work showed that Vip3Aa and Vip3Ca share binding sites in
Mamestra brassicae (Gomis-Cebolla et al., 2017). Some of the Cry-re-
sistant insect colonies evaluated in this study had previously been ex-
amined for alteration in Cry protein binding and reduced binding was
found for the Cry proteins used as the selective agent. For example,
Cry1Ac toxins did not bind to gut membrane proteins in the Cry1Ac-
resistant T. ni colony (Wang et al.; 2007), gut proteins from a Dipel-
resistant P. interpunctella colony had drastically reduced binding of
Cry1Ab (Herrero et al., 2001), and gut proteins from the Cry2Ab-re-
sistant H. armigera colony had a greatly reduced binding of Cry2Ab
(Caccia et al., 2010). In the case of O. furnacalis, no binding assays have
been reported with resistant strains. Although binding is not the sole
mechanism of resistance to Bt toxins, it is the one that confers more
specific and higher levels of resistance (Ferré and Van Rie, 2002; Ferré
et al., 2008).
Despite the fact that Vip3Aa and Vip3Ca have been shown to share
binding sites in M. brassicae (Gomis-Cebolla et al., 2017), our cross-
resistance result is not straightforward to explain, Vip3Aa binding ap-
parently was not affected in the Vip3Aa-resistant H. armigera colony
(Chackroun et al., 2016b). We can think of several scenarios to explain
this apparent paradox. First, the binding of Vip3Aa to a “functional”
receptor (by this we mean a membrane molecule that triggers the
subsequent steps to kill the cell) can be masked by binding to other
molecules in the membrane. Examples have been reported for Cry
proteins, such as the case of Cry1Ac in H. virescens, which binds to three
binding sites while only binding site A is responsible for toxicity and,
thus, reduced Cry1Ac binding is not detected in resistant insects (Lee
et al., 1995; Jakka et al., 2015). Second, assuming that no brush border
epitope has been altered in the Vip3Aa-resistant insects, the mechanism
of resistance may lay in successive steps, such as membrane insertion,
pore formation, or any other post-binding event such as a signal
transduction leading to cell death. If this was the case, our results would
indicate that Vip3Aa and Vip3Ca, besides sharing a binding epitope in
the brush border membrane, share a post-binding step which would be
impaired in resistant insects. Whichever the case, our cross-resistance
results indicate these two Vip3 proteins share common steps in the
mode of action.
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a b s t r a c t
The Vip3Ca protein, discovered in a screening of Spanish collections of Bacillus thuringiensis, was known
to be toxic to Chrysodeixis chalcites, Mamestra brassicae and Trichoplusia ni. In the present study, its activ-
ity has been tested with additional insect species and we found that Cydia pomonella is moderately sus-
ceptible to this protein. Vip3Ca (of approximately 90 kDa) was processed to an approximately 70 kDa
protein when incubated with midgut juice in all tested species. The kinetics of proteolysis correlated with
the susceptibility of the insect species to Vip3Ca. The activation was faster to slower in the following
order: M. brassicae (susceptible), Spodoptera littoralis (moderately susceptible), Agrotis ipsilon and
Ostrinia nubilalis (slightly susceptible). Processing Vip3Ca by O. nubilalis or M. brassicae midgut juice
did not significantly changed its toxicity to either insect species, indicating that the low susceptibility
of O. nubilalis is not due to a problem in the midgut processing of the toxin. M. brassicae larvae fed with
Vip3Ca showed binding of this toxin to the apical membrane of the midgut epithelial cells.
Histopathological inspection showed sloughing of the epithelial cells with further disruption, which sug-
gests that the mode of action of Vip3Ca is similar to that described for Vip3Aa. Biotin-labeled Vip3Ca and
Vip3Aa bound specifically to M. brassicae brush border membrane vesicles and both toxins competed for
binding sites. This result suggests that insects resistant to Vip3A may also be cross-resistant to Vip3C,
which has implications for Insect Resistance Management (IRM).
 2016 Elsevier Inc. All rights reserved.
1. Introduction
Bacillus thuringiensis is a gram positive bacterium that during
the vegetative growth phase produces proteins (Vip, phospholi-
pases, proteases, chitinases, etc.) which are secreted to the med-
ium, contributing to the pathogenicity of this bacterium against
insects (Schnepf et al., 1998). Vip proteins are a class of secreted
insecticidal proteins which were first described in 1996 and which
share no sequence homology with the Cry proteins (Estruch et al.,
1996). To date, more than 100 vip3 genes have been identified
(http://www.btnomenclature.info/). Vip3Aa was the first member
of the family of Vip3 proteins ever described and most studies
dealing with the insecticidal activity and mode of action Vip3 pro-
teins have been carried out with this protein (Chakroun et al.,
2016). The fact that Vip3A proteins differ from the Cry1 and Cry2
proteins in terms of insecticidal spectra and because they target
different midgut binding sites (Lee et al., 2006; Sena et al., 2009;
Gouffon et al., 2011; Chakroun and Ferré, 2014) makes them ideal
candidates to be used in combination with Cry proteins in IRM
programs.
The mode of action of the Vip3Aa protein resembles that of the
Cry proteins in that they are synthesized in the form of protoxins
which are processed by proteases in the larva midgut rendering
the active toxin (Yu et al., 1997; Lee et al., 2003). The activated
toxin binds to specific receptors in the midgut membrane (Lee
et al., 2003, 2006; Abdelkefi-Mesrati et al., 2009; Sena et al.,
2009; Gouffon et al., 2011; Chakroun and Ferré, 2014). Finally,
http://dx.doi.org/10.1016/j.jip.2016.10.001
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the bound toxin provokes the disruption of the midgut epithelial
cells (Yu et al., 1997; Abdelkefi-Mesrati et al., 2011a,b) by the for-
mation of pores in the apical membrane (Lee et al., 2003; Liu et al.,
2011).
A screening of Spanish collections of Bacillus thuringiensis was
undertaken to search for novel members of the Vip3 family. As a
result, new vip3 genes were discovered constituting a novel family
which was classified as vip3Ca (Palma et al., 2012). All Vip3Ca pro-
teins discovered so far contain 803 amino acids (molecular mass of
approximately 90 kDa) and they have insecticidal activity to some
lepidopteran species. The aim of the present paper was to explore
additional insect species potentially susceptible to Vip3Ca and, at
the same time, to study its mode of action in Mamestra brassicae,
an insect species that have shown susceptibility to this protein.
2. Materials and methods
2.1. Insect colonies
Insects were grown in the insectaries of the Public University of
Navarra and of the University of Valencia at 25 ± 2 C, 60 ± 5% RH,
and L16: D8 h. Sesamia nonagrioides, Grapholita molesta, Cydia
pomonella, Mamestra brassicae and Pectinophora gossypiella were
reared in artificial diet (Poitout and Bues, 1974; Greene et al.,
1976; Guennelon et al., 1981; Eizaguirre and Albajes, 1992;
Pérez-Guerrero et al., 2004). Galleria mellonella was reared in a
honey based diet (10.5% glycerine, 22% honey, 14% cornmeal,
5.5% brewer’s yeast, 14% wheat flour, 14% infant cereals, 9.5% milk
powder and 10.5% water). Plutella xylostella and Tuta absoluta were
reared on leaves of Brassica oleracea var. capitata and Solanum
lycopersicum, respectively. Ephestia kuehniella larvae were reared
in wheat flour. Nezara viridula nymphs and adults were reared in
Phaseolus vulgaris pods supplemented with peanuts (Arachis hypo-
gaea). Drosophila melanogaster was reared on laboratory in corn-
meal/yeast medium.
2.2. Source and expression of Vip3 proteins
Vip3Aa (NCBI accession No. AAW65132) was overexpressed in
recombinant Escherichia coli BL21 carrying the vip3Aa16 gene
(Abdelkefi-Mesrati et al., 2009). The Vip3Ad (NCBI accession No.
CAI43276) protein was expressed from E. coli WK6 carrying the
vip3Ad2 gene (kindly supplied by Bayer CropScience N.V., Ghent,
Belgium). Vip3Ca (NCBI accession No. AEE98106) protein was pre-
pared from recombinant E. coli WK6 carrying the vip3Ca2 gene
(Palma et al., 2012).
The Vip3Aa protein was expressed following the conditions
described by Chakroun et al. (2012). In the case of the Vip3Ca
and Vip3Ad, a single colony was inoculated in 4 ml of LB medium
containing 100 lg/ml ampicillin and grown overnight at 37 C and
180 rpm. A 1/100 dilution of the culture in 700 ml LB medium con-
taining 100 lg/ml ampicillin was further incubated at 37 C and
180 rpm. When the OD was in the range value 0.7–0.8, 1 mM IPTG
(final concentration) was added for induction. The culture was
growth overnight at 37 C and 200 rpm. Cells were collected at
6000g for 15 min at 4 C and the pellet was weighed and resus-
pended in 3 ml lysis buffer (PBS, pH 8.0, containing 3 mg/ml lyso-
zyme, 10 lg/ml DNase, and 100 lM PMSF) per gram of pellet. The
sample was incubated at 37 C for 30 min and then kept in the
freezer at least 30 min. Then the sample was sonicated on ice
applying two 1 min pulses at 70 W and at a constant duty cycle,
separated by a 10 s cooling period on ice. Insoluble material was
separated by centrifugation at 16,000g for 15 min at 4 C and the
soluble cellular fraction sequentially filtered through sterile
0.45 lm and 0.22 lm cellulose acetate filters (GE Healthcare Life
Sciences).
2.3. Purification of the Vip3 proteins
Vip3 proteins used for bioassays or proteolysis assays were
purified by immobilized metal ion absorption chromatography
(IMAC) on a Hi-Trap chelating HP column (GE Healthcare) charged
with Ni2+. The eluted Vip3 protein was collected on PBS containing
0.1 mM EDTA (pH 8.0) to avoid inactivation of the protein. Buffer
exchange was performed immediately with storage buffer
(20 mM Tris, 150 mM NaCl, pH 9.0) with a PD-10 desalting column
(GE Healthcare) to prevent protein precipitation and aggregation.
Concentration of the purified protein was estimated with the Brad-
ford method (Bradford, 1976). The purity of the expressed protein
was then analyzed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and stained with Coomassie brilliant
blue R-250 (Sigma-Aldrich).
For histopathological studies, the Vip3Aa, Vip3Ad, and Vip3Ca,
proteins were purified by isoelectric point precipitation
(Chakroun et al., 2012). The pH of the lysate was lowered with
acetic acid to pH 5.5 for Vip3Aa, pH 4.95 for Vip3Ad, and pH 5.95
for Vip3Ca. The pellets were recovered by centrifugation at
16,000g for 10 min and then resuspended in storage buffer and
dialysed against the same buffer overnight. The purified proteins
were stored at 20 C.
For binding assays, Vip3 proteins were purified by isoelectric
point precipitation as described above. Solubilized Vip3 proteins
were incubated with 1% trypsin (wt/wt) for 2 h at 37 C. Activated
Vip3Ca and Vip3Aa were used as competitors in binding assays. For
biotin labeling, Vip3Aa was further purified by anion-exchange
chromatography. After overnight dialysis against 20 mM Tris-HCl
(pH 9), the Vip3Aa activated protein was purified on a HiTrap Q
HP (5-ml bed volume) column equilibrated in the same dialysis
buffer, using an ÄKTA explorer 100 chromatography system (GE
Healthcare, United Kingdom). Proteins were eluted with a 100 ml
linear gradient (0–80%) of 1 M NaCl.
2.4. Insect toxicity assays
Several methodologies were used in the bioassays depending on
the insect species tested. For M. brassicae, S. nonagrioides, C. pomo-
nella, and G. molesta, bioassays were performed on neonates using
surface contamination assays. Surface contamination assays were
also employed with L3 larvae for G. mellonella and P. xylostella.
Bioassays with P. gossypiella and E. kuehniella were conducted with
neonates and L3 larvae, respectively, using toxins in diet incorpo-
ration assays. Bioassays with T. absoluta were performed on L2 lar-
vae in leaf disks. With the homopteran N. viridula, bioassays were
conducted on N1 using toxins in feeding assays (Palma et al., 2014).
With the dipteran D. melanogaster, bioassays were conducted on L1
using surface contamination assays.
For a preliminary screening of the activity of the Vip3Ca protein,
two concentrations (0.4 and 4 lg/cm2) were tested when the assay
was done on artificial diet in surface contamination assays. In diet
incorporation assays, the Vip3Ca protein was tested at a single con-
centration of 60 lg/g and 100 lg/g, for P. gossypiella and E. kueh-
niella, respectively. For the leaf disk and feeding assays the
Vip3Ca was tested also at a single concentration in both bioassays
(200 mg/ml and 1 mg/ml, respectively). Sixteen larvae were used
for each protein concentration and the bioassay was repeated at
least twice. Bioassays were conducted at 25 C, 60 ± 5% RH, and a
16:8 (light/dark) photoperiod. Mortality and effective mortality
(dead larvae plus number of larvae that remained in the initial
instar) were scored after 21 days for P. gossypiella, 7 days for S.
nonagrioides,M. brassicae, G. molesta, C. pomonella and G. mellonella,
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4 days for P. xylostella, E. kuehniella and D. melanogaster, and 3 days
for T. absoluta and N. viridula. Determination of the LC50 (concen-
tration of protein killing 50% of tested individuals) for Vip3Ca
was done for the most susceptible species (M. brassicae, C. pomo-
nella and E. kuehniella) as reported elsewhere (Ruiz de Escudero
et al., 2014). The LC50 of Vip3Aa for C. pomonella was calculated
in the same way as for Vip3Ca. The storage buffer was use to dilute
Vip3 proteins and as the negative control. Only the bioassays with
less than 10% control mortality were considered.
2.5. Midgut juice preparation and Vip3 proteins processing
Midgut juice preparation was obtained from last instar larvae of
M. brassicae, Agrotis ipsilon, Spodoptera littoralis and Ostrinia nubi-
lalis. Midguts were dissected and cut open to eliminate food
clumps. The midgut with the remaining contents was centrifuged
at 16,000g for 10 min and the supernatant, which constituted the
midgut juice, was recovered. The protein concentration was mea-
sured with the Bradford method (Bradford, 1976).
For the time course assays, the Vip3Ca protein was mixed with
several dilutions of midgut juice in a final volume of 25 ll and
incubated at 30 C. The reaction was stopped at different time
intervals by adding the electrophoresis loading buffer and heating
at 99 C for 10 min. Reaction products were separated by 12% SDS-
PAGE and the gels stained with Coomassie brilliant blue R-250
(Sigma-Aldrich).
For the insect toxicity assays, Vip3Aa and Vip3Ca were pro-
cessed with midgut juice from M. brassicae and O. nubilalis, and
with commercial bovine trypsin (Sigma-Aldrich). Both proteins
where incubated with midgut juices for 24 h at 30 C, at the ratio
100:0.36 and 100:16 (protein:midgut juice of M. brassicae and O.
nubilalis, respectively). Trypsin activation was performed as
described above.
2.6. Insect toxicity assays of the activated Vip3 proteins with midgut
juice from M. brassicae and O. nubilalis and with trypsin
As for M. brassicae, bioassays with O. nubilalis were performed
on neonates using surface contamination assays and mortality
was scored after 7 days. M. brassicae and O. nubilalis larvae (three
replicates of 24 larvae) were fed with the native and the activated
forms of Vip3Aa and Vip3Ca. Larvae groups received 0.74 lg/cm2
and 4.5 lg/cm2 of each protein form, which corresponded to the
LC30 and an LC90 values, respectively, of Vip3Ca for M. brassicae.
Bioassays were repeated three times.
2.7. Histopathological effects and in vivo binding of Vip3 proteins in M.
brassicae
Vip3Aa, Vip3Ad, and Vip3Ca (6 lg each) were used to intoxicate
L2/L3 instar larvae of M. brassicae. Briefly, after 1 h, 3 h and 6 h of
exposure, larvae were cut at the two ends and immediately fixed
with 4% paraformaldehyde (PFA) for two days and then transferred
to 30% sucrose in PBS for two additional days. Larvae were keep at
80 C until they were fixed to a support and coated with Tissue
Tech gel (Sakura, Japan). Sections of 30 lm were prepared using
the cryostat microtome Leica CM 1510S. Slides with the tissue sec-
tions were stored at 20 C until used (Chakroun and Ferré, 2014).
Histopathological effects were observed in midgut sections
after staining with hematoxylin-eosin (Ruiz et al., 2004). Binding
of the Vip3Ca protein to the midgut epithelial membrane was per-
formed as described by Chakroun and Ferré (2014) using an anti-
Vip3Aa polyclonal antibody coupled to anti-Ig conjugated with
FITC.
2.8. Vip3 toxins labeling, preparation of M. brassicae BBMV, and
binding analyses
Vip3Aa and Vip3Ca proteins were labeled with biotin using the
ECL Protein Biotinylation Module kit (GE Healthcare), according to
the manufacturer’s instructions. Brush border membrane vesicles
(BBMV) were prepared by the differential magnesium precipitation
method from last instar larvae (Wolfersberger et al., 1987). Protein
concentration in BBMV was estimated by the Bradford’s method
(Bradford, 1976).
For competition experiments, 20 ng of biotinylated toxin was
incubated with 20 lg of BBMV in 0.1 ml of binding buffer (PBS
pH 7.4, 0.1% BSA) at different concentrations of competitor (unla-
beled toxin) at room temperature for 90 min. The reaction was
stopped by changing to a new microcentrifuge tube and centrifu-
gation at 16,000g for 10 min. The pellet, containing the toxin
bound to BBMV, was washed with 500 ll of the binding buffer.
The final pellet was resuspended in 10 ll of the binding buffer
without BSA and then transferred to a new microcentrifuge tube
containing 5 ll of electrophoresis loading buffer (5). The mixture
was heated at 99 C for 5 min. Samples were run on 10% SDS-PAGE
and proteins blotted into a nitrocellulose filter. The filter was
blocked with 3 mg/ml of blocking reagent (GE Healtcare) for 1 h.
The retained labeled toxins were revealed by probing with
streptavidin-conjugated peroxidase (GE Healtcare) and then the
AmershamTM ECLTM Western Blotting Detection Reagents lumines-
cence kit.
3. Results
3.1. Host range and insecticidal activity of Vip3Ca
In an attempt to expand the range of susceptible insect species,
Vip3Ca was tested with ten new insect species at high protein con-
centrations (Table 1). Of the six species tested by surface contam-
ination, C. pomonella was the most susceptible, followed by G.
mellonella, with percentages of mortality higher than 50%. From
the other types of bioassays, E. kuehniella and T. absoluta showed
some susceptibility to high concentrations of Vip3Ca (between
30% and 50% mortality). The rest of species (G. molesta, P. gossyp-
iella, P. xylostella, S. nonagrioides, D. melanogaster and N. viridula)
can be considered non-susceptible, with percentages of mortality
lower than 30%.
The LC50 of the Vip3Ca protein was calculated for C. pomonella
(6 lg/cm2), E. kuehniella (180 lg/g), and M. brassicae (1.3 lg/cm2),
which was shown to be one of the most susceptible insect species
in a previous work (Palma et al., 2012). In addition, the LC50 of
Vip3Aa to C. pomonellawas also calculated (0.014 lg/cm2) for com-
parison (Table 2).
3.2. Proteolysis of the Vip3Ca protein by midgut juice from different
insect species
To determine whether species with different susceptibility to
Vip3Ca showed different efficiencies in the activation process of
the Vip3Ca protoxin, the time course of the conversion of protoxin
(of approximately 90 kDa) into toxin (of approximately 70 kDa)
was measured using midgut juice from four lepidopteran species,
which, from less to more susceptible to Vip3Ca, were: O. nubilalis,
A. ipsilon, S. littoralis, and M. brassicae (Palma et al., 2012). The
results showed a correlation between susceptibility and speed of
protoxin processing (Fig. 1). In the same experimental conditions,
the midgut juice of O. nubilalis hardly converted the protoxin to
the 70 kDa form even at 60 min using the highest concentration
of midgut juice. The A. ipsilon midgut juice was able to convert
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approximately 50% of the protoxin into the 70 kDa form after
60 min. The midgut juice from S. littoralis processed most of the
protoxin, especially at the highest concentration. The midgut juice
of the most susceptible species,M. brassicae, not only converted the
protoxin to the 70 kDa form but even processed further this form
to smaller products.
Table 1
Absolute and functional mortality produced by Vip3Ca on ten insect species.
Bioassay method Insect species Larval instar Vip3Ca concentration Absolute mortality Functional mortality Days
Surface contamination Cydia pomonella Neonate 0.4 lg/cm2 28.6 ± 0.2 28.6 ± 0.2 7
4 lg/cm2 81.20 ± 0.10 100.0 ± 0.0 7
Grapholita molesta Neonate 0.4 lg/cm2 0.10 ± 0.10 0.10 ± 0.10 7
4 lg/cm2 22.30 ± 0.10 22.30 ± 0.10 7
Sesamia nonagrioides Neonate 0.4 lg/cm2 6.7 ± 0.7 6.7 ± 0.7 7
4 lg/cm2 29.6 ± 0.7 29.6 ± 0.7 7
Galleria mellonella L3 0.4 lg/cm2 36 ± 6 36 ± 6 4
4 lg/cm2 54 ± 4 54 ± 4 4
Plutella xylostella L3 0.4 lg/cm2 15.80 ± 0.10 15.80 ± 0.10 7
4 lg/cm2 18.80 ± 0.10 18.80 ± 0.10 7
Drosophila melanogaster Neonate 0.4 lg/cm2 0.0 ± 0.0 0.0 ± 0.0 4
4 lg/cm2 0.0 ± 0.0 0.0 ± 0.0 4
Diet incorporation Pectinophora gossypiella Neonate 60 lg/g 9.00 ± 0.10 9.00 ± 0.10 21
Ephestia kuehniella L3 100 lg/g 42 ± 13 44 ± 2 4
Leaf disk Tuta absoluta L2 200 mg/ml 34 ± 10 37 ± 7 3
Feeding assay Nezara viridula Neonate 1 mg/ml 10 ± 7 10 ± 7 3
Table 2
Quantitative parameters from concentration–mortality responses of some susceptible species to the Vip3Ca protein.
Treatment Regression line LC50 Goodness of fit value 95% FLa
Slope ± SE ab ± SE v2 dfc Lower Upper
E. kuehniella lg/g
Vip3Cad 1.6 ± 0.3 1.3 ± 0.6 180 0.55 2 140 270
M. brassicae lg/cm2
Vip3Cae 2.5 ± 0.3 4.70 ± 0.10 1.3 1.83 3 1.1 1.6
Vip3Aaf 1.50 ± 0.10 3.30 ± 0.10 0.014 0.9 3 0.011 0.018
C. pomonella lg/cm2
Vip3Cae 0.6 ± 1.0 4.62 ± 0.06 6 4.88 6 3 19
Vip3Aae 0.64 ± 0.12 1.21 ± 0.19 0.013 1.20 2 0.004 0.029
a Fiducial limits.
b Intercept.
c Degrees of freedom.
d The LC50 was calculated at 3 days.
e The LC50 was calculated at 7 days.
f Data adapted from Ruiz de Escudero et al. (2014).
Fig. 1. Time course of the Vip3Ca processing by midgut juice from lepidopteran insects with different susceptibility to the protein. The assay was performed with 10 lg of
Vip3Ca in a final volume of 25 ll. Vip3Ca was incubated with 20 ng and 40 ng of total midgut juice protein for 5 min, 30 min and 60 min at 30 C. Molecular markers (M1 and
M2, in kDa) are indicated in the gels. Arrowheads show the position of the activated toxin.
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To show that all four species were able to fully convert the pro-
toxin to the activated 70 kDa form given the appropriate condi-
tions, the Vip3Ca protoxin was incubated with different
concentrations of midgut juice. Using 20 ng of midgut juice from
both O. nubilalis and A. ipsilon to 1 lg of Vip3Ca, the protoxin
was completely converted to the 70 kDa form (data not shown).
For M. brassicae, the Vip3Ca protoxin was incubated with more
diluted midgut juice (0.8 and 0.17 ng of midgut juice total protein
for every 1 lg of the Vip3Ca protein). With the lowest dilution,
after 24 h the Vip3Ca was completely converted to the 70 kDa form
without practically further processing (Fig. 2).
3.3. Insecticidal activity of the Vip3Ca activated with midgut juice of
M. brassicae and O. nubilalis, and with trypsin
To determine whether the low toxicity of Vip3Ca to O. nubilalis
is related with an inappropriate activation in the larva midgut, O.
nubilalis neonate larvae were exposed to Vip3Ca activated by mid-
gut juice from M. brassicae (a more susceptible species) and, recip-
rocally, M. brassicae neonate larvae were exposed to Vip3Ca
activated by midgut juice from O. nubilalis. Vip3Aa was used for
comparison. The results showed that Vip3Ca activated by midgut
juice from O. nubilaliswas as active, againstM. brassicae, as the pro-
toxin and the trypsin-activated forms (Fig. 3A). Similar results
were obtained for Vip3Aa treated in the same way (Fig. 3B). Simi-
larly, Vip3Ca activated by midgut juice from M. brassicae was prac-
tically as active against O. nubilalis as the trypsin-activated or the
non-activated protoxin (Fig. 3A). In the case of Vip3Aa, neither
the protoxin nor the activated toxins, by either trypsin or M. bras-
sicae midgut juice, were toxic to O. nubilalis (Fig. 3B).
3.4. Comparative histopathological effects of Vip3 proteins to M.
brassicae midgut sections
The histopathological effects of Vip3Aa, Vip3Ca and Vip3Ad to
M. brassicae were studied in midgut sections of second or third
instar larvae which had been fed with a solution of Vip3 protein
with sucrose. No tissue damage could be observed after one hour
of intoxication with any of the Vip3 proteins. After 3 h, visible
damage was observed along the whole midgut only in the case of
Vip3Aa, the most toxic protein. After 6 h, the midgut was highly
damage in larvae that had ingested Vip3Aa. For Vip3Ca, the midgut
showed signs of damage but they were not as drastic as for Vip3Aa.
For the non-toxic Vip3Ad protein, no damage was evident at any
time (Fig. 4).
3.5. In vivo binding of Vip3Ca to M. brassicae midgut epithelium
To know if that Vip3Ca binds to the midgut apical membrane
after ingestion, larvae were fed with Vip3Ca for different times, dis-
sected and the Vip3Ca protein revealed with a polyclonal Vip3
antibody. Hardly any binding could be detected in larvae that
had been dissected one hour after the start of the ingestion. How-
ever, after 3 h, binding of Vip3Ca to the brush border membrane
was evident (green signal) (Fig. 5). No bound Vip3Ca could be
observed after 6 h due to disruption of the apical membrane (as
revealed by the loss of the red signal).
Fig. 2. Time course of the Vip3Ca processing by diluted midgut juice ofM. brassicae.
The assay conditions are as in Fig. 1 except for the ratio Vip3Ca/midgut juice protein
and that the assay was extended up to 24 h.
Fig. 3. Toxicity of protoxin, trypsin activated, and midgut juice activated Vip3Ca (A)
and Vip3Aa (B) against M. brassicae and O. nubilalis neonate larvae. Bars represent
mean mortality (with SE) of three replicates (of 24 larvae each) after 7 days, at a
toxin concentration of 0.74 lg/cm2 (white bars) and 4.5 lg/cm2 (grey bars).
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3.6. In vitro binding of Vip3 proteins to M. brassicae BBMV
To show that Vip3Aa and Vip3Ca bound specifically to M. bras-
sicae BBMV, competition experiments were performed with biotin-
labeled toxins. Both toxins bound specifically, since the unlabeled
homolog (the same unlabeled toxin as the labeled one) competed
for binding with the labeled toxin (Fig. 6A and B). To determine
whether the two Vip3 proteins recognized common binding sites,
heterologous competition (the competitor is a different toxin than
the labeled one) was performed with labeled Vip3Ca and unlabeled
Vip3Aa and vice versa. The results showed that both toxins com-
peted heterologously with the labeled toxin, indicating that Vip3Aa
and Vip3Ca share binding sites (Fig. 6A and C).
4. Discussion
The Vip3Ca protein is the first member of the most recent new
family of Vip3 proteins, discovered in a screening program of Span-
ish collections of Bacillus thuringiensis, and it was shown to be toxic
to some lepidopteran species, M. brassicae among them (Palma
et al., 2012). In order to further characterize the insecticidal spec-
trum of the Vip3Ca protein, we tested ten additional insect species,
(eight lepidopterans, one dipteran and one homopteran) (Table 1).
LC50 values were obtained from the two most susceptible species
and also from E. kuehniella because of its importance for storage
grain in Spain. Compared to Vip3Aa, the LC50 values of Vip3Ca for
C. pomonella and M. brassicaewere two orders of magnitude higher
(Table 2), indicating that Vip3Ca although toxic, is much less toxic
than the Vip3Aa protein for these two species.
Since the mode of action of Vip3Ca proteins has never been
approached before, we set out to determine the role of proteolysis
and binding in the toxicity of this protein. We first studied the pro-
cessing of the Vip3Ca protein by the midgut juice of M. brassicae, S.
littoralis, A. ipsilon and O. nubilalis (Figs. 1 and 2). In all cases, the
Vip3Ca protoxin was processed to a 70 kDa protein, in contrast to
the 62 kDa protein generated from Vip3Aa when incubated with
midgut juice (Lee et al., 2003; Chakroun et al., 2012; Caccia et al.,
2014). The kinetics of the proteolysis positively correlated with
the susceptibility of the species. The conversion of the protoxin
into the activated toxin proceeded much faster with the midgut
juice of the most susceptible species. This result suggests that
the speed of conversion of the protoxin into the 70 kDa toxin might
contribute to the susceptibility of the species to the Vip3Ca protein.
Fig. 4. Histopathological effects of Vip3Ca to the M. brassicae midgut after oral ingestion. The Vip3Aa protein was included as a positive control and Vip3Ad protein as a
negative control. Midgut sections (30 lm) were stained with hematoxylin-eosin (Ruiz et al., 2004). Magnification 100. BM, basal membrane; AM, apical membrane; L, gut
lumen. White arrows point at excised cells.
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In contrast, this type of correlation has not been found for Vip3Aa
(Yu et al., 1997).
Yu et al. (1997), showed that the processing of Vip3Aa by mid-
gut juice of different lepidopteran species, including O. nubilalis,
did not have an effect on its toxicity against them, indicating that
midgut processing was not responsible for the very low suscepti-
bility of O. nubilalis to this toxin. We have found the same result
with Vip3Aa and Vip3Ca using M. brassicae and O. nubilalis
(Fig. 3). Therefore, other factors different to the protoxin activation
must be critical in the tolerance of O. nubilalis to these two Vip3
toxins.
Several studies have dealt with the histopathological effects of
Vip3Aa to larvae from different species (Yu et al., 1997;
Abdelkefi-Mesrati et al., 2011a,b; Sellami et al., 2015). We have
obtained similar results with M. brassicae larvae fed with Vip3Ca,
for which disruption of the midgut epithelium could be observed
(Fig. 4). However, compared with the most toxic protein Vip3Aa,
the damage caused by Vip3Ca took longer to be visible, in agree-
ment with its lower toxicity. Vip3Ad was used as a negative control
since it has no toxicity to M. brassicae (Ruiz de Escudero et al.,
2014). As expected, the Vip3Ad caused no visible damage to the
midgut epithelium.
The in vivo binding of Vip3Ca was shown by fluorescence
microscopy of the midgut sections stained with specific fluo-
rophores (Fig. 5). The ingested Vip3Ca protein bound to the brush
border membrane of the midgut epithelial cells, similarly as it has
been reported for Vip3Aa (Yu et al., 1997; Chakroun and Ferré,
2014). To show that binding of Vip3Ca to the brush border mem-
brane is specific, BBMV from M. brassicae were prepared and used
for in vitro binding assays with biotin-labeled Vip3Ca and Vip3Aa.
Binding was shown to be specific since homologous competition of
Vip3Ca and Vip3Aa was observed (Fig. 6). Heterologous competi-
tion experiments also showed that Vip3Aa competed for Vip3Ca
binding sites and vice versa, indicating that they bind to shared
binding sites. Although the overall similarity of the full length
Vip3Aa and Vip3Ca proteins is just of 70%, the two proteins share
highly conserved regions (92% similarity of the N-terminal region
up to amino acid 195 and 66% similarity in a carbohydrate binding
domain spanning from amino acid position 544–662) that might
be involved in interaction with membrane binding sites. According
to our results, at least some of the binding sites would be recog-
nized by both Vip3 proteins. This result might have implications
for IRM since, in the event that insects would become resistant
to one of these Vip3 proteins due to a change in one of the shared
membrane receptors, they could also develop cross-resistance to
the other Vip3 protein.
Fig. 5. In vivo binding of Vip3Ca in M. brassicae after oral ingestion. Larvae fed with just a sucrose solution were used like as negative controls. Binding of the Vip3Ca protein
was detected in midgut sections (30 lm) with an anti-Vip3Aa polyclonal antibody and was revealed with anti-IgG coupled with FITC (green fluorescence). Nuclei and actin
were stained with DAPI (blue fluorescence) and phalloidin (red fluorescence), respectively. Magnification 100. BM, basal membrane; AM, apical membrane; L, gut lumen.
The white arrow shows binding to the apical membrane.
Fig. 6. Binding of biotinylated Vip3Ca and Vip3Aa toxins to M. brassicae BBMV. For
biotinylated Vip3Ca (A), a 100-fold excess of unlabeled competitor was used (, no
competitor; 3Ca, Vip3Ca; 3Aa, Vip3Aa). For biotinylated Vip3Aa, binding was tested
without competitor () and in the presence of an excess (5-fold to 50-fold) of
unlabeled Vip3Aa (B) and Vip3Ca (C), as indicated on the top of the figure.
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In summary, the Vip3Ca protein (the first representative of this
new family of Vip3C proteins) seems to follow a mode of action
similar to that of the Vip3Aa protein: it is processed by gut pro-
teases to a smaller molecular weight protein and binds to the
brush border of the midgut epithelial membrane, with eventual
lysis of midgut cells. Vip3Ca shares binding sites with Vip3Aa,
which might have implications for IRM. It seems that there is a dif-
ference compared to Vip3Aa mode of action, since the kinetics of
the activation of Vip3Ca may play a role in the degree of suscepti-
bility of susceptible insects. With this study, we aimed to shed
some light on the activity spectrum and mode of action of the
recent new family of Vip3C proteins.
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     Chapter 3 
7.2 - Stability of the Vip3Ca protein to the serine proteases and midgut 
juice proteases of Mamestra brassicae. 
Joaquín Gomis-Cebolla1 and Juan Ferré1
1 Estructura de Recerca Interdiciplinar en Biotecnología y Biomedicina (ERI BIOTECMED), 
Departamento de Genética, Facultad de Ciencias Biológicas, Universitat de València, 46100 Burjassot, 
Spain.  
Objective: 
Determination of the oligomer formation of the Vip3Ca protein digested with trypsin and 
midgut juice proteases from Mamestra brassicae. 
Materials and Methodology: 
1. - Vip3Ca expression and purification
The Vip3Ca protein (NCBI accession No AEE98106) was prepared from recombinant 
Escherichia coli WK6 carrying the vip3Ca2 gene (1). A single colony of Vip3Ca was 
inoculated in 4 ml of LB medium containing 100 μg/ml ampicillin and grown overnight 
at 37°C and 180 rpm. A 1/100 dilution of the culture in 700 ml LB medium containing 
100 μg/ml ampicillin was further incubated at 37°C and 180 rpm, until and OD value of 
0.7-0.8. For the induction, 1mM IPTG was added. The culture was growth overnight at 
37°C and 200 rpm. The cells were collected and resuspended in lysis buffer (20 mM 
phosphate saline buffer, pH 8.0, with 3 mg/mL lysozyme, 10 µg/mL DNAse and 100 µM 
PMSF) and incubated with shaking for 30 min at 37°C. The cells were lysed by sonication 
and the supernatant recovered by centrifugation at 27,000 x g and filtered through sterile 
0.45 μm and 0.22 μm cellulose acetate filters. The Vip3Ca protein was purified by ion 
metal affinity chromatography as described previously (2). 
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2. - Vip3Ca processing, trypsin and midgut juice treatment 
 
The Vip3Ca protein was subjected to different proteolysis treatments. In all of them, the 
reaction was stopped with SDS-PAGE loading buffer, heated at 99°C for 10 min and 
frozen in liquid nitrogen. The samples were stored at -20°C until use.  
 
Trypsin treatment 
The Vip3Ca was incubated with commercial trypsin (trypsin from bovine pancreas, 
SIGMA T8003) with the storage buffer (20 mM Tris 150 mM NaCl, pH 9). For the time 
course assays, the Vip3Ca was activated at different time intervals (0, 0.5, 1, 2, 6, 24, 48, 
76 hours) with at the following ratio 1µg of Vip3Ca protein: 0.24 µg of trypsin in a final 
volume of 25 µl at 30°C.  
 
Midgut juice treatment 
The midgut juice (MJ) was obtained from the last instar larvae of M. brassicae. Midguts 
were dissected and centrifuged at 16,000 g for 10 min and the supernatant was recovered. 
The protein concentration was measured with the Bradford method (3). For the time 
course assays, the Vip3Ca protein was mixed at the ratio of 1 µg of protein : 0.8 µg of MJ 
for 30 minutes, in a final volume of 25 µl of storage buffer at 30°C. The proteolysis 
reactions were stopped adding 5 µl of loading buffer and boiling the samples for 10 min 
at 99ºC. 
 
3. - Gel filtration chromatography 
 
Gel filtration chromatography was performed with an ÄKTA explorer 100 
chromatography system (GE Healthcare) in a Superdex-200 10/300 GL column (GE 
Healthcare Life sciences, USA) equilibrated and eluted with the storage buffer, to a flow 
rate of 0.5 ml/min. The Superdex-200 10/300 GL column was calibrated with the gel 
filtration calibration kit HMW (Ge Healthcare Ref: 28-4038-42) with the following 
standard proteins: 250 µl of 10 mg/ml thyroglobulin, 50 µl of 3 mg/ ml ferritin, 200 µl of 
10 mg/ml aldolase, 150 µl of 10 mg/ml conalbumin and 200 µl of 200 µl of ovalbumin, 
at a flow rate of 0.5 ml/min. Blue Dextran (SIGMA D-5751) was used to determine the 
void volume of the column. The elution time, expressed as milliliters, was calculated from 
the middle of the elution peak. The expected size of the processed Vip3Ca (24 % w:w 
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trypsin, for 0.5 h and 48 h; 1 µg Vip3Ca : 0.8 µg MJ) was estimated with the linear 
regression of the standard line (r2 0.98, y=-0.3075x + 1.9102, where x is the log of the 
molecular weight in Da and y is the kAv). The eluted proteins were collected in fractions 




1. - Time course of trypsin processing of Vip3Ca  
 
Trypsin treatment of the Vip3Ca protein in Tris-HCl buffer (pH 9.0), at 24:100 trypsin 
Vip3Ca (w:w), for 30 min, rendered a major band of around 70 kDa, as well as other 
smaller bands (Figure 1). Whereas the concentration of the smaller bands decreased with 
the incubation time, the ~70 kDa band seemed to become more intense as the incubation 
proceeded. The controls at time 0 and 76 h show that the Vip3Ca2 protoxin is stable at 
30ºC and the smaller bands do not come from protein degradation. 
 
2. - Size exclusion chromatography of the Vip3Ca2 activated with trypsin at 24 % (w:w) 
protoxin:toxin for 30 min and 48 h 
 
In an attempt to know if the processed Vip3Ca with trypsin form oligomers, the processed 
Vip3Ca was analysed under non denaturing conditions in a gel filtration chromatography 
column. For this purpose, Vip3Ca, treated with trypsin at 0.5 h and 48 h, was loaded on 
the Superdex-200 10/300 GL column (exclusion limit of the 1300 kDa). For the Vip3Ca 
processed with trypsin for 30 min, a main peak was eluted at 11.6 ml, while if the Vip3Ca 
is processed for 48 h, a main peak was eluted at 11.4 ml (Figure 2b and 2d). This peak 
correspond to the toxin bands of ~70 kDa and ~20 kDa (Figure 2a and 2c) with a size of 
451 kDa for at 0.5 h and 512 kDa at 48 h (Table 1). The toxin band of ~20 kDa was only 
detected in the output fractions at 0.5 h and not at 48 h due to the few amount of the 
sample injected (Figure 2c). Moreover, other minor peaks were also detected at different 






                                                                                                                                                        Chapter 3 
Mining of new insecticidal protein genes plus determination of the insecticidal spectrum and 
mode of action of Bacillus thuringiensis Vip3Ca protein 
 
Figure 1. Time course of trypsin processing of Vip3Ca. Reactions were performed at 
30°C at different concentrations of trypsin in Tris-HCl buffer. The ratios of trypsin: 
Vip3Ca (w:w) was 24:100. Aliquots were withdrawn at different times, as shown at the 




Figure 2. Gel filtration chromatography of Vip3Ca processed with trypsin. a) SDS-PAGE 
of the processed Vip3Ca protein incubated for 0.5 h. b) Gel filtration chromatography of 
the Vip3Ca processed with 24 % w:w trypsin: protoxin for 30 min. c) SDS-PAGE of the 
processed Vip3Ca protein with at 24 % w:w of trypsin : protoxin for 48 h. d) Gel filtration 
chromatography of the Vip3Ca processed with 24 % w:w of trypsin : protoxin for 48 h. 
Molecular weight marker: M, Pink Plus Prestained Protein Ladder, Genedirex and 
Precision Plus Protein™ Unstained Protein Standards, BioRad. 
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3. - Stability of Vip3Ca protoxin to M. brassicae midgut juice 
 
When the Vip3Ca protein, apparently degraded after treatment with a very high 
concentration of MJ (Figure 5, lane of 0.5 h), was subjected to gel filtration 
chromatography, the Vip3Ca protein eluted as a single main peak at 11 ml with an 
approximately size of 395 kDa (Table 1), along with two peaks associated with the MJ 
(Figure 5b). The size of the SDS-PAGE of the fractions of the peak at 11 ml showed three 
bands, one of 66 kDa, 35 kDa and 17 kDa (Figure 3, lane A10 - A12). This result 
confirmed the existence of a core of 66 kDa extremely stable to MJ proteases, and showed 
that the apparent degradation of Vip3Ca at high concentrations of MJ, as observed by 
SDS-PAGE, was an artefact. 
 
Table 1. Estimation of the molecular weight of the processed Vip3Ca (30 min trypsin-




ET (ml) MW (kDa) 
Trypsin_0.5 h 11.6 451.85 Tetramer 
Trypsin_48 h 11.4 512.86 Tetramer 
Midgut juice_1µg of protein: 0.8 µg of 
midgut juice 11.9 395.36 Tetramer 
1 Elution time expressed as milliliters 
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Figure 3. Gel filtration chromatography of Vip3Ca processed with midgut juice of M. 
brassicae. a) SDS-PAGE of the processed Vip3Ca protein incubated midgut juice of M. 
brassicae at a ratio of 1µg of protein : 0.8 µg of midgut juice for 5 min. b) Gel filtration 
chromatography of the Vip3Ca protein incubated midgut juice of M. brassicae at ratio of 
1 µg of protein : 0.8 µg of midgut juice for 5 min. M: Pink Plus Prestained Protein Ladder, 
Genedirex. 
Discussion 
The mode of action of the Vip3A has been assimilated to that of the Cry proteins. Recent 
reports suggest that the main steps of the mode of actions of the Vip3 proteins are not so 
similar to the ones described for Cry proteins. The full length of the Vip3 protein, 
protoxin, form oligomers of 4 units that is activated by the is activated in the insect midgut 
to the active form of the Vip3 proteins that is also an oligomer of 4 units (4–9). This 
observation indicate that the 60 kDa and 20 kDa bands remain together and are needed 
for the protein structure and insect toxicity (9,10). So far it has been proposed that the 
Vip3A monomer (60 kDa and 20 kDa) cross the peritrophic membrane and binding to 
specific sites in the epithelial membrane. However, recent studies suggest that the 
activated form of the Vip3 proteins (tetrameric conformation) could make pores in a 
planar lipids bilayer (7), thus further work is needed to demonstrate if the oligomer or 
monomer bind to the midgut epithelium. 
Regarding the instability of the 60 kDa band after the proteolysis with trypsin and midgut 
juice (11–14) is an artefact produced by an inadequate inactivation of the proteases. When 
the samples is heated in the presence of SDS and ẞ-mercaptoetanol, the protein unfolds 
and become available hidden cut sites for the trypsin or midgut juice proteases (15).  
Mining of new insecticidal protein genes plus determination of the insecticidal spectrum and 
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Our results suggest that, when exposed to trypsin the Vip3Ca protoxin render two 
fragments of 17 kDa and 66 kDa approximately. The increase of the 66 kDa band with 
time at high concentrations of trypsin (Figure 1) can be explained as follows: since trypsin 
autodigests, the shorter the incubation time of the Vip3Ca protein with trypsin, then the 
higher the trypsin concentration still present in the sample, and thus, the more efficient 
processing of the 66 kDa peptide by trypsin under denaturing conditions. Regarding the 
apparent degradation of the 66 kDa fragment at high concentrations of trypsin or MJ 
(Figure 2) may due to the action of the proteases upon addition of SDS with the loading 
buffer. This is inferred from the results when the sample is subjected to gel filtration 
chromatography and trypsin is separated from the activated Vip3Ca prior to SDS-PAGE 
analysis. 
Gel filtration chromatography shows that the proteolytically processed Vip3Ca protein 
elutes as a high molecular mass protein, 395 - 512 kDa (Table 1). The SDS-PAGE 
analysis of the elution peak shows two bands of 66 kDa and 17 kDa, which indicates that 
these two molecules remain associated under native conditions in an oligomer (tetramer), 
as was previously reported for the Vip3Aa (4,9,15). The elution of the processed Vip3Ca 
protein from the gel filtration column, as a high molecular mass protein, is in agreement 
with a previous studies (4,6,7,9,15) that show that the trypsin-activated Vip3Aa protein 
aggregates in solution to form an oligomer.  
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Changes in gene expression and 
apoptotic response in Spodoptera 
exigua larvae exposed to sublethal 
proteins
Patricia Hernández-Martínez, Joaquín Gomis-Cebolla, Juan Ferré & Baltasar Escriche  
Bacillus thuringiensis (Bt), along with the classical Bt Cry proteins, 
are currently used in Bt-crops to control insect pests, since they do not share the same mode of action. 
Here we characterized the response of Spodoptera exigua
showed that the up-regulated genes were mainly involved in immune response, whereas the down-
regulated genes were mainly involved in the digestion process. Other mechanisms of cellular response 
to the damage such as apoptosis were analyzed. For this analysis, sections from the midguts were 
examined by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining. The 
caspase genes. The 
present study shows that exposure of S. exigua
shedding, and apoptotic cell death.
The concern over the excessive use of chemical insecticides has increased in recent years, due to the ecological 
impact, as well as to the selection for resistance in field insect populations1. Among the different biological alter-
natives for pest control, one of the most popular is the use of bioinsecticies based on Bacillus thuringiensis2. This 
bacterium produces a wide range of insecticidal proteins which are active against a number of agricultural pest 
species3. Insecticidal crystal proteins (Cry proteins) are being used to control insect pests in formulated sprays 
since 19384 and, since 1996, they have been expressed in transgenic crops to protect them from insect attack5. 
More recently, a novel class of insecticidal proteins (Vip3 proteins) have also been introduced in transgenic crops 
to complement the toxic action of the Cry proteins, as well as to reduce the risk of insect resistance development 
in the field6 (ISAAA GM Approval Database. http://www.isaaa.org/gmapprovaldatabase).
Cry proteins are highly specific against their target insects and are generally recognized as pore-forming toxins 
(PFTs)7. The mode of action of these proteins has been extensively studied for more than 20 years, especially for 
Cry1A proteins8,9. In general, it is accepted that these toxins are solubilized in the insect gut and then activated 
by the action of digestive enzymes. The active forms bind to specific receptors in the brush border of epithelial 
midgut cells and induce pores in the membrane which eventually lead to septicemia and insect death9. Nowadays, 
different models have been proposed to explain how these proteins exert their cytotoxicity, however some aspects 
remain unclear8,10. Much less is known about the mode of action of Vip3 proteins. The Vip3Aa protein was the 
first member of the family of Vip3 proteins being described11 and most studies dealing with the mode of action 
of Vip3 proteins have been performed with this protein12. The available information supports that these pro-
teins act by forming pores in the midgut epithelial cells13,14. As for Cry proteins, Vip3 proteins are synthesized 
)
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as protoxins which are processed by proteases in the larva midgut rendering the active form, which then binds 
to specific receptors in the brush border of epithelial midgut cells15–18. After binding, the Vip3 protein induces 
disruption of the midgut epithelial cells18–21 by its pore forming activity13,14. One very interesting feature of the 
Vip3 proteins mode of action is that they do not share membrane binding sites with Cry proteins, a property 
which does not only complement the spectrum of activity of Cry proteins, but also decreases the chances of 
cross-resistance13,14,17,22,23.
The insect gut is not only an organ of digestion but also constitutes the first physical barrier that protects the 
host against penetration of both pathogenic and commensal microorganisms24,25. In mammals, some studies have 
identified the mechanisms that regulate gut mucosal immunity, revealing a central role of innate immunity in 
these processes26. Despite the fact only few studies have been conducted in insects, the available data suggest that 
midgut epithelial tissue of the insects challenged with either pathogenic or nonpathogenic bacteria27–29 is able to 
trigger an immune response to reduce the cellular and tissue damage. Therefore, the insecticidal activity of Cry 
and Vip proteins might be affected by the host defense response, since they exert their toxic action in the midgut 
of the target insects.
Transcriptomic and proteomic approaches are being helpful to elucidate which mechanisms are involved in 
the host responses to B. thuringiensis proteins in non-model insects of agricultural importance30–37. In general, 
these analyses point out that, after protein exposure, the insects usually increase their immune function in addi-
tion to reduce their digestive activity38,39. Some reports have shown that the expression of some components of the 
mitogen-activated protein kinase (MAPK) cascade were up-regulated in response to Cry proteins in Coleoptera, 
Diptera, and Lepidoptera40–43. Additionally, other gene families have been described to be transcriptionally regu-
lated in response to Cry and Vip3 proteins in Spodoptera exigua larvae30,31,44–46, such as the response to pathogens 
(REPAT) genes, though their specific role in host response still remains unclear38,45.
Apoptosis has also been described as a mechanism of cellular response after the exposure of cultured cells 
with different PFTs47–50. In vitro experiments with midgut primary culture cells from Heliothis virescens showed 
that Cry toxins induced apoptosis in epithelial cells51. More recently, similar results were observed when CF1 or 
Sf9 cultured cells were exposed to Cry1A or Vip3Aa proteins, respectively52,53. In vivo assays also showed that 
apoptosis could be observed in insect midgut epithelial cells when Cry proteins were administered to both Culex 
pipiens and Bombyx mori larvae54,55.
The activation of different mechanisms of response in S. exigua larvae after the exposure to different B. thur-
ingiensis proteins (Cry and Vip3 proteins) has been reported30,31,38,56. These mechanisms of response might con-
tribute to reduce the damage produced by B. thuringiensis proteins to the insect. To date, the genes identified in 
the S. exigua response to B. thuringiensis proteins have been found to be involved in many different aspects of the 
insect biology such as: metabolism, immune-response, detoxification, and epithelial renewal, among others38. The 
present work extends previous studies carried out on S. exigua larvae with the analysis of the expression profile 
of 47 genes after Vip3Ca exposure. These selected genes were previously found differentially expressed after the 
exposure to other B. thuringiensis proteins and other pathogens31,56,57. Thus, the data obtained in the present study 
could help understand whether the S. exigua response to Vip3Ca is specific or, on the contrary, it is a conserved 
feature independent of the toxic agent to which the insects are exposed to. Furthermore, the damage produced by 
Vip3Ca and Vip3Aa proteins has been characterized by measuring the in vivo response of the midgut epithelial 
cells (APN shedding and apoptosis).
Growth inhibition assays. Susceptibility of S. exigua 4th instar larvae against the Vip3Ca protein was deter-
mined in terms of the effect on larval growth inhibition. The results showed a dose-response relationship, with an 
EC50 of 38.4 ng/cm2 (Fig. 1). Therefore, despite the fact that Vip3Ca has negligible activity, in terms of mortality, 
against S. exigua58, it has a clear effect on larval growth inhibition.
The expression profile of 47 genes was ana-
lyzed in S. exigua midguts by qRT-PCR, after 24 h exposure to Vip3Ca. To be able to compare gene expression 
Figure 1. Growth inhibition dose-response curve of newly molted 4th instar S. exigua larvae after exposure to 
Vip3Ca for 24 h. Each value represents the mean of at least three independent experiments (±SEM).
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results with those previously reported after Vip3Aa challenge31,56, the concentration of Vip3Ca to cause 99% 
growth inhibition on 4th instar S. exigua larvae (1000 ng/cm2) was used. In order to test whether a lower or higher 
concentration of Vip3Ca could alter the regulatory effect on these genes, their expression levels were also deter-
mined after a challenge with either 100 or 10000 ng/cm2 of Vip3Ca.
The results showed that the number of genes whose expression was altered was different depending on the 
exposure condition (concentration of Vip3Ca) (Fig. 2). At the lowest concentration of Vip3Ca (100 ng/cm2), only 
5 genes (about 11%) were regulated (Fig. 2 and Supplementary Table S1), whereas at the other two concentra-
tions tested, 1000 and 10000 ng/cm2, the number of regulated genes was 20 (about 43%) and 29 (around 62%), 
respectively. The distribution of up- and down-regulated genes, according to the concentration of Vip3Ca used in 
each treatment, is summarized in Supplementary Fig. S1. Almost all the regulated genes at 100 and 1000 ng/cm2 
were also found regulated at 10000 ng/cm2 of Vip3Ca, suggesting that the response can be dose-dependent. The 
ratio of up-regulated and down-regulated genes at 100 and 1000 ng/cm2 was similar (3 up- and 2 down-regulated, 
and 12 up- and 8 down-regulated, respectively). However, at 10000 ng/cm2, the ratio of up-regulated genes and 
down-regulated genes was higher (22 vs. 7, respectively). The levels of transcriptional activation ranged from 
2.8-fold to 46.5-fold, whereas the levels of transcriptional repression ranged from 2.5-fold to 653-fold (Figs 3, 4 
and Supplementary Table S1).
At 100 ng/cm2, the up-regulated genes included a member of the REPAT family (REPAT2), a gene coding for 
a juvenile hormone binding protein (SE_U56776), and one for for a pancreatic lipase (SE_U08322). Of the two 
down-regulated genes, one had homology with a lipase gene, whereas the other two had no homology to known 
genes from public sequence databases (SE_U12696).
Figure 2. Overview of the regulated genes in S. exigua midgut after Vip3Ca challenged at 100 (a), 1000 (b), and 
10000 (c) ng/cm2. A total of 47 genes were analyzed. The number of up- and down-regulated genes are indicated 
in red and green bars, respectively.
Figure 3. Analysis of the genes whose expression is up-regulated after 24 h exposure at three concentrations 
of Vip3Ca. (a) Immuno-related genes (b) Non immuno-related genes. White, grey, and black bars represent 
the gene expression of each transcript after Vip3Ca challenged at 100, 1000, and 10000 ng/cm2, respectively. 
Abbreviations: βGRP: beta-1,3-glucan recognition protein. The expression of each gene in the gut of Vip3Ca 
exposed larvae was compared to its control in the gut of control larvae (exposed to WK6). Fold-changes were 
determined by using the REST MCS software. Each bar represents the mean of three independent experiments 
(±SD). Significant differences were indicated by an asterisk.
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At the concentration of Vip3Ca to provoke 99% growth inhibition on 4th instar S. exigua larvae (1000 ng/cm2) 
most of the up-regulated genes (7 out of 12) encoded antimicrobial peptides (AMPs), being the most up-regulated 
ones Diapausin A6 and Lebocin 1. The gene coding for the beta-1,3-glucan recognition protein (β-GRP) was only 
slightly overexpressed. Additionally, the other up-regulated genes showed homology with genes that encoded 
juvenile hormone binding proteins (SE_U17986 and SE_U13239) and for pancreatic lipases (SE_U20473 and 
SE_U08322). Around 88% of the down-regulated genes showed homology to known genes from public sequence 
databases, including those coding for lipases, proteases and chitin deacetylases (Supplementary Table S1). The 
biggest repression (653-fold) was observed for one gene which no homology to known gene (SE_U12696). 
The Cobatoxin B gene, as well as the immune signaling pathway JAK-STAT gene, were also found slightly 
down-regulated.
At the highest concentration used (10000 ng/cm2) the scenario observed was similar to the one described 
for the larvae exposed to 1000 ng/cm2. Fifteen of the twenty-two up-regulated genes encoded AMPs (Fig. 3). 
These 15 AMPs belong to different groups such as the cysteine-rich peptides (Diapausin A1-A3, A6 and A7, and 
Spodoptericin), glycine- and proline-rich peptides (Gloverin), amphipatic peptides (Cecropin B, C, and E, and 
Moricin) and lysozymes (LYZ1, 2, and 3). Other up-regulated genes showed homology with genes that encoded 
juvenile hormone binding proteins (SE_56776, SE_U17986, and SE_U13239), for a Diapausin precursor (SE_
U33476), for pancreatic lipases (SE_U20473 and SE_U08322), and for a gene with no homology to any known 
gene (SE_U08997). The down-regulated genes showed homology with those coding for lipases, proteases and 
chitin deacetylases (Supplementary Table S1). Again, the biggest repression (167-fold) was observed for the gene 
SE_U12696. The gene encoding for the AMP LLP1 was also found slightly down-regulated.
Shedding of membrane-bound APN 
to the lumen, as a marker for epithelial damage, was measured after 24 h exposure to Vip3 proteins at the concen-
tration of 100 ng/cm2 of Vip3Aa and at 3 different concentrations of Vip3Ca (100, 1000, and 10000 ng/cm2). The 
results showed that, in larvae exposed to Vip3Ca, the APN activity in the luminal fluid increased ca. 3-fold and 
6-fold at 1000 or 10000 ng/cm2, respectively, though no significant change was observed at 100 ng/cm2 (Fig. 5). 
A correlation between growth inhibition and the amount of APN released into the luminal fluid produced by 
Vip3Ca protein was observed (Supplementary Fig. S2).
The luminal APN activity of those larvae exposed to 100 ng/cm2 of Vip3Aa increased ca. 5-fold. Interestingly, 
the APN activity in the lumen fluid of larvae exposed to a concentration that produces a 99% of growth inhibition 
for each respective Vip3 protein (100 ng/cm2 for Vip3Aa and 1000 ng/cm2 for Vip3Ca) was significantly higher 
for Vip3Aa.
Determination of epithelial cell damage by the TUNEL assay. To test whether exposure to sub-
lethal concentrations of Vip3Ca could trigger a signaling pathway leading to the death of the epithelial cells 
by apoptosis, midguts of larvae exposed for 24 h to Vip3Ca were sectioned and stained with the DeadEndTM 
Fluorimentric TUNEL system. Midguts of larvae exposed to Vip3Aa were used for comparative purposes. The 
results showed that in control larvae (exposed to WK6 proteins) and in starving larvae, no TUNEL-positive cells 
were observed. No TUNEL-positive cells were observed either after Vip3Ca treatment at the two lowest con-
centrations used (10 and 100 ng/cm2). However, a few TUNEL-positive cells were observed in the gut of larvae 
intoxicated with 1000 ng/cm2 of Vip3Ca and, at the highest concentration used (10000 ng/cm2), almost all the 
cells were TUNEL-positive (Fig. 6). In the case of Vip3Aa challenge, TUNEL-positive cells were observed in the 
gut of the larvae intoxicated with the three lowest concentrations (1, 10 and 100 ng/cm2) and no TUNEL-positive 
cells were found at the highest concentration (1000 ng/cm2) (Fig. 6).
Figure 4. Analysis of the genes whose expression is down-regulated after exposure 24 h at three concentrations 
of Vip3Ca. White, grey, and black bars represent the gene expression of each transcript after Vip3Ca challenged 
at 100, 1000, and 10000 ng/cm2, respectively. The expression of each gene in the gut of Vip3Ca exposed larvae 
was compared to its control in the gut of control larvae (exposed to WK6). Fold-changes were determined 
by using the REST MCS software. Each bar represents the mean of three independent experiments (±SD). 
Significant differences were indicated by an asterisk.
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S. exigua larval midgut chal-
The induction of the apoptotic process was analyzed in the midgut epithelial cells, at 
the molecular level, by measuring the change in transcription levels of 5 caspase genes by qRT-PCR. The tran-
scription levels of the gene encoding a component of the JAK-STAT pathway was also analyzed since this pathway 
has been related with the renewal of the midgut tissue59,60. To analyze the time course of apoptosis, the expression 
level of the six genes were monitored at 4 different time points: 3 h, 6 h, 12 h, and 24 h after Vip3Ca challenge at 
10000 ng/cm2. After either 3 h or 6 h of exposure, only Se-Caspase-4 was found up-regulated, whereas after 12 h of 
exposure four of the 5 caspase genes studied were found up-regulated (Fig. 7). In contrast, none of the 5 caspase 
genes studied were found regulated after 24 h exposure. These data suggest that the main transcriptional induc-
tion of apoptotic machinery occurs after 12 h exposure. The gene coding a component of the JAK-STAT pathway 
was found down-regulated after 3 h, 6 h, and 12 h of Vip3Ca challenge (Fig. 7).
Fitness cost analysis. Since the exposure to Vip3 proteins affected the transcriptional pattern of S. exigua 
larvae and caused epithelial and cellular damage, we wanted to determine whether the exposure also had an asso-
ciated fitness cost. The results showed significant differences in the time to pupation for those larvae exposed to 
higher concentrations of either Vip3Aa (10, 100, and 10000 ng/cm2) or Vip3Ca (100, 1000, and 10000 ng/cm2), 
as compared to control larvae and with larvae exposed to lower concentrations (Fig. 8a). Interestingly, the time 
to pupation was also found significantly longer in starving larvae. The percentage of pupation was found signifi-
cantly lower in those larvae exposed to the highest concentration of either Vip3Aa or Vip3Ca (Fig. 8b).
Discussion
A better knowledge of the different mechanisms of insect response after the exposure to different B. thuringiensis 
proteins will broaden our understanding of how larvae response might help to reduce the damage produced by 
these insecticidal proteins. In the present study, the expression profile of 47 selected genes was analyzed in S. 
exigua larvae challenged with three concentrations of Vip3Ca. These genes were previously found differentially 
expressed after the exposure to Vip3Aa, Cry1Ca, and other pathogens31,56,57. In order to compare our results with 
those obtained previously by Bel et al.31 and by Crava et al.56, a concentration of Vip3Ca which caused a 99% of 
growth inhibition was used as a starting point. Thus, the data obtained could help understand whether the S. 
exigua response to Vip3Ca is specific or, on the contrary, it is a conserved feature independent of the toxic agent 
to which they are exposed to.
The gene expression results showed that at the lowest concentration of Vip3Ca tested (100 ng/cm2) the num-
ber of regulated genes was lower (about 11%) than when larvae were exposed to 1000 or 10000 ng/cm2 of Vip3Ca 
(around 43% and 62%, respectively). Moreover, almost all the regulated genes at 100 and 1000 ng/cm2 were also 
found regulated at 10000 ng/cm2 of Vip3Ca, suggesting that the host response is dose-dependent. In general, our 
results agree with previous gene expression studies which showed the up-regulation of genes involved in immune 
system and hormone modulation (e.g. JH binding protein), and the down-regulation of genes involved in the 
digestion process (e.g. serine proteases) and peritrophic membrane permeability (e.g. chitin deacetylases), upon 
exposure to different B. thuringiensis proteins28,30,31,35,36,61–65. The highest value of down-regulation (653-fold) 
found in this study was obtained for one gene with unknown function when larvae were exposed to 1000 ng/cm2 
of Vip3Ca. Similar results were observed by Bel et al.31 when S. exigua larvae were exposed to Vip3Aa. This gene 
encodes a putative protein called REVIP because it was detected in Response-to-Vip intoxication.
In our study we have included different S. exigua immune-related genes which were classified in three catego-
ries by Pascual et al.66: (a) pathogen recognition, (b) immune signaling pathways and melanization process, and 
(c) antimicrobial effectors (Supplementary Table S1). A general upregulation of the immune-related genes was 
Figure 5. Activity of the APN protein in the midgut lumen of larvae exposed for 24 h to WK6 proteins (control 
larvae), Vip3Ca (three concentrations) or Vip3Aa (one concentration). Means were compared by one-way 
ANOVA, followed by Dunnett’s comparison test (P < 0.001). Significant differences between control larvae and 
treated larvae were indicated by different letters.
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Figure 6. Effect of sublethal concentrations of Vip3Ca and Vip3Aa proteins to Spodoptera exigua midgut 
epithelial cells. L4 newly molted larvae were intoxicated with Vip3 proteins for 24 h and then midgut tissue 
sections were prepared and stained with TUNEL (green signal) and DAPI (blue signal). As controls, larvae 
fed with the empty vector (WK6) and 24 h starving larvae were used. Magnification was 100× for the Vip3Ca 
protein and 200× for the Vip3Aa protein. L, gut lumen.
Figure 7. Analysis of the transcriptional induction of apoptotic related genes at 10000 ng/cm2 of Vip3Ca for 
3 h, 6 h, 12 h, and 24 h. The expression of each gene in the gut of larvae exposed to Vip3Ca was compared to its 
control in the gut of control larvae (exposed to WK6 empty vector). Fold-changes were determined by using 
the REST MCS software. Each bar represents the mean of three independent experiments (±SD). Significant 
differences were indicated by an asterisk.
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observed after Vip3Ca exposure at 1000 and 10000 ng/cm2, though it is worth to note that the genes belonging to 
the antimicrobial effectors were more clearly regulated after Vip3Ca exposure than the other genes. These anti-
microbial effectors are produced to act as barriers against the progress of bacterial infections67. Here we analyzed 
the transcriptional response of 24 genes coding for 21 AMPs and 3 lysozymes. These genes were described in a 
detailed study performed by Crava et al.56 where most of the 24 genes were found up-regulated after Vip3Aa expo-
sure at a concentration to provoke 99% growth inhibition on 4th instar S. exigua larvae. Our results showed that 
none of these genes were found regulated in response to the lowest concentration of Vip3Ca used. Conversely, 
when S. exigua larvae were exposed at 1000 or 10000 ng/cm2 of Vip3Ca, the number of regulated AMPs genes was 
8 and 15, respectively. Our data agree with previous data obtained from Crava et al.56 in that the response of the 
S. exigua larvae might be associated to the level of cell damage produced by the different B. thuringiensis proteins 
used and not to the mode of action of these proteins.
Genes from the three main immune signaling pathways (Toll, Imd, and JAK-STAT) were also represented in 
our study. The results showed that neither the Toll-like receptor gene nor the Imd gene were found to be regulated 
at any of the 3 concentrations tested. In contrast, the gene encoding a component of the JAK-STAT pathway was 
down-regulated after 24 h exposure to 1000 ng/cm2 of Vip3Ca. Additionally, the expression of this gene was also 
found down-regulated when larvae were exposed at 10000 ng/cm2 of Vip3Ca for lower times (3 h, 6 h, and 12 h). 
The JAK-STAT pathway has been shown to be involved in the activation of the midgut renewal by the proliferation 
and differentiation of the stem cells59,60,68. Thus, we speculate that the negative regulation of this pathway might 
be affecting the renewal of the midgut cells that have been damaged by the action of the Vip3Ca protein. This 
negative regulation might be a host defense response for gut healing processes after entomopathogen exposure39. 
The lack of regulation of the Toll and Imd immune signaling pathways was also described when S. exigua larvae 
were exposed to Vip3Aa protein31. It is worth to note that the activation of most of the immune signaling path-
ways relies mainly on post-translational modifications (e.g. phosphorylation) and to a lesser extent on transcrip-
tional regulations40,69.
The effect of Vip3Aa and Vip3Ca proteins on the midgut epithelial cells was measured by determining the 
APN activity into the luminal fluid. The results showed that both Vip3 proteins cause APN shedding into the 
luminal fluid in S. exigua larvae. The ability of some B. thuringiensis proteins and other pore forming toxins 
(PFTs) to cause shedding of cell surface proteins has already been reported70–72. In agreement with our results, 
Valaitis et al.70 found that exposure to Vip3Aa induced shedding of APN in Lymantria dispar larvae. However, 
they hypothesized that the APN shedding would not be involved in host defense to B. thuringiensis proteins, 
since the inhibition of the APN shedding by cyclic AMP did not affect their toxicity70. Here we observed a clear 
dose-response relationship between the growth inhibition produced by increasing concentrations of Vip3Ca and 
the APN activity in the lumen of the larvae. This result supports that the depletion of the APN is stronger when 
the damage produced to the epithelial cells is larger. Moreover, when comparing the APN shedding observed after 
exposure using a concentration of either Vip3Aa or Vip3Ca proteins which produces 99% growth inhibition (100 
and 1000 ng/cm2, respectively), the results showed that the luminal APN activity is higher in those larvae exposed 
to Vip3Aa than in those exposed to Vip3Ca. This result suggests that the cell damage produced by the Vip3Aa 
protein might be larger than the one produced by the Vip3Ca protein. Moreover, this result is in agreement with 
the results obtained in the gene expression analysis, since the exposure to Vip3Aa seems to regulate the expression 
of more genes that the exposure to Vip3Ca, at the same dose, in S. exigua larvae.
The analysis of the S. exigua midguts exposed to sublethal concentrations of Vip3Aa and Vip3Ca proteins by 
TUNEL assays showed the presence of TUNEL-positive cells at different concentrations of each protein (Fig. 6). 
TUNEL-positive cells were clearly observed at the highest concentration (10000 ng/cm2) of the Vip3Ca protein. 
In contrast, TUNEL-positive cells were detected at the lowest and intermediate concentrations of Vip3Aa (1, 10, 
and 100 ng/cm2). No TUNEL-positive cells were observed at the highest concentration of Vip3Aa (1000 ng/cm2), 
Figure 8. Analysis of the associated fitness cost on S. exigua 4th instar larvae after Vip3Ca or Vip3Aa exposure. 
Two parameters were measured: (a) number of days to pupation, and (b) % of pupation. Means were compared 
by one-way ANOVA, followed by Dunnett’s comparison test (P < 0.001). Significant differences between control 
larvae and treated larvae were indicated by an asterisk.
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probably due to the fact that, at this concentration, epithelial cells might be responding by other mechanisms 
and/or by other signal-transduction pathways to respond to such an attack73,74 or it might happen that most of 
the cell membrane was disrupted. The histopathological effects produced in larvae from Mamestra brassicae after 
exposure to either Vip3Aa or Vip3Ca has been described by Gomis-Cebolla et al. (2016)18. The results showed 
that feeding with both Vip3 proteins produced disruption of the midgut epithelium, though the damage caused 
by Vip3Aa protein was detected earlier, in agreement with its higher toxicity. Consistent with our data, Tanaka 
et al.55 reported the presence of TUNEL-positive midgut cells in B. mori larvae when treated with sublethal con-
centrations of Cry1Aa and few TUNEL-positive cells when larvae were exposed to lethal concentrations. On the 
basis of these observations, we can speculate that disruption of midgut cell membranes, by the pore formation 
activity, is a main event that occurs when the insect species are exposed to a high dose of an active B. thuringiensis 
protein. Nevertheless, other events, such as apoptosis, may happen when larvae are exposed to sublethal doses. 
Thus, apoptotic events might involve a host defense response to the damage produced by the toxic agent, leading 
to renewal of the epithelial layer39,73.
Although the mode of action of Vip3 proteins is still not completely resolved, it is commonly accepted that, 
similarly to Cry proteins, they bind to specific receptors and form pores in the brush border of the epithelial 
cells13,15,17,18. Additionally, some studies have reported that Cry proteins can activate different intracellular cas-
cade pathways, leading to apoptotic cell death10,51,52,54,55. The ability to produce pores in their target cells and also 
to activate different intracellular cascade pathways has also been described for other toxins (e.g. aerolysin and 
alpha-toxin) produced by other bacteria75,76. Apoptosis is a special and highly regulated type of programmed cell 
death that can be induced by different factors. Apoptosis has a fundamental role in biological process such as: 
development, tissue homeostasis, DNA damage response, and immune response77. In mammalian cells, PFTs kill 
cells by two different mechanisms: (1) apoptosis, characterized by the activation of initiator caspases that trigger 
effector- caspases to cleave cellular substrates, and (2) inflammatory responses by the activation of inflammatory 
caspases78. Caspases (cysteine-dependent aspartate-specific proteases) are a family of evolutionary conserved 
proteins that have been described for playing a key role in apoptosis79. In addition to the TUNEL assays, apoptosis 
was monitored by the analysis of the expression levels of five caspase genes. The results showed that expression 
level of the Se-Caspase-4 was highly up-regulated after 3 h, 6 h, and 12 h. This gene has special sequence features 
and its function has not been assessed yet79. Nevertheless, as this gene is regulated after 3 h of exposure we can 
hypothesized that it might play a role in the pro-apoptotic proteolytic cascade as an initiator caspase. The expres-
sion levels of the initiator Se-Caspase-6 and the effector Se-Caspases-1 and -2 genes were found up-regulated after 
12 h of Vip3Ca exposure. The expression levels of the gene coding Se-Caspase-3 was not regulated at the different 
times tested, indicating that maybe it would not be involved in the host response to Vip3 exposure.
Here we show for the first time that Vip3Aa and Vip3Ca trigger apoptosis in S. exigua midgut epithelial cells in 
vivo. However, further research will be required to define the apoptotic signal transduction pathway induced by 
both Vip3 proteins in S. exigua larvae. It was recently reported that Vip3Aa can induce apoptosis in Sf9 cultured 
cells and that this is mediated by the mitochondrial and caspase dependent pathways53. Portugal et al.52 showed 
that Cry1A proteins induced apoptosis in CF1 cultured cells. Interestingly, the authors observed that the pore 
formation activity of the Cry1A proteins is necessary to induce apoptosis. It is possible that, with Vip3 proteins, 
pore formation is also a necessary step for cells to enter the apoptotic pathway.
In summary, the results from the present study show that exposure of S. exigua larvae to sublethal concen-
trations of Vip3Ca (a protein with low activity against this insect) activates different insect response pathways 
which trigger the regulation of some genes (such as the antimicrobial effectors, caspases), induces APN shedding, 
and triggers other signals that lead to apoptotic cell death. Understanding the host response process to the B. 
thuringiensis proteins currently used in insect control will help to shed light on insect defensive mechanisms to 
toxic agents.
Materials and Methods
Insects. Larvae from the S. exigua FRA colony were kindly supplied by M. López-Ferber, INRA (St Christol 
les Alés, France). The insects were reared on artificial diet at 25 °C with a relative humidity of 70% RH and a pho-
toperiod of 16 h/8 h (light/dark). The FRA colony had been maintained for more than 10 years without exposure 
to pathogens80.
The Vip3Aa protein (NCBI acces-
sion No. AAW65132) was overexpressed in recombinant Escherichia coli BL21 carrying the vip3Aa16 gene. The 
Vip3Ca protein (NCBI accession No. AEE98106) was overexpressed in E. coli WK6 carrying the expression vector 
pMaab 10 (kindly supplied by Bayer CropScience N.V., Ghent, Belgium). Protein expression and lysis of Vip3Aa 
and Vip3Ca was carried out following the conditions described by Abdelkefi-Mesrati et al.81 and Gomis-Cebolla 
et al. (2016)18, respectively.
Vip3Aa and Vip3Ca proteins in the cell lysates were further purified by isoelectric point precipitation (Ipp) as 
described by Chakroun et al.82. The pH of the lysates was lowered with acetic acid to pH 5.5 for Vip3Aa, and to pH 
5.9 for Vip3Ca. After centrifugation, the precipitated proteins were resuspended in solubilization buffer (20 mM 
Tris-HCl, 150 mM NaCl, pH 9) and dialyzed against the same buffer overnight. The amount of Vip3 proteins was 
quantified by densitometry after SDS-PAGE electrophoresis using the TotalLab 1D v13.01 software. As a control, 
the empty E. coli WK6 strain was cultured and processed in the same way as described above for the Vip3Ca 
producing strain.
Growth inhibition assays. Susceptibility of newly molted 4th instar S. exigua larvae to Vip3Ca was deter-
mined by growth inhibition assays using surface contamination method as previously described80. Sixteen lar-
vae were individually exposed to each concentration for 24 h. As a control, 16 larvae were exposed to a protein 
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preparation from the empty E. coli WK6 strain. For this, the pellet obtained after the Ipp of the empty E. coli WK6 
was prepared in the same way as with the Vip3Ca protein. Five independent biological replicates were performed. 
The percentage of growth inhibition (% GI) was calculated as described Herrero et al.83, using the formula: % 
GI = [1 − (RGt/RGc)] × 100, where RGt and RGc represent the relative growth of larvae after exposure to either 
Vip3Ca or the empty E. coli WK6 strain preparation (control larvae), respectively. Relative growth was calculated 
as RG = [(W1 − W0)/W0], where W0 and W1 are the initial and final weight of the larva, respectively. The effec-
tive concentrations which produced a reduction in the larval growth of 50% and 99% were calculated using the 
GraphPad Prism v. 5.1 (GraphPad Inc., La Jolla, CA, US) using a non-linear logistic model (Hill equation).
The effect of Vip3Ca and Vip3Aa proteins 
on two parameters of fitness was determined: time to pupation and percentage of pupation. Sixteen 4th instar 
larvae were individually exposed to 10, 100, 1000, and 10000 ng/cm2 of Vip3Ca or to 1, 10, 100, and 1000 ng/cm2 
of Vip3Aa. As a control, 16 larvae were exposed to a protein preparation from the empty E. coli WK6 strain. After 
24 h exposure, larvae were transferred to non-intoxicated diet to complete their development. Three independent 
biological replicates were performed. The developmental time from 4th instar larvae to pupa and the number of 
pupae was daily recorded.
Gene expression analysis. The expression profile of 47S. exigua genes, which were previously described 
as responding to a Vip3Aa challenge or other pathogens31,56,57 (Supplementary Table S1), was analyzed under 
two different conditions: WK6 exposed (used as a control) and Vip3Ca exposed. For this purpose, sixteen 
newly molted 4th instar larvae were individually exposed to 100, 1000, and 10000 ng/cm2 of Vip3Ca for 24 h. 
For the analysis of the expression levels of apoptosis-related genes, five S. exigua caspase genes were selected79 
(Supplementary Table S2). Six newly molted 4th instar larvae were individually exposed to 10000 ng/cm2 of 
Vip3Ca for 3 h, 6 h, 12 h and 24 h. Then, larvae were dissected and midguts pooled and stored at −80 °C until 
used. Three independent biological replicates were performed.
RNA was purified from larval midguts using the RNAzol RT reagent (Sigma-Aldrich, St. Louis, MO, US) 
according to the manufacturer’s instructions. Purified RNA (0.5 μg) was then treated with DNase I (Invitrogen, 
Carlsbad, CA, US) and subsequently reverse-transcribed to cDNA using oligo-(dT) primers and the SuperScript 
II Reverse Transcriptase (Invitrogen), following the manufacturer’s protocol. Quantitative real-time PCR 
(qRT-PCR) was carried out using EvaGreen® (Biotis, Vilnius, Lithuania) following standard protocols and meas-
ured in an ABI Prism 7700 Sequence Detection System (Applied Biosystems). Each reaction was performed in 
a final volume of 20 μl, which contained 4 μl of cDNA (300 ng). Forward and reverse primers were added to a 
final concentration of 300 pM. Primers used in this study are described in Supplementary Tables S1 and S2. The 
47 selected genes analyzed in this study, including the house-keeping gene, were previously designed and their 
efficiency tested by other authors31,56,57. Specific primers for the five S. exigua caspase genes used in this study 
were designed on the basis of their sequences from the NCBI database (HQ328953, HQ328958, HQ328966, 
HQ328975, and HQ328993) using Primer Express Software from Applied Biosystems (Carlsbad, CA, US) 
(Supplementary Table S2). Prior to quantifying differential expression among different treatments, the efficiency 
of each pair of primers was evaluated by performing 3-fold dilution series experiments. The specific amplification 
of transcripts was verified by dissociation curve analysis. The Rest MCS software (version 2) was used to obtain 
the expression ratios (-fold change)84.
Measurement of aminopeptidase activity in the midgut lumen. The APN activity in the midgut 
lumen from S. exigua larva treated with either Vip3Ca or Vip3Aa proteins was measured as a marker to evaluate 
the damage produced by the proteins after 24 h exposure. At least three independent replicates were performed 
for each condition. In each replicate, sixteen 4th instar newly molted larvae were exposed to four different con-
centrations of Vip3Ca (10 100, 1000, and 10000 ng/cm2) and to one single concentration of Vip3Aa (100 ng/
cm2). The concentration of Vip3Aa used produced a 99% of growth inhibition according to a previous study31. 
As a control, WK6 proteins prepared as for the Vip3Ca sample were used. The contents from at least 10 midguts 
(for each condition) were obtained and transferred into 100 μl of 50 mM Tris-HCl, pH 7.5, 1 mM PMSF. Then, 
midgut contents were vortexed for 30 s, centrifuged at 21 000 x g for 5 min at 4 °C, and the supernatant was used 
for activity assays. Protein concentration was determined by Bradford85. APN activity was determined using 4 
mM L-leucyl-p-nitroanilide in 50 mM Tris-HCl (pH 7.5) buffer as substrate. The released of p-nitroanilide was 
monitored at 405 nm for 2 min using a Tecan Infinite 200 plate reader (Switzerland). An extinction coefficient of 
9.9 mM−1 cm−1 for p-nitroanilide was used.
Sectioning of insect tissues and TUNEL staining. Fragmentation of the DNA in the midgut epithelial 
cells from S. exigua larva exposed to either Vip3Ca or Vip3Aa proteins was measured as a marker of apoptosis. 
DNA fragmentation was measured using the principle of TUNEL (TdT-mediated dUTP Nick-End Labeling), 
which consists on the catalytical incorporation of a labelled dUTP (2′-deoxyuridine 5′-triphosphate) at the 
3′- hydroxyl (-OH) group of the DNA end using a terminal deoxynucleotidyl transferase. For TUNEL staining 
assays, 4th instar newly molted larvae were treated for 24 h under four different conditions: WK6 exposed (used 
as a control), Vip3Ca exposed, Vip3Aa exposed, and starving (larvae kept without food for 24 h). In each assay, 
16 larvae were exposed to four different concentrations of Vip3Ca (10, 100, 1000, and 10000 ng/cm2) or Vip3Aa 
(1, 10, 100, and 1000 ng/cm2). Three independent biological replicates for each treatment were performed. After 
24 h exposure, only larvae actively eating (as determined by observing the food bites) were selected, flash frozen 
and kept at −80 °C until used. Sections of 10 μm were prepared by the microscopy facilities at the Universitat de 
València using the cryostat microtome Leica CM 1510 S. Slides with the tissue sections were stored at −20 °C until 
used. Tissue sections were treated with the DeadEndTM Fluorimentric TUNEL system (Promega) following the 
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manufacturer’s instructions. Nuclear DNA was stained with DAPI (4′,6-diamidino-2-phenylindole) as described 
by Chazotte86. Coverslips were mounted using mounting medium from Sigma. Tissue sections were then exam-
ined using Leica DMI2500 microscope equipped with a digital color camera (Leica DFC300 FX). Tissue sections 
were stained with hematoxylin and eosin as was described elsewhere87 to check the quality of the midgut sections 
(Supplementary Fig. S3).
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8. - General Discussion 
 
B. thuringiensis is one of the entomopathogenic bacteria used for the control of the plant 
eating insect species. B. thuringiensis shows high specificity to lepidopteran pests due the 
presence of parasporal crystals that contain the insecticidal proteins such as Cry proteins. 
An approach to improve the effect of these insecticidal proteins is combining them either 
in a B. thuringiensis formulation (B. thuringiensis isolates selected by their combination 
of insecticidal proteins in the parasporal crystal) or by plant expression (Bt crops). The 
use of Bt crops has increased quickly during the last decade and, despite its high efficacy 
as a biological control agent, there are some concerns over the narrow spectrum of activity 
of the individual toxins and also the threat of emergence of resistance in insects 
populations. 
An way to address these concerns is the search for novel toxins with new insecticidal 
spectra or new mode of action. One way to discover new insecticidal protein genes is the 
screening of B. thuringiensis collections (PCR or NGS approach) from different locations 
and environments. Several studies have been performed with this aim which have 
rendered a high number of new insecticidal protein genes 
(http://www.lifesci.sussex.ac.uk/Home/Neil_Crickmore/Bt/). As an example, the B. 
thuringiensis vegetative insecticidal proteins (Vip1, Vip2, Vip3 and Sip) are a class of 
new proteins discovered in a screening of different B. thuringiensis collections (1–3). 
Interestingly this class of new insecticidal proteins has shown to be significantly more 
active against several agronomically important insects, specifically the Vip3 proteins. 
Knowing the importance of these proteins for the biological control, this thesis has been 
dedicated to determine the toxicity and mode of action of Vip3Ca (a member of a new 
Vip3 protein family) and mining of new insecticidal protein genes in B. thuringiensis 
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8.1 - Characterization of the mode of action of Vip1 and Vip2 proteins and mining 
of new vip1 and vip2 protein genes 
 
Our first observation starts with the identification of vip1-, vip2- and vip4-type genes in 
the eleven B. thuringiensis isolates selected based on their content in vip1 and vip2 genes 
(4). As a first step, the PCR-Sanger Sequencing approach revealed, in 7 out 9 B. 
thuringiensis isolates, two new alleles of the binary toxins Vip2Ac-Vip1Ca and Vip2Bb-
Vip1Bb and, in 2 out 9 B. thuringiensis isolates, the presence of two sequences with low 
similarity to vip1Bb1 (from the B. thuringiensis isolate E-SE10.2) and vip4Aa1 (from the 
B. thuringiensis isolate O-V84.2). In a second step, the genes from the B. thuringiensis 
isolates harbouring the new alleles of the binary toxins Vip2Ac-Vip1Ca and Vip2Bb-
Vip1Bb were cloned to determine the full length of the vip1 and vip2 gene pairs. Also the 
Bt isolates E-SE10.2 and O-V84.2 were subjected to whole genome sequencing and in 
gel digestion LC/MSMS analysis of the supernatant and spore/crystal mixture. 
The sequence of the two new alleles of the binary toxins Vip2Ac-Vip1Ca and Vip2Bb-
Vip1Bb was determined by genome walking and deposited in the GenBanK and in the 
Bacillus thuringiensis toxin nomenclature database: vip2Bb3 (KR065728) - vip1Bb2 
(KR065727), vip2Ac2 (KR065726) - vip1Ca2 (KR0065725) (See Annex 10.1). 
Regarding the mining of new vip1 and vip2 genes in the B. thuringinsis isolates E-SE10.2 
and O-V84.2, these were subjected to whole genome sequencing and in gel digestion 
LC/MSMS analysis to identify and quantify the expressed B. thuringiensis proteins. The 
genomes of both B. thuringiensis isolates contained 6156 coding sequences (CDS) and 
6457 CDS, respectively. This result indicated that the CDS represent the 80 % of the 
genome length in both B. thuringiensis isolates. Regarding the number of expressed of B. 
thuringiensis proteins in three different growth phases (supernatant at 24 h and 48 h, and 
crystal 72 h), these were determined by in gel digestion LC/MSMS analysis. The total 
proteins encountered in the different growth phases for the B. thuringiensis isolates E-
SE10.2 and O-V84.2 were 10.2/3.5 %, 10.4/8.2 %, and 8.3/2.8 %, respectively, of their 
respective genome CDS in each growth phase.  
The supernatants (at 24 h [growth phase T1] and 48 h [growth phase T2]) and the crystal 
proteins [growth phase T3] of both B.thuringiensis isolates were also analyzed and 
annotated with GO terms. In each growth phase (T1, T2 and T3), the number of annotated 
proteins were 42.3 %, 49.8 % and 56.9 %, respectively. The distribution of the GO terms 
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along the different growth phases showed that the most common and abundant GO terms 
in all the phases are the following: “cellular biosynthetic process”, “organic substance 
biosynthetic process”, “cellular nitrogen compound metabolic process” and 
“organonitrogen compound metabolic process”. Regarding the presence of an specific 
GO term in each growth phase, there was only present one, in the T3, with the annotation 
of the term “macromolecule metabolic process”. 
Related to the predicted insecticidal protein genes in both B. thuringiensis genomes, we 
found part of the predicted genes by the CDS prediction software. Specifically, one new 
couple of binary Vip-like proteins (Vip2Ac-like_1-Vip4Aa-like_1), two new Vip-like 
proteins (Vip2Ac-like_1 and Vip4Aa-like_2); one Sip1A-like protein (Sip1A-like_1) and 
eight Crystal-like proteins (Cry23A-like, Cry45Aa-like_1, Cry45Aa-like_2, Cry45Aa-
like_3, Cry32Ea-like, Cry32eDa-like, Cry32Eb-like and Cry73Aa-like). To determine the 
subcellular localization of the B. thuringiensis-like proteins, the supernatant and 
solubilized crystal proteins were analyzed by LC/MSMS. In the supernatant of both B. 
thuringiensis isolates, we detected the Vip4Aa-like_1, Vip4Aa-like_2, Vip2Ac-like_1, 
Vip2Ac-like_2, Sip1Aa-like_1 proteins. As regard the crystal proteins, they were found 
in the crystal of both B. thuringiensis isolates except for the Cry23Aa-like protein, that 
was also found in the supernatant at 24 h and 48 h.  
The relative abundance of the B. thuringiensis-like proteins was estimated in the 
supernatant and in the solubilized crystal proteins of both B. thuringiensis isolates. In the 
supernatant (24h and 48h) of both B. thuringiensis isolates, the Vip-like, Sip1-like and 
Cry23Aa-like proteins were marginally expressed. The expression level of the Vip-like, 
Sip1-like and Cry23Aa-like was compared between 24 h and 48h. The Vip4Aa-like_1 
protein was increased 2-fold at 24h vs. 48 h, while the Vip4Aa-like_2 only was expressed 
at 24 h. As regard to the rest of the Vip2Ac-like, Sip1A-like and Cry23A-like proteins, 
no expression differences were observed between the 24 h and 48 h. Regarding the crystal 
proteins in the B. thuringiensis isolate O-V84.2, the Cry-like proteins represented the half 
of the total weight percentage, while for the B. thuringiensis isolate E-SE10.2 the 
Cry23Aa-like protein represent a weight in the range of 2.5 % - 30 %. In addition, the 
crystal composition of the B. thuringiensis isolate O-V84.2 was determined for those 
proteins with a percentage of similarity lower than 45%. The crystal was composed by 
four kinds of proteins: 7.0 % - 9.8 % Cry45-like proteins, 30.4 % - 30.5 % Cry32-like 
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proteins, and 2.8 % - 4.25 % Cry73Aa-like proteins, while the B. thuringiensis isolate E-
SE10.2 only expressed a Cry23Aa-like protein. 
To evaluate the toxicity of the concentrated supernatant and crystal proteins of the B. 
thuringiensis isolates E-SE10.2 and O-V84.2, a single dose assay was performed against 
S. exigua and S. littoralis. The result of the autoclaved and non-autoclaved concentrated 
supernatants showed that S. exigua and S. littoralis were not susceptible to the Vip-like 
and Sip-like proteins detected in the supernatant. Regarding the solubilized crystal 
proteins, Cry23Aa-like showed some toxicity to the S. exigua (30 % mortality at 7 days) 
and S. littoralis (50 % mortality at7 days), while the for the B. thuringiensis isolate O-
V84.2, there were none active against S. exigua and S. littoralis. Although the solubilized 
crystal proteins of the B. thuringiensis isolate E-SE10.2 are toxic against Spodoptera 
species, we cannot confirm that the observed mortality was due only to Cry23Aa-like, 
because other proteins present in the mixture could synergize with Cry23Aa-like or 
contribute to the observed mortality. Further experiments are needed to confirm this 
hypothesis (See Annex 10.2). 
 
8.2 - Toxicity of the Vip3Ca protein and analysis of cross-resistance to Vip3Ca in 
insect populations selected for resistance against Cry1Ac, Cry2Ab, Vip3Aa and 
Vip3Aa/Cry2Ab 
 
Our second observation starts with the increment of the insecticidal spectrum of the 
Vip3Ca protein and analysis of cross-resistance to the Vip3Ca protein in insect 
populations selected for resistance against Cry1Ac, Cry2Ab, Vip3Aa and 
Vip3Aa/Cry2Ab. The Vip3Ca protein is a new Vip3 protein family from B. thuringiensis, 
moderately active against Chrysodeixis chalcites, H. armigera, M. brassicae, T. ni and S. 
littoralis. Strong growth inhibition was observed in S. exigua and S. frugiperda, whereas 
O. nubilalis and Lobestria botrana showed very low susceptibility to the Vip3Ca protein 
(5). 
The insecticidal spectrum of the Vip3Ca protein was broaden, adding ten new 
lepidopteran pests (Cydia pomonella, Grapholita molesta, Sesamia nonagrioides, 
Galleria mellonella, P. xylostella, Pectinophora gossypiella, E. kuehniella, Plodia 
interpunctella and O. furnacalis), one aphid pest (Nezara viridula) and one model 
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organism (Drosophila melanogaster) (6–8). Of the six species tested by surface 
contamination, C. pomonella was the most susceptible to the Vip3Ca protein, followed 
by Trichoplusia ni and G. mellonella, with percentages of mortality higher than 50% 
(7,8). Regarding the four species tested by diet incorporation, O. furnacalis was the most 
susceptible to the Vip3Ca protein with an LC50 value (0.31 µg/g) in the range of the 
positive control, Cry1Ab (0.97 µg/g) (8). From the other types of bioassays, Tuta absoluta 
showed some susceptibility to high concentrations of Vip3Ca (up to 30 % mortality). The 
rest of species (G. molesta, P. gossypiella, P. xylostella, P. interpunctella, E. kuehniella, 
S. nonagrioides, Drosophila melanogaster and N. viridula) can be considered non-
susceptible (6–8). Interestingly, for most of the new insect species tested, the Vip3Aa 
protein (positive control of toxicity) is more active than the Vip3Ca protein. As an 
example, for both C. pomonella and M. brassicae the Vip3Aa protein is 100-fold more 
active than the Vip3Ca protein. In the case of O. furnacalis is the other way round: the 
Vip3Aa is marginally toxic whereas the Vip3Ca protein is very active. Therefore, this 
points out at O. furnacalis as a good target of the Vip3Ca protein (7,8). 
In an attempt to determine if the resistance to Cry1A-, Cry2A-, Dipel-, Vip3- and 
Vip3/Cry2Ab conferred cross-resistance to the Vip3 proteins, resistant insect colonies 
were tested against the Vip3Ca protein and the Vip3Aa protein (along with their 
respective susceptible colonies). The results indicated that the insect colonies resistant to 
Cry1Ac, Dipel (H. armigera, T. ni, O. furnacalis and P. interpunctella) or Cry2Ab (H. 
armigera and T. ni) were not cross-resistant to the Vip3 proteins (Vip3Aa and Vip3Ca). 
Regarding the H. armigera colonies resistant to Vip3Aa or Vip3Aa/Cry2Ab, they showed 
cross-resistance to the Vip3Ca protein (8). These results complement the published cross-
resistance studies between Vip3 and Cry proteins and show, for the first time, cross-
resistance between proteins within the Vip3 subfamily (9–19). 
*************** 
The monographic study about the susceptibility of G. molesta to B. thuringiensis (B. 
thuringiensis formulations, individual toxins and their mixtures) was performed due the 
lack of toxicity data of this insect species. As a first step, to determine the susceptibility 
of G. molesta to Dipel ®, Xentari ®, active Cry1 proteins (Cry1Aa, Cry1Ac and Cry1C) 
and Vip3 protoxins (Vip3Aa, Vip3Af and Vip3Ca), the test consisted on performing 
bioassays at a high concentration of the insecticidal toxins. The results obtained indicated 
that DiPel® and XenTari® are very effective for the control of G. molesta under 
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laboratory conditions, that the B. thuringiensis toxins Cry1Aa, Cry1Ac, Cry1Ca, Vip3Aa 
and Vip3Af showed high toxicity to G. molesta, and that the Vip3Ca was nontoxic (6).  
Dose-response assays were carried out for the B. thuringiensis formulations (Dipel ® and 
Xentari ®) and for the individual toxins (Cry1Aa, Cry1Ac, Cry1Ca, Vip3Aa and 
Vip3Af). The B. thuringiensis formulation DiPel® was slightly more toxic than 
XenTari®, with significantly lower LC50 and LC90 values. The individual proteins were 
very active, with LC50 values from 1.8 ng/cm2 (Vip3Aa) to 57 ng/cm2 (Cry1Ca). For Cry1 
proteins, Cry1Aa was not significantly different to Cry1Ac at the LC50 level, but when 
compared to Cry1Ca, Cry1Aa is 7.6-fold more toxic. In the case of the Vip3 proteins, 
Vip3Aa was 15-fold more toxic than Vip3Af at the LC50 level. At the LC90 level, no 
significant differences were found among the Cry1 and Vip3 proteins. To evaluate the 
synergistic or antagonistic interactions of the Vip3Aa protein and the active Cry1 
proteins, different combinations (at a concentration close to their LC50 values) were 
chosen for the single dose assays. Significant antagonistic interactions were found for 
Vip3Aa - Cry1Aa and Vip3Aa - Cry1Ca. No significant interaction was found for Vip3Aa 
- Cry1Ac. The interactions of Vip3Aa - Cry1Aa and Vip3Aa-Cry1Ca were investigated 
in dose-response assays at different ratios where the antagonistic effect became more 
evident as the proportion of Vip3Aa in the mixture increased, and this effect was 
especially drastic in the Vip3Aa - Cry1Ca mixture, with an antagonism factor (AF) of 
64.5. 
 
8.3 - Determination of the mode of action of the Vip3Ca protein in Mamestra 
brassicae and characterization of the cell death response in Spodoptera exigua after 
Vip3Ca intoxication 
 
Our third observation starts with the study of the mode of action the Vip3Ca protein in 
M. brassicae and the characterization of the cell death response of S. exigua intoxicated 
with Vip3Ca2. For the study of the mode of action of the Vip3Ca protein, we were based 
on the previous work of Palma et al. (5), and regarding the cell death response of larvae 
intoxicated with the Vip3Ca protein, we were based on the published articles by Bel et 
al., Jakubowska et al., and Crava et al. (20–22). The study of the mode of action of the 
Vip3Ca protein was done in the following order: [1] proteolysis of Vip3Ca with trypsin 
174
                                                                                                                                                        Discussion 
Mining of new insecticidal protein genes plus determination of the insecticidal spectrum and 
mode of action of Bacillus thuringiensis Vip3Ca protein 
and midgut juice, [2] oligomerization of the Vip3Ca, [3] histopathological effects of 
Vip3Ca in the midgut epithelium and [4] in vivo and in vitro binding assays.  
In a first step, the proteolytic pattern of the Vip3Ca protein was determined digesting the 
toxin with trypsin and midgut juice from insect species with different susceptibility to 
Vip3Ca. The result obtained indicated that the Vip3Ca protein (molecular weight ~90 
kDa) was processed to protein bands of ~70 kDa and ~20 kDa when the protein was 
incubated with trypsin (See Annex 10.3) or the midgut juice from all tested species. 
Regarding the kinetics of Vip3Ca with the midgut juice from insect species with different 
susceptibility to Vip3Ca, it correlated with the susceptibility of the insect species to 
Vip3Ca. The activation was from faster to slower in the following order: M. brassicae 
(susceptible), S. littoralis (moderately susceptible), A. ipsilon (slightly susceptible) and 
O. nubilalis (no susceptible). To discard that the differences in the toxicity of the Vip3Ca 
protein was due to inappropriate activation of the protein, the Vip3Ca protein was 
processed with midgut juice of O. nubilalis or M. brassicae and fed to each other species; 
there was no significant change in its toxicity to either insect species. This result 
suggested that the low susceptibility of O. nubilalis and the other insect species was not 
due to a problem in the midgut processing of the toxin. The kinetics of Vip3Ca with 
trypsin showed, after 0.5 h, major bands of around ~70 kDa and ~20 kDa, as well as other 
smaller bands. Instead, the amount of the smaller bands decreased with the incubation 
time and the ~70 kDa band seemed to become more intense (See Subchapter 7.2). 
In a second step, the oligomerization of the Vip3Ca digested with trypsin and midgut 
juice of M. brassicae was determined by size exclusion chromatography (See Annex 
10.3). As a result, the activated Vip3Ca protein (at the ratio of 1µg of protein : 0.24 µg of 
trypsin) for 0.5 h and 48 h eluted in one peak at 11 ml approximately. This peak 
correspond to the toxins bands of ~70 kDa and ~20 kDa, with a apparent size from 395 - 
512 kDa. Regarding the activated Vip3Ca protein at the ratio of 1µg of protein : 0.80 µg 
of midgut juice for 0.5 h, although the input showed a fully degraded protein, a main peak 
was eluted at 11 ml. This peak correspond to the toxins bands of ~70 kDa and ~20 kDa, 
with an approximately size of 395 kDa, and a ~35 kDa band that belonged to the midgut 
juice (See Subchapter 10.3). These results suggest that the ~70 kDa and ~20 kDa 
fragments remain together after the activation with trypsin or midgut juice of M. brassicae 
and that they form an oligomer of 4 to 6 units that which is stable up to two days. The 
same behaviour has been described for the Vip3A proteins (23–27), for which the trypsin-
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activated Vip3Aa protein aggregates in solution to form a tetramer. In addition, the 
proteolysis of the Vip3Ca protein with midgut juice can produce artefactual band patterns 
probably due to the partial inactivation, at the end of the incubation and prior to SDS-
PAGE, of the proteases present in the midgut juice as reported Bet et al. and Banyuls et 
al. for the Vip3Aa and Vip3Af proteins (25,28). 
In a third step, the histopathological effects of Vip3Ca with the Vip3Aa (positive control 
of toxicity) and Vip3Ad (negative control of toxicity) were determined in midgut sections 
of M .brassicae intoxicated at different intervals with the respective proteins. The results 
obtained show that the Vip3Ca protein was able to disrupt the midgut epithelium of M. 
brassicae. Nevertheless, compared with the Vip3Aa protein, the damage produced by 
Vip3Ca took longer to be visible. To determine if the damage caused by the Vip3Ca 
protein in the midgut epithelium was due to the binding of Vip3Ca to the midgut apical 
membrane, the larvae were fed with Vip3Ca at different intervals, then dissected and the 
toxin localization revealed with an anti-Vip3Aa polyclonal antibody. After 3 h of 
exposure, the binding of the Vip3Ca protein to the midgut epithelium became more 
intense while at 1h and 6h hardly any binding could be detected in the midgut sections.  
Finally, to show that the Vip3Ca protein bound specifically to the BBMV of M. brassicae 
and competed for the same binding sites of Vip3Aa, competition experiments were 
performed with biotin-labelled Vip3 proteins. The homologous competition showed that 
the Vip3Aa and the Vip3Ca proteins bound specifically to the BBMV since both Vip3 
proteins were able to displace the respective unlabelled homolog proteins. The 
heterologous competition experiments indicated that Vip3Ca and Vip3Aa share binding 
sites. This result has implications in the Insect Resistance Management since the Vip3Ca 
protein could develop cross-resistance to other Vip3A proteins, as it has been reported in 
this doctoral thesis for the H. armigera insect colony resistant to the Vip3Aa protein that 
showed cross-resistance to the Vip3Ca protein. 
*************** 
Regarding the characterization of the cell death response of S. exigua intoxicated with 
Vip3Ca, this was performed in 4th instar larvae. First, we determined the growth inhibition 
dose-response curve for Vip3Ca in newly molted S. exigua larvae with and EC50 of 38.4 
ng/cm2, indicating that the Vip3Ca show a clear effect in growth inhibition of the larvae 
despite the fact that the activity of the protein is marginal. Therefore, S. exigua show 
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different responses to the Vip3 proteins: Vip3Aa is highly toxic with negligible effect in 
the in growth inhibition, while Vip3Ca shows a strong growth inhibition with marginal 
toxicity (5,29). The study of the gene expression analysis upon the Vip3Ca challenge at 
three concentrations was done for 47 S. exigua genes that had been described as 
responding to the Vip3Aa challenge (20–22). The gene expression analysis indicated that 
the number of the S. exigua genes is dose-dependent where most of the S. exigua genes 
were regulated at the three concentrations (100, 1000 and 10000 ng/cm2). Regarding the 
different kinds of S. exigua regulated genes, the results showed the up-regulation of genes 
involved in the immune system and hormone modulation, and the down-regulation of 
genes involved in the digestion process and peritrophic permeability. In addition, the 
regulation of the immune signalling pathways (Toll, Imd and Jak-Stat) was assessed in 
the current study. The gene encoding a component of the Jak-Stat pathway was found 
down-regulated after 24 h exposure to 10000 ng/cm2, thus we suggest that this gene is 
involved in the renewal of the damaged cells of the midgut and in the activation of the 
apoptosis pathway to eliminate the damaged cells. 
The effect of the Vip3Aa and Vip3Ca proteins on the midgut epithelium was determined 
by the release of the APN activity into the luminal fluid. The result obtained supports that 
release APN is higher when the larvae were exposed to concentrations of Vip3Aa (100 
ng/cm2) and Vip3Ca (1000 ng/cm2) that produce growth inhibition > 99 %. In addition, 
the fitness cost produced by the intoxication with the Vip3 proteins show an increase in 
the time of pupation and a reduction of the percentage of pupation, especially for those 
larvae exposed to the highest concentrations of Vip3Aa and Vip3Ca. Since the exposure 
to Vip3 proteins affected the transcriptional pattern, caused epithelial and cellular 
damage, plus a fitness cost, we would like to determine if the down-regulation of the Jak-
Stat pathway involves the apoptosis as a host defence response to damage produced by 
the Vip3 proteins. The result showed the presence of TUNEL-positive cells in the S. 
exigua midgut sections exposed to sublethal concentrations of Vip3Aa and Vip3Ca 
proteins. In the case of the Vip3Ca protein, the TUNEL-positive cells were observed at 
10000 ng/cm2, while for the Vip3Aa protein, the TUNEL-positive cells were observed at 
1, 10, 100 ng/cm2, but not at 1000 ng/cm2. The lack of TUNEL-positive cells was 
probably due to the fact that the cells respond by other mechanisms or that the cells of the 
midgut epithelium were disrupted. In addition, the expression level of the S. exigua 
caspases was evaluated after 3 h, 6 h and 12 h. As a result, the Se-caspase-4 was up-
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regulated at all the time intervals while the Se-caspase-1, Se-caspase-1 and Se-caspase-2 
were up-regulated at 12 h.  
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Conclusions: 
I. Thirteen new insecticidal proteins were identified from two selected (E-SE10.2 
and O-V84.2) B. thuringiensis isolates. The secretable proteins (Vip-like and Sip-
like) were marginally expressed in the supernatant. Regarding the crystal proteins 
(Cry-like), these were found in the parasporal crystal; the isolate E-SE10.2 
produces a pure crystal, while the isolate O-V84.2 produces a crystal with a 
mixture of four proteins
II. The insecticidal spectrum of the Vip3Ca protein was increased in 12 new insect 
species, among which O. furnacalis was the most susceptible. Regarding the 
analysis of cross-resistance in lepidopteran pests, the results indicate that the 
resistance due to selection with Cry proteins does not confer cross-resistance to 
Vip3Ca. In contrast, the insect populations resistant to Vip3A show cross-
resistance to Vip3Ca
III. Grapholita molesta is highly susceptible to B. thuringiensis formulations and their 
individual toxins (Cry and Vip3 proteins). Regarding the interactions between the 
Cry and Vip3 proteins, antagonism was found and this was higher as the amount 
of Vip3A protein increased
IV. The Vip3Ca protein was processed into two protein fragments of ~70 kDa and 
~20 kDa, both by trypsin and midgut juice from insect species with different 
susceptibility to Vip3Ca protein. The Vip3Ca protein activated with trypsin and 
midgut juice of M. brassicae form an oligomer of 4 subunits. The Vip3Ca protein 
was able to bind to the midgut epithelium producing the cellular lysis and the 
disruption of the midgut epithelium. Also, the binding assays showed that Vip3Ca 
bound specifically and competed for the same binding sites than the Vip3Aa 
protein
V. The exposure of S. exigua larvae to sublethal concentrations of the Vip3Ca protein 
activates different insect response pathways which trigger the regulation of some 
genes belonging to the pathogen response group, induces APN shedding, and 
triggers the caspase dependent pathway that induce the apoptotic response 
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   Annexes 
10.1 - Identification of the vip1 and vip2 gene pairs, vip2Ac2 - vip1Ca2 
and vip2Bb4 - vip1Bb3 from Bacillus thuringiensis. 
Joaquin Gomis-Cebolla1 and Juan Ferré1 
1 ERI de Biotecnología y Biomedicina (BIOTECMED), Department of Genetics, Universitat de València, 
46100-Burjassot, Spain; Juan.Ferre@uv.es and Joaquin.Gomis@uv.es 
Objective: Identification of the vip1 and vip2 genes pairs, vip2Ac2 - vip1Ca2 and 
vip2Bb4 - vip1Bb3 
Materials and Methodology: 
1. - Cloning of the genes pairs vip2Ac2 - vip1Ca2 and vip2Bb4 - vip1Bb3 from the 
respective Bacillus thuringiensis isolates
From the results of the identification of vip1- and vip2- type genes reported by Gomis-
Cebolla et al., 2018 a set degenerative primers were designed to determine the full length 
of the genes pairs vip2Ac2 - vip1Ca2 and vip2Bb4 - vip1Bb3 in the Bacillus thuringiensis 
isolates V-V54.26 and V-J20.2 (Table 1). The PCR reactions were performed with the 
Kapa Hifi PCR Kit (KR0368 – v11.17) according to the manufacturer's instructions. The 
PC amplification were carried out in an Eppendorf Mastercycler thermal cycler as 
follows: PCR_1: 5 min denaturation at 95 ºC, 35 cycles of amplification (20 sec at 98 ºC, 
15 sec of annealing at 47 ºC, and 1 min at 72 ºC), and an extra extension step of 10 min 
at 72 ºC. PCR_2: 5 min denaturation at 95 ºC, 35 cycles of amplification (20 sec at 98 ºC, 
15 sec of annealing at 43 ºC, and 90 sec at 72 ºC), and an extra extension step of 10 min 
at 72 ºC. PCR_3 and 4: 5 min denaturation at 95 ºC, 35 cycles of amplification (20 sec at 
98 ºC, 15 sec of annealing at 45 ºC, and 90 sec at 72 ºC), and an extra extension step of 
10 min at 72 ºC.  
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Table 1. Set of degenerative primers used to determine the full length of the genes pairs 
vip2Ac2 - vip1Ca2 and vip2Bb4 - vip1Bb3. 
*IUPAC nucleotide code: S: G or C; M: A or C; N: any base.
To determine the sequence of the gene pairs vip2Ac2 - vip1Ca2 and vip2Bb4 - vip1Bb3, 
the amplified sequences were ligated into the pGEM®-T Easy plasmid (Promega), cloned 
in Escherichia coli DH10ẞ, and sequenced. DNA sequence analysis and contig assembly 
was performed using DNAstar v5 and NCBI BLAST tools (Blastx) (1). 
Results: 
The gene pairs vip2Ac2 - vip1Ca2 and vip2Bb4 - vip1Bb3 were organized in operon in 
the genomic or plasmid DNA of the Bacillus thuringiensis isolates V-J20.2 and V-
V54.26, respectively. The vip2 genes (vip2Ac2 and vip2Bb4) were located before the 
vip1genes (vip1Ca2 and vip1Bb3) in the DNA sequence by an intergenic region of 4 bp 
(lowercase letter). Regarding the conserved domains in the vip1 and vip2 genes are the 
following: 
1. Signal peptide of the gram - positive bacteria in the first 30 - 50 nucleotides of the 
DNA sequences (underlined)
2. Vip2 superfamily: A family of actin-of ADP-ribosylating toxin. A member of the 
Bacillus sp produced vegetative insecticidal proteins (VIPs) possesses high 
specificity against the major insect pest, corn rootworms, and belongs to a classs 
of binary toxins and regulators of biological pathways distinct from classical A-B 
toxins. VIP2 shares significant sequence similarity with enzymatic components 
Reactions Primers Sequence (5’  3’)* Length (nt) 
Primer 
parameters 
% GC Tm (ºC) 
PCR_1 
Vip2-Vip1_f ccsatmccagaaaatattac 20 35-40 47 Vip2-Vip1_r gctgtttgttgatcataaataag 23 30 
PCR_2 
Vip1-TAA_f atggatgattttaactccc 19 36 
Vip1Ca1-TAA_r ttatctaagatttgttaggtc 21 29 45 
Vip1Bb1-TAA_r ttatagatctgaaatatttaaatg 24 17 44 
PCR_3 
Vip2Ba2_f gctatgaaagtgaaaaattan 21 29 45 Vip2Ba2_r ttattttgttaataatgtagcatc 24 21 
PCR_4 
Vip2Ac1_f atgaaaagaatggagggaaa 20 33 
46 Vip2Ac1_r ttaatttgttaataatgttgcatc 20 21 
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of other binary toxins, Clostridium botulinum C2 toxin, C. perfringens iota toxin, 
C. piroforme toxin and C. difficile toxin (bold purple)
3. PA14 domain: This domain forms an insert in bacterial beta-glucosidases and is 
found in other glycosidases, glycosyltransferases, proteases, amidases, yeast 
adhesins, and bacterial toxins, including anthrax protective antigen (PA). The 
crystal structure of PA shows that this domain has a beta-barrel structure. The 
PA14 domain sequence suggests a binding function, rather than a catalytic role. 
The PA14 domain distribution is compatible with carbohydrate binding (bold 
green)
4. Clostridial binary toxin B/anthrax toxin PA: The N-terminal region of this family 
contains a calcium-binding motif that may be an EF-hand (bold orange) 
Sequence: 
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10.2 - Insecticidal activity of the concentrated supernatant and the 
spore/crystal mixture of Bacillus thuringiensis isolates E-SE10.2 and O-
V84.2 in Spodoptera exigua and Spodoptera littoralis 
 
Joaquin Gomis-Cebolla1, Ana Paula Scaramal Ricietto1,2 and Juan Ferré1 
 
1 ERI de Biotecnología y Biomedicina (BIOTECMED), Department of Genetics, Universitat de València, 
46100-Burjassot, Spain; Juan.Ferre@uv.es and Joaquin.Gomis@uv.es 
2 Departamento de Biologia Geral, Universidade Estadual de Londrina, Londrina, Paraná, Brazil; 
ricietto@gmail.com 
 
Objective: Determine the insecticidal activity of the supernatant and the solubilized 
crystal proteins of the Bacillus thuringiensis isolates E-SE10.2 and O-V84.2 in 
Spodoptera exigua and Spodoptera littoralis 
 
Materials and Methodology: 
 
1. - Sample preparation for insecticidal activity of Bacillus thuringiensis isolates 
 
A single colony of Bacillus thuringiensis was grown in 100 ml of LB at 29 °C for 24 h 
and 48 h for detection of the secretable proteins, while for the detection of proteins in the 
parasporal crystal the culture was grown in 100 ml of CCY at 29 °C until culture 
sporulation (72 hours). The supernatant of B. thuringiensis was concentrated by 
trichloroacetic acid (TCA) precipitation. Briefly, the cells were collected at 6,000 g for 
15 min at 4 °C and filtered through sterile 0.45 μm cellulose acetate filters (GE Healthcare 
Life Sciences). The sample was incubated with 10% TCA (final concentration) and kept 
at 4 °C for 24 h. Then, the sample was centrifuged at 16000 g for 20 min at 4 °C. The 
pellet was washed with 100 ml of cold acetone (-18 °C), centrifuged at 16000 g for 20 
min at 4 °C, and let dry at room temperature for 5 min. The precipitated proteins were 
solubilized in 50 mM carbonate buffer containing 10 mM dithiothreitol (pH 11.3) for 48 
h, with two buffer changes.  
Crystals (together with spores) were separated by centrifugation at 6000 × g for 12 min 
at 4 °C. The pellet containing the parasporal crystals was washed three times with ice cold 
solution A (1 M NaCl, 5 mM EDTA, 10 mM PMSF, 1% Triton X-100) and centrifuged 
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at 17,000 x g for 12 min at 4 °C between washes. The pellet was then washed three times 
with ice cold solution B (10 mM KCl) and centrifuged at 24,000 x g for 15 min at 4 °C. 
The crystals in the final pellet were solubilized in 20 ml of 50 mM carbonate buffer 
containing 10 mM dithiothreitol (pH 11.3) by incubation at room temperature for 2 h with 
continuous shaking. Concentration of the proteins in the supernatant and in the solubilized 
crystals were estimated with the Bradford method (1). The purity of the expressed 
proteins in the supernatant and the crystal was analyzed by SDS-PAGE and stained with 
Coomassie brilliant blue R-250 (Sigma-Aldrich). 
 
2. - Insecticidal activity of the Bacillus thuringiensis isolates E-SE10.2 and O-V84.2 
 
Spodoptera littoralis and Spodoptera exigua were grown in the insectaries of the 
University of Valencia at 25 ± 2 °C, 70 ± 5% RH, and L16: D8 h and reared in artificial 
diet (2). The autoclaved (121 °C, 1 bar, 20 min) and non-autoclaved concentrated 
supernatant (E-SE10.2 10-fold and O-V84.2 20-fold concentrated), and the solubilized 
crystal proteins were dispensed on the diet surface. Prior to the sample application, the 
surface of the diet was sterilized under UV light for 5 min. A volume of 50 µl of the 
autoclaved and non-autoclaved concentrated supernatant was applied on the surface of 
the solidified diet and let dry at room temperature. Once dried, one larva was transferred 
to each well using 16 neonates per replicate, with two replicates per concentration. Larvae 




To determine whether any of the Vip, Sip, and Cry proteins expressed in the B. 
thuringiensis isolates E-SE10.2 and O-V84.2, we performed bioassays with Spodoptera 
exigua and Spodoptera littoralis neonate larvae with the autoclaved and non-autoclaved 
concentrated supernatant, and the solubilized proteins from the spore/crystal mixture 
(Table 1). The analysis of the solubilized proteins from the crystal of E-SE10.2 indicated 
that they showed some toxicity to both S. exigua and S. littoralis, whereas no toxicity was 
found for the solubilized crystals of O-V84.2 (Table 1). Neither the autoclaved nor the 
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Table 1. Insecticidal activity of the autoclaved supernatants, non-autoclaved supernatants 
and crystal proteins of the Bacillus thuringiensis isolates E-SE102 and O-V84. 
 
† In the single dose assays, we used the first replicate (R1) at 24h, 48h and 72h that is 
shown in the Chapter 1, Table 5. 
‡ The amount indicated correspond to the total amount of protein in the sample measured 
by Bradford. Inside of the brackets is indicated the inferred amount of the putative 
Bacillus thuringiensis toxins from the weight percentage of the first replicate (Chapter 1, 
Table 5). 
* Bioassays were performed with 16 larvae per sample, with two replicates (n=32), and 
the mortality was scored at 7 days and corrected subtracting the mortality of the negative 




1.  Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of 
protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–54.  
2.  Greene, G.L.; Leppla, N.C.; Dickerson W. Velvetbean caterpillar: a rearing procedure and 
















Sample Replicate† Amount (µg (ng))‡ % Mortality* 
S. exigua S. littoralis 
E-SE10.2     
       24 h Non autoclaved R1 17.5 (250) 0 ± 0 0 ± 0 
       24 h Autoclaved R1 - 0 ± 0 6.2 ± 6.2 
       48 h Non-autoclaved R1 51.0 (1,100) 0 ± 0 0 ± 0 
       48 h Autoclaved R1 - 0 ± 0 0 ± 0 
Crystal solubilized R1 7.5 (2,280) 31.2 ± 5.2 50 ± 6.7 
O-V84.2     
       24 h Non-autoclaved R1 4.1 (0,13) 0 ± 0 13.1 ± 6.8 
       24 h Autoclaved R1 - 5.7 ± 5.7 6.2 ± 6.2 
       48 h Non-autoclaved R1 20.5 (227) 13.8 ± 4.9 0 ± 0 
       48 h Autoclaved R1 - 0 ± 0 6.2 ± 6.2 
Crystal solubilized R1 13 (6,871) 3.54 ± 2.7 0 ± 0 
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Toxins 2018, 10, 193; doi:10.3390/toxins10050193 S1 of S2
Supplementary Materials: A Genomic and Proteomic 
Approach to Identify and Quantify the Expressed 
Bacillus thuringiensis Proteins in the Supernatant and 
Parasporal Crystal 
Joaquín Gomis-Cebolla, Ana Paula Scaramal Ricietto and Juan Ferré  
Figure S1. Subsystem category distribution of the Bt isolates E-SE10.2 and O-V84.2 by the genome annotation 
based on the Rast server. The right pie chart indicates the percentage or predicted encoding genes associated 
to at least one subsystem. 
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Toxins 2018, 10, 193; doi:10.3390/toxins10050193 S2 of S2
Figure S2. Functional annotation of the protein identification from the concentrated supernatants at 24 h and 
48 h in LB medium, and of the solubilized proteins from the crystal at 72 h in CCY medium. The number of 
sequences that belong to the group are indicated in brackets. 
Figure S3. SDS-PAGE of the three replicates of the concentrated supernatants and solubilized proteins from 








The supplementary material tables (Table S1 - S5) can be download from the following 
link: http://www.mdpi.com/2072-6651/10/5/193/s1.  
A simplified version of the supplementary tables have been attached to the doctoral thesis. 
The simplified version of the supplementary tables are the following: 
Table S1: Protein summary of three replicates of concentrated supernatants 
and solubilized proteins from spore/crystal mixtures with Protein Pilot v4.5
Table S2: Peptide summary of three replicates of concentrated supernatants and 
solubilized proteins from spore/crystal mixtures identified with Protein Pilot v4.5 
Table S3: Result of the Mascot search in the three replicates of the concentrated 
supernatants and solubilized proteins form spore/crystal mixtures 
Regarding the label free analysis of concentrated supernatant at 24 h vs 48 h of the 
Bacillus thueingiensis isolates E-SE10.2 and O-V84.2 a report with the main results have 
been attached to the doctoral thesis 
205
206
Sample Replicate N Unused %Cov Homology Peptides(95%)
 E‐SE10.2 
Supernatant 24 h 1 58 19.33 44.89 Vip2Ac‐like_1 10
65 17.79 45.60 Sip1Aa‐like_1 9
24 30.88 70.90 Cry23Aa‐like 30
2 86 16.85 38.67 Vip2Ac‐like_1 8
198 8.70 31.32 Sip1Aa‐like_1 7
21 35.08 70.90 Cry23Aa‐like 34
3 52 22.63 43.33 Vip2Ac‐like_1 12
83 16.00 38.19 Sip1Aa‐like_1 9
18 40.59 76.49 Cry23Aa‐like 39
E‐SE10.2 
Supernatant 48 h 1 96 16.84 35.56 Vip2Ac‐like_1 9
118 14.29 35.44 Sip1Aa‐like_1 8
34 30.69 72.39 Cry23Aa‐like 34
2 98 16.41 40.00 Vip2Ac‐like_1 8
175 10.11 28.30 Sip1Aa‐like_1 7
59 21.53 45.15 Cry23Aa‐like 21
3 138 14.95 34.22 Vip2Ac‐like_1 7
275 6.80 25.55 Sip1Aa‐like_1 5
81 21.56 47.39 Cry23A‐like 21
E‐SE10.2 Crystal 72 h 1 1 67.44 94.78 Cry23A‐like 68
2 2 60.41 91.04 Cry23Aa‐like_1 61
3 9 39.33 71.27 Cry23Aa‐like 31
O‐V84.2 Supernatant 
24 h 1 46 12.71 22.34 Vip4Aa‐like_1 7
74 6.02 15.69 Vip4Aa‐like_2 4
63 8.94 13.03 Vip2Ac‐like_2 5
2 58 12.18 22.91 Vip4Aa‐like_1 6
178 1.53 4.59 Vip4Aa‐like_2 1
176 1.73 5.32 Vip2Ac‐like_2 1
3 54 10.01 8.13 Vip4Aa‐like_1 7
95 4.02 10.22 Vip2Ac‐like_2 2
173 1.57 7.65 Sip1Aa‐like_2 1
O‐V84.2 Supernatant 
48 h 1 289 2.74 8.02 Vip4Aa‐like_1 1
2 142 8.41 11.91 Vip4Aa‐like_1 6
277 3.09 11.20 Vip2Ac‐like_2 2
3 241 4.02 14.78 Vip4Aa‐like_1 2
227 4.74 11.48 Vip2Ac‐like_2 3
O‐ V84.2 Crystal 72 h 1 8 29.44 59.71 Cry45Aa‐like_1 17
9 26.00 59.11 Cry45Aa‐like_2 18
13 23.10 83.40 Cry45Aa‐like_3 17
Table S1. Protein  summary of  three  replicates of  concentrated  supernatants 
and solubilized proteins from spore/crystal mixtures with Protein Pilot v4.5
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Sample Replicate N Unused %Cov Homology Peptides(95%)
O‐ V84.2 Crystal 72 h 1 163.9 70.94 Cry32Ea‐like 48
2 80.18 49.56 Cry32Da‐like 121
4 55.05 53.35 Cry32Eb‐like 38
5 54.18 60 Cry73Aa‐like 35
2 9 39.49 90.48 Cry45Aa‐like_1 29
17 23.59 72.86 Cry45Aa‐like_2 21
10 33.54 89.36 Cry45Aa‐like_3 27
1 180.55 82.06 Cry32Ea‐like 163
2 101.10 67.87 Cry32Da‐like 64
7 57.44 67.66 Cry32Eb‐like 49
3 79.34 76.28 Cry73Aa‐like 62
3 8 27.66 58.24 Cry45Aa‐like_1 17
13 23.45 65.06 Cry45Aa‐like_2 19
11 23.59 83.4 Cry45Aa‐like_3 17
1 172.42 73.31 Cry32Ea‐like 136
5 47.1 54.25 Cry32Da‐like 32
2 74.45 52.95 Cry32Eb‐like 45
3 59.08 61.24 Cry73Aa‐like 40
 
Table S1. Protein  summary of  three  replicates of  concentrated  supernatants 
and solubilized proteins from spore/crystal mixtures with Protein Pilot v4.5
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Sample Replicate Homology  Contrib Conf Sequence
E‐SE10.2 
Supernatant 24 














































































































































































































Sample Replicate Homology  Contrib Conf Sequence
0.197911 54.81 LKEMNDKIDR
0.121478 40.45 SLDFEKDKEK










































































































Sample Replicate Homology  Contrib Conf Sequence


























































































































































































































Sample Replicate Homology  Contrib Conf Sequence












Vip4Aa‐like_2 1.508638 99 LTLETTQASGLYGR
0.020907 89.21 IAFDTTEQNGK
0.003926 26.75 AKENQLGDVLK
Vip2Ac‐like_2 1.721247 99 HIGSNANISDDPK
0.007889 40.47 NVVEYMVEK
0.004365 27.83 FTNIYFK






Vip2Ac‐like_2 2 99 HIGSNANISDDPK
2 99 WTNSLSSTHIK
0.013676 23.82 EFHQLTPYAK


























3 Vip4Aa‐like_1 2 99 ESVTGIVFDQK
2 99 LPQYGPETTLNASQGYQR
0.019088 27.37 AKENQIGNVLQAGSTYPDK































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Supernatant_24h 1 Cry23Aa‐like 29,277 1.74 1.26
Vip2Ac‐like_1 51,622 0.07 0.09
Sip1Aa‐like_1 40,792 0.09 0.09
2 Cry23Aa‐like 29,277 1.16 0.86
Vip2Ac‐like_1 51,622 0.05 0.06
Sip1Aa‐like_1 40,792 0.03 0.03
3 Cry23Aa‐like 29,277 0.81 0.60
Vip2Ac‐like_1 51,622 0.02 0.03
Sip1Aa‐like_1 40,792 0.02 0.02
E‐SE10.2 
Supernatant_48h 1 Cry23Aa‐like 29,277 2.66 1.99
Vip2Ac‐like_1 51,622 0.07 0.09
Sip1Aa‐like_1 40,792 0.06 0.06
2 Cry23Aa‐like 29,277 0.77 0.42
Vip2Ac‐like_1 51,622 0.08 0.01
Sip1Aa‐like_1 40,792 0.08 0.01
3 Cry23Aa‐like 29,277 0.42 0.30
Vip2Ac‐like_1 51,622 0.05 0.06
Sip1Aa‐like_1 40,792 0.02 0.02
E‐SE10.2 
Crystal_72h 1 Cry23Aa‐like 29,277 33.84 30.48
2 Cry23Aa‐like 29,277 5.60 4.74
3 Cry23Aa‐like 29,277 2.79 2.49
O‐V84.2 
Supernatant_24h 1 Vip4Aa‐like_1 97,552 5.68E‐04 1.08E‐05
Vip4Aa‐like_2 87,546 2.60E‐04 3.19E‐06
Vip2Ac‐like_2 80,797 6.00E‐04 1.13E‐05
2 Vip4Aa‐like_1 97,552 3.49E‐04 8.67E‐04
Vip4Aa‐like_2 87,546 8.31E‐05 1.85E‐04
Vip2Ac‐like_2 80,797 1.41E‐04 2.91E‐04
Vip2Ac‐like_3 23,282 1.66E‐04 9.86E‐05
Sip1Aa‐like_2 38,717 9.14E‐05 9.02E‐05
3 Vip4Aa‐like_1 97,552 6.48E‐04 1.61E‐03
Vip4Aa‐like_2 87,546 1.08E‐04 2.41E‐04
Vip2Ac‐like_2 80,797 4.97E‐04 1.02E‐03
Sip1Aa‐like_2 38,717 2.38E‐04 2.34E‐04
O‐V84.2 
Supernatant_48h 1 Vip4Aa‐like_1 97,552 7.89E‐03 1.96E‐02
Vip4Aa‐like_2 80,797 4.47E‐03 9.22E‐03
2 Vip4Aa‐like_1 97,552 2.68E‐03 6.64E‐03
Vip4Aa‐like_2 80,797 2.75E‐03 5.66E‐03
3 Vip4Aa‐like_1 97,552 1.19E‐03 2.99E‐03









O‐V84.2 Crystal_72h 1 Cry45Aa‐like_1 30,698 3.72 2.83
Cry45Aa‐like_2 29,334 4.22 3.06
Cry45Aa‐like_3 25,605 2.98 1.88
Cry32Ea‐like 151,178 6.50 24.30
Cry32Da‐like 153,302 1.61 6.11
Cry32Eb‐like 76,802 3.27 6.20
Cry73Aa‐like 72,173 1.57 2.80
2 Cry45Aa‐like_1 30,698 3.04 2.47
Cry45Aa‐like_2 29,334 2.62 2.03
Cry45Aa‐like_3 25,605 7.82 5.29
Cry32Ea‐like 151,178 6.27 25.07
Cry32Da‐like 153,302 1.33 5.40
Cry32Eb‐like 76,802 2.20 4.46
Cry73Aa‐like 72,173 2.19 4.19
3 Cry45Aa‐like_1 30,698 1.81 2.82
Cry45Aa‐like_2 29,334 4.48 6.27
Cry45Aa‐like_3 25,605 3.34 5.28
Cry32Ea‐like 151,178 6.65 25.89
Cry32Da‐like 153,302 1.17 6.21
Cry32Eb‐like 76,802 2.54 7.23





Label free analysis of the concentrated supernatant of the Bacillus 
thuringiensis isolates E-SE10.2 and O-V84.2. 
SAMPLE INFORMATION: 
Number of sample: 18. Six experimental conditions, three samples in each group. 
Bt isolate E-SE10.2 concentrated supernatant at 24 h (E24h) and 48 h (E48h). 
Bt isolate O-V84.2 concentrated supernatant at 24 h (O24h) and 48 h (O48h). 





Figure 1. Samples (30 μg of each) loaded into the (1D) SDS-PAGE electrophoresis gel 
without resolving 
IN GEL DIGESTION
The bands were cut out and the samples were digested with sequencing grade trypsin 
(Promega) as described elsewhere (Shevchenko A, Jensen ON, Podtelejnikov AV, 
Sagliocco F, Wilm M, Vorm O, Mortensen P, Boucherie H, Mann M. Linking genome 
and proteome by mass spectrometry: large-scale identification of yeast proteins from two 
dimensional gels. Proceedings of the National Academy of Sciences of the United States 
of America 1996; 93:14440‐14445). The digestion mixture were dried in a vacuum 
centrifuge, resuspended in 50 μL of 2% acetonitrile (ACN), 0.1% trifluoroacetic acid 
(TFA). 
LC/MSMS ANALYSIS 
5 μl of each sample were loaded onto a trap column (NanoLC Column, 3μ C18‐CL, 75 
µm x 15 cm; Eksigent) and desalted with 0.1 % TFA at  3μl/min during 5 min. The 
peptides were loaded onto an analytical column (LC Column, 3 μ C18‐CL, 75umx12cm, 
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Nikkyo) equilibrated in 5 % acetonitrile 0.1 % FA (formic acid). Peptide elution was 
carried out with a linear gradient of 5 to 35 % B in 45 min (A: 0.1% FA; B: ACN, 0.1% 
FA) for at a flow rate of 300 nl/min (Figure 1 and 2).  
Figure 2. Chromatogram of the concentrated supernatant (24 h and 48 h) and solubilized 
proteins from the crystal form the Bacillus thuringiensis isolate E-SE10.2 
Figure 3. Chromatogram of the concentrated supernatant (24 h and 48 h) and solubilized 
proteins from the crystal form the Bacillus thuringiensis isolate O-V84.2 
Peptides were analysed in a mass spectrometer nanoESI qQTOF (5600 TripleTOF, 
ABSCIEX). Eluted peptides were ionized applying 2.8 kV to the spray emitter. Analysis 
were carried out in a data‐dependent mode (DDA). Survey MS1 scans were acquired from 
350–1250 m/z for 250 ms. The quadrupole resolution was set to ‘UNIT’ for MS2 
experiments, which were acquired 100–1500 m/z for 50 ms in ‘high sensitivity’ mode. 
Following switch criteria were used: charge: 2+ to 5+; minimum intensity; 70 counts per 
second (cps). Up to 25 ions were selected for fragmentation after each survey scan. 
Dynamic exclusion was set to 15 s.  
The collision energy was automatically selected by the instrument according to the 
following equations: |CE| = (slope) x (m/z) + (intercept). 
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Table 1. Parameters used for the calculation of the collision energy of the concentrated 
supernatant and solubilized crystal proteins from the Bt isolates E-SE10.2 and O-V84.2. 
Charge Slope  Intercept 
Unknown 0.0575  9 






The MS/MS information (TripleTof wiff files) were analyzed with Protein Pilot v 4.5 
(ABSciex). ProteinPilot default parameters were used to generate peak list directly from 
5600 TripleTof wiff files. The Paragon algorithm of ProteinPilot was used to search in a 
homemade Bacillus thuringiensis protein database, called Bt_combined 
(https://sourceforge.net/projects/bt-combined/files/Bt_combined/) with the following 
parameters: trypsin specificity, cys‐alkylation, no taxonomy restriction, and the search 
effort through. To avoid using the same spectral evidence in more than one protein, the 
identified proteins are grouped based on MS/MS spectra by the Protein‐Pilot Progroup 
algorithm. Thus, proteins sharing MS/MS spectra are grouped, regardless of the peptide 
sequence assigned. The protein within each group that can explain more spectral data 
with confidence is shown as the primary protein of the group. Only the proteins of the 
group for which there is individual evidence (unique peptides with enough confidence) 
are also listed, usually toward the end of the protein list. 
For protein library construction a joint search were performed with all samples for global 
analysis and with the supernatant at 24 h and 48 h for the Bt isolates E-SE10.2 and O-
V84.2. 
RESULT INTERPRETATION 
The MSMS output files (wiff files) obtained from the 5600 TripleTof were analysed by 
Peak View 1.1 with proteins identified by Unused ≥1.3, confidence > 95% with maximum 
50 peptides for protein. The quantitative data obtained by Peak View were visualized with 
Marker View 1.3 
1. - GLOBAL ANALYSIS:
A joint search with the Bt_combined protein database was performed with the three 
replicates of the concentrated supernatant (24h and 48h) and solubilized crystal proteins. 
The search in the respective analysis were done with the following parameters: trypsin 
specificity, cys-alkylation, and the search effort set to through.  
The joined search with all the samples identified 1816 proteins and the quantitative data 
obtained was analyzed with Marker View 1.3. 
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1.1. - GROUPED DATA ANALYSIS
A PCA analysis was done with the non-normalized area of the peaks (Figure 4) and with 
the area peaks corrected by the total areas sum (Figure 5).  
Figure 4. PCA analysis with the non-normalized area of the concentrated supernatant (24 
h and 48 h) and solubilized crystal proteins from the Bt isolates E-SE10.2 and O-V84.2. 
Figure 5. PCA analysis with the area peaks corrected by the total areas sum of the 
concentrated supernatant (24 h and 48 h) and solubilized crystal proteins from the Bt 
isolates E-SE10.2 and O-V84.2. 
To evaluate the samples distribution inside of each grouped data, a PCA analysis was 
done with the distribution of the peaks area corrected by the total areas sum. 
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Figure 6. PCA analysis with the distribution of the peaks area corrected by the total areas 
sum of the concentrated supernatant (24 h and 48 h) and solubilized crystal proteins from 
the Bt isolates E-SE10.2 and O-V84.2. 
RESULT 
The data obtained from the global analysis of the concentrated supernatant (24 h and 48 
h) and solubilized proteins form the crystal indicate the follow results:
1. The solubilized crystal of the Bt isolates E-SE10.2 and O-V84.2 have been
grouped in two clusters (Figure 4 and 5). The distribution of the peaks area of the
solubilized proteins from the crystal, suggest that the variability of the protein
amount are not statistically significant (Figure 6).
2. The supernatant of the Bt isolates E-SE10.2 at 24 h and 48 h have been grouped
in the same cluster, suggesting that the protein composition of the supernatant is
similar at 24 h and 48 h (Figure 4 and 5). The distribution of the peaks area of the
supernatant at 24 h and 48 h, suggest that the variability of the protein amount
between 24 h and 48 h are statistically significant (Figure 6).
3. The supernatant of the Bt isolates O-V84.2 at 24 h and 48 h have been grouped in
two cluster, suggesting that the protein composition of the supernatant between
the 24 h and 48 h statistically different (Figure 4 and 5). The distribution of the
peaks area of the supernatant at 24 h and 48 h, suggest that the variability between
24 h and 48 h are not statistically significant (Figure 6).
2. - SPECIFIC ANALYSIS:
A joint search with the Bt_combined protein database was performed with the three 
replicates of the concentrated supernatant of the Bt isolate at 24h and 48h. The search in 
the respective analysis were done with the following parameters: trypsin specificity, cys-
alkylation, and the search effort set to through.  
The joined search with the supernatant at 24 h and 48 h identified 875 proteins and the 
quantitative data obtained was analyzed with Marker View 1.3. 
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2.1. - GROUPED DATA ANALYSIS E-SE10.2 
A PCA analysis was done with the non-normalized area of the peaks (Figure 7) and with 
the area peaks corrected by the total areas sum (Figure 8) of the concentrated supernatant 
at 24 h and 48 h. 
Figure 7. PCA analysis with the non-normalized area of the concentrated supernatant of 
the Bt isolate 24 h and 48 h. 
Figure 8. PCA analysis with the area peaks corrected by the total areas sum of the 
concentrated supernatant 24 h and 48 h of the Bt isolate E-SE10.2 
2.1. - DIFFERENTAL EXPRESION ANALYSIS E-SE10.2 
A Student t-test analysis was performed with the supernatant of the Bt isolate E-SE10.2 
at 24 h and 48 h in the Marker View 1.3. As a result, 39 proteins were differential 
expressed between two groups, 11 up‐ regulated (red) and 28 down‐regulated (green).  
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3.00E‐04 2.71E+04 6.16E+04 3.73E+03 3.16E+03 4.40E‐01 ‐3.57E‐01










2.86E‐03 8.52E+04 3.34E+05 3.93E+04 4.93E+04 2.55E‐01 ‐5.93E‐01
Malonyl CoA‐acyl carrier protein 
transacylase (EC 2.3.1.39)
3.72E‐03 6.72E+04 1.37E+05 1.42E+04 9.00E+03 4.92E‐01 ‐3.08E‐01
3‐deoxy‐manno‐octulosonate 
cytidylyltransferase (EC 2.7.7.38)
3.74E‐03 2.29E+04 1.30E+04 7.52E+02 1.70E+03 1.76E+00 2.46E‐01
putative cytochrome P450 
hydroxylase
4.23E‐03 7.31E+04 2.08E+05 2.23E+04 2.98E+04 3.51E‐01 ‐4.54E‐01
FIG01226668: hypothetical 
protein
6.40E‐03 9.66E+04 1.79E+05 1.93E+04 1.95E+04 5.38E‐01 ‐2.69E‐01
Isocitrate lyase (EC 4.1.3.1) 8.10E‐03 2.06E+05 1.39E+05 1.78E+04 1.48E+04 1.48E+00 1.70E‐01
S‐layer protein, putative 1.02E‐02 6.20E+04 1.84E+05 2.99E+04 1.25E+04 3.36E‐01 ‐4.74E‐01
Specific proteins of the Bt isolate E‐SE10.2
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Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)
Translation elongation factor Tu 1.77E‐02 5.12E+05 1.27E+06 1.37E+05 2.49E+05 4.04E‐01 ‐3.94E‐01
Possible response regulator 
aspartate phosphatase
1.84E‐02 1.91E+05 3.65E+05 4.76E+04 5.96E+04 5.23E‐01 ‐2.81E‐01
spore coat polysaccharide 
synthesis





2.79E‐02 1.55E+05 1.15E+06 5.99E+04 3.13E+05 1.35E‐01 ‐8.70E‐01
N‐acetyltransferase family 
protein
3.08E‐02 2.49E+05 6.20E+05 1.15E+05 1.51E+05 4.02E‐01 ‐3.96E‐01
Exosporium protein K 3.32E‐02 2.03E+04 5.53E+04 5.83E+03 1.38E+04 3.66E‐01 ‐4.36E‐01
polyketide synthase type I 3.53E‐02 1.09E+05 1.73E+05 2.02E+04 2.71E+04 6.33E‐01 ‐1.98E‐01
Possible response regulator 
aspartate phosphatase
3.56E‐02 6.74E+04 2.18E+05 1.61E+04 5.65E+04 3.09E‐01 ‐5.10E‐01
NADP‐dependent malic enzyme 
(EC 1.1.1.40)
3.74E‐02 5.38E+05 3.21E+05 8.14E+03 7.61E+04 1.67E+00 2.24E‐01
FIG01234973: hypothetical 
protein
3.75E‐02 5.98E+05 1.64E+05 1.75E+05 6.40E+04 3.64E+00 5.61E‐01
Pyruvate formate‐lyase (EC 
2.3.1.54)
3.82E‐02 5.14E+05 1.94E+05 1.13E+05 1.09E+04 2.64E+00 4.22E‐01
O‐antigen biosynthesis protein 
RfbC
3.93E‐02 1.20E+05 3.42E+04 3.57E+04 1.39E+04 3.51E+00 5.45E‐01
L‐serine dehydratase, beta 
subunit (EC 4.3.1.17)
4.28E‐02 1.05E+04 2.20E+04 5.28E+03 3.45E+03 4.79E‐01 ‐3.20E‐01
Beta‐lysine acetyltransferase (EC 
2.3.1.‐)
4.28E‐02 1.17E+05 1.72E+05 7.54E+03 2.30E+04 6.79E‐01 ‐1.68E‐01
hypothetical protein 4.31E‐02 1.83E+04 4.45E+04 9.70E+03 1.18E+04 4.11E‐01 ‐3.86E‐01
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Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)
zwittermicin A resistance protein 4.32E‐02 5.35E+04 1.46E+05 3.17E+04 4.24E+04 3.67E‐01 ‐4.35E‐01
Topoisomerase IV subunit A (EC 
5.99.1.‐)




4.73E‐02 1.51E+04 5.37E+04 3.99E+03 1.62E+04 2.82E‐01 ‐5.50E‐01
FIG01227334: hypothetical 
protein
4.75E‐02 1.37E+03 8.22E+03 1.24E+03 3.12E+03 1.66E‐01 ‐7.80E‐01
Porphobilinogen synthase (EC 
4.2.1.24)








5.34E‐02 3.52E+04 8.19E+04 2.24E+04 9.01E+03 4.30E‐01 ‐3.66E‐01
Flagellin protein FlaA 5.52E‐02 1.75E+07 8.16E+06 4.33E+06 1.22E+06 2.15E+00 3.32E‐01
Butyryl‐CoA dehydrogenase (EC 
1.3.99.2)
5.53E‐02 3.70E+04 1.68E+05 1.00E+04 5.77E+04 2.20E‐01 ‐6.57E‐01
Pyrrolidone‐carboxylate 
peptidase (EC 3.4.19.3)




6.09E‐02 1.17E+05 2.86E+05 8.78E+03 7.71E+04 4.08E‐01 ‐3.90E‐01
Homoserine O‐acetyltransferase 
(EC 2.3.1.31)
6.21E‐02 3.81E+04 8.27E+04 1.17E+04 2.35E+04 4.61E‐01 ‐3.37E‐01
FIG01226051: hypothetical 
protein
6.29E‐02 8.65E+04 1.67E+05 2.59E+04 4.30E+04 5.19E‐01 ‐2.85E‐01
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6.46E‐02 1.35E+04 4.75E+04 6.83E+03 1.77E+04 2.83E‐01 ‐5.48E‐01
4‐hydroxybenzoyl‐CoA 
thioesterase family active site
6.50E‐02 1.01E+05 1.95E+05 1.71E+04 4.83E+04 5.18E‐01 ‐2.86E‐01
D‐alanyl‐D‐alanine 
carboxypeptidase (EC 3.4.16.4)
6.50E‐02 2.68E+05 1.52E+05 5.11E+04 6.01E+04 1.76E+00 2.46E‐01
Polypeptide composition of the 
spore coat protein CotJC
6.59E‐02 4.29E+03 1.19E+04 1.81E+03 4.08E+03 3.59E‐01 ‐4.44E‐01
hypothetical protein 6.75E‐02 3.03E+04 1.31E+04 9.27E+03 7.10E+03 2.31E+00 3.63E‐01
hypothetical protein 6.75E‐02 2.21E+05 7.43E+04 7.25E+04 7.21E+04 2.98E+00 4.74E‐01
hypothetical protein 6.81E‐02 1.15E+03 4.67E+03 1.39E+03 1.93E+03 2.46E‐01 ‐6.09E‐01
FIG01227037: hypothetical 
protein
6.84E‐02 8.21E+04 3.45E+05 2.08E+04 1.29E+05 2.38E‐01 ‐6.23E‐01
acetyltransferase, GNAT family 7.15E‐02 1.32E+04 3.08E+04 4.82E+03 9.84E+03 4.28E‐01 ‐3.68E‐01
Thioredoxin reductase (EC 
1.8.1.9)






7.65E‐02 1.34E+04 4.96E+03 4.43E+03 4.27E+03 2.70E+00 4.31E‐01
FIG01115625: hypothetical 
protein
7.72E‐02 2.18E+04 3.38E+04 6.53E+03 1.77E+03 6.45E‐01 ‐1.91E‐01
6‐phosphogluconolactonase (EC 
3.1.1.31)
7.78E‐02 1.38E+04 4.89E+03 5.11E+03 3.87E+03 2.83E+00 4.51E‐01
Heat shock protein 60 family co‐
chaperone GroES
8.17E‐02 1.22E+05 2.87E+04 5.46E+04 2.34E+04 4.24E+00 6.27E‐01
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8.20E‐02 5.75E+05 1.53E+06 8.77E+04 5.19E+05 3.76E‐01 ‐4.25E‐01
hypothetical protein 8.22E‐02 2.26E+03 9.79E+03 1.04E+03 4.20E+03 2.30E‐01 ‐6.37E‐01




8.36E‐02 1.37E+05 3.17E+05 5.27E+04 1.08E+05 4.31E‐01 ‐3.66E‐01
Spore coat protein B 8.36E‐02 3.25E+03 1.09E+04 5.71E+02 4.15E+03 2.99E‐01 ‐5.24E‐01
endonuclease/exonuclease/phos
phatase family
8.39E‐02 5.23E+04 1.83E+04 2.00E+04 7.61E+03 2.86E+00 4.56E‐01
Chitin binding protein 8.41E‐02 1.01E+06 3.35E+05 3.96E+05 1.54E+05 3.01E+00 4.78E‐01
hypothetical protein 8.56E‐02 1.00E+05 4.50E+05 4.14E+04 1.97E+05 2.22E‐01 ‐6.53E‐01
FIG01227780: hypothetical 
protein














9.34E‐02 4.90E+05 3.01E+05 1.09E+05 1.01E+05 1.63E+00 2.11E‐01
257





9.38E‐02 6.82E+04 1.34E+05 3.99E+04 1.15E+04 5.09E‐01 ‐2.94E‐01
SSU ribosomal protein S11p 
(S14e)








9.68E‐02 1.40E+03 4.93E+02 5.81E+02 3.75E+02 2.84E+00 4.53E‐01
UDP‐N‐acetylglucosamine 4,6‐
dehydratase (EC 4.2.1.‐)
9.72E‐02 1.71E+04 8.10E+03 5.64E+03 2.05E+03 2.11E+00 3.23E‐01
DNA‐binding response regulator 1.02E‐01 2.43E+05 1.46E+05 6.41E+04 2.97E+04 1.67E+00 2.23E‐01
Imidazolonepropionase (EC 
3.5.2.7)
1.06E‐01 5.25E+05 2.37E+05 1.92E+05 1.17E+05 2.21E+00 3.45E‐01
FIG01225201: hypothetical 
protein
1.07E‐01 1.13E+03 4.39E+03 4.58E+02 2.08E+03 2.58E‐01 ‐5.88E‐01
Homoserine dehydrogenase (EC 
1.1.1.3)
1.08E‐01 6.87E+05 1.11E+05 3.60E+05 3.95E+04 6.18E+00 7.91E‐01
SSU ribosomal protein S13p 
(S18e)
1.09E‐01 1.50E+05 1.00E+05 2.06E+04 3.37E+04 1.50E+00 1.76E‐01
DNA polymerase X family 1.12E‐01 5.20E+04 8.70E+04 1.55E+04 2.39E+04 5.97E‐01 ‐2.24E‐01
Alanyl‐tRNA synthetase (EC 
6.1.1.7)
1.12E‐01 1.60E+05 1.26E+05 2.36E+04 1.61E+04 1.28E+00 1.06E‐01
LSU ribosomal protein L7/L12 
(P1/P2)
1.12E‐01 1.29E+05 9.43E+04 9.71E+03 2.38E+04 1.37E+00 1.37E‐01
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1.16E‐01 1.09E+06 1.59E+06 3.52E+05 1.41E+05 6.82E‐01 ‐1.66E‐01
Exodeoxyribonuclease III (EC 
3.1.11.2)
1.17E‐01 9.52E+03 4.12E+04 6.42E+03 2.17E+04 2.31E‐01 ‐6.36E‐01
LSU ribosomal protein L13p 
(L13Ae)
1.18E‐01 8.82E+04 1.53E+05 2.47E+04 4.60E+04 5.76E‐01 ‐2.40E‐01




1.20E‐01 3.50E+05 1.48E+05 1.42E+05 9.63E+04 2.36E+00 3.74E‐01
DNA topoisomerase I (EC 
5.99.1.2)





1.25E‐01 2.66E+04 1.00E+05 2.30E+04 5.33E+04 2.66E‐01 ‐5.76E‐01
Glucose 1‐dehydrogenase (EC 
1.1.1.47)
1.27E‐01 8.77E+04 4.84E+04 1.25E+04 2.87E+04 1.81E+00 2.59E‐01
Collagen adhesion protein 1.28E‐01 4.24E+05 1.60E+05 1.91E+05 6.25E+04 2.66E+00 4.24E‐01
Malonyl CoA‐acyl carrier protein 
transacylase (EC 2.3.1.39)
1.28E‐01 1.25E+05 2.24E+05 6.15E+04 6.49E+04 5.59E‐01 ‐2.52E‐01
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1.31E‐01 3.40E+04 5.76E+04 1.60E+04 1.45E+04 5.90E‐01 ‐2.29E‐01
NADH‐dependent butanol 
dehydrogenase A (EC 1.1.1.‐)
1.32E‐01 4.07E+04 5.04E+04 2.45E+03 7.12E+03 8.08E‐01 ‐9.25E‐02
Thioredoxin reductase (EC 
1.8.1.9)
1.42E‐01 1.41E+05 2.18E+05 5.89E+04 3.90E+04 6.46E‐01 ‐1.90E‐01
Dihydroxyacetone kinase, ATP‐
dependent (EC 2.7.1.29)




1.45E‐01 6.75E+03 3.68E+03 2.38E+03 1.53E+03 1.84E+00 2.64E‐01
Tellurium resistance protein 
TerD
1.46E‐01 2.29E+04 4.20E+04 9.67E+03 1.48E+04 5.44E‐01 ‐2.64E‐01
hypothetical protein 1.49E‐01 2.68E+03 8.45E+03 1.53E+03 4.55E+03 3.17E‐01 ‐4.99E‐01
Flagellar hook‐associated protein 
FliD
1.50E‐01 7.90E+04 3.32E+04 3.51E+04 4.50E+03 2.38E+00 3.77E‐01
CTP synthase (EC 6.3.4.2) 1.53E‐01 5.21E+05 2.91E+05 1.84E+05 1.16E+05 1.79E+00 2.53E‐01
hypothetical protein 1.55E‐01 2.04E+05 2.57E+05 3.04E+04 4.19E+04 7.92E‐01 ‐1.01E‐01
Aminopeptidase YpdF (MP‐, MA‐
, MS‐, AP‐, NP‐ specific)





1.62E‐01 1.28E+04 1.84E+04 1.81E+03 4.70E+03 6.94E‐01 ‐1.59E‐01
Methylthioribose‐1‐phosphate 
isomerase (EC 5.3.1.23)
1.63E‐01 3.03E+04 5.95E+03 1.96E+04 2.33E+03 5.09E+00 7.06E‐01
DegV family protein 1.65E‐01 1.47E+04 7.32E+03 5.55E+03 5.11E+03 2.01E+00 3.04E‐01
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Glycerate kinase (EC 2.7.1.31) 1.65E‐01 7.21E+04 1.88E+04 4.31E+04 2.94E+03 3.83E+00 5.83E‐01
Hydroxyethylthiazole kinase (EC 
2.7.1.50)
1.67E‐01 6.51E+03 3.07E+04 2.10E+03 1.97E+04 2.12E‐01 ‐6.73E‐01
ATP synthase F0 sector subunit b 1.67E‐01 1.51E+05 4.63E+05 3.72E+04 2.56E+05 3.27E‐01 ‐4.86E‐01




1.69E‐01 1.34E+06 7.43E+05 4.18E+05 4.55E+05 1.81E+00 2.57E‐01
Penicillin‐binding protein 1.71E‐01 3.71E+04 2.03E+04 4.02E+03 1.43E+04 1.83E+00 2.62E‐01
Two‐component response 
regulator SA14‐24
1.71E‐01 4.75E+05 3.34E+05 1.19E+05 2.01E+04 1.42E+00 1.54E‐01
Isovaleryl‐CoA dehydrogenase 
(EC 1.3.8.4)
1.71E‐01 4.27E+05 2.26E+05 1.72E+05 9.43E+04 1.89E+00 2.77E‐01
Valyl‐tRNA synthetase (EC 
6.1.1.9)




1.77E‐01 3.76E+04 7.97E+04 3.08E+04 3.22E+04 4.72E‐01 ‐3.26E‐01
Isoleucyl‐tRNA synthetase (EC 
6.1.1.5)
1.77E‐01 1.63E+04 2.99E+04 6.10E+03 1.19E+04 5.45E‐01 ‐2.64E‐01
polyhydroxyalkanoate synthesis 
repressor PhaR
1.80E‐01 3.38E+03 1.18E+04 1.97E+03 7.36E+03 2.86E‐01 ‐5.43E‐01
Hydroxyacylglutathione 
hydrolase (EC 3.1.2.6)
1.82E‐01 2.80E+04 4.62E+04 1.33E+04 1.43E+04 6.05E‐01 ‐2.18E‐01
hypothetical protein 1.82E‐01 4.75E+04 2.37E+04 1.96E+04 1.62E+04 2.01E+00 3.03E‐01
Phage N‐acetylmuramoyl‐L‐
alanine amidase (EC 3.5.1.28)
1.82E‐01 2.88E+05 1.87E+05 6.31E+04 8.61E+04 1.54E+00 1.88E‐01
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1.82E‐01 1.51E+05 6.11E+04 7.95E+04 2.09E+04 2.47E+00 3.94E‐01
Pyridoxamine 5'‐phosphate 
oxidase (EC 1.4.3.5)
1.85E‐01 2.63E+04 5.15E+04 1.10E+04 2.26E+04 5.11E‐01 ‐2.91E‐01
N‐acetylmuramoyl‐L‐alanine 
amidase




1.87E‐01 4.95E+04 8.89E+04 2.42E+04 3.43E+04 5.56E‐01 ‐2.55E‐01
acetyltransferase, GNAT family 1.87E‐01 4.16E+04 2.48E+04 1.45E+04 1.07E+04 1.68E+00 2.26E‐01
Arsenic efflux pump protein 1.88E‐01 7.24E+03 4.49E+03 2.50E+03 1.21E+03 1.61E+00 2.08E‐01
SAM‐dependent 
methyltransferases
1.89E‐01 1.23E+05 6.23E+04 5.42E+04 3.36E+04 1.97E+00 2.95E‐01
Chitosanase 1.90E‐01 6.74E+05 4.63E+05 1.04E+05 1.92E+05 1.46E+00 1.63E‐01




1.93E‐01 1.05E+05 6.66E+05 8.23E+04 5.08E+05 1.57E‐01 ‐8.04E‐01
FIG01245734: hypothetical 
protein
1.96E‐01 8.90E+04 5.75E+04 2.54E+04 2.44E+04 1.55E+00 1.90E‐01
dTDP‐glucose 4,6‐dehydratase 
(EC 4.2.1.46)




1.98E‐01 6.65E+04 1.12E+05 2.21E+04 4.29E+04 5.91E‐01 ‐2.28E‐01
SpoIISA like protein 1.99E‐01 2.09E+03 1.06E+04 1.47E+03 7.85E+03 1.98E‐01 ‐7.03E‐01
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2.02E‐01 5.11E+06 3.16E+06 1.73E+06 1.35E+06 1.62E+00 2.09E‐01
FIG002379: metal‐dependent 
hydrolase
2.03E‐01 3.27E+04 4.58E+04 7.86E+03 1.21E+04 7.14E‐01 ‐1.46E‐01
Streptomycin biosynthesis StrF 
domain protein




2.07E‐01 6.70E+04 3.97E+04 1.66E+04 2.55E+04 1.69E+00 2.27E‐01
DUF124 domain‐containing 
protein
2.07E‐01 3.18E+04 5.00E+04 1.75E+04 9.03E+03 6.35E‐01 ‐1.97E‐01
S‐adenosylmethionine 
synthetase (EC 2.5.1.6)
2.07E‐01 2.24E+05 1.25E+05 9.53E+04 2.76E+04 1.80E+00 2.54E‐01




2.10E‐01 8.10E+04 4.31E+04 3.51E+04 2.51E+04 1.88E+00 2.74E‐01
FIG01226217: hypothetical 
protein
2.12E‐01 1.69E+05 1.21E+05 3.82E+04 4.06E+04 1.39E+00 1.44E‐01
EPSX protein 2.12E‐01 7.21E+04 4.30E+04 2.65E+04 2.07E+04 1.68E+00 2.25E‐01
Succinate dehydrogenase iron‐
sulfur protein (EC 1.3.99.1)
2.13E‐01 1.44E+04 3.15E+04 8.59E+03 1.68E+04 4.56E‐01 ‐3.41E‐01
Phage‐related protein 2.16E‐01 5.22E+05 4.71E+05 1.49E+04 4.99E+04 1.11E+00 4.43E‐02
alkaline serine protease, 
subtilase family
2.16E‐01 4.13E+05 1.65E+05 2.28E+05 1.79E+05 2.50E+00 3.99E‐01
LSU ribosomal protein L1p 
(L10Ae)
2.17E‐01 1.28E+05 7.53E+04 4.34E+04 4.50E+04 1.70E+00 2.31E‐01
hypothetical protein 2.18E‐01 2.97E+05 4.15E+05 9.90E+04 9.89E+04 7.16E‐01 ‐1.45E‐01
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2.19E‐01 1.67E+04 3.14E+04 2.69E+03 1.45E+04 5.32E‐01 ‐2.74E‐01
S‐layer homology domain 
protein
2.20E‐01 3.13E+05 2.14E+05 6.32E+04 9.54E+04 1.46E+00 1.64E‐01
FIG01226904: hypothetical 
protein
2.22E‐01 2.68E+03 1.33E+04 2.30E+03 1.07E+04 2.01E‐01 ‐6.96E‐01
NADH dehydrogenase (EC 
1.6.99.3)




2.23E‐01 6.36E+05 4.92E+05 1.19E+05 1.24E+05 1.29E+00 1.11E‐01
FIG01225131: hypothetical 
protein
2.23E‐01 2.22E+04 1.11E+04 1.12E+04 3.26E+03 2.00E+00 3.00E‐01
Penicillin‐binding protein 2.23E‐01 6.37E+04 1.07E+05 2.47E+04 4.32E+04 5.95E‐01 ‐2.26E‐01
ATP synthase delta chain (EC 
3.6.3.14)




2.26E‐01 4.45E+05 6.96E+05 1.33E+04 2.51E+05 6.40E‐01 ‐1.94E‐01
phaP protein 2.26E‐01 3.12E+04 5.42E+04 7.00E+03 2.34E+04 5.76E‐01 ‐2.39E‐01




2.27E‐01 9.44E+05 1.27E+06 3.35E+05 1.16E+05 7.42E‐01 ‐1.30E‐01
Cysteine synthase (EC 2.5.1.47) 2.27E‐01 3.19E+05 4.77E+05 1.36E+05 1.35E+05 6.70E‐01 ‐1.74E‐01




2.33E‐01 3.72E+04 4.92E+04 1.01E+04 1.07E+04 7.58E‐01 ‐1.20E‐01
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2.33E‐01 2.09E+05 1.48E+05 5.92E+04 4.50E+04 1.41E+00 1.50E‐01
sensor histidine kinase, putative 2.34E‐01 3.74E+04 5.10E+04 1.24E+04 1.13E+04 7.33E‐01 ‐1.35E‐01
Putative uncharacterized protein 
YndJ
2.36E‐01 1.92E+06 2.68E+06 3.31E+05 7.99E+05 7.17E‐01 ‐1.45E‐01
hypothetical protein 2.37E‐01 3.19E+04 1.74E+04 1.35E+04 1.19E+04 1.83E+00 2.63E‐01
ABC transporter, ATP‐binding 
protein
2.39E‐01 1.06E+07 1.68E+07 3.34E+06 6.48E+06 6.33E‐01 ‐1.99E‐01
hypothetical protein 2.39E‐01 8.28E+04 1.84E+05 1.06E+04 1.06E+05 4.49E‐01 ‐3.47E‐01
ABC transporter, ATP‐binding 
protein




2.41E‐01 1.66E+05 7.04E+04 1.02E+05 4.56E+04 2.36E+00 3.73E‐01
Short‐chain 
dehydrogenase/reductase SDR
2.41E‐01 1.81E+05 1.06E+05 4.19E+04 7.95E+04 1.71E+00 2.33E‐01
Fructose‐bisphosphate aldolase 
class II (EC 4.1.2.13)




2.44E‐01 7.97E+05 5.55E+05 1.79E+05 2.44E+05 1.44E+00 1.57E‐01
Inner spore coat protein D 2.45E‐01 2.76E+03 1.26E+04 1.50E+03 1.05E+04 2.20E‐01 ‐6.58E‐01
SSU ribosomal protein S10p 
(S20e)
2.49E‐01 1.87E+03 6.56E+03 2.06E+03 5.10E+03 2.86E‐01 ‐5.44E‐01
hypothetical protein 2.51E‐01 5.67E+05 8.00E+05 2.53E+05 1.28E+05 7.09E‐01 ‐1.50E‐01
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2.54E‐01 9.16E+03 2.43E+04 1.04E+04 1.61E+04 3.77E‐01 ‐4.24E‐01
Malate dehydrogenase (EC 
1.1.1.37)




2.57E‐01 1.77E+05 1.20E+05 4.54E+04 5.89E+04 1.48E+00 1.70E‐01
Deblocking aminopeptidase (EC 
3.4.11.‐)
2.58E‐01 5.83E+04 1.48E+05 3.50E+02 9.97E+04 3.93E‐01 ‐4.06E‐01
Glutamate‐1‐semialdehyde 
aminotransferase (EC 5.4.3.8)
2.58E‐01 3.61E+04 1.60E+04 2.08E+04 1.58E+04 2.26E+00 3.55E‐01
membrane protein, putative 2.58E‐01 2.31E+05 1.00E+05 1.46E+05 3.19E+04 2.30E+00 3.63E‐01
Catalase (EC 1.11.1.6) 2.59E‐01 1.20E+06 1.03E+06 1.81E+05 1.31E+05 1.17E+00 6.71E‐02
Dipicolinate synthase subunit B 2.61E‐01 1.48E+05 2.73E+05 4.24E+04 1.41E+05 5.43E‐01 ‐2.65E‐01
FIG01235645: hypothetical 
protein





2.63E‐01 1.33E+05 6.93E+04 7.02E+04 4.11E+04 1.92E+00 2.83E‐01
Manganese‐dependent inorganic 
pyrophosphatase (EC 3.6.1.1)
2.65E‐01 6.03E+05 3.63E+05 2.13E+05 2.39E+05 1.66E+00 2.21E‐01
FIG01226521: hypothetical 
protein
2.65E‐01 2.88E+03 1.69E+03 7.75E+02 1.32E+03 1.70E+00 2.32E‐01
L‐serine dehydratase, alpha 
subunit (EC 4.3.1.17)
2.69E‐01 1.60E+06 3.73E+05 1.42E+06 4.21E+05 4.29E+00 6.33E‐01
hypothetical protein 2.69E‐01 9.97E+04 1.32E+05 2.63E+04 3.37E+04 7.58E‐01 ‐1.21E‐01
hypothetical protein 2.71E‐01 6.68E+02 2.07E+03 8.37E+02 1.61E+03 3.22E‐01 ‐4.92E‐01
266
Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)
DNA‐binding response regulator 2.73E‐01 1.57E+03 2.68E+04 2.32E+03 2.92E+04 5.86E‐02 ‐1.23E+00
hypothetical protein 2.76E‐01 2.34E+04 1.49E+04 8.39E+03 8.07E+03 1.57E+00 1.96E‐01
hypothetical protein 2.76E‐01 8.17E+03 3.63E+03 5.21E+03 2.96E+03 2.25E+00 3.52E‐01
hypothetical protein 2.76E‐01 3.12E+05 5.69E+05 3.77E+04 3.01E+05 5.48E‐01 ‐2.61E‐01
Serine hydroxymethyltransferase 
(EC 2.1.2.1)






2.79E‐01 3.81E+05 2.31E+05 7.58E+04 1.77E+05 1.65E+00 2.17E‐01




2.80E‐01 7.03E+03 4.48E+03 2.98E+03 1.59E+03 1.57E+00 1.96E‐01
ATP synthase beta chain (EC 
3.6.3.14)
2.83E‐01 2.69E+05 4.80E+05 5.61E+04 2.53E+05 5.59E‐01 ‐2.52E‐01
FIG01225294: hypothetical 
protein
2.83E‐01 2.47E+05 1.73E+05 6.51E+04 7.83E+04 1.42E+00 1.53E‐01
Phage shock protein A 2.84E‐01 5.78E+04 1.36E+05 3.99E+04 9.32E+04 4.26E‐01 ‐3.70E‐01
LSU ribosomal protein L5p (L11e) 2.88E‐01 3.99E+04 2.34E+04 1.93E+04 1.17E+04 1.71E+00 2.32E‐01
Preprotein translocase subunit 
YajC (TC 3.A.5.1.1)




2.89E‐01 1.24E+05 6.02E+04 7.78E+04 6.21E+03 2.07E+00 3.15E‐01
FIG01229848: hypothetical 
protein
2.92E‐01 5.49E+04 1.02E+05 4.25E+04 5.20E+04 5.37E‐01 ‐2.70E‐01
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2.93E‐01 9.67E+05 2.34E+06 1.09E+06 1.59E+06 4.14E‐01 ‐3.83E‐01
2‐hydroxy‐3‐oxopropionate 
reductase (EC 1.1.1.60)
2.94E‐01 6.92E+04 1.22E+05 5.00E+04 5.68E+04 5.67E‐01 ‐2.47E‐01
Amidohydrolase AmhX 2.94E‐01 2.37E+04 3.99E+04 4.94E+03 2.00E+04 5.94E‐01 ‐2.26E‐01
Glycosyl transferase, group 2 
family protein
2.94E‐01 3.84E+04 2.60E+04 1.53E+04 4.67E+03 1.48E+00 1.69E‐01
Transcriptional regulator, IclR 
family





2.95E‐01 6.73E+04 1.68E+04 6.22E+04 3.63E+03 4.00E+00 6.02E‐01
Phenylalanyl‐tRNA synthetase 
beta chain (EC 6.1.1.20)
2.95E‐01 4.79E+04 2.94E+04 2.30E+04 5.96E+03 1.63E+00 2.12E‐01
Alanine dehydrogenase (EC 
1.4.1.1)
2.97E‐01 2.30E+06 1.69E+06 5.09E+05 6.99E+05 1.36E+00 1.33E‐01
Oligoendopeptidase F (EC 3.4.24.‐
)












3.01E‐01 7.26E+04 1.17E+05 1.87E+04 5.58E+04 6.21E‐01 ‐2.07E‐01
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3.02E‐01 6.59E+03 1.28E+04 1.81E+03 7.82E+03 5.15E‐01 ‐2.88E‐01
FIG017263: hypothetical protein 3.03E‐01 1.31E+05 1.82E+05 2.68E+04 6.41E+04 7.19E‐01 ‐1.43E‐01
Chaperone protein DnaK 3.03E‐01 1.66E+05 1.11E+05 6.85E+04 3.71E+04 1.50E+00 1.76E‐01
Fructose‐1,6‐bisphosphatase, 
GlpX type (EC 3.1.3.11)
3.05E‐01 2.17E+05 1.44E+05 6.79E+04 8.17E+04 1.50E+00 1.77E‐01
Ferrichrome‐binding periplasmic 
protein precursor (TC 3.A.1.14.3)




3.07E‐01 1.25E+06 2.01E+06 7.26E+05 8.41E+05 6.25E‐01 ‐2.04E‐01
Metallo‐dependent hydrolases, 
subgroup C
3.08E‐01 2.38E+04 3.69E+04 7.30E+03 1.67E+04 6.45E‐01 ‐1.91E‐01
FIG01251828: hypothetical 
protein
3.08E‐01 5.14E+05 3.14E+05 2.56E+05 8.66E+04 1.64E+00 2.14E‐01
Nicotinate‐nucleotide 
adenylyltransferase (EC 2.7.7.18)
3.10E‐01 7.75E+04 1.19E+05 3.00E+04 5.12E+04 6.53E‐01 ‐1.85E‐01
hypothetical protein 3.11E‐01 8.65E+04 1.42E+05 4.36E+04 6.83E+04 6.09E‐01 ‐2.15E‐01
Electron transfer flavoprotein, 
alpha subunit
3.13E‐01 1.38E+06 1.02E+06 4.54E+05 2.50E+05 1.35E+00 1.31E‐01
Tellurite resistance protein 3.14E‐01 4.41E+03 1.25E+04 1.95E+03 1.06E+04 3.52E‐01 ‐4.54E‐01
Manganese transport protein 
MntH




3.18E‐01 4.43E+04 1.51E+05 1.35E+04 1.40E+05 2.93E‐01 ‐5.32E‐01
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3.20E‐01 6.08E+05 7.80E+05 2.27E+05 4.62E+04 7.80E‐01 ‐1.08E‐01
ATP/GTP‐binding protein, 
SA1392 homolog




3.27E‐01 9.65E+05 6.02E+05 4.89E+05 6.32E+04 1.60E+00 2.05E‐01
hypothetical protein 3.27E‐01 2.33E+06 3.05E+06 6.92E+05 8.78E+05 7.62E‐01 ‐1.18E‐01
Iron‐sulfur cluster assembly 
protein SufD
3.29E‐01 6.72E+03 1.08E+04 6.45E+02 5.50E+03 6.23E‐01 ‐2.05E‐01
heat shock protein, Hsp20 family 3.29E‐01 7.46E+03 3.85E+04 8.52E+03 4.20E+04 1.94E‐01 ‐7.12E‐01
Citrate synthase (si) (EC 2.3.3.1) 3.29E‐01 6.93E+04 1.61E+05 7.70E+04 1.17E+05 4.30E‐01 ‐3.66E‐01
enterotoxin / cell‐wall binding 
protein
3.29E‐01 6.71E+04 4.31E+04 2.57E+04 2.70E+04 1.55E+00 1.92E‐01
response regulator aspartate 
phosphatase
3.30E‐01 1.75E+04 3.40E+04 3.31E+03 2.24E+04 5.15E‐01 ‐2.88E‐01
Cytochrome c oxidase 
polypeptide I (EC 1.9.3.1)





3.31E‐01 1.04E+06 1.58E+06 6.95E+05 4.67E+05 6.56E‐01 ‐1.83E‐01
ABC transporter, ATP‐binding 
protein
3.32E‐01 1.48E+04 2.91E+04 1.29E+04 1.81E+04 5.07E‐01 ‐2.95E‐01
oxidoreductase, short chain 
dehydrogenase/reductase family
3.34E‐01 8.05E+03 2.21E+04 5.61E+03 1.92E+04 3.65E‐01 ‐4.38E‐01
Hemolysin BL lytic component L2 3.35E‐01 2.04E+04 1.05E+04 1.32E+04 7.12E+03 1.94E+00 2.88E‐01
270
Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)
PXO1‐87 3.37E‐01 2.52E+04 1.20E+04 1.81E+04 7.11E+03 2.10E+00 3.22E‐01
NAD‐dependent malic enzyme 
(EC 1.1.1.38)
3.38E‐01 1.04E+05 2.56E+04 1.09E+05 6.41E+03 4.08E+00 6.10E‐01
alternate gene name: yznA 3.39E‐01 8.96E+03 6.63E+02 1.15E+04 2.35E+02 1.35E+01 1.13E+00
DUF1696 domain‐containing 
protein
3.39E‐01 1.75E+04 2.63E+04 8.41E+03 1.10E+04 6.67E‐01 ‐1.76E‐01
Thermostable carboxypeptidase 
1 (EC 3.4.17.19)
3.40E‐01 2.49E+05 3.26E+05 4.28E+04 1.07E+05 7.63E‐01 ‐1.17E‐01
metallo‐beta‐lactamase family 
protein
3.42E‐01 1.52E+03 2.91E+03 8.23E+02 1.91E+03 5.24E‐01 ‐2.80E‐01
3‐oxoacyl‐[acyl‐carrier‐protein] 
synthase, KASII (EC 2.3.1.41)
3.44E‐01 2.10E+05 1.58E+05 7.35E+04 2.67E+04 1.33E+00 1.25E‐01
D‐Glucosaminate‐6‐phosphate 
ammonia‐lyase (EC 4.3.1.‐)
3.45E‐01 8.01E+04 1.16E+05 4.49E+04 3.66E+04 6.90E‐01 ‐1.61E‐01
Respiratory nitrate reductase 
alpha chain (EC 1.7.99.4)
3.49E‐01 1.84E+04 3.65E+04 7.24E+03 2.59E+04 5.04E‐01 ‐2.97E‐01
FIG01231863: hypothetical 
protein
3.52E‐01 1.09E+05 1.69E+05 8.32E+03 8.65E+04 6.45E‐01 ‐1.90E‐01
FIG01226765: hypothetical 
protein
3.52E‐01 1.64E+03 6.24E+03 1.49E+03 6.63E+03 2.63E‐01 ‐5.80E‐01
Butyryl‐CoA dehydrogenase (EC 
1.3.99.2)
3.53E‐01 3.55E+04 2.46E+04 1.28E+04 1.25E+04 1.44E+00 1.59E‐01
Hypothetical ATP‐binding protein 
UPF0042, contains P‐loop
3.53E‐01 4.08E+04 2.55E+04 2.14E+04 1.15E+04 1.60E+00 2.04E‐01
hypothetical protein 3.54E‐01 1.98E+05 2.90E+05 8.00E+04 1.24E+05 6.85E‐01 ‐1.65E‐01
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3.58E‐01 2.61E+03 4.01E+03 1.14E+03 1.95E+03 6.52E‐01 ‐1.86E‐01
Undecaprenyl‐diphosphatase (EC 
3.6.1.27)





3.59E‐01 2.57E+05 1.56E+05 1.46E+05 5.30E+04 1.64E+00 2.16E‐01
Translation elongation factor G 3.59E‐01 3.80E+06 3.31E+06 4.61E+05 6.64E+05 1.15E+00 5.99E‐02
hypothetical protein 3.61E‐01 3.01E+04 6.23E+04 1.88E+04 4.71E+04 4.82E‐01 ‐3.17E‐01
Porphobilinogen deaminase (EC 
2.5.1.61)
3.64E‐01 2.30E+05 1.18E+05 1.64E+05 6.90E+04 1.95E+00 2.90E‐01
SMS protein 3.64E‐01 1.65E+02 1.58E+03 2.21E+01 2.10E+03 1.05E‐01 ‐9.81E‐01
thermonuclease family protein, 
(pXO1‐141)
3.65E‐01 5.58E+04 7.92E+04 3.38E+04 1.75E+04 7.04E‐01 ‐1.52E‐01
acetyltransferase, 
CYSE/LACA/LPXA/NODL family




3.66E‐01 1.11E+03 2.54E+03 1.45E+03 1.92E+03 4.37E‐01 ‐3.60E‐01
FIG01227508: hypothetical 
protein
3.69E‐01 1.18E+04 2.40E+04 1.34E+04 1.60E+04 4.91E‐01 ‐3.09E‐01
Transketolase (EC 2.2.1.1) 3.71E‐01 7.96E+05 1.15E+06 1.52E+05 5.28E+05 6.95E‐01 ‐1.58E‐01




3.75E‐01 2.45E+05 3.70E+05 1.91E+05 1.35E+04 6.63E‐01 ‐1.78E‐01
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3.79E‐01 4.17E+05 5.28E+05 1.51E+05 1.21E+05 7.90E‐01 ‐1.03E‐01
hypothetical protein 3.79E‐01 2.99E+05 4.49E+05 1.30E+05 2.21E+05 6.65E‐01 ‐1.77E‐01
hypothetical protein 3.80E‐01 1.28E+05 6.32E+04 1.01E+05 7.88E+03 2.03E+00 3.08E‐01
Xaa‐Pro aminopeptidase (EC 
3.4.11.9)
3.80E‐01 4.31E+04 3.31E+04 1.50E+04 8.09E+03 1.30E+00 1.15E‐01
response regulator aspartate 
phosphatase
3.81E‐01 8.09E+04 1.18E+05 5.49E+04 3.31E+04 6.84E‐01 ‐1.65E‐01
Ribosomal‐protein‐L7p‐serine 
acetyltransferase
3.83E‐01 1.27E+04 3.29E+04 1.18E+04 3.12E+04 3.85E‐01 ‐4.14E‐01
hypothetical protein 3.84E‐01 1.03E+05 6.27E+04 6.34E+04 1.59E+04 1.65E+00 2.17E‐01
PTS system, cellobiose‐specific 
IIB component (EC 2.7.1.69)
3.84E‐01 3.22E+03 1.37E+03 2.88E+03 9.12E+02 2.35E+00 3.70E‐01
DNA‐directed RNA polymerase 
beta' subunit (EC 2.7.7.6)
3.85E‐01 1.96E+05 2.18E+05 2.28E+04 3.11E+04 8.99E‐01 ‐4.60E‐02
hypothetical protein 3.85E‐01 1.15E+05 8.56E+04 4.61E+04 1.13E+04 1.34E+00 1.28E‐01
Malate synthase (EC 2.3.3.9) 3.86E‐01 3.73E+04 1.87E+04 2.49E+04 2.18E+04 1.99E+00 3.00E‐01
FIG01231899: hypothetical 
protein
3.86E‐01 7.52E+04 1.22E+05 6.70E+03 7.40E+04 6.15E‐01 ‐2.11E‐01
2,4‐dienoyl‐CoA reductase 
[NADPH] (EC 1.3.1.34)
3.86E‐01 3.47E+03 7.59E+03 2.08E+03 6.45E+03 4.57E‐01 ‐3.40E‐01
Phosphoglucosamine mutase (EC 
5.4.2.10)
3.87E‐01 1.98E+05 1.47E+05 7.71E+04 4.08E+04 1.35E+00 1.29E‐01
response regulator aspartate 
phosphatase




3.89E‐01 6.19E+04 9.90E+04 4.79E+04 4.61E+04 6.26E‐01 ‐2.04E‐01
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3.91E‐01 6.78E+04 1.02E+05 2.31E+04 5.34E+04 6.65E‐01 ‐1.77E‐01
Aminopeptidase Y (Arg, Lys, Leu 
preference) (EC 3.4.11.15)
3.92E‐01 6.70E+05 9.04E+05 2.45E+05 3.38E+05 7.41E‐01 ‐1.30E‐01
Phage major capsid protein 
#Fam0019
3.92E‐01 1.03E+04 5.25E+03 7.14E+03 5.64E+03 1.97E+00 2.93E‐01




3.93E‐01 2.47E+04 5.43E+04 1.20E+04 4.73E+04 4.55E‐01 ‐3.42E‐01
Similar to CDP‐glucose 4,6‐
dehydratase (EC 4.2.1.45)
3.95E‐01 5.21E+03 2.79E+04 5.15E+03 3.65E+04 1.87E‐01 ‐7.29E‐01
response regulator, putative 3.95E‐01 5.27E+05 1.21E+06 3.21E+05 1.09E+06 4.36E‐01 ‐3.61E‐01
Shikimate 5‐dehydrogenase I 
alpha (EC 1.1.1.25)
3.96E‐01 2.75E+04 3.69E+04 1.08E+04 1.32E+04 7.45E‐01 ‐1.28E‐01
Cell surface protein 3.97E‐01 4.68E+04 3.20E+04 1.57E+04 2.16E+04 1.46E+00 1.65E‐01
Methionine aminopeptidase (EC 
3.4.11.18)
3.97E‐01 8.84E+03 3.44E+03 8.49E+03 4.12E+03 2.57E+00 4.10E‐01





4.02E‐01 2.47E+05 3.06E+05 8.10E+04 7.37E+04 8.06E‐01 ‐9.36E‐02
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4.05E‐01 1.23E+03 3.38E+03 8.63E+02 3.55E+03 3.64E‐01 ‐4.39E‐01
Fumarylacetoacetate hydrolase 
family protein
4.05E‐01 2.33E+03 3.43E+03 5.35E+02 1.81E+03 6.80E‐01 ‐1.68E‐01
hypothetical protein 4.07E‐01 2.15E+03 4.97E+03 2.97E+03 4.27E+03 4.32E‐01 ‐3.65E‐01
Spore coat polysaccharide 
biosynthesis protein SpsF
4.09E‐01 6.19E+03 4.05E+03 8.01E+02 3.58E+03 1.53E+00 1.85E‐01
Bll5861 protein 4.10E‐01 1.79E+05 2.49E+05 1.03E+05 8.08E+04 7.19E‐01 ‐1.43E‐01
nitroreductase family protein 4.11E‐01 4.20E+04 2.98E+04 6.67E+03 2.04E+04 1.41E+00 1.50E‐01
Urocanate hydratase (EC 
4.2.1.49)
4.14E‐01 1.14E+06 8.73E+05 4.43E+05 1.32E+05 1.30E+00 1.14E‐01






4.16E‐01 5.25E+04 8.10E+04 2.79E+04 4.52E+04 6.48E‐01 ‐1.88E‐01
Peptide synthetase 4.16E‐01 1.73E+04 3.24E+04 7.57E+03 2.56E+04 5.32E‐01 ‐2.74E‐01
oxidoreductase of aldo/keto 
reductase family, subgroup 1
4.17E‐01 1.94E+04 1.08E+04 1.48E+04 2.01E+03 1.80E+00 2.56E‐01
3‐oxoacyl‐[acyl‐carrier protein] 
reductase (EC 1.1.1.100)
4.18E‐01 1.94E+04 2.82E+04 6.85E+03 1.45E+04 6.90E‐01 ‐1.61E‐01
Ribonuclease J1 (endonuclease 
and 5' exonuclease)
4.20E‐01 2.21E+05 2.66E+05 7.67E+04 2.82E+04 8.30E‐01 ‐8.11E‐02
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4.21E‐01 7.89E+05 1.21E+06 4.65E+05 6.55E+05 6.52E‐01 ‐1.86E‐01
Dihydroxyacetone kinase family 
protein
4.22E‐01 2.82E+04 3.95E+04 1.72E+04 1.30E+04 7.15E‐01 ‐1.45E‐01
Sip1Aa‐like_1 4.22E‐01 1.10E+05 7.69E+04 4.70E+04 4.40E+04 1.43E+00 1.56E‐01




4.24E‐01 2.85E+05 3.88E+05 2.00E+04 1.77E+05 7.36E‐01 ‐1.33E‐01
Ferrochelatase, protoheme ferro‐
lyase (EC 4.99.1.1)




4.28E‐01 5.96E+04 1.15E+05 4.56E+04 9.33E+04 5.19E‐01 ‐2.85E‐01
FIG01233992: hypothetical 
protein
4.28E‐01 5.11E+02 1.93E+03 3.97E+02 2.49E+03 2.65E‐01 ‐5.77E‐01
Fumarate hydratase class II (EC 
4.2.1.2)
4.29E‐01 8.96E+04 5.63E+04 5.71E+04 2.57E+04 1.59E+00 2.02E‐01





4.32E‐01 7.94E+04 8.76E+04 9.66E+03 1.29E+04 9.06E‐01 ‐4.27E‐02
Glucose‐1‐phosphate 
cytidylyltransferase (EC 2.7.7.33)
4.32E‐01 8.02E+04 4.98E+04 5.33E+04 1.89E+04 1.61E+00 2.07E‐01
Glucose‐6‐phosphate isomerase 
(EC 5.3.1.9)
4.34E‐01 1.95E+05 2.52E+05 4.97E+04 9.76E+04 7.73E‐01 ‐1.12E‐01
Acetoacetyl‐CoA reductase (EC 
1.1.1.36)
4.34E‐01 8.16E+03 1.04E+04 3.47E+03 2.93E+03 7.81E‐01 ‐1.07E‐01
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Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)
phage infection protein 4.35E‐01 3.62E+03 5.20E+03 1.62E+03 2.63E+03 6.96E‐01 ‐1.57E‐01
forespore‐specific protein, 
putative
4.47E‐01 3.68E+03 8.60E+03 2.88E+03 8.97E+03 4.28E‐01 ‐3.69E‐01
hypothetical protein 4.49E‐01 2.95E+05 2.55E+05 1.50E+04 7.38E+04 1.16E+00 6.32E‐02
hypothetical protein 4.50E‐01 6.94E+04 1.11E+04 1.08E+05 4.28E+03 6.27E+00 7.97E‐01
Heat shock protein 60 family 
chaperone GroEL
4.51E‐01 1.03E+07 1.24E+07 3.70E+06 1.98E+06 8.32E‐01 ‐7.99E‐02
FIG01229538: hypothetical 
protein
4.52E‐01 4.64E+04 3.33E+04 1.79E+04 2.04E+04 1.39E+00 1.44E‐01
Uncharacterized secreted 
protein associated with spyDAC
4.54E‐01 1.13E+04 7.56E+03 4.00E+03 6.46E+03 1.49E+00 1.73E‐01








4.56E‐01 2.78E+04 1.47E+04 2.40E+04 1.01E+04 1.89E+00 2.76E‐01
Flagellar M‐ring protein FliF 4.59E‐01 3.71E+02 6.90E+02 1.62E+02 6.03E+02 5.37E‐01 ‐2.70E‐01
hypothetical protein 4.59E‐01 6.50E+05 4.43E+05 3.27E+05 2.92E+05 1.47E+00 1.66E‐01
Fe‐S oxidoreductase 4.60E‐01 8.24E+04 1.09E+05 4.37E+04 3.68E+04 7.53E‐01 ‐1.23E‐01
Transcription‐repair coupling 
factor
4.60E‐01 6.44E+03 1.09E+04 7.93E+03 4.90E+03 5.89E‐01 ‐2.30E‐01
Cystine‐binding periplasmic 
protein precursor
4.60E‐01 1.18E+06 6.38E+05 9.03E+05 6.93E+05 1.85E+00 2.67E‐01
hypothetical protein 4.61E‐01 1.94E+06 1.61E+06 3.70E+05 5.95E+05 1.21E+00 8.24E‐02
Glyoxalase family protein 4.61E‐01 6.21E+04 8.73E+04 2.47E+04 4.58E+04 7.11E‐01 ‐1.48E‐01
surface antigen gene 4.64E‐01 5.22E+03 9.11E+03 1.20E+03 7.51E+03 5.72E‐01 ‐2.42E‐01
Streptomycin biosynthesis StrF 
domain protein
4.67E‐01 3.04E+04 5.05E+04 2.34E+04 3.56E+04 6.03E‐01 ‐2.20E‐01
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4.70E‐01 5.72E+04 1.24E+05 4.32E+04 1.29E+05 4.60E‐01 ‐3.37E‐01
Chaperone protein DnaJ 4.70E‐01 7.84E+04 1.08E+05 2.25E+04 5.57E+04 7.29E‐01 ‐1.37E‐01
Spore coat polysaccharide 
biosynthesis protein spsB
4.71E‐01 1.85E+05 9.98E+04 1.66E+05 5.17E+04 1.86E+00 2.69E‐01
Asparaginyl‐tRNA synthetase (EC 
6.1.1.22)
4.71E‐01 1.30E+05 1.05E+05 4.60E+04 2.73E+04 1.24E+00 9.32E‐02
Biotin carboxyl carrier protein of 
acetyl‐CoA carboxylase
4.78E‐01 6.95E+04 8.87E+04 3.64E+04 1.90E+04 7.84E‐01 ‐1.06E‐01
ATP‐dependent RNA helicase 
YfmL
4.79E‐01 2.75E+04 3.86E+04 2.07E+04 1.27E+04 7.11E‐01 ‐1.48E‐01
Cytosol aminopeptidase PepA 
(EC 3.4.11.1)
4.81E‐01 7.60E+05 8.91E+05 1.75E+05 2.30E+05 8.54E‐01 ‐6.88E‐02
DNA‐binding protein HBsu 4.83E‐01 2.86E+04 1.52E+04 2.53E+04 1.47E+04 1.88E+00 2.74E‐01
Membrane‐associated zinc 
metalloprotease
4.84E‐01 6.00E+04 7.21E+04 2.45E+04 5.26E+03 8.32E‐01 ‐7.99E‐02
hypothetical protein 4.84E‐01 2.57E+05 1.54E+05 2.04E+05 8.24E+04 1.67E+00 2.22E‐01
Isoleucyl‐tRNA synthetase (EC 
6.1.1.5)
4.86E‐01 5.08E+05 4.18E+05 1.19E+05 1.64E+05 1.22E+00 8.54E‐02
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4.86E‐01 3.40E+05 5.14E+05 2.40E+05 3.06E+05 6.63E‐01 ‐1.79E‐01











4.91E‐01 2.81E+05 3.71E+05 1.34E+05 1.55E+05 7.58E‐01 ‐1.20E‐01




4.93E‐01 1.74E+05 1.11E+05 1.31E+05 2.80E+04 1.57E+00 1.96E‐01
Cytochrome c oxidase 
polypeptide II (EC 1.9.3.1)
4.94E‐01 1.30E+05 2.18E+05 1.46E+05 1.42E+05 5.95E‐01 ‐2.25E‐01
FIG01225916: hypothetical 
protein
4.96E‐01 4.84E+03 9.67E+03 6.12E+03 9.19E+03 5.00E‐01 ‐3.01E‐01
Methylglutaconyl‐CoA hydratase 
(EC 4.2.1.18)
5.06E‐01 4.02E+04 2.38E+04 3.53E+04 4.98E+03 1.69E+00 2.28E‐01
Thiaminase II (EC 3.5.99.2) 5.06E‐01 8.22E+04 1.11E+05 6.14E+04 9.74E+03 7.42E‐01 ‐1.30E‐01
Malonyl CoA‐acyl carrier protein 
transacylase (EC 2.3.1.39)
5.06E‐01 5.12E+03 8.88E+03 5.23E+03 7.17E+03 5.76E‐01 ‐2.40E‐01
Histidine ammonia‐lyase (EC 
4.3.1.3)
5.13E‐01 4.03E+05 3.25E+05 1.61E+05 8.50E+04 1.24E+00 9.31E‐02
279





5.14E‐01 3.38E+04 3.95E+04 5.41E+03 1.21E+04 8.56E‐01 ‐6.76E‐02
hypothetical protein 5.17E‐01 1.75E+04 3.20E+04 1.39E+04 3.12E+04 5.45E‐01 ‐2.64E‐01
Aldehyde dehydrogenase (EC 
1.2.1.3)
5.21E‐01 4.44E+05 6.42E+05 4.04E+05 2.58E+05 6.92E‐01 ‐1.60E‐01
Vip2Ac‐like_1 5.22E‐01 3.08E+05 2.67E+05 5.40E+04 8.46E+04 1.15E+00 6.25E‐02
FIG006988: Lipase/Acylhydrolase 
with GDSL‐like motif
5.24E‐01 2.51E+03 5.63E+03 2.33E+03 6.93E+03 4.46E‐01 ‐3.51E‐01
hypothetical protein 5.25E‐01 1.42E+03 2.32E+03 1.52E+03 1.65E+03 6.11E‐01 ‐2.14E‐01
Naphthoate synthase (EC 
4.1.3.36)
5.26E‐01 5.14E+05 3.82E+05 2.58E+05 2.06E+05 1.35E+00 1.30E‐01
hypothetical protein 5.30E‐01 7.98E+03 9.31E+03 1.09E+03 3.00E+03 8.57E‐01 ‐6.72E‐02






5.33E‐01 6.89E+04 1.09E+05 4.07E+04 8.86E+04 6.33E‐01 ‐1.98E‐01
hypothetical Membrane 
Spanning Protein
5.33E‐01 1.45E+05 1.90E+05 5.36E+04 9.63E+04 7.66E‐01 ‐1.16E‐01
metallo‐beta‐lactamase family 
protein
5.33E‐01 1.80E+05 3.28E+05 1.32E+05 3.33E+05 5.48E‐01 ‐2.61E‐01
Oxalate decarboxylase (EC 
4.1.1.2)
5.36E‐01 4.27E+04 2.83E+04 3.04E+04 1.97E+04 1.51E+00 1.78E‐01




5.37E‐01 2.14E+04 1.41E+04 1.64E+04 7.76E+03 1.52E+00 1.82E‐01
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Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)
SSU ribosomal protein S4p (S9e) 5.40E‐01 3.54E+04 5.83E+04 3.53E+04 4.72E+04 6.07E‐01 ‐2.17E‐01
Glucose 1‐dehydrogenase (EC 
1.1.1.47)
5.42E‐01 1.01E+04 1.39E+04 5.09E+03 8.06E+03 7.31E‐01 ‐1.36E‐01
hypothetical protein 5.42E‐01 3.64E+04 5.70E+04 4.50E+04 2.70E+04 6.39E‐01 ‐1.95E‐01
hypothetical protein 5.45E‐01 6.06E+03 4.14E+03 4.46E+03 1.77E+03 1.46E+00 1.66E‐01
Leucyl‐tRNA synthetase (EC 
6.1.1.4)
5.45E‐01 2.34E+05 1.73E+05 1.34E+05 8.18E+04 1.35E+00 1.31E‐01
outer membrane protein CC2294 5.46E‐01 1.19E+03 1.98E+03 1.32E+03 1.58E+03 6.02E‐01 ‐2.20E‐01
oxidoreductase of aldo/keto 
reductase family, subgroup 1
5.46E‐01 1.27E+04 9.10E+03 8.47E+03 2.53E+03 1.39E+00 1.44E‐01
D‐alanyl‐D‐alanine 
carboxypeptidase (EC 3.4.16.4)
5.48E‐01 7.82E+04 1.14E+05 1.15E+04 8.68E+04 6.85E‐01 ‐1.64E‐01
hypothetical protein 5.48E‐01 1.32E+04 1.59E+04 6.31E+03 2.89E+03 8.29E‐01 ‐8.16E‐02
FIG01225143: hypothetical 
protein
5.49E‐01 9.43E+03 1.48E+04 5.72E+03 1.25E+04 6.37E‐01 ‐1.96E‐01
Methyltransferase (EC 2.1.1.‐) 5.50E‐01 7.48E+04 5.58E+04 4.13E+04 2.79E+04 1.34E+00 1.27E‐01
Peptide deformylase (EC 
3.5.1.88)
5.50E‐01 5.15E+04 6.22E+04 2.25E+04 1.70E+04 8.28E‐01 ‐8.18E‐02
Orotidine 5'‐phosphate 
decarboxylase (EC 4.1.1.23)




5.53E‐01 3.08E+04 3.71E+04 5.38E+03 1.52E+04 8.29E‐01 ‐8.14E‐02
Butyryl‐CoA dehydrogenase (EC 
1.3.99.2)
5.58E‐01 2.17E+05 1.79E+05 9.04E+04 3.15E+04 1.21E+00 8.19E‐02
Amino acid ABC transporter, 
amino acid‐binding protein
5.59E‐01 4.44E+04 2.81E+04 3.16E+04 3.11E+04 1.58E+00 1.99E‐01
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Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)
conserved hypothetical protein 5.60E‐01 5.01E+03 2.08E+03 7.06E+03 2.99E+03 2.41E+00 3.82E‐01
metallo‐beta‐lactamase family 
protein
5.61E‐01 1.42E+04 2.15E+04 1.35E+04 1.47E+04 6.60E‐01 ‐1.81E‐01
Lysine 2,3‐aminomutase (EC 
5.4.3.2)
5.63E‐01 8.02E+05 1.08E+06 3.29E+05 6.73E+05 7.40E‐01 ‐1.31E‐01
Uracil‐DNA glycosylase, family 1 5.63E‐01 1.32E+04 1.77E+04 3.75E+03 1.12E+04 7.44E‐01 ‐1.29E‐01
Prespore specific transcriptional 
activator RsfA
5.67E‐01 1.41E+05 2.59E+05 1.85E+05 2.69E+05 5.42E‐01 ‐2.66E‐01
FIG01227891: hypothetical 
protein
5.70E‐01 1.80E+04 2.52E+04 6.05E+03 1.82E+04 7.13E‐01 ‐1.47E‐01
Fe‐bacillibactin uptake system 
FeuA, Fe‐bacillibactin binding
5.72E‐01 1.39E+04 2.24E+04 1.71E+04 1.65E+04 6.23E‐01 ‐2.05E‐01
FIG01228827: hypothetical 
protein
5.73E‐01 4.63E+03 7.27E+03 3.47E+03 6.38E+03 6.37E‐01 ‐1.96E‐01
3‐oxoacyl‐[acyl‐carrier protein] 
reductase (EC 1.1.1.100)
5.74E‐01 1.41E+04 8.56E+03 1.08E+04 1.15E+04 1.65E+00 2.18E‐01
2‐oxoglutarate oxidoreductase, 
alpha subunit (EC 1.2.7.3)
5.74E‐01 2.06E+05 1.41E+05 1.55E+05 9.58E+04 1.47E+00 1.66E‐01
Enoyl‐CoA hydratase (EC 
4.2.1.17)
5.76E‐01 6.60E+04 4.51E+04 5.40E+04 1.57E+04 1.47E+00 1.66E‐01
Ribulose‐phosphate 3‐epimerase 
(EC 5.1.3.1)
5.76E‐01 1.09E+05 6.91E+04 9.59E+04 5.84E+04 1.58E+00 1.99E‐01
Flagellar hook‐associated protein 
FlgK
5.76E‐01 1.11E+04 1.53E+04 1.64E+03 1.10E+04 7.25E‐01 ‐1.40E‐01
ECF‐type sigma factor negative 
effector
5.77E‐01 6.26E+03 4.77E+03 1.88E+03 3.68E+03 1.31E+00 1.18E‐01
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5.78E‐01 1.20E+05 1.52E+05 5.06E+04 7.24E+04 7.94E‐01 ‐1.00E‐01
Oligoendopeptidase F (EC 3.4.24.‐
)
5.78E‐01 1.56E+05 1.85E+05 7.56E+04 2.60E+04 8.41E‐01 ‐7.50E‐02
ABC transporter, ATP‐binding 
protein, putative
5.78E‐01 4.92E+02 9.64E+02 5.72E+02 1.18E+03 5.11E‐01 ‐2.92E‐01
FIG01227559: hypothetical 
protein
5.79E‐01 7.29E+04 6.18E+04 2.73E+04 1.49E+04 1.18E+00 7.16E‐02




5.82E‐01 1.62E+04 1.93E+04 8.41E+03 9.63E+02 8.36E‐01 ‐7.76E‐02
acetyltransferase, GNAT family 5.86E‐01 8.20E+04 9.92E+04 1.87E+04 4.45E+04 8.27E‐01 ‐8.26E‐02
D‐Ribose 1,5‐phosphomutase 
(EC 5.4.2.7)
5.88E‐01 4.02E+05 4.80E+05 1.93E+05 1.16E+05 8.38E‐01 ‐7.67E‐02
Phenylalanine‐4‐hydroxylase (EC 
1.14.16.1) ‐ Long
5.88E‐01 1.53E+05 1.34E+05 4.68E+04 2.44E+04 1.14E+00 5.58E‐02
3‐oxoacyl‐[acyl‐carrier‐protein] 
synthase, KASIII (EC 2.3.1.41)
5.89E‐01 2.02E+04 2.55E+04 4.68E+03 1.42E+04 7.91E‐01 ‐1.02E‐01
FIG01226514: hypothetical 
protein
5.90E‐01 3.14E+04 3.56E+04 1.05E+04 5.48E+03 8.84E‐01 ‐5.36E‐02
NADPH dehydrogenase (EC 
1.6.99.1)
5.92E‐01 2.76E+03 5.95E+03 2.46E+03 8.60E+03 4.64E‐01 ‐3.33E‐01
SSU ribosomal protein S3p (S3e) 5.93E‐01 2.01E+05 2.41E+05 9.05E+04 7.53E+04 8.36E‐01 ‐7.79E‐02
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5.94E‐01 3.04E+04 2.09E+04 2.56E+04 8.37E+03 1.46E+00 1.63E‐01
5‐Enolpyruvylshikimate‐3‐
phosphate synthase (EC 2.5.1.19)
5.94E‐01 1.75E+04 2.14E+04 3.19E+03 1.06E+04 8.17E‐01 ‐8.78E‐02
hypothetical protein 5.94E‐01 1.43E+05 1.22E+05 1.44E+04 5.83E+04 1.18E+00 7.02E‐02
Chitinase (EC 3.2.1.14) 5.96E‐01 1.97E+05 2.35E+05 3.26E+04 1.04E+05 8.37E‐01 ‐7.71E‐02
Non‐ribosomal peptide synthase 
(EC 6.3.2.26) (EC 2.3.1.38)
5.97E‐01 7.36E+04 8.28E+04 2.49E+04 9.14E+03 8.89E‐01 ‐5.12E‐02
Methylmalonate‐semialdehyde 
dehydrogenase (EC 1.2.1.27)
5.98E‐01 2.09E+06 1.86E+06 3.04E+05 6.08E+05 1.12E+00 5.09E‐02
hypothetical protein 5.98E‐01 2.79E+04 2.35E+04 7.57E+03 1.09E+04 1.19E+00 7.50E‐02




6.00E‐01 5.63E+05 7.94E+05 1.99E+05 6.36E+05 7.09E‐01 ‐1.49E‐01
Inosine‐uridine preferring 
nucleoside hydrolase (EC 3.2.2.1)




6.03E‐01 5.92E+03 8.19E+03 4.40E+03 5.38E+03 7.23E‐01 ‐1.41E‐01
Formiminoglutamase (EC 3.5.3.8) 6.04E‐01 7.51E+04 9.43E+04 3.42E+04 4.76E+04 7.97E‐01 ‐9.87E‐02
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Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)




6.09E‐01 1.34E+03 9.29E+02 1.01E+03 8.05E+02 1.45E+00 1.61E‐01
Transcription termination 
protein NusA
6.10E‐01 1.32E+04 2.02E+04 1.24E+04 1.79E+04 6.52E‐01 ‐1.86E‐01
hypothetical protein 6.12E‐01 1.42E+03 9.03E+02 1.26E+03 9.89E+02 1.57E+00 1.95E‐01
hypothetical protein 6.12E‐01 8.23E+03 1.09E+04 7.77E+03 1.34E+03 7.54E‐01 ‐1.23E‐01
FIG01225390: hypothetical 
protein
6.12E‐01 1.50E+04 2.08E+04 1.17E+04 1.43E+04 7.19E‐01 ‐1.43E‐01




6.15E‐01 4.77E+05 5.67E+05 2.48E+05 1.26E+05 8.42E‐01 ‐7.49E‐02
Magnesium and cobalt transport 
protein CorA
6.16E‐01 5.23E+04 4.68E+04 1.16E+04 1.30E+04 1.12E+00 4.80E‐02
2‐amino‐3‐ketobutyrate 
coenzyme A ligase (EC 2.3.1.29)
6.17E‐01 7.60E+05 6.55E+05 2.52E+05 2.20E+05 1.16E+00 6.45E‐02
oxidoreductase, aldo/keto 
reductase family
6.17E‐01 1.59E+04 2.16E+04 1.58E+04 8.12E+03 7.36E‐01 ‐1.33E‐01
hypothetical protein 6.20E‐01 3.34E+04 2.47E+04 1.18E+04 2.45E+04 1.35E+00 1.31E‐01




6.22E‐01 5.85E+05 6.38E+05 1.21E+05 1.25E+05 9.16E‐01 ‐3.80E‐02
Peptidyl‐prolyl cis‐trans 
isomerase (EC 5.2.1.8)
6.22E‐01 1.30E+05 1.72E+05 4.77E+04 1.21E+05 7.58E‐01 ‐1.21E‐01
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Arsenate reductase (EC 1.20.4.1) 6.24E‐01 4.26E+03 6.44E+03 4.34E+03 5.60E+03 6.62E‐01 ‐1.79E‐01








6.29E‐01 1.71E+05 1.50E+05 4.25E+04 5.28E+04 1.14E+00 5.56E‐02
Methionyl‐tRNA synthetase (EC 
6.1.1.10)





6.34E‐01 4.60E+04 3.72E+04 2.25E+04 1.89E+04 1.24E+00 9.19E‐02
hypothetical protein 6.34E‐01 8.55E+05 9.42E+05 4.10E+04 2.72E+05 9.07E‐01 ‐4.24E‐02
Putative acyl‐coa dehydrogenase 6.35E‐01 4.38E+04 3.39E+04 2.82E+04 1.62E+04 1.29E+00 1.10E‐01
Prolyl‐tRNA synthetase (EC 
6.1.1.15), archaeal/eukaryal type
6.36E‐01 1.96E+05 1.60E+05 7.52E+04 9.56E+04 1.23E+00 8.86E‐02
hypothetical protein 6.37E‐01 1.68E+06 1.42E+06 7.26E+05 5.17E+05 1.19E+00 7.43E‐02
Hypothetical protein YfkI 6.38E‐01 2.83E+04 2.09E+04 1.84E+04 1.70E+04 1.35E+00 1.31E‐01




6.40E‐01 1.02E+05 9.07E+04 3.25E+04 1.99E+04 1.12E+00 5.10E‐02
Cell division protein FtsX 6.46E‐01 5.48E+03 7.73E+03 4.31E+03 6.44E+03 7.10E‐01 ‐1.49E‐01
Carboxylesterase (EC 3.1.1.1) 6.48E‐01 1.56E+03 9.01E+02 2.01E+03 1.07E+03 1.74E+00 2.40E‐01
Pyridoxamine 5'‐phosphate 
oxidase (EC 1.4.3.5)
6.48E‐01 2.91E+04 3.63E+04 1.02E+04 2.23E+04 8.01E‐01 ‐9.62E‐02
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Log (Fold 
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Protein ecsC 6.52E‐01 2.91E+04 4.13E+04 2.47E+04 3.51E+04 7.06E‐01 ‐1.51E‐01




6.55E‐01 1.12E+05 9.30E+04 1.26E+04 6.37E+04 1.21E+00 8.17E‐02
Penicillin‐binding protein 3 6.56E‐01 1.09E+05 1.28E+05 2.64E+04 6.25E+04 8.48E‐01 ‐7.17E‐02
Malonyl CoA‐acyl carrier protein 
transacylase (EC 2.3.1.39)
6.58E‐01 9.67E+04 1.64E+05 1.15E+05 2.11E+05 5.88E‐01 ‐2.30E‐01
Beta‐lysine acetyltransferase (EC 
2.3.1.‐)
6.59E‐01 3.78E+05 2.92E+05 2.77E+05 1.16E+05 1.29E+00 1.12E‐01
BNR repeat domain protein 6.59E‐01 1.34E+04 1.71E+04 9.21E+03 1.01E+04 7.81E‐01 ‐1.07E‐01
Preprotein translocase secY 
subunit (TC 3.A.5.1.1)
6.60E‐01 4.83E+04 7.36E+04 2.67E+04 8.36E+04 6.56E‐01 ‐1.83E‐01
6,7‐dimethyl‐8‐ribityllumazine 
synthase (EC 2.5.1.78)
6.61E‐01 2.48E+05 1.98E+05 1.63E+05 7.21E+04 1.25E+00 9.86E‐02
UDP‐glucose 4‐epimerase (EC 
5.1.3.2)
6.63E‐01 7.10E+04 5.94E+04 6.52E+03 3.93E+04 1.19E+00 7.72E‐02
Chloramphenicol 
acetyltransferase (EC 2.3.1.28)




6.64E‐01 4.82E+05 6.90E+05 5.82E+05 5.05E+05 6.98E‐01 ‐1.56E‐01
hypothetical protein 6.64E‐01 4.27E+04 5.89E+04 3.10E+04 5.01E+04 7.25E‐01 ‐1.39E‐01
Enterochelin esterase 6.64E‐01 5.64E+04 4.62E+04 6.91E+03 3.47E+04 1.22E+00 8.66E‐02
Chitin binding protein 6.68E‐01 2.90E+05 2.54E+05 1.24E+05 3.23E+04 1.14E+00 5.81E‐02
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6.70E‐01 3.67E+03 6.73E+03 4.43E+03 1.02E+04 5.45E‐01 ‐2.63E‐01
Spore coat protein F 6.75E‐01 4.29E+03 3.40E+03 2.49E+03 2.36E+03 1.26E+00 1.01E‐01
Methionine ABC transporter 
substrate‐binding protein
6.75E‐01 1.27E+04 1.95E+04 1.03E+04 2.33E+04 6.49E‐01 ‐1.87E‐01
FIG007959: peptidase, M16 
family
6.76E‐01 2.64E+05 2.80E+05 4.80E+04 3.48E+04 9.44E‐01 ‐2.48E‐02
FIG01225599: hypothetical 
protein








6.84E‐01 9.79E+03 6.43E+03 7.95E+03 1.05E+04 1.52E+00 1.83E‐01
hypothetical protein 6.86E‐01 4.16E+05 4.47E+05 1.06E+05 5.82E+04 9.31E‐01 ‐3.12E‐02
enterotoxin / cell‐wall binding 
protein
6.86E‐01 1.57E+05 1.25E+05 1.05E+05 7.37E+04 1.26E+00 1.00E‐01
response regulator, putative 6.87E‐01 2.54E+05 3.14E+05 1.22E+05 2.02E+05 8.08E‐01 ‐9.24E‐02
Pyruvate kinase (EC 2.7.1.40) 6.87E‐01 3.93E+05 3.10E+05 3.03E+05 6.94E+04 1.27E+00 1.02E‐01
hypothetical protein 6.91E‐01 7.85E+03 1.09E+04 9.06E+03 8.46E+03 7.19E‐01 ‐1.43E‐01
hypothetical protein 6.94E‐01 4.37E+04 6.03E+04 6.46E+03 6.29E+04 7.26E‐01 ‐1.39E‐01
Succinyl‐CoA ligase [ADP‐
forming] alpha chain (EC 6.2.1.5)
6.95E‐01 8.79E+03 7.07E+03 6.54E+03 1.05E+03 1.24E+00 9.46E‐02
Nitrilotriacetate monooxygenase 
component B (EC 1.14.13.‐)
6.95E‐01 7.40E+04 9.27E+04 3.75E+04 6.53E+04 7.99E‐01 ‐9.76E‐02
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6.97E‐01 2.05E+05 1.82E+05 4.49E+04 8.53E+04 1.13E+00 5.36E‐02
Cytosol aminopeptidase PepA 
(EC 3.4.11.1)
6.99E‐01 2.66E+05 2.24E+05 1.24E+05 1.23E+05 1.19E+00 7.48E‐02












7.07E‐01 1.90E+05 2.39E+05 1.78E+05 1.03E+05 7.95E‐01 ‐9.96E‐02
2‐dehydropantoate 2‐reductase 
(EC 1.1.1.169)
7.10E‐01 1.83E+04 2.50E+04 2.39E+04 1.62E+04 7.32E‐01 ‐1.35E‐01
Cell division trigger factor (EC 
5.2.1.8)
7.12E‐01 8.47E+03 1.16E+04 1.03E+04 9.23E+03 7.28E‐01 ‐1.38E‐01
Cystathionine gamma‐lyase (EC 
4.4.1.1)
7.12E‐01 1.05E+05 1.21E+05 1.38E+04 6.32E+04 8.70E‐01 ‐6.03E‐02
FIG01226713: hypothetical 
protein
7.14E‐01 3.51E+03 4.53E+03 2.62E+03 3.59E+03 7.75E‐01 ‐1.11E‐01
FIG002344: Hydrolase (HAD 
superfamily)
7.14E‐01 6.85E+04 7.87E+04 4.16E+04 5.59E+03 8.71E‐01 ‐6.02E‐02
NAD synthetase (EC 6.3.1.5) 7.15E‐01 3.76E+05 3.35E+05 1.65E+05 6.67E+04 1.12E+00 5.10E‐02
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7.16E‐01 5.41E+05 6.29E+05 3.07E+05 2.36E+05 8.60E‐01 ‐6.53E‐02
FIG01227012: hypothetical 
protein
7.17E‐01 3.03E+04 4.30E+04 4.69E+04 3.05E+04 7.04E‐01 ‐1.52E‐01
Molybdopterin biosynthesis 
protein MoeA













7.22E‐01 7.07E+03 5.76E+03 3.71E+03 4.62E+03 1.23E+00 8.90E‐02
hypothetical Membrane 
Spanning Protein




7.24E‐01 1.29E+05 1.55E+05 9.89E+04 6.37E+04 8.32E‐01 ‐7.97E‐02
FIG01225487: hypothetical 
protein
7.24E‐01 4.15E+04 5.01E+04 2.79E+04 2.81E+04 8.27E‐01 ‐8.23E‐02
Ribonuclease PH (EC 2.7.7.56) 7.26E‐01 1.14E+04 1.36E+04 6.05E+03 7.73E+03 8.42E‐01 ‐7.46E‐02
FIG01225999: hypothetical 
protein
7.28E‐01 7.86E+04 6.41E+04 5.45E+04 3.91E+04 1.23E+00 8.90E‐02
hypothetical protein 7.33E‐01 3.16E+05 2.27E+05 3.33E+05 2.59E+05 1.40E+00 1.45E‐01
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Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)
Zwa5A 7.33E‐01 2.54E+04 3.08E+04 1.84E+04 1.80E+04 8.24E‐01 ‐8.42E‐02
putative cytochrome P450 
hydroxylase
7.36E‐01 4.42E+04 3.81E+04 1.17E+04 2.62E+04 1.16E+00 6.53E‐02
Butyryl‐CoA dehydrogenase (EC 
1.3.99.2)
7.37E‐01 4.32E+04 5.26E+04 3.13E+04 3.28E+04 8.21E‐01 ‐8.55E‐02
FIG01230264: hypothetical 
protein
7.38E‐01 3.35E+04 2.74E+04 2.59E+04 1.19E+04 1.22E+00 8.72E‐02
Adenylate kinase (EC 2.7.4.3) 7.39E‐01 3.26E+04 2.50E+04 3.17E+04 1.65E+04 1.30E+00 1.14E‐01
FIG01226004: hypothetical 
protein
7.40E‐01 7.00E+03 9.08E+03 4.26E+03 8.86E+03 7.71E‐01 ‐1.13E‐01










7.48E‐01 6.87E+05 6.01E+05 1.09E+05 3.95E+05 1.14E+00 5.78E‐02
Cation‐transporting ATPase 7.52E‐01 6.54E+03 7.96E+03 5.81E+03 4.23E+03 8.22E‐01 ‐8.51E‐02
Acetoacetyl‐CoA synthetase 
[leucine] (EC 6.2.1.16)
7.52E‐01 1.33E+05 1.44E+05 4.26E+04 3.65E+04 9.24E‐01 ‐3.45E‐02
Phosphate acetyltransferase (EC 
2.3.1.8)
7.52E‐01 2.00E+05 2.25E+05 3.95E+04 1.15E+05 8.90E‐01 ‐5.05E‐02
N‐acetylmuramic acid 6‐
phosphate etherase





7.57E‐01 2.28E+06 2.35E+06 3.50E+05 1.44E+05 9.68E‐01 ‐1.41E‐02
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7.61E‐01 3.16E+05 2.70E+05 1.73E+05 1.68E+05 1.17E+00 6.74E‐02
L‐fuco‐beta‐pyranose 
dehydrogenase (EC 1.1.1.122)
7.62E‐01 3.75E+05 3.37E+05 1.84E+05 6.54E+04 1.11E+00 4.65E‐02
Oligoendopeptidase F (EC 3.4.24.‐
)
7.63E‐01 8.18E+04 9.31E+04 5.25E+04 2.67E+04 8.79E‐01 ‐5.59E‐02
FIG01226746: hypothetical 
protein
7.65E‐01 4.73E+04 5.96E+04 3.62E+04 5.47E+04 7.94E‐01 ‐1.00E‐01
Phage major tail protein phi13 7.66E‐01 1.10E+04 1.43E+04 9.01E+03 1.53E+04 7.69E‐01 ‐1.14E‐01
hypothetical protein 7.66E‐01 6.37E+04 5.76E+04 1.27E+04 2.98E+04 1.11E+00 4.40E‐02
Transcriptional regulator, AsnC 
family




7.69E‐01 9.29E+03 6.42E+03 1.46E+04 3.46E+03 1.45E+00 1.60E‐01
Glycosyl transferase ,group 2 
family, anthrose biosynthesis
7.69E‐01 9.16E+03 1.05E+04 6.24E+03 4.38E+03 8.68E‐01 ‐6.15E‐02
NAD(P)H‐flavin oxidoreductase 7.70E‐01 8.81E+03 1.16E+04 6.41E+03 1.35E+04 7.60E‐01 ‐1.19E‐01
2',3'‐cyclic‐nucleotide 2'‐
phosphodiesterase (EC 3.1.4.16)
7.71E‐01 7.78E+04 9.49E+04 3.39E+04 8.49E+04 8.20E‐01 ‐8.60E‐02
Cell wall surface anchor family 
protein
7.71E‐01 8.60E+05 9.53E+05 2.98E+05 4.24E+05 9.02E‐01 ‐4.50E‐02
Competence/damage‐inducible 
protein CinA
7.73E‐01 2.09E+04 2.52E+04 1.42E+04 1.93E+04 8.29E‐01 ‐8.12E‐02
Phage protein 7.74E‐01 7.46E+04 8.27E+04 2.27E+04 3.83E+04 9.03E‐01 ‐4.43E‐02
hypothetical protein 7.76E‐01 1.12E+06 1.34E+06 1.16E+06 4.71E+05 8.30E‐01 ‐8.09E‐02
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Change)
hypothetical protein 7.78E‐01 5.80E+06 4.86E+06 4.95E+06 1.26E+06 1.19E+00 7.66E‐02
Spermidine synthase (EC 
2.5.1.16)
7.80E‐01 3.79E+05 4.47E+05 2.90E+05 2.67E+05 8.48E‐01 ‐7.15E‐02
Zinc metalloproteinase precursor 
(EC 3.4.24.29) / aureolysin
7.81E‐01 1.40E+05 1.23E+05 7.50E+04 6.86E+04 1.14E+00 5.78E‐02
FIG01228082: hypothetical 
protein
7.84E‐01 6.79E+04 7.48E+04 2.61E+04 3.10E+04 9.08E‐01 ‐4.19E‐02
Leucine dehydrogenase (EC 
1.4.1.9)
7.86E‐01 6.15E+06 6.47E+06 1.67E+06 9.18E+05 9.50E‐01 ‐2.24E‐02
N‐acetylmuramoyl‐L‐alanine 
amidase (EC 3.5.1.28)
7.92E‐01 2.04E+05 1.80E+05 1.08E+05 9.83E+04 1.13E+00 5.40E‐02
FIG01227456: hypothetical 
protein
7.92E‐01 1.00E+05 8.58E+04 7.26E+04 5.18E+04 1.17E+00 6.82E‐02
Methionine gamma‐lyase (EC 
4.4.1.11)




7.99E‐01 2.17E+04 2.91E+04 2.43E+04 3.92E+04 7.47E‐01 ‐1.27E‐01
COG1649 predicted glycoside 
hydrolase
8.01E‐01 2.44E+04 3.11E+04 3.44E+04 2.46E+04 7.87E‐01 ‐1.04E‐01
Tripeptide aminopeptidase (EC 
3.4.11.4)
8.01E‐01 7.75E+04 7.14E+04 2.21E+04 3.18E+04 1.09E+00 3.55E‐02
2‐methylcitrate dehydratase (EC 
4.2.1.79)
8.01E‐01 3.26E+06 3.78E+06 2.55E+06 2.18E+06 8.62E‐01 ‐6.44E‐02
FIG146262: hypothetical protein 8.04E‐01 2.08E+05 2.56E+05 1.70E+05 2.54E+05 8.15E‐01 ‐8.89E‐02
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8.04E‐01 3.29E+06 3.46E+06 9.21E+05 5.48E+05 9.52E‐01 ‐2.15E‐02
FIG01225424: hypothetical 
protein
8.05E‐01 6.93E+04 6.39E+04 3.05E+04 1.64E+04 1.08E+00 3.51E‐02




8.09E‐01 6.42E+05 6.85E+05 2.26E+05 1.82E+05 9.37E‐01 ‐2.84E‐02
Archaeal S‐adenosylmethionine 
synthetase (EC 2.5.1.6)
8.11E‐01 1.38E+06 1.46E+06 5.02E+05 2.47E+05 9.42E‐01 ‐2.59E‐02
Lysyl‐tRNA synthetase (class II) 
(EC 6.1.1.6)
8.11E‐01 3.80E+05 3.92E+05 5.59E+04 5.71E+04 9.70E‐01 ‐1.33E‐02
FIG009210: peptidase, M16 
family
8.13E‐01 4.57E+05 5.07E+05 1.83E+05 2.84E+05 9.02E‐01 ‐4.50E‐02
4‐hydroxy‐tetrahydrodipicolinate 
synthase (EC 4.3.3.7)
8.14E‐01 1.58E+05 1.70E+05 7.28E+04 4.23E+04 9.27E‐01 ‐3.30E‐02
FIG013761: LmbE family protein 8.17E‐01 1.31E+04 1.54E+04 1.15E+04 1.17E+04 8.48E‐01 ‐7.14E‐02
Glutamate‐1‐semialdehyde 
aminotransferase (EC 5.4.3.8)
8.18E‐01 1.15E+05 1.03E+05 5.46E+04 6.34E+04 1.12E+00 4.75E‐02
Glyoxalase family protein 8.19E‐01 6.01E+03 5.26E+03 4.07E+03 3.36E+03 1.14E+00 5.78E‐02
hypothetical protein 8.19E‐01 1.44E+05 1.33E+05 2.47E+04 6.93E+04 1.08E+00 3.39E‐02
dTDP‐glucose 4,6‐dehydratase 
(EC 4.2.1.46)
8.23E‐01 3.90E+04 3.51E+04 1.86E+04 2.11E+04 1.11E+00 4.56E‐02
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8.24E‐01 8.14E+04 7.53E+04 2.80E+04 3.36E+04 1.08E+00 3.34E‐02
Macrocin O‐methyltransferase 
(EC 2.1.1.101)
8.25E‐01 1.58E+03 1.25E+03 2.13E+03 9.24E+02 1.26E+00 1.00E‐01
3'‐>5' exoribonuclease Bsu YhaM 8.25E‐01 7.70E+04 8.24E+04 3.14E+04 2.37E+04 9.35E‐01 ‐2.93E‐02




8.31E‐01 2.42E+05 2.67E+05 7.46E+04 1.69E+05 9.07E‐01 ‐4.26E‐02
DNA gyrase subunit B (EC 
5.99.1.3)




8.35E‐01 1.86E+05 2.00E+05 7.14E+04 7.75E+04 9.32E‐01 ‐3.05E‐02
Phosphate butyryltransferase 
(EC 2.3.1.19)
8.38E‐01 2.46E+05 2.36E+05 5.88E+04 5.47E+04 1.04E+00 1.82E‐02
6‐phospho‐beta‐glucosidase (EC 
3.2.1.86)
8.38E‐01 5.61E+05 6.20E+05 8.15E+04 4.39E+05 9.04E‐01 ‐4.37E‐02
Ornithine aminotransferase (EC 
2.6.1.13)
8.38E‐01 1.19E+05 1.34E+05 3.77E+04 1.05E+05 8.91E‐01 ‐4.99E‐02
ABC transporter, substrate‐
binding protein, putative
8.40E‐01 4.79E+04 5.77E+04 3.22E+04 7.02E+04 8.29E‐01 ‐8.13E‐02
transcriptional regulator/TPR 
domain protein
8.41E‐01 9.33E+04 8.83E+04 2.28E+04 3.30E+04 1.06E+00 2.39E‐02
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8.42E‐01 2.02E+05 2.25E+05 9.62E+04 1.57E+05 8.98E‐01 ‐4.68E‐02
Threonyl‐tRNA synthetase (EC 
6.1.1.3)
8.42E‐01 3.61E+04 2.97E+04 3.83E+04 3.50E+04 1.21E+00 8.42E‐02
Cysteine desulfurase (EC 2.8.1.7), 
SufS subfamily





8.45E‐01 8.51E+03 7.08E+03 1.04E+04 5.17E+03 1.20E+00 8.02E‐02
hypothetical protein 8.47E‐01 5.06E+04 4.86E+04 6.52E+03 1.50E+04 1.04E+00 1.75E‐02
sensory box/GGDEF family 
protein, putative
8.52E‐01 4.70E+04 5.29E+04 7.73E+03 4.75E+04 8.89E‐01 ‐5.09E‐02
aminopeptidase 8.53E‐01 3.19E+05 3.25E+05 1.76E+04 4.73E+04 9.82E‐01 ‐8.02E‐03
Translation elongation factor Ts 8.54E‐01 4.05E+05 4.58E+05 3.26E+05 3.37E+05 8.84E‐01 ‐5.36E‐02
penicillin‐binding protein, 
putative
8.54E‐01 1.65E+05 1.74E+05 5.66E+04 5.82E+04 9.47E‐01 ‐2.36E‐02
4‐hydroxyphenylacetate 3‐
monooxygenase (EC 1.14.13.3)
8.64E‐01 9.72E+04 1.02E+05 2.14E+04 3.88E+04 9.53E‐01 ‐2.08E‐02
Carboxylesterase (EC 3.1.1.1) 8.66E‐01 2.14E+04 1.79E+04 2.36E+04 2.38E+04 1.19E+00 7.69E‐02
Ketol‐acid reductoisomerase (EC 
1.1.1.86)
8.68E‐01 3.06E+04 2.81E+04 1.23E+04 2.14E+04 1.09E+00 3.81E‐02
Uridine monophosphate kinase 
(EC 2.7.4.22)
8.69E‐01 2.41E+04 2.58E+04 1.38E+04 7.97E+03 9.36E‐01 ‐2.86E‐02
hypothetical protein 8.69E‐01 4.32E+05 3.88E+05 3.25E+05 2.77E+05 1.11E+00 4.61E‐02
hypothetical protein 8.71E‐01 2.37E+04 2.15E+04 1.57E+04 1.44E+04 1.10E+00 4.09E‐02
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8.72E‐01 3.73E+04 3.55E+04 1.50E+04 8.24E+03 1.05E+00 2.07E‐02
D‐alanine aminotransferase (EC 
2.6.1.21)
8.72E‐01 2.67E+05 2.45E+05 1.86E+05 1.23E+05 1.09E+00 3.79E‐02
Trehalose‐6‐phosphate 
hydrolase (EC 3.2.1.93)
8.72E‐01 3.30E+05 3.11E+05 1.13E+05 1.46E+05 1.06E+00 2.48E‐02
DinB family protein 8.73E‐01 2.89E+03 3.11E+03 1.98E+03 8.36E+02 9.30E‐01 ‐3.17E‐02
FIG01229492: hypothetical 
protein
8.73E‐01 5.14E+03 5.81E+03 4.29E+03 5.27E+03 8.85E‐01 ‐5.31E‐02
Aspartyl‐tRNA synthetase (EC 
6.1.1.12)
8.78E‐01 6.87E+04 6.32E+04 3.83E+04 4.34E+04 1.09E+00 3.62E‐02
Endonuclease IV (EC 3.1.21.2) 8.78E‐01 6.33E+04 5.85E+04 2.05E+04 4.45E+04 1.08E+00 3.39E‐02
GTP‐binding protein TypA/BipA 8.81E‐01 2.31E+05 2.11E+05 1.15E+05 1.80E+05 1.09E+00 3.91E‐02
2‐oxoglutarate oxidoreductase, 
beta subunit (EC 1.2.7.3)
8.84E‐01 1.37E+05 1.30E+05 4.98E+04 5.43E+04 1.05E+00 2.16E‐02
hypothetical protein 8.85E‐01 3.50E+04 3.85E+04 1.88E+04 3.32E+04 9.10E‐01 ‐4.09E‐02
D‐alanine aminotransferase (EC 
2.6.1.21)
8.85E‐01 3.85E+04 3.46E+04 2.55E+04 3.48E+04 1.11E+00 4.59E‐02
Transaldolase (EC 2.2.1.2) 8.87E‐01 3.88E+05 4.21E+05 2.65E+05 2.79E+05 9.20E‐01 ‐3.62E‐02
Ornithine carbamoyltransferase 
(EC 2.1.3.3)




8.91E‐01 1.61E+05 1.53E+05 7.54E+04 5.96E+04 1.05E+00 2.25E‐02
Succinyl‐CoA synthetase, alpha 
subunit‐related enzymes
8.98E‐01 4.56E+04 4.83E+04 6.42E+03 3.23E+04 9.43E‐01 ‐2.54E‐02
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9.01E‐01 3.62E+05 3.89E+05 2.29E+05 2.54E+05 9.33E‐01 ‐3.03E‐02
Methylisocitrate lyase (EC 
4.1.3.30)
9.03E‐01 4.31E+05 4.06E+05 2.09E+05 2.60E+05 1.06E+00 2.59E‐02
Hypothetical protein ywlG 9.05E‐01 1.93E+04 2.01E+04 4.88E+03 9.14E+03 9.62E‐01 ‐1.70E‐02
2‐methylcitrate synthase (EC 
2.3.3.5)
9.07E‐01 1.62E+05 1.74E+05 9.83E+04 1.32E+05 9.32E‐01 ‐3.05E‐02
Methionine ABC transporter 
substrate‐binding protein
9.08E‐01 2.04E+05 2.28E+05 2.68E+05 2.13E+05 8.93E‐01 ‐4.92E‐02
L‐alanine‐DL‐glutamate 
epimerase
9.09E‐01 1.51E+05 1.64E+05 4.28E+04 1.70E+05 9.21E‐01 ‐3.58E‐02
CBS domain containing protein 9.12E‐01 2.02E+04 1.81E+04 1.88E+04 2.49E+04 1.12E+00 4.86E‐02
Pyrimidine‐nucleoside 
phosphorylase (EC 2.4.2.2)





9.12E‐01 3.34E+05 3.15E+05 1.16E+05 2.49E+05 1.06E+00 2.56E‐02




9.14E‐01 8.24E+04 7.90E+04 4.46E+04 2.42E+04 1.04E+00 1.84E‐02





9.19E‐01 3.27E+05 3.40E+05 1.39E+05 1.64E+05 9.61E‐01 ‐1.74E‐02
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9.22E‐01 1.34E+03 1.19E+03 1.82E+03 1.72E+03 1.13E+00 5.21E‐02
Phenylalanyl‐tRNA synthetase 
alpha subunit
9.23E‐01 4.67E+05 4.85E+05 2.00E+05 2.28E+05 9.63E‐01 ‐1.64E‐02
Formate‐‐tetrahydrofolate ligase 
(EC 6.3.4.3)




9.27E‐01 1.55E+06 1.58E+06 2.02E+05 5.08E+05 9.80E‐01 ‐8.83E‐03
Butyryl‐CoA dehydrogenase (EC 
1.3.99.2)






9.39E‐01 1.87E+04 1.96E+04 7.21E+03 1.55E+04 9.57E‐01 ‐1.89E‐02
hypothetical protein 9.43E‐01 1.66E+04 1.82E+04 2.11E+04 2.93E+04 9.12E‐01 ‐3.99E‐02
Phosphopentomutase (EC 
5.4.2.7)
9.43E‐01 1.80E+05 1.83E+05 7.97E+04 1.15E+04 9.80E‐01 ‐8.95E‐03
Glycerophosphoryl diester 
phosphodiesterase (EC 3.1.4.46)
9.45E‐01 1.54E+04 1.60E+04 1.27E+04 6.56E+03 9.61E‐01 ‐1.71E‐02
Coenzyme F420‐0:L‐glutamate 
ligase @ Coenzyme F420‐1:L‐
9.45E‐01 1.11E+05 1.13E+05 3.53E+04 3.28E+04 9.82E‐01 ‐7.89E‐03
UDP‐glucose/GDP‐mannose 
dehydrogenase family
9.46E‐01 5.97E+04 6.15E+04 1.45E+04 3.84E+04 9.71E‐01 ‐1.27E‐02
Macrolide glycosyltransferase 
(EC 2.4.1.‐)
9.53E‐01 8.39E+04 8.64E+04 2.64E+04 6.08E+04 9.71E‐01 ‐1.27E‐02
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9.57E‐01 2.00E+03 1.92E+03 2.32E+03 5.61E+02 1.04E+00 1.81E‐02
HPr kinase/phosphorylase (EC 
2.7.1.‐) (EC 2.7.4.‐)
9.58E‐01 7.38E+04 7.25E+04 3.16E+04 2.56E+04 1.02E+00 7.90E‐03
Methionine ABC transporter ATP‐
binding protein




9.59E‐01 1.21E+05 1.19E+05 4.25E+04 5.77E+04 1.02E+00 8.33E‐03
3‐hydroxyisobutyrate 
dehydrogenase (EC 1.1.1.31)
9.59E‐01 2.73E+05 2.77E+05 1.06E+05 7.38E+04 9.85E‐01 ‐6.59E‐03
DNA‐directed RNA polymerase 
beta subunit (EC 2.7.7.6)
9.61E‐01 8.00E+05 8.11E+05 3.13E+05 2.27E+05 9.85E‐01 ‐6.35E‐03
N‐succinyl arginine/lysine 
racemase
9.64E‐01 1.15E+04 1.11E+04 1.17E+04 8.85E+03 1.04E+00 1.57E‐02
enterotoxin / cell‐wall binding 
protein
9.67E‐01 5.68E+02 5.89E+02 3.44E+02 7.26E+02 9.64E‐01 ‐1.57E‐02
hypothetical protein 9.67E‐01 1.62E+04 1.59E+04 1.71E+03 1.07E+04 1.02E+00 7.90E‐03
FIG01225386: hypothetical 
protein
9.68E‐01 1.19E+04 1.22E+04 6.53E+03 9.64E+03 9.76E‐01 ‐1.05E‐02
DNA polymerase, DinB family 9.68E‐01 4.95E+04 4.84E+04 1.86E+04 3.89E+04 1.02E+00 9.68E‐03
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Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)
Threonine synthase (EC 4.2.3.1) 9.68E‐01 6.30E+04 6.15E+04 2.80E+04 5.40E+04 1.02E+00 1.05E‐02
dTDP‐4‐dehydrorhamnose 3,5‐
epimerase (EC 5.1.3.13)
9.69E‐01 1.80E+05 1.83E+05 8.99E+04 7.76E+04 9.84E‐01 ‐6.82E‐03
DNA gyrase subunit A (EC 
5.99.1.3)





9.71E‐01 2.34E+04 2.30E+04 1.55E+04 9.14E+03 1.02E+00 7.69E‐03
FIG01229000: hypothetical 
protein
9.72E‐01 2.69E+04 2.59E+04 2.27E+04 3.75E+04 1.04E+00 1.59E‐02
Choloylglycine hydrolase (EC 
3.5.1.24)
9.72E‐01 5.20E+04 5.33E+04 4.75E+04 3.49E+04 9.76E‐01 ‐1.06E‐02
ATP synthase epsilon chain (EC 
3.6.3.14)
9.72E‐01 1.15E+04 1.12E+04 5.89E+03 1.00E+04 1.02E+00 9.66E‐03




9.83E‐01 1.64E+05 1.62E+05 1.55E+05 2.80E+04 1.01E+00 5.73E‐03
Non‐heme chloroperoxidase (EC 
1.11.1.10)
9.89E‐01 1.43E+05 1.44E+05 3.74E+04 6.80E+04 9.95E‐01 ‐1.99E‐03
3‐hydroxybutyryl‐CoA 
dehydrogenase (EC 1.1.1.157)
9.90E‐01 4.79E+05 4.77E+05 2.24E+05 3.59E+04 1.00E+00 1.73E‐03
Flagellar hook protein FlgE 9.92E‐01 8.57E+04 8.54E+04 3.75E+04 2.95E+04 1.00E+00 1.55E‐03
Patatin‐like phospholipase family 9.93E‐01 7.17E+04 7.14E+04 2.53E+04 3.36E+04 1.00E+00 1.37E‐03
Heat shock protein GrpE 9.93E‐01 1.27E+04 1.27E+04 9.30E+03 5.79E+03 1.00E+00 1.99E‐03
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9.96E‐01 1.49E+04 1.49E+04 8.01E+03 1.44E+03 1.00E+00 8.62E‐04
UDP‐N‐acetylglucosamine 2‐
epimerase (EC 5.1.3.14)
9.96E‐01 2.44E+05 2.45E+05 1.33E+05 1.38E+05 9.97E‐01 ‐1.16E‐03
FIG01226109: hypothetical 
protein
9.96E‐01 2.39E+04 2.39E+04 1.63E+04 1.23E+04 9.97E‐01 ‐1.17E‐03
hypothetical protein 9.96E‐01 2.63E+05 2.63E+05 5.96E+04 1.02E+05 9.99E‐01 ‐5.40E‐04
Arginyl‐tRNA synthetase (EC 
6.1.1.19)
9.97E‐01 2.08E+05 2.08E+05 6.01E+04 6.26E+04 9.99E‐01 ‐4.44E‐04
hypothetical protein 9.97E‐01 2.42E+06 2.42E+06 5.17E+05 5.74E+05 9.99E‐01 ‐3.08E‐04
NLP/P60 family protein 9.97E‐01 6.35E+04 6.36E+04 3.95E+04 5.70E+04 9.98E‐01 ‐9.58E‐04
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1.46E‐02 1.12E+05 2.04E+05 2.92E+04 2.48E+04 5.47E‐01 ‐2.62E‐01
Membrane protease family 
protein BA0301
1.67E‐02 2.29E+04 1.06E+05 1.22E+04 2.58E+04 2.15E‐01 ‐6.68E‐01
ATP synthase alpha chain (EC 
3.6.3.14)
2.30E‐02 5.19E+05 1.21E+06 2.44E+05 2.28E+05 4.28E‐01 ‐3.69E‐01
Electron transfer flavoprotein, 
beta subunit
2.52E‐02 6.60E+05 2.57E+05 1.13E+05 1.54E+05 2.57E+00 4.09E‐01
ATP synthase gamma chain (EC 
3.6.3.14)
2.83E‐02 1.31E+05 4.28E+05 1.51E+04 9.25E+04 3.07E‐01 ‐5.13E‐01
FIG01229881: hypothetical 
protein
3.35E‐02 1.17E+03 3.72E+03 1.01E+03 9.49E+02 3.13E‐01 ‐5.04E‐01
Cell division protein FtsZ (EC 
3.4.24.‐)
3.66E‐02 1.49E+04 3.22E+04 6.88E+03 6.84E+03 4.63E‐01 ‐3.35E‐01
probable metal‐dependent 
peptidase
4.26E‐02 6.47E+03 1.68E+04 2.14E+02 3.83E+03 3.86E‐01 ‐4.14E‐01
Triosephosphate isomerase (EC 
5.3.1.1)
5.96E‐02 5.72E+05 3.68E+05 9.42E+04 9.78E+04 1.56E+00 1.92E‐01
FIG01225442: hypothetical 
protein
6.15E‐02 5.56E+03 2.20E+04 8.71E+03 4.97E+03 2.53E‐01 ‐5.97E‐01
Tryptophan 2‐monooxygenase 
(EC 1.13.12.3)
6.37E‐02 3.89E+04 4.75E+04 4.04E+03 4.26E+03 8.18E‐01 ‐8.71E‐02
2H phosphoesterase superfamily 
protein Bsu1186 (yjcG)
6.97E‐02 4.59E+03 1.84E+04 2.99E+03 7.46E+03 2.50E‐01 ‐6.03E‐01
6‐phosphofructokinase (EC 
2.7.1.11)
7.02E‐02 4.49E+05 3.01E+05 7.92E+04 2.86E+04 1.49E+00 1.74E‐01
CBS domain protein AcuB 8.01E‐02 3.28E+04 1.05E+05 1.89E+04 4.20E+04 3.13E‐01 ‐5.04E‐01
Azoreductase 8.08E‐02 1.54E+05 3.64E+05 1.85E+04 1.13E+05 4.24E‐01 ‐3.72E‐01
Shared proteins of the Bt isolate E‐SE10.2 with the Bt isolate O‐V84.2
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8.91E‐02 1.39E+04 1.70E+03 7.17E+03 2.02E+03 8.18E+00 9.13E‐01
hypothetical Membrane 
Spanning Protein
8.91E‐02 7.11E+03 2.22E+04 4.26E+03 9.29E+03 3.20E‐01 ‐4.94E‐01
LSU ribosomal protein L19p 9.20E‐02 1.21E+05 3.26E+05 5.12E+04 1.27E+05 3.72E‐01 ‐4.29E‐01
GTP‐sensing transcriptional 
pleiotropic repressor codY
9.86E‐02 9.28E+04 4.19E+04 9.85E+03 3.19E+04 2.22E+00 3.46E‐01
Menaquinone‐cytochrome c 
reductase, cytochrome B subunit
1.00E‐01 2.86E+03 1.32E+04 1.34E+03 6.34E+03 2.17E‐01 ‐6.63E‐01
Arginine deiminase (EC 3.5.3.6) 1.14E‐01 3.43E+05 1.02E+05 1.61E+05 4.35E+04 3.35E+00 5.25E‐01
Chaperone protein DnaK 1.14E‐01 2.18E+05 1.34E+05 5.80E+04 3.72E+04 1.63E+00 2.11E‐01
acetyltransferase, GNAT family 1.47E‐01 2.29E+03 8.01E+03 2.06E+03 4.53E+03 2.86E‐01 ‐5.44E‐01








1.60E‐01 7.54E+03 1.64E+04 7.30E+03 4.07E+03 4.60E‐01 ‐3.37E‐01
Cystathionine beta‐synthase (EC 
4.2.1.22)
1.61E‐01 4.65E+03 1.44E+03 2.62E+03 6.91E+02 3.22E+00 5.08E‐01
FIG01225730: hypothetical 
protein
1.75E‐01 5.53E+03 1.59E+04 1.50E+03 8.80E+03 3.47E‐01 ‐4.59E‐01
FIG01225993: hypothetical 
protein
1.76E‐01 1.10E+04 3.69E+04 6.21E+03 2.24E+04 2.98E‐01 ‐5.25E‐01
Formamidase amiF (EC 3.5.1.49) 1.77E‐01 2.17E+03 6.01E+03 1.42E+03 3.37E+03 3.61E‐01 ‐4.43E‐01
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Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)
RNA‐binding protein Hfq 1.77E‐01 1.06E+05 2.85E+04 6.76E+04 3.73E+04 3.71E+00 5.70E‐01
SSU ribosomal protein S5p (S2e) 1.85E‐01 6.62E+03 1.11E+04 2.20E+03 3.95E+03 5.99E‐01 ‐2.22E‐01
PTS system, cellobiose‐specific 
IIA component (EC 2.7.1.69)
1.88E‐01 9.26E+03 1.89E+04 7.72E+03 7.18E+03 4.90E‐01 ‐3.10E‐01
Isocitrate dehydrogenase [NADP] 
(EC 1.1.1.42)
1.91E‐01 2.04E+05 3.09E+05 9.17E+04 6.92E+04 6.58E‐01 ‐1.82E‐01
Spore coat protein Z 2.02E‐01 1.09E+04 1.74E+05 9.00E+03 1.51E+05 6.27E‐02 ‐1.20E+00
FIG01228325: hypothetical 
protein




2.04E‐01 2.54E+04 1.77E+04 5.36E+03 6.82E+03 1.43E+00 1.57E‐01
SSU ribosomal protein S2p (SAe) 2.04E‐01 3.05E+05 1.80E+05 1.15E+05 8.09E+04 1.70E+00 2.30E‐01
Enoyl‐[acyl‐carrier‐protein] 
reductase [NADH] (EC 1.3.1.9)







2.09E‐01 2.12E+04 3.81E+04 1.43E+04 1.33E+04 5.57E‐01 ‐2.54E‐01
FIG006542: Phosphoesterase 2.17E‐01 1.88E+04 8.85E+03 9.23E+03 6.98E+03 2.12E+00 3.27E‐01
Methionine aminopeptidase (EC 
3.4.11.18)
2.20E‐01 3.81E+05 2.07E+05 4.26E+04 1.74E+05 1.84E+00 2.66E‐01
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Log (Fold 
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LSU ribosomal protein L4p (L1e) 2.20E‐01 4.01E+04 7.11E+04 2.67E+04 2.54E+04 5.65E‐01 ‐2.48E‐01
LSU ribosomal protein L16p 
(L10e)
2.21E‐01 4.52E+04 1.66E+04 2.83E+04 1.63E+04 2.72E+00 4.35E‐01
Menaquinone‐cytochrome C 
reductase iron‐sulfur subunit
2.24E‐01 1.21E+05 2.14E+05 6.32E+04 9.02E+04 5.65E‐01 ‐2.48E‐01
NAD‐specific glutamate 
dehydrogenase (EC 1.4.1.2)
2.25E‐01 6.04E+05 1.33E+06 4.38E+05 7.22E+05 4.54E‐01 ‐3.43E‐01
hypothetical Membrane 
Spanning Protein
2.31E‐01 3.62E+03 1.75E+04 2.71E+03 1.43E+04 2.06E‐01 ‐6.85E‐01
Rod shape‐determining protein 
MreB
2.35E‐01 1.05E+04 3.10E+04 6.18E+03 2.15E+04 3.37E‐01 ‐4.72E‐01
Nucleoside‐diphosphate‐sugar 
epimerases




2.39E‐01 1.61E+03 1.28E+04 3.09E+02 1.17E+04 1.25E‐01 ‐9.03E‐01
Transcriptional regulator, ArsR 
family
2.42E‐01 1.17E+03 3.72E+03 8.52E+02 2.73E+03 3.14E‐01 ‐5.03E‐01
LSU ribosomal protein L35p 2.49E‐01 8.29E+03 1.67E+04 4.08E+03 9.15E+03 4.97E‐01 ‐3.04E‐01
LSU ribosomal protein L36p 2.51E‐01 1.79E+05 2.96E+05 9.69E+04 1.14E+05 6.06E‐01 ‐2.17E‐01
Translation initiation factor 1 2.58E‐01 8.92E+03 1.74E+04 7.71E+03 8.07E+03 5.12E‐01 ‐2.91E‐01
Cytochrome c‐type biogenesis 
protein Ccs1/ResB
2.58E‐01 5.99E+04 1.44E+04 5.03E+04 1.21E+03 4.15E+00 6.18E‐01
Dihydroxyacetone kinase, ATP‐
dependent (EC 2.7.1.29)




2.60E‐01 5.09E+03 1.35E+04 4.74E+02 9.37E+03 3.77E‐01 ‐4.24E‐01
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Proline dipeptidase (EC 3.4.13.9) 2.60E‐01 2.44E+05 2.99E+05 5.61E+04 4.55E+04 8.16E‐01 ‐8.83E‐02
Fe‐S oxidoreductase 2.67E‐01 1.61E+04 2.71E+04 1.44E+03 1.26E+04 5.93E‐01 ‐2.27E‐01
Molybdenum cofactor 
biosynthesis protein MoaC
2.73E‐01 2.74E+04 1.83E+04 9.43E+03 8.06E+03 1.50E+00 1.76E‐01
Ferrichrome‐binding periplasmic 
protein precursor (TC 3.A.1.14.3)
2.74E‐01 2.58E+04 4.70E+04 1.76E+04 2.28E+04 5.48E‐01 ‐2.61E‐01
ATP‐dependent hsl protease ATP‐
binding subunit HslU
2.75E‐01 2.64E+05 1.42E+05 1.42E+05 2.47E+04 1.86E+00 2.69E‐01
Tellurium resistance protein 
TerD
2.76E‐01 6.01E+04 8.90E+04 1.55E+04 3.37E+04 6.75E‐01 ‐1.70E‐01
Ribosomal subunit interface 
protein
2.78E‐01 2.80E+04 1.04E+05 2.94E+04 9.03E+04 2.68E‐01 ‐5.71E‐01
Large‐conductance 
mechanosensitive channel
2.79E‐01 2.25E+02 7.55E+02 4.56E+01 6.26E+02 2.97E‐01 ‐5.27E‐01
Cysteinyl‐tRNA synthetase (EC 
6.1.1.16)
2.83E‐01 5.56E+04 1.08E+05 3.35E+04 6.09E+04 5.17E‐01 ‐2.86E‐01
Cytochrome c oxidase 
polypeptide III (EC 1.9.3.1)
2.84E‐01 3.89E+04 1.06E+05 2.32E+03 7.98E+04 3.68E‐01 ‐4.34E‐01
Spore cortex‐lytic enzyme CwlJ 2.85E‐01 1.13E+05 1.51E+05 1.78E+04 4.64E+04 7.46E‐01 ‐1.27E‐01
ATP synthase beta chain (EC 
3.6.3.14)
2.86E‐01 2.95E+05 5.65E+05 6.61E+04 3.26E+05 5.22E‐01 ‐2.83E‐01
Sporulation protein, YTFJ Bacillus 
subtilis ortholog




3.06E‐01 1.25E+04 7.19E+04 5.56E+03 7.56E+04 1.73E‐01 ‐7.61E‐01
Extracellular protein 3.11E‐01 8.05E+03 1.56E+04 8.05E+03 7.85E+03 5.17E‐01 ‐2.87E‐01
Ribosome recycling factor 3.11E‐01 5.34E+04 7.02E+04 1.60E+04 1.92E+04 7.61E‐01 ‐1.19E‐01
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3.20E‐01 8.96E+03 1.87E+04 7.68E+03 1.23E+04 4.80E‐01 ‐3.19E‐01
Phosphocarrier protein of PTS 
system
3.35E‐01 2.14E+04 5.49E+04 2.82E+04 4.37E+04 3.89E‐01 ‐4.10E‐01
Membrane‐attached cytochrome 
c550
3.37E‐01 5.60E+04 1.71E+05 2.79E+04 1.59E+05 3.28E‐01 ‐4.84E‐01
Transcription termination factor 
Rho
3.42E‐01 3.05E+04 1.87E+06 7.18E+03 2.57E+06 1.63E‐02 ‐1.79E+00
LSU ribosomal protein L21p 3.45E‐01 2.18E+04 4.23E+04 3.33E+03 2.90E+04 5.15E‐01 ‐2.88E‐01
Aspartate‐semialdehyde 
dehydrogenase (EC 1.2.1.11)
3.45E‐01 1.66E+04 7.66E+03 1.26E+04 3.85E+03 2.17E+00 3.36E‐01
SSU ribosomal protein S12p 
(S23e)
3.51E‐01 1.43E+04 3.40E+04 4.11E+03 2.83E+04 4.20E‐01 ‐3.77E‐01
DNA‐binding protein HBsu 3.57E‐01 6.19E+04 3.67E+04 3.63E+04 1.47E+04 1.69E+00 2.27E‐01
SSU ribosomal protein S9p 
(S16e)
3.76E‐01 2.03E+03 3.91E+03 1.22E+03 2.84E+03 5.19E‐01 ‐2.84E‐01
Glyoxalase family protein 3.89E‐01 3.38E+02 1.41E+03 1.02E+02 1.71E+03 2.39E‐01 ‐6.21E‐01




3.94E‐01 6.79E+02 9.90E+02 4.85E+02 2.39E+02 6.86E‐01 ‐1.64E‐01
comA operon protein, putative 3.95E‐01 1.92E+02 1.32E+03 4.10E+01 1.82E+03 1.45E‐01 ‐8.37E‐01
Ferrichrome‐binding periplasmic 
protein precursor (TC 3.A.1.14.3)
3.98E‐01 9.34E+03 1.76E+04 8.47E+03 1.23E+04 5.30E‐01 ‐2.76E‐01
Phosphatidylinositol‐specific 
phospholipase C (EC 4.6.1.13)
4.05E‐01 9.22E+02 1.74E+02 1.24E+03 4.39E+01 5.31E+00 7.25E‐01
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4.27E‐01 3.56E+03 1.15E+04 2.00E+03 1.40E+04 3.08E‐01 ‐5.11E‐01
DNA‐binding protein HBsu 4.34E‐01 6.72E+04 1.45E+04 9.39E+04 1.67E+04 4.65E+00 6.67E‐01
hypothetical 
fig|282458.1.peg.581 homolog




4.43E‐01 4.37E+04 7.50E+04 2.53E+04 5.54E+04 5.83E‐01 ‐2.35E‐01
LSU ribosomal protein L20p 4.44E‐01 8.02E+04 5.47E+04 4.68E+04 5.83E+03 1.47E+00 1.67E‐01
Acetyl‐coenzyme A synthetase 
(EC 6.2.1.1)
4.64E‐01 1.89E+03 3.61E+03 1.24E+03 3.24E+03 5.24E‐01 ‐2.81E‐01
Thiol peroxidase, Tpx‐type (EC 
1.11.1.15)
4.65E‐01 6.16E+04 8.88E+04 1.37E+04 5.21E+04 6.94E‐01 ‐1.58E‐01
hypothetical Membrane 
Spanning Protein
4.66E‐01 1.60E+04 2.14E+04 1.02E+04 3.94E+03 7.49E‐01 ‐1.26E‐01
ATP synthase F0 sector subunit a 4.76E‐01 5.66E+02 1.02E+03 6.56E+02 7.42E+02 5.57E‐01 ‐2.54E‐01
UDP‐N‐acetylmuramoylalanine‐‐
D‐glutamate ligase (EC 6.3.2.9)
4.76E‐01 2.91E+04 1.55E+04 2.37E+04 1.78E+04 1.87E+00 2.72E‐01
Stage III sporulation protein D 4.80E‐01 2.44E+03 4.23E+03 1.41E+03 3.52E+03 5.77E‐01 ‐2.39E‐01
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4.98E‐01 1.01E+04 5.70E+03 8.15E+03 5.87E+03 1.76E+00 2.47E‐01
FIG01226376: hypothetical 
protein




5.01E‐01 8.82E+02 2.85E+03 8.69E+02 4.16E+03 3.10E‐01 ‐5.09E‐01
Beta‐glucosidase (EC 3.2.1.21) 5.24E‐01 2.94E+04 5.04E+04 3.69E+04 3.68E+04 5.84E‐01 ‐2.34E‐01
Signal recognition particle, 
subunit Ffh SRP54 (TC 3.A.5.1.1)
5.31E‐01 8.70E+03 2.81E+03 1.35E+04 2.07E+03 3.10E+00 4.91E‐01
Protein‐glutamine gamma‐
glutamyltransferase (EC 2.3.2.13)
5.41E‐01 7.08E+03 4.59E+03 4.43E+03 4.70E+03 1.54E+00 1.88E‐01
DEAD‐box ATP‐dependent RNA 
helicase CshA (EC 3.6.4.13)




5.44E‐01 3.35E+04 2.39E+04 1.34E+04 2.09E+04 1.40E+00 1.47E‐01
ATP‐dependent Clp protease ATP‐
binding subunit ClpX
5.47E‐01 5.55E+02 1.00E+03 3.84E+02 1.04E+03 5.55E‐01 ‐2.55E‐01




5.50E‐01 1.02E+04 1.27E+04 1.60E+03 5.91E+03 8.06E‐01 ‐9.35E‐02
Lipoate synthase 5.63E‐01 6.38E+04 3.65E+04 6.64E+04 2.66E+04 1.74E+00 2.42E‐01
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Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)





5.69E‐01 4.26E+03 2.93E+03 3.39E+03 4.11E+02 1.45E+00 1.62E‐01
Serine protease (EC 3.4.21.‐) 5.79E‐01 5.50E+03 9.48E+03 3.69E+03 1.03E+04 5.80E‐01 ‐2.37E‐01




5.85E‐01 3.25E+04 2.11E+04 2.88E+04 1.44E+04 1.54E+00 1.87E‐01
Acyl carrier protein 5.86E‐01 1.02E+04 1.53E+04 5.56E+03 1.33E+04 6.65E‐01 ‐1.77E‐01
Tryptophan 2,3‐dioxygenase (EC 
1.13.11.11)
5.89E‐01 1.13E+03 7.66E+02 7.85E+02 7.37E+02 1.48E+00 1.69E‐01




6.19E‐01 3.81E+04 4.24E+04 2.07E+03 1.28E+04 8.98E‐01 ‐4.68E‐02
Catabolite control protein A 6.20E‐01 3.34E+04 4.48E+04 2.40E+04 2.79E+04 7.45E‐01 ‐1.28E‐01
Methionine ABC transporter 
substrate‐binding protein
6.27E‐01 2.69E+03 3.30E+03 7.25E+02 1.77E+03 8.16E‐01 ‐8.83E‐02
Single‐stranded DNA‐binding 
protein
6.45E‐01 1.22E+05 1.60E+05 5.97E+04 1.16E+05 7.60E‐01 ‐1.19E‐01
Agmatinase (EC 3.5.3.11) 6.46E‐01 1.45E+03 2.08E+03 1.27E+03 1.75E+03 6.99E‐01 ‐1.56E‐01
Tryptophanyl‐tRNA synthetase 
(EC 6.1.1.2)
6.50E‐01 1.08E+05 1.38E+05 9.27E+04 4.89E+04 7.80E‐01 ‐1.08E‐01
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6.58E‐01 7.81E+04 6.35E+04 4.25E+04 3.10E+04 1.23E+00 8.99E‐02
Universal stress protein family 6.60E‐01 2.16E+04 2.78E+04 9.13E+03 1.99E+04 7.77E‐01 ‐1.09E‐01
Prolipoprotein diacylglyceryl 
transferase (EC 2.4.99.‐)
6.64E‐01 6.35E+02 1.02E+03 4.56E+02 1.30E+03 6.20E‐01 ‐2.08E‐01
acetyltransferase, GNAT family 6.64E‐01 7.10E+03 9.36E+03 4.65E+03 6.84E+03 7.59E‐01 ‐1.20E‐01
LSU ribosomal protein L2p (L8e) 6.66E‐01 2.65E+05 3.19E+05 1.60E+05 1.15E+05 8.32E‐01 ‐7.98E‐02
PTS system, glucose‐specific IIA 
component (EC 2.7.1.69)
6.73E‐01 7.08E+03 5.61E+03 4.64E+03 2.94E+03 1.26E+00 1.01E‐01
hypothetical Membrane 
Spanning Protein
6.76E‐01 1.46E+04 1.73E+04 8.45E+03 6.00E+03 8.43E‐01 ‐7.43E‐02
Alkaline shock protein 6.80E‐01 3.13E+03 1.70E+03 5.18E+03 6.97E+02 1.84E+00 2.65E‐01
N‐acetyl‐L,L‐diaminopimelate 
deacetylase (EC 3.5.1.47)




6.92E‐01 1.12E+04 1.53E+04 1.23E+04 1.12E+04 7.31E‐01 ‐1.36E‐01




6.99E‐01 1.68E+04 2.23E+04 1.63E+04 1.62E+04 7.53E‐01 ‐1.23E‐01
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7.02E‐01 2.35E+04 1.55E+04 3.00E+04 1.28E+04 1.52E+00 1.81E‐01
DNA‐directed RNA polymerase 
alpha subunit (EC 2.7.7.6)
7.10E‐01 2.35E+05 2.17E+05 5.87E+03 7.10E+04 1.08E+00 3.39E‐02
Two‐component response 
regulator YvcP
7.10E‐01 9.82E+04 1.21E+05 7.40E+04 6.82E+04 8.09E‐01 ‐9.23E‐02
alternate gene name: ipa‐62r 7.14E‐01 2.65E+05 2.28E+05 7.96E+04 1.43E+05 1.17E+00 6.67E‐02
L‐lactate dehydrogenase (EC 
1.1.1.27)
7.20E‐01 7.85E+04 6.76E+04 4.29E+04 2.03E+04 1.16E+00 6.46E‐02
Protease production regulatory 
protein Hpr (ScoC)
7.20E‐01 1.32E+04 1.12E+04 8.23E+03 7.49E+02 1.18E+00 7.01E‐02
Histidyl‐tRNA synthetase (EC 
6.1.1.21)
7.24E‐01 2.66E+04 3.72E+04 8.90E+03 4.44E+04 7.17E‐01 ‐1.44E‐01
Metal‐dependent hydrolase 7.32E‐01 1.34E+04 1.80E+04 7.27E+03 1.97E+04 7.43E‐01 ‐1.29E‐01
hypothetical Membrane 
Spanning Protein




7.35E‐01 3.07E+03 4.65E+03 1.73E+03 6.91E+03 6.60E‐01 ‐1.80E‐01
Translocation‐enhancing protein 
TepA




7.40E‐01 2.47E+04 2.06E+04 1.48E+04 1.27E+04 1.19E+00 7.72E‐02
Phage major capsid protein 7.44E‐01 1.39E+05 1.84E+05 1.18E+05 1.83E+05 7.57E‐01 ‐1.21E‐01
FIG01226061: hypothetical 
protein
7.51E‐01 2.35E+04 2.91E+04 1.29E+04 2.44E+04 8.09E‐01 ‐9.19E‐02
Outer spore coat protein E 7.51E‐01 5.01E+05 5.97E+05 3.77E+05 3.11E+05 8.39E‐01 ‐7.62E‐02
tRNA:m(5)U‐54 MTase gid 7.56E‐01 1.22E+05 1.94E+05 1.88E+05 3.18E+05 6.28E‐01 ‐2.02E‐01
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7.64E‐01 5.18E+06 4.26E+06 4.16E+06 2.52E+06 1.22E+00 8.47E‐02
SSU ribosomal protein S17p 
(S11e)
7.68E‐01 2.20E+04 1.88E+04 9.98E+03 1.43E+04 1.17E+00 6.84E‐02
Iron‐sulfur cluster assembly 
protein SufB
7.75E‐01 3.69E+04 4.39E+04 8.23E+03 3.68E+04 8.40E‐01 ‐7.58E‐02
RNA binding protein, contains 
ribosomal protein S1 domain
7.85E‐01 2.23E+04 2.57E+04 1.84E+04 4.64E+03 8.70E‐01 ‐6.07E‐02
UDP‐N‐acetylmuramate‐‐alanine 
ligase (EC 6.3.2.8)
7.86E‐01 5.27E+03 6.54E+03 2.60E+03 6.87E+03 8.05E‐01 ‐9.43E‐02
Glycine cleavage system H 
protein




8.03E‐01 2.71E+03 2.10E+03 2.62E+03 3.04E+03 1.30E+00 1.12E‐01
Alkyl hydroperoxide reductase 
protein F (EC 1.6.4.‐)
8.04E‐01 2.83E+05 3.24E+05 2.06E+05 1.75E+05 8.72E‐01 ‐5.95E‐02
Fumarate hydratase class I, 
aerobic (EC 4.2.1.2)





8.41E‐01 4.61E+04 5.01E+04 2.71E+04 1.67E+04 9.20E‐01 ‐3.61E‐02
Peptidase T (EC 3.4.11.4) 8.42E‐01 3.52E+05 3.29E+05 1.39E+05 1.23E+05 1.07E+00 2.89E‐02
general stress protein 26 8.49E‐01 2.53E+04 2.20E+04 1.39E+04 2.44E+04 1.15E+00 6.18E‐02
Excinuclease ABC subunit A 8.54E‐01 1.36E+04 1.46E+04 4.36E+03 7.40E+03 9.32E‐01 ‐3.04E‐02
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8.73E‐01 1.26E+03 1.46E+03 1.07E+03 1.70E+03 8.62E‐01 ‐6.43E‐02
hypothetical protein 8.79E‐01 3.57E+04 3.34E+04 1.56E+04 1.93E+04 1.07E+00 2.93E‐02
D‐alanyl‐D‐alanine 
carboxypeptidase (EC 3.4.16.4)
8.82E‐01 8.02E+03 7.55E+03 3.91E+03 3.32E+03 1.06E+00 2.61E‐02
LSU ribosomal protein L17p 8.88E‐01 2.15E+04 2.46E+04 3.17E+04 1.37E+04 8.74E‐01 ‐5.83E‐02
Alkyl hydroperoxide reductase 
protein C (EC 1.6.4.‐)
8.91E‐01 8.18E+05 7.92E+05 2.45E+05 1.90E+05 1.03E+00 1.41E‐02
Purine nucleoside phosphorylase 
(EC 2.4.2.1)
8.94E‐01 3.90E+04 4.19E+04 2.78E+04 2.24E+04 9.30E‐01 ‐3.15E‐02
Two‐component response 
regulator SA14‐24
9.01E‐01 3.32E+04 3.43E+04 1.25E+04 6.20E+03 9.68E‐01 ‐1.40E‐02
SSU ribosomal protein S8p 
(S15Ae)
9.09E‐01 1.73E+04 1.95E+04 2.67E+04 1.60E+04 8.87E‐01 ‐5.23E‐02
FIG01228193: hypothetical 
protein




9.12E‐01 4.31E+04 4.81E+04 4.20E+04 5.97E+04 8.97E‐01 ‐4.74E‐02
lysophospholipase‐like family 
protein
9.14E‐01 4.84E+03 5.46E+03 7.75E+03 4.85E+03 8.87E‐01 ‐5.21E‐02
Hypothetical protein SAV1839 9.18E‐01 4.47E+04 4.76E+04 4.12E+04 1.93E+04 9.38E‐01 ‐2.77E‐02
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Description p‐value Mean  24 Mean 48 Sigma 24 Sigma 48 Fold Change 24/48
Log (Fold 
Change)
LSU ribosomal protein L3p (L3e) 9.22E‐01 2.68E+04 2.87E+04 2.56E+04 1.54E+04 9.36E‐01 ‐2.87E‐02
GTP‐binding protein Obg 9.44E‐01 1.32E+03 1.39E+03 8.87E+02 1.34E+03 9.50E‐01 ‐2.23E‐02
ATPase, AAA family 9.46E‐01 3.41E+04 3.10E+04 5.74E+04 4.80E+04 1.10E+00 4.18E‐02
Alanine dehydrogenase (EC 
1.4.1.1)
9.52E‐01 4.58E+05 4.65E+05 1.55E+05 9.24E+04 9.85E‐01 ‐6.43E‐03
CBS domain protein, lmo1865 
homolog





9.73E‐01 2.00E+06 2.02E+06 6.76E+05 7.23E+05 9.90E‐01 ‐4.43E‐03
Biotin carboxyl carrier protein of 
methylcrotonyl‐CoA carboxylase




9.81E‐01 4.01E+04 3.98E+04 1.31E+04 1.68E+04 1.01E+00 3.41E‐03
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2.2. - GROUPED DATA ANALYSIS O-V84.2 
 
A PCA analysis was done with the non-normalized area of the peaks (Figure 9) and with 
the area peaks corrected by the total areas sum (Figure 10) of the concentrated supernatant 
at 24 h and 48 h. 
 
 
Figure 9. PCA analysis with the non-normalized area of the concentrated supernatant of 
the Bt isolate 24 h and 48 h. 
 
 
Figure 10. PCA analysis with the area peaks corrected by the total areas sum of the 
concentrated supernatant 24 h and 48 h of the Bt isolate E-SE10.2 
 
2.1. - DIFFERENTAL EXPRESION ANALYSIS O-V84.2 
 
A Student t-test analysis was performed with the supernatant of the Bt isolate O-V84.2 at 
24 h and 48 h in the Marker View 1.3. As a result, 159 proteins were differential expressed 




Description p‐value Mean 24 Mean 48 Sigma 24 Sigma 48
Fold Change 24/48 Log (Fold Change)
Alcohol dehydrogenase (EC 1.1.1.1) 1.08E‐05 2.94E+04 4.14E+05 1.59E+04 1.16E+04 7.12E‐02 ‐1.15E+00
Dihydrolipoamide dehydrogenase of 
branched‐chain alpha‐keto acid 
dehydrogenase (EC 1.8.1.4) 2.53E‐05 6.69E+04 6.28E+05 2.98E+04 2.21E+04 1.07E‐01 ‐9.72E‐01
Prephenate dehydratase (EC 4.2.1.51) 8.54E‐05 2.02E+03 2.38E+04 1.55E+03 1.70E+03 8.49E‐02 ‐1.07E+00
hypothetical protein 2.00E‐04 4.17E+04 3.27E+05 2.00E+04 2.69E+04 1.28E‐01 ‐8.94E‐01
O‐methyltransferase (EC 2.1.1.‐) 4.20E‐04 2.04E+03 3.17E+04 1.01E+03 2.27E+03 6.44E‐02 ‐1.19E+00
Adenylosuccinate lyase (EC 4.3.2.2) 4.60E‐04 1.03E+04 8.62E+04 8.67E+03 8.99E+03 1.19E‐01 ‐9.23E‐01
Spermidine synthase (EC 2.5.1.16) 6.50E‐04 4.66E+04 1.93E+05 7.75E+03 1.51E+04 2.41E‐01 ‐6.18E‐01
NADPH‐dependent glyceraldehyde‐3‐
phosphate dehydrogenase (EC 1.2.1.13) 6.70E‐04 6.20E+03 3.93E+04 4.39E+03 3.96E+03 1.58E‐01 ‐8.02E‐01
ATP‐dependent protease HslV (EC 3.4.25.‐) 7.30E‐04 1.89E+04 3.42E+05 2.27E+04 3.84E+04 5.53E‐02 ‐1.26E+00
L‐alanine‐DL‐glutamate epimerase 7.40E‐04 8.11E+02 1.35E+04 8.29E+02 2.21E+02 5.99E‐02 ‐1.22E+00
Translation elongation factor G 7.80E‐04 3.91E+04 3.38E+05 1.75E+04 3.32E+04 1.16E‐01 ‐9.37E‐01
Preprotein translocase subunit YajC (TC 
3.A.5.1.1) 8.50E‐04 3.48E+03 4.17E+04 2.26E+03 4.33E+03 8.36E‐02 ‐1.08E+00
LSU ribosomal protein L1p (L10Ae) 9.00E‐04 3.22E+03 1.81E+04 1.50E+03 2.09E+03 1.78E‐01 ‐7.50E‐01
hypothetical Membrane Spanning Protein 1.86E‐03 3.59E+05 8.09E+04 8.85E+03 2.91E+04 4.44E+00 6.47E‐01
Acetylornithine deacetylase (EC 3.5.1.16) 1.87E‐03 3.58E+04 4.35E+05 1.05E+04 3.94E+04 8.21E‐02 ‐1.09E+00
Chitinase (EC 3.2.1.14) 2.04E‐03 2.14E+05 7.88E+04 7.36E+03 1.78E+04 2.72E+00 4.35E‐01
3‐hydroxyisobutyrate dehydrogenase (EC 
1.1.1.31) 2.06E‐03 5.55E+04 5.98E+05 2.90E+04 7.08E+04 9.29E‐02 ‐1.03E+00
Acyl carrier protein 2.10E‐03 1.61E+04 5.17E+03 1.79E+03 1.05E+03 3.11E+00 4.93E‐01
Specific proteins of the Bt isolate O‐V84.2
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deacylases 2.41E‐03 2.95E+04 2.03E+05 3.00E+04 3.20E+04 1.45E‐01 ‐8.37E‐01
SSU ribosomal protein S11p (S14e) 2.60E‐03 2.04E+02 9.63E+02 1.37E+02 1.41E+02 2.12E‐01 ‐6.74E‐01
hypothetical protein 2.83E‐03 1.86E+05 2.22E+06 2.25E+05 3.74E+05 8.37E‐02 ‐1.08E+00
Phosphoenolpyruvate carboxykinase [ATP] 
(EC 4.1.1.49) 2.96E‐03 3.86E+04 4.80E+05 2.47E+04 6.40E+04 8.03E‐02 ‐1.10E+00
Phosphatidylinositol‐specific phospholipase 
C (EC 4.6.1.13) 3.19E‐03 1.13E+04 2.08E+05 1.03E+04 2.84E+04 5.41E‐02 ‐1.27E+00
Ornithine aminotransferase (EC 2.6.1.13) 3.21E‐03 4.33E+04 2.05E+05 3.16E+04 3.10E+04 2.12E‐01 ‐6.75E‐01
Streptomycin biosynthesis StrF domain 
protein 3.23E‐03 1.07E+03 6.28E+03 1.00E+03 1.02E+03 1.70E‐01 ‐7.70E‐01
Urocanate hydratase (EC 4.2.1.49) 3.27E‐03 9.98E+04 7.02E+05 1.04E+05 1.24E+05 1.42E‐01 ‐8.47E‐01
Ferredoxin‐‐sulfite reductase, bacillial type 
(EC 1.8.7.1) 3.98E‐03 6.23E+03 4.80E+04 9.00E+03 6.43E+03 1.30E‐01 ‐8.86E‐01
FIG01227664: hypothetical protein 4.17E‐03 1.94E+04 1.49E+05 1.35E+04 2.54E+04 1.31E‐01 ‐8.84E‐01
Catalyzes the cleavage of p‐aminobenzoyl‐
glutamate to p‐aminobenzoate and 
glutamate, subunit A 4.22E‐03 8.33E+03 3.55E+04 5.62E+03 5.71E+03 2.35E‐01 ‐6.29E‐01
Immune inhibitor A precursor 4.80E‐03 4.37E+05 2.13E+05 3.79E+04 5.13E+04 2.05E+00 3.12E‐01
Ribulose‐5‐phosphate 4‐epimerase and 
related epimerases and aldolases 5.35E‐03 2.65E+04 7.82E+04 1.21E+04 8.29E+03 3.39E‐01 ‐4.70E‐01
Pantothenate kinase type II, eukaryotic (EC 
2.7.1.33) 5.42E‐03 4.53E+03 3.71E+04 1.81E+03 5.55E+03 1.22E‐01 ‐9.13E‐01
Gamma‐aminobutyrate:alpha‐ketoglutarate 
aminotransferase (EC 2.6.1.19) 5.85E‐03 1.14E+05 3.01E+05 3.80E+04 4.52E+04 3.79E‐01 ‐4.21E‐01
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2.1.1.14) 6.42E‐03 8.18E+04 1.45E+06 5.87E+04 2.30E+05 5.63E‐02 ‐1.25E+00
Branched‐chain amino acid 
aminotransferase (EC 2.6.1.42) 6.56E‐03 9.40E+03 3.25E+05 3.38E+03 4.53E+04 2.90E‐02 ‐1.54E+00
transcriptional regulator, XRE family 6.78E‐03 1.07E+08 4.36E+07 1.40E+07 6.71E+06 2.46E+00 3.90E‐01
hypothetical Membrane Spanning Protein 7.23E‐03 1.02E+05 2.92E+05 3.71E+04 4.93E+04 3.48E‐01 ‐4.58E‐01
aminopeptidase 7.49E‐03 5.19E+04 2.27E+05 3.14E+04 4.54E+04 2.29E‐01 ‐6.40E‐01
5'‐methylthioadenosine nucleosidase (EC 
3.2.2.16) / S‐adenosylhomocysteine 
nucleosidase (EC 3.2.2.9) 7.52E‐03 5.17E+03 3.39E+04 5.58E+03 7.51E+03 1.53E‐01 ‐8.16E‐01
Cytochrome c oxidase polypeptide III (EC 
1.9.3.1) 7.66E‐03 2.52E+03 4.09E+04 2.20E+03 7.33E+03 6.17E‐02 ‐1.21E+00
hypothetical protein 7.75E‐03 1.24E+04 8.61E+04 6.37E+03 1.59E+04 1.44E‐01 ‐8.42E‐01
NADP‐dependent malic enzyme (EC 
1.1.1.40) 7.88E‐03 3.79E+03 1.96E+04 1.40E+03 3.45E+03 1.93E‐01 ‐7.14E‐01
Cystine‐binding periplasmic protein 
precursor 7.98E‐03 4.22E+04 5.34E+05 9.20E+03 7.96E+04 7.91E‐02 ‐1.10E+00
transcriptional regulator, XRE family 8.24E‐03 1.43E+06 4.70E+05 2.08E+05 7.91E+04 3.05E+00 4.84E‐01
hypothetical Membrane Spanning Protein 8.27E‐03 1.97E+03 1.86E+04 2.54E+03 4.29E+03 1.06E‐01 ‐9.75E‐01
hypothetical protein 8.34E‐03 5.91E+02 6.78E+03 2.90E+02 1.16E+03 8.72E‐02 ‐1.06E+00
Fe‐bacillibactin uptake system FeuA, Fe‐
bacillibactin binding 8.54E‐03 8.87E+03 4.35E+04 7.18E+03 9.42E+03 2.04E‐01 ‐6.90E‐01
DUF124 domain‐containing protein 8.60E‐03 5.89E+03 4.12E+04 7.94E+03 9.57E+03 1.43E‐01 ‐8.46E‐01
Cysteine synthase (EC 2.5.1.47) 8.94E‐03 4.31E+04 5.19E+05 5.45E+04 1.16E+05 8.31E‐02 ‐1.08E+00
Polyribonucleotide nucleotidyltransferase 
(EC 2.7.7.8) 9.04E‐03 2.92E+04 6.44E+04 9.70E+03 7.78E+03 4.54E‐01 ‐3.43E‐01
Translation elongation factor Ts 9.07E‐03 1.86E+03 7.93E+03 1.27E+03 1.68E+03 2.35E‐01 ‐6.30E‐01
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Fold Change 24/48 Log (Fold Change)
Pyruvate carboxylase (EC 6.4.1.1) 9.56E‐03 2.69E+04 5.32E+05 1.02E+04 8.94E+04 5.05E‐02 ‐1.30E+00
Peptidase, M42 family 9.73E‐03 3.85E+04 1.75E+05 3.67E+04 3.55E+04 2.20E‐01 ‐6.58E‐01
Methionine ABC transporter substrate‐
binding protein 9.79E‐03 4.15E+04 1.40E+05 2.77E+04 2.28E+04 2.96E‐01 ‐5.28E‐01
hypothetical protein 1.00E‐02 1.76E+04 1.32E+05 2.29E+04 3.25E+04 1.33E‐01 ‐8.75E‐01
Porphobilinogen deaminase (EC 2.5.1.61) 1.01E‐02 1.27E+03 2.68E+04 6.98E+02 4.76E+03 4.75E‐02 ‐1.32E+00
hypothetical protein 1.02E‐02 7.44E+03 2.40E+04 4.71E+03 3.12E+03 3.09E‐01 ‐5.10E‐01
Pyrimidine‐nucleoside phosphorylase (EC 
2.4.2.2) 1.10E‐02 1.51E+04 1.27E+05 1.08E+04 2.75E+04 1.19E‐01 ‐9.24E‐01
3‐ketoacyl‐CoA thiolase [isoleucine 
degradation] (EC 2.3.1.16) 1.21E‐02 9.78E+04 9.55E+05 7.46E+04 2.11E+05 1.02E‐01 ‐9.89E‐01
SSU ribosomal protein S2p (SAe) 1.26E‐02 2.80E+03 2.11E+04 3.56E+02 3.68E+03 1.33E‐01 ‐8.77E‐01
Aspartate‐semialdehyde dehydrogenase (EC 




pyrophosphatase subunit (EC 6.3.5.2) 1.43E‐02 4.53E+03 2.78E+04 3.32E+03 6.82E+03 1.63E‐01 ‐7.87E‐01
Chaperone protein DnaK 1.46E‐02 3.35E+04 1.19E+05 1.86E+04 2.72E+04 2.83E‐01 ‐5.49E‐01
hypothetical Membrane Spanning Protein 1.51E‐02 1.12E+04 2.00E+04 2.58E+03 2.67E+03 5.62E‐01 ‐2.51E‐01
aldehyde dehydrogenase family protein 1.55E‐02 5.87E+03 2.67E+04 2.33E+03 5.89E+03 2.20E‐01 ‐6.58E‐01
Methionine ABC transporter substrate‐
binding protein 1.55E‐02 4.10E+04 2.26E+05 3.01E+04 5.73E+04 1.81E‐01 ‐7.41E‐01
Chitinase (EC 3.2.1.14) 1.57E‐02 1.42E+05 5.42E+05 1.20E+05 1.23E+05 2.61E‐01 ‐5.83E‐01
hypothetical Membrane Spanning Protein 1.65E‐02 2.45E+04 6.07E+04 1.03E+04 1.18E+04 4.03E‐01 ‐3.94E‐01
hypothetical protein 1.66E‐02 8.06E+03 2.01E+04 3.50E+03 3.86E+03 4.02E‐01 ‐3.96E‐01
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Methionine ABC transporter substrate‐
binding protein 1.66E‐02 1.33E+04 2.87E+04 5.11E+03 3.30E+03 4.63E‐01 ‐3.35E‐01
Catalase (EC 1.11.1.6) 1.77E‐02 2.01E+05 4.56E+06 1.18E+05 1.05E+06 4.41E‐02 ‐1.36E+00
Proline dipeptidase (EC 3.4.13.9) 1.78E‐02 1.31E+04 9.10E+04 7.11E+03 2.20E+04 1.44E‐01 ‐8.40E‐01
hypothetical protein 1.87E‐02 9.38E+03 2.13E+05 6.77E+03 5.09E+04 4.41E‐02 ‐1.36E+00
hypothetical Membrane Spanning Protein 1.92E‐02 1.56E+05 5.35E+05 1.17E+05 1.26E+05 2.92E‐01 ‐5.35E‐01
Butyryl‐CoA dehydrogenase (EC 1.3.99.2) 1.95E‐02 1.33E+04 8.77E+04 1.05E+04 2.38E+04 1.51E‐01 ‐8.20E‐01
Alkyl hydroperoxide reductase protein F (EC 
1.6.4.‐) 1.96E‐02 1.87E+04 5.85E+05 9.84E+03 1.41E+05 3.19E‐02 ‐1.50E+00
Oligopeptide ABC transporter, periplasmic 
oligopeptide‐binding protein OppA (TC 
3.A.1.5.1) 2.07E‐02 2.35E+05 1.47E+06 1.13E+05 3.67E+05 1.60E‐01 ‐7.97E‐01
3‐ketoacyl‐CoA thiolase (EC 2.3.1.16) @ 
Acetyl‐CoA acetyltransferase (EC 2.3.1.9) 2.11E‐02 4.78E+04 8.81E+05 3.28E+04 2.23E+05 5.43E‐02 ‐1.27E+00
Long‐chain‐fatty‐acid‐‐CoA ligase (EC 
6.2.1.3) 2.19E‐02 2.62E+04 2.20E+05 3.27E+04 6.70E+04 1.19E‐01 ‐9.24E‐01
Threonine synthase (EC 4.2.3.1) 2.30E‐02 2.09E+04 1.38E+05 2.21E+04 4.20E+04 1.51E‐01 ‐8.20E‐01
NADH dehydrogenase (EC 1.6.99.3) 2.31E‐02 3.64E+03 8.21E+04 2.59E+03 2.17E+04 4.44E‐02 ‐1.35E+00
EPSX protein 2.33E‐02 3.61E+05 5.75E+04 1.04E+05 4.55E+04 6.29E+00 7.99E‐01
4‐hydroxyphenylpyruvate dioxygenase (EC 
1.13.11.27) 2.33E‐02 1.42E+05 1.56E+06 1.48E+05 4.52E+05 9.10E‐02 ‐1.04E+00
2‐methylcitrate dehydratase (EC 4.2.1.79) 2.34E‐02 7.67E+04 1.15E+06 1.13E+04 2.91E+05 6.66E‐02 ‐1.18E+00
hypothetical protein 2.35E‐02 2.19E+04 2.65E+05 1.30E+04 7.00E+04 8.27E‐02 ‐1.08E+00
FIG01225390: hypothetical protein 2.37E‐02 1.75E+03 8.74E+03 2.47E+03 1.19E+03 2.01E‐01 ‐6.98E‐01
hypothetical protein 2.39E‐02 6.05E+04 4.25E+05 7.97E+04 1.35E+05 1.42E‐01 ‐8.47E‐01
Autoinducer 2 (AI‐2) aldolase LsrF (EC 4.2.1.‐
) 2.42E‐02 2.76E+04 1.50E+05 7.02E+03 3.61E+04 1.84E‐01 ‐7.36E‐01
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Histidine ammonia‐lyase (EC 4.3.1.3) 2.62E‐02 5.57E+04 4.53E+05 1.79E+04 1.18E+05 1.23E‐01 ‐9.10E‐01
Formate‐‐tetrahydrofolate ligase (EC 
6.3.4.3) 2.63E‐02 3.13E+04 1.59E+05 3.34E+04 4.96E+04 1.97E‐01 ‐7.06E‐01
phosphotransbutyrylase (EC 2.3.1.19) 2.73E‐02 4.69E+04 2.17E+05 7.91E+03 5.18E+04 2.16E‐01 ‐6.65E‐01
Ortholog yrbG, yetE, ykjA, ydfS, ydfR 
B.subtilis 2.75E‐02 4.35E+06 1.56E+06 9.96E+05 1.02E+06 2.79E+00 4.46E‐01
Oligopeptide ABC transporter, periplasmic
oligopeptide‐binding protein OppA (TC




2.6.1.9) 2.83E‐02 1.06E+04 8.33E+04 1.13E+04 2.68E+04 1.28E‐01 ‐8.94E‐01
Non‐heme chloroperoxidase (EC 1.11.1.10) 2.94E‐02 1.21E+04 6.37E+04 7.56E+03 1.90E+04 1.91E‐01 ‐7.20E‐01
Dihydrolipoamide dehydrogenase of 
pyruvate dehydrogenase complex (EC 
1.8.1.4) 3.05E‐02 4.39E+04 2.58E+05 4.81E+04 8.60E+04 1.70E‐01 ‐7.69E‐01
Pyruvate dehydrogenase E1 component 
beta subunit (EC 1.2.4.1) 3.05E‐02 1.43E+04 4.99E+03 2.29E+03 3.77E+03 2.86E+00 4.56E‐01




acetyltransferase (EC 2.3.1.157) 3.11E‐02 7.27E+03 3.85E+04 3.70E+03 1.13E+04 1.89E‐01 ‐7.24E‐01
alkaline serine protease, subtilase family 3.12E‐02 1.06E+05 2.13E+06 1.43E+05 6.82E+05 4.97E‐02 ‐1.30E+00
FIG002379: metal‐dependent hydrolase 3.15E‐02 4.24E+03 1.89E+04 5.11E+03 1.35E+03 2.25E‐01 ‐6.48E‐01
3‐hydroxybutyryl‐CoA dehydrogenase (EC 
1.1.1.157) 3.17E‐02 1.32E+04 3.77E+05 8.12E+03 1.16E+05 3.49E‐02 ‐1.46E+00
Leucine dehydrogenase (EC 1.4.1.9) 3.17E‐02 5.39E+05 3.96E+06 1.57E+05 1.12E+06 1.36E‐01 ‐8.66E‐01
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S‐layer protein, putative 3.22E‐02 3.10E+03 1.09E+04 1.45E+02 2.49E+03 2.85E‐01 ‐5.45E‐01
3‐oxoacyl‐[acyl‐carrier‐protein] synthase, 
KASII (EC 2.3.1.41) 3.23E‐02 4.06E+03 6.34E+04 1.72E+03 1.92E+04 6.41E‐02 ‐1.19E+00
Nitrilotriacetate monooxygenase 
component B (EC 1.14.13.‐) 3.25E‐02 2.53E+04 5.05E+05 3.39E+04 1.64E+05 5.01E‐02 ‐1.30E+00
hypothetical Membrane Spanning Protein 3.29E‐02 8.62E+04 5.17E+05 9.87E+04 1.78E+05 1.67E‐01 ‐7.78E‐01
Dihydroorotase (EC 3.5.2.3) 3.41E‐02 9.90E+03 5.54E+04 7.36E+03 1.80E+04 1.79E‐01 ‐7.47E‐01
Thioredoxin reductase (EC 1.8.1.9) 3.44E‐02 2.45E+03 3.48E+04 2.63E+03 1.15E+04 7.05E‐02 ‐1.15E+00
Intracellular serine protease 3.48E‐02 2.93E+02 9.48E+02 2.55E+02 9.34E+01 3.09E‐01 ‐5.10E‐01
Acid phosphatase (EC 3.1.3.2) 3.52E‐02 6.69E+04 2.76E+04 1.39E+04 2.59E+03 2.42E+00 3.84E‐01
RND multidrug efflux transporter; Acriflavin 
resistance protein 3.55E‐02 6.92E+05 5.47E+04 2.15E+05 1.33E+04 1.27E+01 1.10E+00
hypothetical protein 3.60E‐02 1.88E+04 5.25E+04 1.24E+04 1.40E+04 3.59E‐01 ‐4.45E‐01
Cysteine desulfurase (EC 2.8.1.7) 3.62E‐02 2.08E+04 5.66E+04 1.33E+04 3.47E+03 3.67E‐01 ‐4.35E‐01
Dihydroneopterin aldolase (EC 4.1.2.25) 3.67E‐02 2.52E+03 6.22E+04 4.97E+02 2.04E+04 4.06E‐02 ‐1.39E+00
Two‐component response regulator SA14‐
24 3.82E‐02 4.86E+04 2.19E+05 5.39E+04 7.51E+04 2.22E‐01 ‐6.53E‐01
Beta‐lactamase (EC 3.5.2.6) 3.85E‐02 1.13E+05 5.33E+06 3.92E+04 1.83E+06 2.11E‐02 ‐1.68E+00
Phosphatidylinositol‐specific phospholipase 
C (EC 4.6.1.13) 3.90E‐02 1.30E+04 7.01E+04 6.36E+03 2.24E+04 1.85E‐01 ‐7.32E‐01
CBS domain protein AcuB 3.94E‐02 3.85E+03 1.83E+04 1.51E+03 5.64E+03 2.10E‐01 ‐6.77E‐01
Aminopeptidase S (Leu, Val, Phe, Tyr 
preference) (EC 3.4.11.24) 3.96E‐02 3.75E+04 2.87E+05 5.72E+04 1.10E+05 1.31E‐01 ‐8.84E‐01
hypothetical protein 3.99E‐02 1.58E+03 4.25E+03 1.07E+03 3.23E+02 3.72E‐01 ‐4.29E‐01
Aminopeptidase YpdF (MP‐, MA‐, MS‐, AP‐, 
NP‐ specific) 3.99E‐02 1.39E+04 7.63E+04 1.18E+04 2.68E+04 1.83E‐01 ‐7.39E‐01
Phosphopentomutase (EC 5.4.2.7) 4.00E‐02 4.27E+04 1.95E+05 9.71E+03 5.68E+04 2.19E‐01 ‐6.60E‐01
acetyltransferase, GNAT family 4.01E‐02 1.23E+03 7.23E+03 7.93E+02 2.43E+03 1.71E‐01 ‐7.68E‐01
RNA‐binding protein Hfq 4.05E‐02 3.87E+03 3.36E+05 5.46E+03 1.20E+05 1.15E‐02 ‐1.94E+00
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Electron transfer flavoprotein, beta subunit 4.08E‐02 1.19E+05 2.92E+05 7.73E+04 5.99E+04 4.08E‐01 ‐3.89E‐01
N‐acetyl‐L,L‐diaminopimelate deacetylase 
(EC 3.5.1.47) 4.21E‐02 2.32E+03 1.82E+04 2.06E+03 6.56E+03 1.28E‐01 ‐8.94E‐01
Oligoendopeptidase F (EC 3.4.24.‐) 4.26E‐02 2.64E+05 5.87E+04 8.66E+04 2.99E+04 4.49E+00 6.52E‐01
Vip4Aa‐like_1 4.27E‐02 1.34E+05 6.88E+04 2.68E+04 7.64E+03 1.95E+00 2.91E‐01
Glucosamine‐‐fructose‐6‐phosphate 
aminotransferase [isomerizing] (EC 2.6.1.16) 4.28E‐02 3.80E+04 3.07E+05 1.16E+04 1.01E+05 1.24E‐01 ‐9.07E‐01
hypothetical Membrane Spanning Protein 4.30E‐02 1.08E+05 3.67E+05 1.17E+05 5.68E+04 2.94E‐01 ‐5.32E‐01
oxidoreductase, aldo/keto reductase family 4.50E‐02 1.64E+04 1.00E+05 6.73E+03 3.36E+04 1.64E‐01 ‐7.85E‐01
Acetyl‐CoA:acetoacetyl‐CoA transferase, 
alpha subunit (EC 2.8.3.8) 4.63E‐02 7.08E+02 3.30E+04 2.65E+02 1.25E+04 2.14E‐02 ‐1.67E+00
DNA‐directed RNA polymerase beta subunit 
(EC 2.7.7.6) 4.66E‐02 4.18E+04 1.51E+05 3.54E+04 5.19E+04 2.77E‐01 ‐5.57E‐01
2‐hydroxy‐3‐oxopropionate reductase (EC 
1.1.1.60) 4.68E‐02 1.51E+04 1.00E+05 1.92E+04 3.97E+04 1.51E‐01 ‐8.21E‐01
hypothetical Membrane Spanning Protein 4.69E‐02 7.10E+04 1.10E+06 5.11E+04 4.07E+05 6.48E‐02 ‐1.19E+00
Imidazoleglycerol‐phosphate dehydratase 
(EC 4.2.1.19) 4.74E‐02 1.38E+04 5.27E+04 1.75E+04 6.68E+03 2.63E‐01 ‐5.81E‐01
Glutamyl‐tRNA synthetase (EC 6.1.1.17) @ 
Glutamyl‐tRNA(Gln) synthetase (EC 6.1.1.24) 4.81E‐02 3.93E+04 9.29E+04 2.20E+04 3.86E+03 4.23E‐01 ‐3.74E‐01
2,3‐bisphosphoglycerate‐independent 
phosphoglycerate mutase (EC 5.4.2.1) 4.82E‐02 3.97E+04 9.18E+04 1.69E+04 2.51E+04 4.33E‐01 ‐3.64E‐01
Glucose‐6‐phosphate isomerase (EC 5.3.1.9) 4.86E‐02 1.71E+04 3.73E+05 4.53E+03 1.41E+05 4.59E‐02 ‐1.34E+00
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Phosphatidylinositol‐specific phospholipase 
C (EC 4.6.1.13) 5.00E‐02 1.56E+04 5.69E+04 1.93E+04 8.07E+03 2.74E‐01 ‐5.62E‐01
Peptide deformylase (EC 3.5.1.88) 5.03E‐02 2.59E+03 3.14E+04 1.40E+03 1.19E+04 8.26E‐02 ‐1.08E+00
Aconitate hydratase (EC 4.2.1.3) @ 2‐
methylisocitrate dehydratase (EC 4.2.1.99) 5.08E‐02 2.25E+04 1.03E+05 3.27E+04 3.82E+04 2.18E‐01 ‐6.62E‐01
prophage LambdaBa02, site‐specific 
recombinase, phage integrase family 5.21E‐02 3.99E+04 5.49E+05 9.88E+03 2.10E+05 7.26E‐02 ‐1.14E+00
Peptidyl‐prolyl cis‐trans isomerase (EC 
5.2.1.8) 5.25E‐02 8.49E+03 4.48E+04 3.06E+03 1.57E+04 1.89E‐01 ‐7.23E‐01
Oligopeptide ABC transporter, periplasmic 
oligopeptide‐binding protein OppA (TC 
3.A.1.5.1) 5.32E‐02 2.49E+06 3.13E+05 9.19E+05 9.07E+04 7.96E+00 9.01E‐01
Isovaleryl‐CoA dehydrogenase (EC 1.3.8.4) 5.33E‐02 4.71E+04 6.41E+05 2.62E+04 2.51E+05 7.35E‐02 ‐1.13E+00
2‐oxoglutarate oxidoreductase, alpha 
subunit (EC 1.2.7.3) 5.36E‐02 3.98E+04 2.51E+05 1.47E+04 9.14E+04 1.58E‐01 ‐8.00E‐01
Methylthioribose‐1‐phosphate isomerase 
(EC 5.3.1.23) 5.42E‐02 1.20E+04 1.13E+05 8.84E+03 4.45E+04 1.06E‐01 ‐9.74E‐01
ATP synthase beta chain (EC 3.6.3.14) 5.54E‐02 3.10E+04 1.04E+05 3.73E+04 2.30E+04 2.97E‐01 ‐5.27E‐01
1‐hydroxy‐2‐methyl‐2‐(E)‐butenyl 4‐
diphosphate synthase (EC 1.17.7.1) 5.55E‐02 1.28E+04 7.58E+04 1.44E+03 2.70E+04 1.68E‐01 ‐7.74E‐01
NADH‐dependent butanol dehydrogenase A 
(EC 1.1.1.‐) 5.70E‐02 2.35E+03 9.11E+03 1.65E+03 3.42E+03 2.58E‐01 ‐5.89E‐01
Deblocking aminopeptidase (EC 3.4.11.‐) 5.76E‐02 3.29E+03 2.16E+04 1.28E+03 8.21E+03 1.52E‐01 ‐8.18E‐01
Acetylornithine aminotransferase (EC 
2.6.1.11) 5.85E‐02 1.24E+03 1.23E+04 1.04E+03 5.09E+03 1.00E‐01 ‐9.98E‐01
hypothetical Membrane Spanning Protein 5.88E‐02 4.86E+05 1.30E+07 1.21E+05 5.53E+06 3.72E‐02 ‐1.43E+00
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3.A.1.5.1) 5.99E‐02 3.47E+04 4.97E+05 1.46E+04 2.06E+05 6.98E‐02 ‐1.16E+00
hypothetical protein 6.04E‐02 8.43E+03 2.79E+04 2.65E+03 9.38E+03 3.02E‐01 ‐5.19E‐01
Manganese superoxide dismutase (EC 
1.15.1.1) 6.11E‐02 3.63E+05 8.54E+06 8.41E+04 3.67E+06 4.25E‐02 ‐1.37E+00
Ribosome‐associated heat shock protein 
implicated in the recycling of the 50S 
subunit (S4 paralog) 6.11E‐02 7.27E+03 4.62E+04 1.03E+04 2.04E+04 1.57E‐01 ‐8.03E‐01
hypothetical protein 6.22E‐02 3.97E+03 2.18E+04 3.86E+03 9.23E+03 1.82E‐01 ‐7.41E‐01
Delta‐1‐pyrroline‐5‐carboxylate 
dehydrogenase (EC 1.5.1.12) 6.29E‐02 3.07E+04 2.17E+05 3.01E+04 9.35E+04 1.41E‐01 ‐8.50E‐01
Cystathionine gamma‐lyase (EC 4.4.1.1) 6.42E‐02 1.50E+04 1.81E+05 1.60E+04 7.98E+04 8.29E‐02 ‐1.08E+00
hypothetical protein 6.44E‐02 4.46E+05 2.87E+05 8.43E+04 6.51E+04 1.56E+00 1.92E‐01
hypothetical protein 6.56E‐02 3.61E+04 3.25E+05 2.71E+04 1.40E+05 1.11E‐01 ‐9.54E‐01
Chitin binding protein 6.57E‐02 1.21E+04 1.16E+05 7.34E+03 4.96E+04 1.05E‐01 ‐9.81E‐01
Ketol‐acid reductoisomerase (EC 1.1.1.86) 6.62E‐02 7.31E+02 6.38E+03 2.05E+02 2.67E+03 1.14E‐01 ‐9.41E‐01
Amidohydrolase AmhX 6.77E‐02 1.19E+04 1.08E+05 3.77E+03 4.61E+04 1.10E‐01 ‐9.60E‐01
Ribonuclease PH (EC 2.7.7.56) 6.78E‐02 3.59E+03 2.02E+04 2.50E+03 8.54E+03 1.77E‐01 ‐7.51E‐01
Pyruvate kinase (EC 2.7.1.40) 6.81E‐02 3.02E+04 4.52E+05 4.80E+03 2.01E+05 6.69E‐02 ‐1.17E+00
FIG01226061: hypothetical protein 6.89E‐02 7.72E+03 1.61E+04 1.74E+03 4.47E+03 4.81E‐01 ‐3.18E‐01
Alanine dehydrogenase (EC 1.4.1.1) 6.89E‐02 3.40E+05 8.44E+05 9.20E+04 2.66E+05 4.03E‐01 ‐3.95E‐01
CBS domain containing protein 7.00E‐02 1.94E+04 1.45E+05 1.02E+04 6.23E+04 1.34E‐01 ‐8.73E‐01
ATP synthase alpha chain (EC 3.6.3.14) 7.01E‐02 1.35E+04 5.58E+04 1.15E+04 2.35E+04 2.41E‐01 ‐6.18E‐01
MaoC family protein 7.02E‐02 9.51E+03 6.41E+04 5.70E+03 2.76E+04 1.48E‐01 ‐8.29E‐01
Fumarate hydratase class I, aerobic (EC 
4.2.1.2) 7.05E‐02 3.56E+03 1.12E+04 4.15E+03 3.38E+03 3.17E‐01 ‐4.99E‐01
D‐alanine aminotransferase (EC 2.6.1.21) 7.26E‐02 8.94E+04 2.91E+05 1.15E+05 6.26E+04 3.07E‐01 ‐5.13E‐01
hypothetical protein 7.47E‐02 1.72E+03 9.62E+03 1.64E+03 4.39E+03 1.78E‐01 ‐7.49E‐01
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3.A.1.9.1) 7.59E‐02 5.10E+02 8.09E+03 3.98E+02 3.88E+03 6.30E‐02 ‐1.20E+00
D‐Ribose 1,5‐phosphomutase (EC 5.4.2.7) 7.80E‐02 2.11E+04 1.86E+05 9.68E+03 8.59E+04 1.14E‐01 ‐9.45E‐01
5‐Enolpyruvylshikimate‐3‐phosphate 
synthase (EC 2.5.1.19) 7.88E‐02 1.09E+04 3.63E+04 1.07E+04 1.47E+04 3.01E‐01 ‐5.21E‐01
Deblocking aminopeptidase (EC 3.4.11.‐) 7.92E‐02 1.69E+04 6.81E+04 5.91E+03 2.77E+04 2.48E‐01 ‐6.05E‐01
FIG01226521: hypothetical protein 7.97E‐02 1.79E+03 2.59E+04 1.04E+03 1.26E+04 6.91E‐02 ‐1.16E+00
NAD synthetase (EC 6.3.1.5) 8.07E‐02 3.18E+04 1.38E+05 3.33E+04 6.28E+04 2.31E‐01 ‐6.36E‐01
Xanthine permease 8.11E‐02 1.33E+05 5.55E+05 4.10E+04 2.29E+05 2.39E‐01 ‐6.21E‐01
FIG001621: Zinc protease 8.13E‐02 1.20E+04 5.76E+04 1.00E+04 2.64E+04 2.09E‐01 ‐6.80E‐01
Single‐stranded DNA‐binding protein 8.15E‐02 1.31E+04 2.68E+05 2.52E+03 1.34E+05 4.87E‐02 ‐1.31E+00
Phosphonate ABC transporter phosphate‐
binding periplasmic component (TC 
3.A.1.9.1) 8.17E‐02 1.47E+04 5.21E+04 1.77E+04 2.12E+04 2.83E‐01 ‐5.49E‐01
NLP/P60 family protein 8.31E‐02 3.97E+04 1.09E+05 3.14E+04 4.02E+04 3.65E‐01 ‐4.37E‐01
ATP synthase delta chain (EC 3.6.3.14) 8.32E‐02 2.97E+03 7.21E+03 1.61E+03 2.55E+03 4.12E‐01 ‐3.85E‐01
Glyoxalase family protein 8.36E‐02 5.94E+03 2.57E+04 5.45E+03 1.18E+04 2.31E‐01 ‐6.37E‐01
hypothetical protein 8.40E‐02 7.14E+03 1.83E+05 6.33E+03 9.47E+04 3.91E‐02 ‐1.41E+00
FIG017263: hypothetical protein 8.50E‐02 8.90E+04 3.60E+05 9.84E+04 1.64E+05 2.48E‐01 ‐6.06E‐01
Heat shock protein 60 family chaperone 
GroEL 8.64E‐02 7.43E+05 2.43E+06 7.74E+05 1.01E+06 3.05E‐01 ‐5.15E‐01
Isocitrate lyase (EC 4.1.3.1) 8.92E‐02 4.53E+04 6.60E+05 5.99E+04 3.50E+05 6.87E‐02 ‐1.16E+00
hypothetical Membrane Spanning Protein 9.02E‐02 5.74E+03 5.28E+04 4.51E+03 2.69E+04 1.09E‐01 ‐9.64E‐01
transcriptional regulator, XRE family 9.03E‐02 2.80E+04 4.82E+05 1.32E+04 2.55E+05 5.80E‐02 ‐1.24E+00
Tripeptide aminopeptidase (EC 3.4.11.4) 9.13E‐02 1.00E+04 6.50E+04 3.11E+03 3.12E+04 1.54E‐01 ‐8.13E‐01
NADPH dehydrogenase (EC 1.6.99.1) 9.15E‐02 1.24E+03 2.98E+04 5.81E+02 1.61E+04 4.18E‐02 ‐1.38E+00
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Nicotinamidase (EC 3.5.1.19) 9.22E‐02 2.55E+03 7.46E+04 3.41E+03 4.10E+04 3.42E‐02 ‐1.47E+00
Glycine dehydrogenase [decarboxylating] 
(glycine cleavage system P2 protein) (EC 
1.4.4.2) 9.45E‐02 2.39E+04 9.23E+04 9.71E+03 4.10E+04 2.59E‐01 ‐5.87E‐01
Lysine 2,3‐aminomutase (EC 5.4.3.2) 9.50E‐02 2.38E+04 1.35E+05 2.85E+04 6.99E+04 1.76E‐01 ‐7.54E‐01
Phosphate acetyltransferase (EC 2.3.1.8) 9.50E‐02 8.72E+04 1.62E+05 2.82E+04 4.79E+04 5.37E‐01 ‐2.70E‐01
Methionyl‐tRNA synthetase (EC 6.1.1.10) 9.81E‐02 2.10E+04 1.06E+05 2.09E+03 4.97E+04 1.99E‐01 ‐7.02E‐01
hypothetical protein 9.82E‐02 4.09E+04 1.06E+04 1.86E+04 4.75E+03 3.85E+00 5.85E‐01
Chitin binding protein 1.00E‐01 4.82E+05 1.07E+05 2.26E+05 3.24E+04 4.51E+00 6.54E‐01
transcriptional regulator, XRE family 1.00E‐01 1.41E+05 7.02E+04 4.65E+04 2.25E+04 2.01E+00 3.04E‐01
Putative secretion accessory protein 
EsaA/YueB / Bacteriophage SPP1 receptor 1.01E‐01 5.84E+03 1.46E+03 2.86E+03 1.30E+03 3.99E+00 6.01E‐01
Homogentisate 1,2‐dioxygenase (EC 
1.13.11.5) 1.05E‐01 2.69E+04 2.13E+05 2.53E+04 1.18E+05 1.26E‐01 ‐8.99E‐01
Exoenzymes regulatory protein AepA in lipid‐
linked oligosaccharide synthesis cluster 1.06E‐01 2.78E+03 1.53E+04 1.34E+03 7.83E+03 1.82E‐01 ‐7.40E‐01
hypothetical protein 1.07E‐01 2.66E+05 1.12E+06 4.85E+04 5.34E+05 2.37E‐01 ‐6.26E‐01
Aspartate aminotransferase (EC 2.6.1.1) 1.08E‐01 5.54E+03 2.73E+04 3.93E+03 1.41E+04 2.03E‐01 ‐6.93E‐01
hypothetical Membrane Spanning Protein 1.10E‐01 1.37E+05 5.11E+04 5.74E+04 2.09E+04 2.68E+00 4.28E‐01
Purine nucleoside phosphorylase (EC 
2.4.2.1) 1.10E‐01 9.00E+03 1.91E+04 6.69E+03 5.09E+03 4.70E‐01 ‐3.28E‐01
hypothetical Membrane Spanning Protein 1.10E‐01 2.37E+04 6.15E+04 2.35E+04 2.16E+04 3.85E‐01 ‐4.14E‐01
Membrane‐associated zinc metalloprotease 1.11E‐01 1.84E+04 5.09E+04 6.42E+03 2.15E+04 3.61E‐01 ‐4.42E‐01
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Menaquinone‐cytochrome C reductase iron‐
sulfur subunit 1.13E‐01 9.17E+03 1.02E+05 4.26E+03 5.95E+04 8.98E‐02 ‐1.05E+00
Cell division protein FtsZ (EC 3.4.24.‐) 1.13E‐01 5.44E+03 6.31E+04 2.12E+03 3.69E+04 8.62E‐02 ‐1.06E+00
SSU ribosomal protein S19p (S15e) 1.14E‐01 3.58E+03 2.60E+04 2.80E+03 1.47E+04 1.37E‐01 ‐8.62E‐01
Oligoendopeptidase F (EC 3.4.24.‐) 1.14E‐01 6.62E+04 8.23E+05 5.54E+04 4.91E+05 8.04E‐02 ‐1.09E+00
Glutamate‐1‐semialdehyde 
aminotransferase (EC 5.4.3.8) 1.15E‐01 1.09E+03 3.77E+03 4.96E+01 1.73E+03 2.88E‐01 ‐5.41E‐01
Fe‐bacillibactin uptake system FeuA, Fe‐
bacillibactin binding 1.15E‐01 4.29E+05 2.59E+05 1.14E+05 2.75E+04 1.66E+00 2.19E‐01
Enoyl‐CoA hydratase [isoleucine 
degradation] (EC 4.2.1.17) / 3‐hydroxyacyl‐
CoA dehydrogenase (EC 1.1.1.35) 1.17E‐01 5.64E+02 8.40E+03 2.17E+02 5.11E+03 6.71E‐02 ‐1.17E+00
O‐acetylhomoserine sulfhydrylase (EC 
2.5.1.49) / O‐succinylhomoserine 
sulfhydrylase (EC 2.5.1.48) 1.18E‐01 4.42E+04 1.37E+05 6.41E+04 2.29E+04 3.24E‐01 ‐4.90E‐01
Chitinase (EC 3.2.1.14) 1.19E‐01 6.25E+04 2.23E+05 1.22E+04 1.07E+05 2.80E‐01 ‐5.53E‐01
4‐hydroxy‐tetrahydrodipicolinate synthase 
(EC 4.3.3.7) 1.20E‐01 9.99E+04 2.92E+05 1.37E+05 6.36E+04 3.42E‐01 ‐4.66E‐01
Electron transfer flavoprotein, alpha subunit 1.20E‐01 1.81E+05 2.65E+05 4.68E+04 5.62E+04 6.83E‐01 ‐1.65E‐01
Aminomethyltransferase (glycine cleavage 
system T protein) (EC 2.1.2.10) 1.20E‐01 2.30E+03 1.31E+04 2.38E+03 7.55E+03 1.75E‐01 ‐7.57E‐01
6,7‐dimethyl‐8‐ribityllumazine synthase (EC 
2.5.1.78) 1.21E‐01 3.38E+04 2.23E+05 3.28E+04 1.30E+05 1.52E‐01 ‐8.18E‐01
Azoreductase 1.24E‐01 4.30E+04 2.96E+05 1.89E+04 1.72E+05 1.45E‐01 ‐8.38E‐01
FIG009210: peptidase, M16 family 1.24E‐01 2.86E+04 9.72E+04 3.08E+04 4.92E+04 2.95E‐01 ‐5.31E‐01
Formamidase amiF (EC 3.5.1.49) 1.24E‐01 7.29E+03 5.93E+04 1.98E+03 3.52E+04 1.23E‐01 ‐9.10E‐01
N‐acetyl‐gamma‐glutamyl‐phosphate 
reductase (EC 1.2.1.38) 1.27E‐01 5.97E+03 1.88E+04 8.80E+03 3.63E+02 3.17E‐01 ‐4.98E‐01
SSU ribosomal protein S13p (S18e) 1.28E‐01 1.54E+04 3.23E+05 1.23E+04 2.12E+05 4.77E‐02 ‐1.32E+00
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ClpB protein 1.28E‐01 8.17E+03 2.98E+04 6.00E+03 1.58E+04 2.74E‐01 ‐5.62E‐01
Non‐specific DNA‐binding protein Dps / Iron‐
binding ferritin‐like antioxidant protein / 
Ferroxidase (EC 1.16.3.1) 1.31E‐01 1.94E+05 1.56E+06 8.67E+04 9.56E+05 1.25E‐01 ‐9.04E‐01
3'‐>5' exoribonuclease Bsu YhaM 1.31E‐01 2.80E+02 5.73E+03 1.28E+02 3.81E+03 4.88E‐02 ‐1.31E+00
Thioredoxin reductase (EC 1.8.1.9) 1.33E‐01 1.54E+04 1.22E+05 2.07E+03 7.50E+04 1.26E‐01 ‐8.98E‐01
FIG007421: forespore shell protein 1.35E‐01 3.32E+03 1.84E+04 2.40E+03 1.10E+04 1.80E‐01 ‐7.45E‐01
Membrane‐attached cytochrome c550 1.35E‐01 1.60E+03 1.79E+04 1.31E+03 1.16E+04 8.96E‐02 ‐1.05E+00
transcriptional regulator, XRE family 1.35E‐01 4.86E+04 1.05E+04 2.74E+04 4.17E+03 4.61E+00 6.64E‐01
Purine nucleoside phosphorylase (EC 
2.4.2.1); N‐Ribosylnicotinamide 
phosphorylase (EC 2.4.2.1) ## possible 1.35E‐01 3.05E+04 3.05E+05 8.52E+03 1.95E+05 1.00E‐01 ‐1.00E+00
Carbamoyl‐phosphate synthase large chain 
(EC 6.3.5.5) 1.36E‐01 2.02E+03 2.18E+04 9.65E+02 1.42E+04 9.26E‐02 ‐1.03E+00
Dihydroxyacetone kinase, ATP‐dependent 
(EC 2.7.1.29) 1.36E‐01 1.71E+03 3.92E+04 1.05E+03 2.68E+04 4.36E‐02 ‐1.36E+00
Oligopeptide transport ATP‐binding protein 
OppF (TC 3.A.1.5.1) 1.37E‐01 7.00E+03 1.60E+04 3.80E+03 6.79E+03 4.39E‐01 ‐3.57E‐01
alkaline serine protease, subtilase family 1.38E‐01 2.65E+04 1.96E+05 2.59E+04 1.25E+05 1.36E‐01 ‐8.68E‐01
carbonic anhydrase, family 3 1.40E‐01 8.68E+03 2.48E+04 8.86E+03 1.20E+04 3.49E‐01 ‐4.57E‐01
Molybdenum ABC transporter, periplasmic 
molybdenum‐binding protein ModA (TC 
3.A.1.8.1) 1.40E‐01 4.28E+05 3.78E+04 2.85E+05 2.09E+04 1.13E+01 1.05E+00
Glycine dehydrogenase [decarboxylating] 
(glycine cleavage system P1 protein) (EC 
1.4.4.2) 1.42E‐01 3.84E+04 1.47E+05 2.57E+04 8.25E+04 2.62E‐01 ‐5.81E‐01
DNA‐directed RNA polymerase beta' subunit 
(EC 2.7.7.6) 1.42E‐01 8.14E+03 1.76E+04 4.60E+03 7.27E+03 4.62E‐01 ‐3.36E‐01
hypothetical protein 1.43E‐01 1.14E+04 9.64E+04 6.60E+03 6.29E+04 1.19E‐01 ‐9.26E‐01
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prolyl‐dipeptidyl aminopeptidase) (X‐PDAP) 1.43E‐01 1.72E+04 5.68E+04 2.35E+04 2.90E+04 3.03E‐01 ‐5.18E‐01
Cyclic beta‐1,2‐glucan modification 
transmembrane protein 1.44E‐01 8.77E+03 1.67E+03 5.24E+03 2.12E+02 5.25E+00 7.20E‐01
Choline binding protein A 1.44E‐01 9.49E+04 1.97E+05 5.81E+04 7.60E+04 4.82E‐01 ‐3.17E‐01
Lysyl‐tRNA synthetase (class II) (EC 6.1.1.6) 1.44E‐01 6.12E+04 1.74E+05 7.66E+04 7.63E+04 3.51E‐01 ‐4.55E‐01
hypothetical protein 1.45E‐01 3.90E+03 1.34E+05 8.28E+02 9.66E+04 2.91E‐02 ‐1.54E+00
hypothetical protein 1.45E‐01 6.20E+05 3.94E+05 5.04E+04 1.74E+05 1.57E+00 1.96E‐01
Chitosanase 1.45E‐01 3.10E+05 1.33E+06 1.61E+05 7.75E+05 2.33E‐01 ‐6.32E‐01
metallo‐beta‐lactamase family protein 1.48E‐01 3.64E+03 4.73E+04 3.09E+03 3.30E+04 7.69E‐02 ‐1.11E+00
6‐phosphofructokinase (EC 2.7.1.11) 1.48E‐01 8.61E+04 2.81E+05 3.63E+04 1.51E+05 3.06E‐01 ‐5.14E‐01
Oligopeptide ABC transporter, periplasmic 
oligopeptide‐binding protein OppA (TC 
3.A.1.5.1) 1.52E‐01 4.87E+05 1.20E+06 1.44E+05 5.60E+05 4.07E‐01 ‐3.91E‐01
Hypothetical radical SAM family enzyme in 
heat shock gene cluster, similarity with CPO 
of BS HemN‐type 1.52E‐01 5.58E+05 1.61E+06 1.34E+05 8.16E+05 3.47E‐01 ‐4.60E‐01
NAD‐specific glutamate dehydrogenase (EC 
1.4.1.2) 1.53E‐01 6.45E+03 7.15E+04 6.10E+03 5.04E+04 9.03E‐02 ‐1.04E+00
LSU ribosomal protein L21p 1.53E‐01 2.70E+03 5.33E+03 8.09E+02 2.12E+03 5.06E‐01 ‐2.96E‐01
DNA polymerase X family 1.56E‐01 1.50E+04 3.72E+04 1.09E+04 1.80E+04 4.02E‐01 ‐3.96E‐01
hypothetical protein 1.57E‐01 4.91E+03 1.91E+04 7.81E+03 1.13E+04 2.57E‐01 ‐5.90E‐01
Oligopeptide ABC transporter, periplasmic 
oligopeptide‐binding protein OppA (TC 
3.A.1.5.1) 1.57E‐01 3.13E+03 9.99E+03 3.52E+03 5.54E+03 3.13E‐01 ‐5.05E‐01
response regulator, putative 1.58E‐01 6.69E+02 7.74E+03 7.74E+02 5.59E+03 8.64E‐02 ‐1.06E+00
NAD‐dependent glyceraldehyde‐3‐
phosphate dehydrogenase (EC 1.2.1.12) 1.58E‐01 1.37E+04 8.64E+04 5.82E+03 5.73E+04 1.59E‐01 ‐7.99E‐01
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hypothetical protein 1.60E‐01 7.70E+03 7.81E+04 6.74E+03 5.60E+04 9.85E‐02 ‐1.01E+00
UDP‐glucose 4‐epimerase (EC 5.1.3.2) 1.63E‐01 2.28E+04 1.85E+05 1.38E+04 1.30E+05 1.23E‐01 ‐9.08E‐01
hypothetical protein 1.63E‐01 3.48E+04 4.42E+05 8.02E+03 3.27E+05 7.88E‐02 ‐1.10E+00
alternate gene name: yznA 1.65E‐01 5.77E+04 3.40E+04 1.86E+04 1.52E+04 1.70E+00 2.29E‐01
Oligopeptide ABC transporter, periplasmic 
oligopeptide‐binding protein OppA (TC 
3.A.1.5.1) 1.68E‐01 1.75E+05 1.36E+04 1.32E+05 1.82E+03 1.28E+01 1.11E+00
Heat shock protein 60 family co‐chaperone 
GroES 1.68E‐01 5.40E+04 1.00E+05 3.13E+04 3.54E+04 5.40E‐01 ‐2.67E‐01
PlcB, ORFX, ORFP, ORFB, ORFA, ldh gene 1.72E‐01 2.79E+03 6.41E+04 2.46E+03 5.09E+04 4.35E‐02 ‐1.36E+00
FIG01225420: hypothetical protein 1.74E‐01 1.92E+04 5.45E+04 7.24E+03 3.01E+04 3.52E‐01 ‐4.54E‐01
hypothetical protein 1.74E‐01 7.72E+04 2.21E+05 1.16E+05 9.21E+04 3.50E‐01 ‐4.56E‐01
ATP synthase gamma chain (EC 3.6.3.14) 1.74E‐01 1.33E+04 1.09E+05 9.04E+03 8.01E+04 1.22E‐01 ‐9.13E‐01
DNA‐directed RNA polymerase alpha 
subunit (EC 2.7.7.6) 1.77E‐01 4.05E+03 4.36E+04 3.05E+03 3.36E+04 9.30E‐02 ‐1.03E+00
hypothetical protein 1.78E‐01 1.11E+03 2.07E+04 9.85E+02 1.67E+04 5.35E‐02 ‐1.27E+00
hypothetical Membrane Spanning Protein 1.80E‐01 5.01E+05 7.73E+05 1.29E+05 2.39E+05 6.49E‐01 ‐1.88E‐01
Petrobactin ABC transporter, periplasmic 
binding protein 1.80E‐01 3.31E+04 6.39E+05 6.31E+03 5.19E+05 5.18E‐02 ‐1.29E+00
hypothetical protein 1.82E‐01 2.31E+03 7.42E+03 8.23E+02 4.46E+03 3.12E‐01 ‐5.06E‐01
Serine hydroxymethyltransferase (EC 
2.1.2.1) 1.88E‐01 2.80E+03 2.16E+04 3.75E+03 1.69E+04 1.29E‐01 ‐8.88E‐01
Dihydrolipoamide succinyltransferase 
component (E2) of 2‐oxoglutarate 
dehydrogenase complex (EC 2.3.1.61) 1.91E‐01 2.79E+03 1.87E+04 3.45E+03 1.44E+04 1.49E‐01 ‐8.27E‐01
Microbial collagenase (EC 3.4.24.3) 1.92E‐01 6.82E+04 1.49E+05 1.83E+04 7.30E+04 4.59E‐01 ‐3.38E‐01
N‐succinyl arginine/lysine racemase 1.92E‐01 9.02E+02 7.77E+03 1.06E+03 6.19E+03 1.16E‐01 ‐9.35E‐01
Isoleucyl‐tRNA synthetase (EC 6.1.1.5) 1.92E‐01 9.82E+03 2.07E+04 9.87E+03 1.84E+03 4.74E‐01 ‐3.25E‐01
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Hypothetical protein YfkI 1.94E‐01 7.10E+03 1.84E+04 1.04E+04 4.42E+03 3.87E‐01 ‐4.13E‐01
wall‐associated protein, putative 1.94E‐01 7.73E+03 1.88E+04 1.02E+04 3.96E+03 4.12E‐01 ‐3.85E‐01
Triosephosphate isomerase (EC 5.3.1.1) 1.94E‐01 1.70E+05 5.68E+05 1.32E+05 3.67E+05 3.00E‐01 ‐5.23E‐01
Acetolactate synthase small subunit (EC 
2.2.1.6) 1.94E‐01 5.40E+02 2.90E+03 4.85E+02 2.16E+03 1.86E‐01 ‐7.30E‐01
Arginine decarboxylase (EC 4.1.1.19) 1.94E‐01 4.91E+02 4.56E+03 2.60E+02 3.68E+03 1.07E‐01 ‐9.69E‐01
transcriptional regulator, XRE family 1.95E‐01 9.41E+02 9.25E+03 1.35E+03 7.59E+03 1.02E‐01 ‐9.92E‐01
Non‐specific DNA‐binding protein Dps / Iron‐
binding ferritin‐like antioxidant protein / 
Ferroxidase (EC 1.16.3.1) 1.96E‐01 2.11E+05 2.14E+06 1.32E+05 1.75E+06 9.86E‐02 ‐1.01E+00
DUF1696 domain‐containing protein 2.01E‐01 1.27E+04 5.58E+04 2.47E+03 3.98E+04 2.27E‐01 ‐6.43E‐01
Cysteine desulfurase (EC 2.8.1.7), SufS 
subfamily 2.06E‐01 7.20E+03 3.77E+04 7.46E+03 2.91E+04 1.91E‐01 ‐7.19E‐01
FIG01225418: hypothetical protein 2.09E‐01 4.86E+04 8.57E+03 3.85E+04 9.77E+03 5.67E+00 7.53E‐01
Thermostable carboxypeptidase 1 (EC 
3.4.17.19) 2.10E‐01 4.03E+04 1.45E+05 1.47E+04 1.00E+05 2.77E‐01 ‐5.57E‐01
transcriptional regulator, XRE family 2.13E‐01 6.21E+03 5.03E+02 5.48E+03 1.19E+02 1.23E+01 1.09E+00
metallo‐beta‐lactamase family protein 2.13E‐01 7.01E+02 2.06E+03 9.53E+02 1.25E+03 3.40E‐01 ‐4.68E‐01
Phosphonate ABC transporter phosphate‐
binding periplasmic component (TC 
3.A.1.9.1) 2.14E‐01 3.34E+03 1.29E+04 1.31E+03 9.26E+03 2.59E‐01 ‐5.86E‐01
Oligopeptide ABC transporter, periplasmic 
oligopeptide‐binding protein OppA (TC 
3.A.1.5.1) 2.16E‐01 1.96E+06 1.25E+06 6.99E+05 1.07E+05 1.57E+00 1.97E‐01
transcriptional regulator, XRE family 2.17E‐01 5.23E+05 2.86E+05 2.32E+05 1.33E+05 1.83E+00 2.62E‐01
Pyruvate dehydrogenase E1 component 
alpha subunit (EC 1.2.4.1) 2.19E‐01 8.97E+03 1.45E+04 3.88E+03 5.26E+03 6.16E‐01 ‐2.10E‐01
Oligoendopeptidase F (EC 3.4.24.‐) 2.20E‐01 1.02E+04 9.21E+04 2.13E+03 8.05E+04 1.11E‐01 ‐9.54E‐01
Polypeptide composition of the spore coat 
protein CotJC 2.21E‐01 5.19E+05 2.08E+05 3.08E+05 3.65E+04 2.50E+00 3.98E‐01
hypothetical protein 2.22E‐01 9.44E+03 2.72E+04 1.42E+04 1.58E+04 3.47E‐01 ‐4.59E‐01
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FIG01225999: hypothetical protein 2.22E‐01 1.86E+05 3.63E+05 1.36E+05 1.61E+05 5.13E‐01 ‐2.90E‐01
FIG01239190: hypothetical protein 2.24E‐01 2.71E+05 3.99E+06 2.51E+05 3.71E+06 6.79E‐02 ‐1.17E+00
Two‐component response regulator SA14‐
24 2.24E‐01 1.52E+03 6.04E+03 1.46E+03 4.58E+03 2.52E‐01 ‐5.99E‐01
Hemolysin BL lytic component L2 2.25E‐01 1.59E+06 2.28E+05 1.37E+06 1.33E+05 6.97E+00 8.43E‐01
hypothetical protein 2.27E‐01 6.10E+05 8.38E+04 5.30E+05 4.71E+04 7.27E+00 8.62E‐01
Glycerate kinase (EC 2.7.1.31) 2.27E‐01 1.04E+05 1.83E+05 7.26E+04 6.17E+04 5.70E‐01 ‐2.44E‐01
FIG01226746: hypothetical protein 2.28E‐01 2.41E+03 5.91E+03 3.25E+03 2.72E+03 4.07E‐01 ‐3.90E‐01
Maltose/maltodextrin ABC transporter, 
permease protein MalG 2.28E‐01 6.43E+04 1.56E+04 4.96E+04 1.01E+04 4.13E+00 6.16E‐01
Hemoprotein HemQ, essential component 
of heme biosynthetic pathway in Gram‐
positive bacteria 2.29E‐01 7.74E+04 1.70E+05 4.62E+04 9.45E+04 4.56E‐01 ‐3.41E‐01
Subtilase family domain protein 2.29E‐01 1.10E+05 6.98E+04 4.14E+04 2.17E+04 1.58E+00 1.99E‐01
Beta‐lysine acetyltransferase (EC 2.3.1.‐) 2.29E‐01 3.41E+03 5.77E+04 2.50E+03 5.50E+04 5.91E‐02 ‐1.23E+00
FIG007959: peptidase, M16 family 2.30E‐01 6.03E+03 1.80E+04 6.74E+03 1.22E+04 3.35E‐01 ‐4.75E‐01
hypothetical Membrane Spanning Protein 2.30E‐01 2.30E+06 4.39E+06 2.11E+06 1.26E+06 5.24E‐01 ‐2.80E‐01
Cytosol aminopeptidase PepA (EC 3.4.11.1) 2.32E‐01 2.76E+05 6.70E+05 4.07E+05 1.01E+05 4.12E‐01 ‐3.85E‐01
Phosphatidylinositol‐specific phospholipase 
C (EC 4.6.1.13) 2.34E‐01 2.80E+05 7.08E+05 4.38E+05 2.55E+05 3.95E‐01 ‐4.03E‐01
LSU ribosomal protein L29p (L35e) 2.38E‐01 1.07E+04 6.33E+03 4.66E+03 1.71E+03 1.70E+00 2.30E‐01
Non‐phosphorylating glyceraldehyde‐3‐
phosphate dehydrogenase (NADP) (EC 
1.2.1.9) 2.38E‐01 4.14E+03 1.57E+04 7.86E+02 1.20E+04 2.64E‐01 ‐5.79E‐01
hypothetical Membrane Spanning Protein 2.39E‐01 1.91E+05 5.55E+05 1.47E+05 3.87E+05 3.44E‐01 ‐4.63E‐01
D‐alanine aminotransferase (EC 2.6.1.21) 2.41E‐01 1.29E+04 4.12E+04 3.92E+03 2.99E+04 3.13E‐01 ‐5.04E‐01
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GTP cyclohydrolase I (EC 3.5.4.16) type 1 2.43E‐01 3.04E+04 5.80E+04 2.41E+04 2.53E+04 5.24E‐01 ‐2.81E‐01
Enolase (EC 4.2.1.11) 2.44E‐01 4.53E+05 8.06E+05 6.53E+04 3.77E+05 5.62E‐01 ‐2.51E‐01
Butyryl‐CoA dehydrogenase (EC 1.3.99.2) 2.45E‐01 2.06E+04 4.85E+04 2.16E+04 2.77E+04 4.24E‐01 ‐3.73E‐01
Nucleoside diphosphate kinase (EC 2.7.4.6) 2.45E‐01 3.77E+05 1.13E+06 1.35E+05 8.08E+05 3.33E‐01 ‐4.77E‐01
comA operon protein, putative 2.45E‐01 1.06E+03 5.10E+03 1.36E+03 4.35E+03 2.09E‐01 ‐6.80E‐01
Tellurium resistance protein TerD 2.50E‐01 4.78E+04 1.42E+05 1.15E+04 1.03E+05 3.36E‐01 ‐4.74E‐01
hypothetical protein 2.51E‐01 1.74E+03 3.27E+04 9.49E+02 3.36E+04 5.32E‐02 ‐1.27E+00
ATP synthase F0 sector subunit b 2.52E‐01 4.35E+04 1.71E+04 2.90E+04 1.13E+04 2.54E+00 4.05E‐01
hypothetical Membrane Spanning Protein 2.52E‐01 3.58E+03 9.21E+02 2.93E+03 1.10E+03 3.89E+00 5.90E‐01
Protein of unknown function identified by 
role in sporulation (SpoVG) 2.54E‐01 1.05E+04 2.43E+04 1.33E+04 1.21E+04 4.30E‐01 ‐3.66E‐01
4‐hydroxy‐tetrahydrodipicolinate reductase 
(EC 1.17.1.8) 2.57E‐01 2.03E+04 5.92E+04 1.60E+04 4.34E+04 3.43E‐01 ‐4.64E‐01
Phage major capsid protein 2.57E‐01 2.39E+04 4.19E+03 2.18E+04 3.18E+03 5.71E+00 7.56E‐01
alternate gene name: ipa‐62r 2.60E‐01 3.09E+04 2.88E+05 2.11E+04 2.86E+05 1.07E‐01 ‐9.70E‐01
Tellurium resistance protein TerD 2.60E‐01 1.12E+03 3.87E+03 2.32E+02 3.06E+03 2.90E‐01 ‐5.37E‐01
HPr kinase/phosphorylase (EC 2.7.1.‐) (EC 
2.7.4.‐) 2.62E‐01 7.92E+03 2.73E+04 7.46E+03 2.19E+04 2.90E‐01 ‐5.38E‐01
Fructose‐bisphosphate aldolase class II (EC 
4.1.2.13) 2.67E‐01 3.62E+03 8.52E+03 2.09E+03 5.61E+03 4.25E‐01 ‐3.71E‐01
Secreted and spore coat‐associated protein 
1, similar to biofilm matrix component TasA 
and to camelysin 2.70E‐01 1.73E+04 1.06E+04 2.80E+03 7.76E+03 1.63E+00 2.13E‐01
collagen triple helix repeat domain protein 2.71E‐01 1.58E+03 3.40E+04 1.73E+03 3.73E+04 4.64E‐02 ‐1.33E+00
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S‐ribosylhomocysteine lyase (EC 4.4.1.21) / 
Autoinducer‐2 production protein LuxS 2.74E‐01 9.86E+03 4.09E+04 6.73E+03 3.62E+04 2.41E‐01 ‐6.18E‐01
FIG01228215: hypothetical protein 2.77E‐01 3.23E+04 2.39E+03 3.51E+04 2.21E+03 1.35E+01 1.13E+00
Penicillin‐binding protein 2.78E‐01 3.62E+03 5.74E+03 1.30E+03 2.46E+03 6.31E‐01 ‐2.00E‐01
Isocitrate dehydrogenase [NADP] (EC 
1.1.1.42) 2.80E‐01 2.22E+04 4.86E+04 3.12E+04 1.11E+03 4.56E‐01 ‐3.41E‐01
FIG146262: hypothetical protein 2.80E‐01 4.00E+02 1.92E+03 3.87E+02 1.80E+03 2.09E‐01 ‐6.80E‐01
hypothetical Membrane Spanning Protein 2.81E‐01 1.20E+03 3.80E+03 1.58E+03 3.06E+03 3.14E‐01 ‐5.02E‐01
Chorismate mutase I (EC 5.4.99.5) / 2‐keto‐3‐
deoxy‐D‐arabino‐heptulosonate‐7‐
phosphate synthase I beta (EC 2.5.1.54) 2.82E‐01 6.05E+03 3.25E+04 1.28E+03 3.14E+04 1.86E‐01 ‐7.30E‐01
Imidazolonepropionase (EC 3.5.2.7) 2.84E‐01 5.76E+03 4.43E+04 4.89E+03 4.60E+04 1.30E‐01 ‐8.86E‐01
Ferrichrome‐binding periplasmic protein 
precursor (TC 3.A.1.14.3) 2.86E‐01 2.36E+03 7.95E+03 1.47E+03 6.74E+03 2.97E‐01 ‐5.28E‐01
FIG01227877: hypothetical protein 2.87E‐01 7.91E+02 3.33E+03 8.52E+02 3.08E+03 2.37E‐01 ‐6.24E‐01
UTP‐‐glucose‐1‐phosphate 
uridylyltransferase (EC 2.7.7.9) 2.98E‐01 6.35E+05 4.38E+04 7.35E+05 3.53E+03 1.45E+01 1.16E+00
hypothetical protein 3.03E‐01 4.96E+03 7.46E+03 2.72E+03 2.43E+03 6.66E‐01 ‐1.77E‐01
Sip1Aa‐like_2 3.04E‐01 4.70E+04 2.24E+03 5.66E+04 1.18E+03 2.10E+01 1.32E+00
hypothetical protein 3.11E‐01 5.32E+06 2.72E+06 3.35E+06 4.74E+05 1.95E+00 2.91E‐01
Alkyl hydroperoxide reductase protein C (EC 
1.6.4.‐) 3.11E‐01 1.09E+05 2.88E+05 3.68E+04 2.30E+05 3.80E‐01 ‐4.20E‐01
hypothetical protein 3.11E‐01 5.07E+02 2.84E+03 5.62E+02 3.02E+03 1.79E‐01 ‐7.48E‐01
Methionine aminopeptidase (EC 3.4.11.18) 3.12E‐01 5.33E+03 1.01E+05 3.24E+03 1.24E+05 5.28E‐02 ‐1.28E+00
hypothetical Membrane Spanning Protein 3.13E‐01 2.05E+04 4.20E+04 9.81E+03 2.79E+04 4.88E‐01 ‐3.12E‐01
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hypothetical Membrane Spanning Protein 3.16E‐01 2.44E+05 3.40E+05 1.17E+05 8.08E+04 7.18E‐01 ‐1.44E‐01
response regulator, putative 3.18E‐01 4.03E+03 1.97E+04 3.20E+03 2.06E+04 2.05E‐01 ‐6.88E‐01
hypothetical protein 3.20E‐01 7.11E+03 2.72E+04 4.62E+03 2.65E+04 2.62E‐01 ‐5.82E‐01
DNA polymerase IV (EC 2.7.7.7) 3.21E‐01 1.17E+03 3.72E+03 1.44E+03 3.36E+03 3.15E‐01 ‐5.02E‐01
Vip4Aa1‐like_2 3.23E‐01 3.08E+04 1.47E+05 7.31E+03 1.55E+05 2.09E‐01 ‐6.80E‐01
2‐oxoglutarate oxidoreductase, beta subunit 
(EC 1.2.7.3) 3.24E‐01 7.16E+03 3.02E+05 5.30E+03 3.94E+05 2.37E‐02 ‐1.63E+00
Outer spore coat protein E 3.24E‐01 8.48E+04 2.51E+05 1.31E+05 2.11E+05 3.38E‐01 ‐4.71E‐01
Thioredoxin 3.34E‐01 2.40E+04 3.06E+04 5.36E+03 8.62E+03 7.84E‐01 ‐1.06E‐01
Histidinol dehydrogenase (EC 1.1.1.23) 3.34E‐01 9.07E+03 2.13E+04 1.26E+04 1.45E+04 4.27E‐01 ‐3.70E‐01
Protein GerPF, required for proper assembly 
of spore coat, mutations lead to super‐
dormant spore 3.55E‐01 1.76E+03 3.25E+03 2.07E+03 1.22E+03 5.40E‐01 ‐2.67E‐01
Acetate kinase (EC 2.7.2.1) 3.60E‐01 2.29E+03 2.09E+04 1.56E+03 2.74E+04 1.10E‐01 ‐9.60E‐01
Spore coat protein Z 3.61E‐01 4.44E+02 6.32E+03 2.26E+02 8.67E+03 7.02E‐02 ‐1.15E+00
MazG nucleotide pyrophosphohydrolase 3.64E‐01 3.05E+03 8.76E+03 4.77E+03 8.09E+03 3.48E‐01 ‐4.58E‐01
Thiol peroxidase, Tpx‐type (EC 1.11.1.15) 3.75E‐01 2.00E+04 3.36E+04 1.42E+04 1.86E+04 5.95E‐01 ‐2.25E‐01
3‐dehydroquinate synthase (EC 4.2.3.4) 3.88E‐01 7.68E+04 3.17E+04 7.12E+04 7.13E+03 2.42E+00 3.84E‐01
substrate‐binding family protein, putative 3.92E‐01 6.84E+03 4.09E+03 1.26E+03 4.39E+03 1.67E+00 2.24E‐01
NAD kinase (EC 2.7.1.23) 3.93E‐01 3.81E+02 2.31E+03 1.96E+02 3.09E+03 1.65E‐01 ‐7.83E‐01
hypothetical protein 3.96E‐01 2.29E+04 1.44E+05 9.44E+03 1.96E+05 1.59E‐01 ‐7.98E‐01
Glycine cleavage system H protein 3.98E‐01 2.03E+04 5.08E+04 3.32E+04 4.43E+04 3.99E‐01 ‐3.99E‐01
Spore cortex‐lytic enzyme CwlJ 3.98E‐01 4.05E+02 2.88E+03 2.78E+02 4.03E+03 1.41E‐01 ‐8.52E‐01
Putative deoxyribonuclease YcfH 3.99E‐01 1.54E+03 2.91E+04 1.54E+03 4.50E+04 5.28E‐02 ‐1.28E+00
Hypothetical protein ywlG 4.02E‐01 4.85E+02 9.93E+02 2.69E+02 8.27E+02 4.88E‐01 ‐3.11E‐01
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Sulfate adenylyltransferase, dissimilatory‐
type (EC 2.7.7.4) 4.04E‐01 3.05E+04 4.32E+04 2.03E+04 9.64E+03 7.07E‐01 ‐1.51E‐01
transcriptional regulator, XRE family 4.05E‐01 1.28E+03 1.63E+02 1.84E+03 7.46E+01 7.82E+00 8.93E‐01
Lipase (EC 3.1.1.3) 4.11E‐01 1.56E+05 2.71E+04 2.16E+05 8.48E+03 5.75E+00 7.60E‐01
Acetolactate synthase large subunit (EC 
2.2.1.6) 4.14E‐01 3.84E+04 5.73E+04 3.17E+04 1.16E+04 6.69E‐01 ‐1.74E‐01
Chitin binding protein 4.15E‐01 3.66E+05 2.52E+05 1.92E+05 6.71E+04 1.45E+00 1.62E‐01
Acetyltransferase AcuA, acetyl‐CoA 
synthetase inhibitor 4.23E‐01 2.41E+04 1.57E+05 4.61E+03 2.31E+05 1.53E‐01 ‐8.16E‐01
FIG01227780: hypothetical protein 4.27E‐01 3.67E+04 2.34E+04 2.32E+04 6.28E+03 1.57E+00 1.96E‐01
Phosphatidylinositol‐specific phospholipase 
C (EC 4.6.1.13) 4.42E‐01 4.65E+03 2.60E+03 3.68E+03 1.26E+03 1.79E+00 2.52E‐01
LSU ribosomal protein L2p (L8e) 4.44E‐01 4.03E+04 5.81E+04 3.26E+04 7.11E+03 6.93E‐01 ‐1.59E‐01
Ser/Thr protein phosphatase family protein 4.49E‐01 3.02E+04 4.76E+04 1.67E+04 3.05E+04 6.35E‐01 ‐1.97E‐01
Phenylalanine‐4‐hydroxylase (EC 1.14.16.1) 4.49E‐01 4.04E+04 7.97E+04 1.77E+04 7.25E+04 5.07E‐01 ‐2.95E‐01
Phenylalanyl‐tRNA synthetase domain 
protein (Bsu YtpR) 4.54E‐01 1.08E+03 2.39E+03 7.92E+02 2.44E+03 4.50E‐01 ‐3.47E‐01
NADH‐ubiquinone oxidoreductase chain D 
(EC 1.6.5.3) 4.59E‐01 1.67E+04 2.00E+03 2.81E+04 2.17E+03 8.36E+00 9.22E‐01
Glycine betaine ABC transport system, 
glycine betaine‐binding protein OpuAC 4.61E‐01 3.23E+05 5.14E+05 1.13E+05 3.61E+05 6.28E‐01 ‐2.02E‐01
Pyridoxamine 5'‐phosphate oxidase (EC 
1.4.3.5) 4.64E‐01 1.26E+05 1.71E+04 2.11E+05 4.71E+03 7.40E+00 8.69E‐01
5'‐nucleotidase (EC 3.1.3.5) 4.67E‐01 3.76E+04 1.55E+05 7.80E+03 2.28E+05 2.43E‐01 ‐6.15E‐01
Ribosomal subunit interface protein 4.72E‐01 4.49E+04 8.46E+03 7.17E+04 3.48E+03 5.31E+00 7.25E‐01
Arginine/ornithine antiporter ArcD 4.74E‐01 2.76E+04 1.21E+04 3.06E+04 7.59E+02 2.27E+00 3.57E‐01
sporulation kinase A 4.81E‐01 7.95E+03 1.56E+04 2.05E+03 1.54E+04 5.10E‐01 ‐2.92E‐01
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Predicted ATPase related to phosphate 
starvation‐inducible protein PhoH 4.91E‐01 1.66E+03 4.39E+02 2.51E+03 4.29E+02 3.78E+00 5.78E‐01
Amino acid ABC transporter, amino acid‐
binding protein 5.00E‐01 3.52E+04 4.66E+04 2.20E+04 1.42E+04 7.55E‐01 ‐1.22E‐01
SSU ribosomal protein S1p 5.06E‐01 5.87E+03 2.00E+04 1.52E+03 3.04E+04 2.94E‐01 ‐5.32E‐01
FIG012187: hypothetical protein 5.07E‐01 2.08E+03 1.49E+03 1.25E+03 4.14E+02 1.40E+00 1.45E‐01
Branched‐chain alpha‐keto acid 
dehydrogenase, E1 component, alpha 
subunit (EC 1.2.4.4) 5.19E‐01 7.10E+04 3.95E+04 6.81E+04 2.94E+04 1.80E+00 2.55E‐01
hypothetical protein 5.20E‐01 5.59E+05 3.82E+05 3.92E+05 1.01E+05 1.46E+00 1.65E‐01
Manganese‐dependent inorganic 
pyrophosphatase (EC 3.6.1.1) 5.21E‐01 8.67E+04 1.16E+05 6.42E+04 2.22E+04 7.48E‐01 ‐1.26E‐01
FIG01235195: hypothetical protein 5.30E‐01 1.09E+04 1.64E+04 8.15E+03 1.11E+04 6.64E‐01 ‐1.78E‐01
hypothetical protein 5.34E‐01 3.31E+03 1.51E+03 4.12E+03 1.32E+03 2.19E+00 3.41E‐01
hypothetical protein 5.36E‐01 3.52E+03 5.09E+03 3.51E+03 1.60E+03 6.92E‐01 ‐1.60E‐01
Aliphatic amidase AmiE (EC 3.5.1.4) 5.46E‐01 2.15E+04 6.64E+03 3.57E+04 6.02E+03 3.24E+00 5.11E‐01
Phosphatidylinositol‐specific phospholipase 
C (EC 4.6.1.13) 5.50E‐01 3.22E+04 1.10E+04 5.10E+04 1.35E+04 2.93E+00 4.68E‐01
Collagen adhesion protein 5.52E‐01 5.65E+05 3.97E+05 4.08E+05 7.35E+04 1.42E+00 1.53E‐01
acetyltransferase, GNAT family 5.53E‐01 1.65E+04 5.06E+03 2.80E+04 1.77E+03 3.27E+00 5.14E‐01
Branched‐chain amino acid ABC transporter, 
amino acid‐binding protein (TC 3.A.1.4.1) 5.53E‐01 4.17E+03 6.37E+03 4.56E+03 3.73E+03 6.54E‐01 ‐1.84E‐01
FIG01233253: hypothetical protein 5.55E‐01 2.75E+04 1.12E+04 4.01E+04 5.92E+03 2.45E+00 3.90E‐01
Transcription termination protein NusA 5.58E‐01 1.06E+04 4.02E+03 1.63E+04 2.55E+03 2.64E+00 4.21E‐01
ATP‐dependent hsl protease ATP‐binding 
subunit HslU 5.59E‐01 4.09E+03 6.46E+03 1.57E+03 5.82E+03 6.34E‐01 ‐1.98E‐01
Homoserine O‐acetyltransferase (EC 
2.3.1.31) 5.62E‐01 6.86E+03 1.02E+04 3.97E+03 7.84E+03 6.75E‐01 ‐1.71E‐01
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endonuclease/exonuclease/phosphatase 
family 5.63E‐01 3.01E+05 3.80E+05 1.12E+05 1.83E+05 7.91E‐01 ‐1.02E‐01
Ferredoxin 5.64E‐01 1.36E+03 2.08E+03 8.87E+02 1.72E+03 6.53E‐01 ‐1.85E‐01
Branched‐chain alpha‐keto acid 
dehydrogenase, E1 component, beta 
subunit (EC 1.2.4.4) 5.70E‐01 2.98E+04 3.87E+04 1.72E+04 1.81E+04 7.70E‐01 ‐1.14E‐01
putative cytochrome P450 hydroxylase 5.71E‐01 1.30E+04 2.08E+04 1.69E+04 1.39E+04 6.24E‐01 ‐2.05E‐01
neutral metalloprotease, putative 5.76E‐01 5.51E+05 4.23E+05 3.26E+05 1.22E+05 1.30E+00 1.15E‐01
FIG01226324: hypothetical protein 5.86E‐01 5.77E+04 1.01E+05 9.74E+04 7.95E+04 5.72E‐01 ‐2.42E‐01
Chitin binding protein 5.86E‐01 1.13E+06 1.32E+06 3.56E+05 4.34E+05 8.55E‐01 ‐6.82E‐02
hypothetical protein 5.87E‐01 2.84E+03 4.44E+03 4.19E+03 1.58E+03 6.40E‐01 ‐1.94E‐01
FIG01225999: hypothetical protein 5.97E‐01 1.46E+05 9.24E+04 1.46E+05 5.55E+04 1.58E+00 2.00E‐01
FIG01233823: hypothetical protein 5.99E‐01 1.35E+05 8.01E+04 1.48E+05 6.22E+04 1.69E+00 2.27E‐01
Succinate dehydrogenase iron‐sulfur protein 
(EC 1.3.99.1) 6.09E‐01 1.01E+03 1.55E+03 8.21E+02 1.41E+03 6.56E‐01 ‐1.83E‐01
Aminopeptidase Y (Arg, Lys, Leu preference) 
(EC 3.4.11.15) 6.10E‐01 1.10E+05 1.27E+05 3.43E+04 4.21E+04 8.64E‐01 ‐6.37E‐02
Phosphoglycerate kinase (EC 2.7.2.3) 6.12E‐01 8.47E+04 6.04E+04 6.72E+04 3.04E+04 1.40E+00 1.46E‐01
Vip2Ac‐like_1 6.13E‐01 3.25E+04 2.76E+04 1.34E+04 7.51E+03 1.18E+00 7.20E‐02
SSU ribosomal protein S4p (S9e) 6.28E‐01 2.30E+04 3.20E+04 2.59E+04 1.21E+04 7.20E‐01 ‐1.43E‐01
hypothetical protein 6.30E‐01 1.56E+03 3.17E+03 2.44E+03 4.63E+03 4.91E‐01 ‐3.09E‐01
Butyryl‐CoA dehydrogenase (EC 1.3.99.2) 6.45E‐01 6.46E+06 4.47E+06 5.87E+06 3.46E+06 1.45E+00 1.60E‐01
Phosphonate ABC transporter phosphate‐
binding periplasmic component (TC 
3.A.1.9.1) 6.60E‐01 3.21E+03 1.64E+03 5.28E+03 7.06E+02 1.96E+00 2.91E‐01
hypothetical Membrane Spanning Protein 6.66E‐01 3.41E+06 2.69E+06 2.15E+06 1.57E+06 1.27E+00 1.03E‐01
Ribosome recycling factor 6.76E‐01 3.45E+04 2.35E+04 3.89E+04 6.30E+03 1.47E+00 1.66E‐01
Respiratory nitrate reductase alpha chain 
(EC 1.7.99.4) 6.76E‐01 4.91E+04 6.78E+04 6.67E+04 5.04E+03 7.25E‐01 ‐1.40E‐01
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Phage shock protein A 6.77E‐01 2.38E+03 3.49E+03 1.23E+03 3.90E+03 6.81E‐01 ‐1.67E‐01
hypothetical Membrane Spanning Protein 6.82E‐01 1.09E+04 8.17E+03 7.99E+03 6.78E+03 1.33E+00 1.23E‐01
FIG01226054: hypothetical protein 6.94E‐01 3.34E+04 4.68E+04 5.05E+04 1.16E+04 7.13E‐01 ‐1.47E‐01
O‐succinylbenzoic acid‐‐CoA ligase (EC 
6.2.1.26) 6.99E‐01 7.39E+03 4.39E+03 1.16E+04 2.14E+03 1.68E+00 2.26E‐01
Cell division trigger factor (EC 5.2.1.8) 7.02E‐01 9.61E+02 6.58E+02 1.15E+03 4.42E+02 1.46E+00 1.65E‐01
hypothetical Membrane Spanning Protein 7.03E‐01 3.14E+05 4.14E+05 3.77E+05 1.67E+05 7.58E‐01 ‐1.21E‐01
Ribonuclease J2 (endoribonuclease in RNA 
processing) 7.11E‐01 2.14E+04 2.71E+04 1.96E+04 1.50E+04 7.89E‐01 ‐1.03E‐01
L‐serine dehydratase, alpha subunit (EC 
4.3.1.17) 7.13E‐01 1.57E+05 1.84E+05 1.04E+05 4.30E+04 8.55E‐01 ‐6.80E‐02
Lipase 7.23E‐01 3.65E+03 2.32E+03 5.63E+03 6.54E+02 1.57E+00 1.97E‐01
Cell surface protein IsdA1 7.38E‐01 2.50E+03 1.71E+03 3.35E+03 1.63E+03 1.46E+00 1.65E‐01
Prolyl‐tRNA synthetase (EC 6.1.1.15), 
archaeal/eukaryal type 7.51E‐01 1.01E+04 1.41E+04 9.46E+03 1.73E+04 7.19E‐01 ‐1.44E‐01
Transcriptional regulator, MerR family 7.58E‐01 6.04E+03 8.04E+03 3.35E+03 9.49E+03 7.51E‐01 ‐1.24E‐01
Unspecified monosaccharide ABC transport 
system, substrate‐binding component 7.58E‐01 9.71E+03 1.22E+04 1.01E+04 8.14E+03 7.96E‐01 ‐9.89E‐02
2',3'‐cyclic‐nucleotide 2'‐phosphodiesterase 
(EC 3.1.4.16) 7.61E‐01 2.76E+05 2.52E+05 2.47E+04 1.21E+05 1.10E+00 4.04E‐02
Oligopeptide transport ATP‐binding protein 
OppD (TC 3.A.1.5.1) 7.64E‐01 3.13E+04 3.98E+04 4.32E+04 2.56E+03 7.84E‐01 ‐1.05E‐01
transcriptional regulator, XRE family 7.83E‐01 8.54E+05 8.13E+05 9.48E+04 2.19E+05 1.05E+00 2.17E‐02
ATP synthase epsilon chain (EC 3.6.3.14) 7.85E‐01 4.65E+03 3.26E+03 7.25E+03 3.43E+03 1.42E+00 1.54E‐01
Cell wall surface anchor family protein 7.86E‐01 2.57E+04 2.07E+04 2.55E+04 1.46E+04 1.24E+00 9.42E‐02
N‐formylglutamate deformylase (EC 
3.5.1.68) 7.86E‐01 6.63E+04 7.05E+04 1.39E+04 2.05E+04 9.41E‐01 ‐2.65E‐02
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Alcohol dehydrogenase (EC 1.1.1.1); 
Acetaldehyde dehydrogenase (EC 1.2.1.10) 7.88E‐01 1.72E+04 1.54E+04 7.79E+03 7.07E+03 1.11E+00 4.66E‐02
hypothetical protein 7.99E‐01 5.49E+04 4.92E+04 8.01E+03 3.36E+04 1.12E+00 4.78E‐02
LSU ribosomal protein L36p 8.41E‐01 5.83E+03 4.78E+03 7.94E+03 8.56E+02 1.22E+00 8.60E‐02
FIG01229284: hypothetical protein 8.43E‐01 5.73E+03 6.81E+03 8.25E+03 1.88E+03 8.41E‐01 ‐7.54E‐02
Cell surface protein IsdA, transfers heme 
from hemoglobin to apo‐IsdC 8.47E‐01 2.03E+03 2.39E+03 2.58E+03 1.64E+03 8.47E‐01 ‐7.20E‐02
hypothetical Membrane Spanning Protein 8.49E‐01 1.74E+05 1.94E+05 1.54E+05 4.29E+04 8.98E‐01 ‐4.66E‐02
Glutamyl aminopeptidase (EC 3.4.11.7); 
Deblocking aminopeptidase 8.54E‐01 1.68E+05 1.36E+05 2.66E+05 4.69E+04 1.24E+00 9.25E‐02
transcriptional regulator, XRE family 8.68E‐01 6.34E+05 5.65E+05 3.59E+05 5.61E+05 1.12E+00 5.01E‐02
Ornithine carbamoyltransferase (EC 2.1.3.3) 8.69E‐01 7.55E+03 8.69E+03 6.40E+03 9.13E+03 8.69E‐01 ‐6.12E‐02
Ribonuclease P protein component (EC 
3.1.26.5) 8.70E‐01 9.44E+05 8.90E+05 2.97E+05 4.38E+05 1.06E+00 2.54E‐02
Zinc metalloproteinase precursor (EC 
3.4.24.29) / aureolysin 8.71E‐01 2.13E+05 2.08E+05 3.66E+04 3.57E+04 1.02E+00 1.06E‐02
Tellurium resistance protein TerD 8.80E‐01 7.70E+04 7.10E+04 3.72E+04 5.28E+04 1.09E+00 3.55E‐02
Methylmalonate‐semialdehyde 
dehydrogenase (EC 1.2.1.27) 8.87E‐01 1.35E+05 1.18E+05 1.85E+05 2.15E+04 1.15E+00 5.90E‐02
LSU ribosomal protein L11p (L12e) 8.93E‐01 3.55E+04 3.07E+04 5.35E+04 1.96E+04 1.16E+00 6.40E‐02
Fumarylacetoacetate hydrolase family 
protein 9.02E‐01 2.01E+04 1.82E+04 2.20E+04 1.29E+04 1.11E+00 4.44E‐02
Stage IV sporulation protein A 9.07E‐01 1.36E+03 1.53E+03 1.94E+03 1.15E+03 8.92E‐01 ‐4.97E‐02
Heat shock protein GrpE 9.17E‐01 8.40E+03 7.63E+03 1.11E+04 2.70E+03 1.10E+00 4.15E‐02
Stage V sporulation protein required for 
dehydratation of the spore core and 
assembly of the coat (SpoVS) 9.43E‐01 1.30E+03 1.36E+03 1.27E+03 4.88E+02 9.55E‐01 ‐2.02E‐02
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Tryptophan 2,3‐dioxygenase (EC 1.13.11.11) 9.44E‐01 4.07E+03 4.33E+03 2.37E+03 5.47E+03 9.39E‐01 ‐2.72E‐02
Hypothetical protein SAV1845 9.51E‐01 1.97E+04 1.91E+04 7.77E+03 1.10E+04 1.03E+00 1.15E‐02
LSU ribosomal protein L7/L12 (P1/P2) 9.67E‐01 4.44E+04 4.54E+04 3.54E+04 3.77E+03 9.79E‐01 ‐9.16E‐03
IMP cyclohydrolase (EC 3.5.4.10) / 
Phosphoribosylaminoimidazolecarboxamide 
formyltransferase (EC 2.1.2.3) 9.83E‐01 1.87E+04 1.91E+04 2.74E+04 5.39E+03 9.80E‐01 ‐8.80E‐03
Signal transduction histidine kinase 9.87E‐01 2.34E+03 2.30E+03 3.77E+03 4.57E+02 1.02E+00 7.36E‐03
ATP‐dependent Clp protease, ATP‐binding 
subunit ClpC / Negative regulator of genetic 
competence clcC/mecB 9.99E‐01 8.32E+03 8.32E+03 1.13E+04 1.88E+03 1.00E+00 3.54E‐04
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Aldehyde dehydrogenase (EC 1.2.1.3) 1.10E‐04 4.51E+03 7.69E+04 5.70E+03 4.15E+03 5.87E‐02 ‐1.23E+00
Malate dehydrogenase (EC 1.1.1.37) 2.11E‐03 1.15E+04 6.81E+04 1.03E+04 8.23E+03 1.68E‐01 ‐7.74E‐01
Peptidase T (EC 3.4.11.4) 5.29E‐03 8.54E+04 6.12E+05 5.56E+04 1.10E+05 1.39E‐01 ‐8.55E‐01
SSU ribosomal protein S7p (S5e) 1.34E‐02 1.69E+04 6.59E+04 1.49E+04 1.32E+04 2.56E‐01 ‐5.91E‐01
Flagellin protein FlaA 2.37E‐02 9.47E+06 9.96E+05 2.52E+06 5.70E+05 9.50E+00 9.78E‐01
Molybdenum cofactor biosynthesis protein 
MoaB 3.26E‐02 2.74E+03 1.46E+04 2.68E+03 4.88E+03 1.88E‐01 ‐7.27E‐01
Chaperone protein DnaK 4.93E‐02 3.40E+04 9.35E+04 2.66E+04 2.56E+04 3.64E‐01 ‐4.39E‐01
ABC transporter, ATP‐binding protein 6.88E‐02 8.92E+04 2.70E+05 9.72E+04 3.92E+04 3.31E‐01 ‐4.81E‐01
Glycerophosphoryl diester 
phosphodiesterase (EC 3.1.4.46) 9.23E‐02 1.38E+03 3.32E+04 9.67E+02 1.81E+04 4.15E‐02 ‐1.38E+00
Heat shock protein 60 family chaperone 
GroEL 9.73E‐02 7.45E+05 2.34E+06 7.79E+05 9.95E+05 3.18E‐01 ‐4.98E‐01
Porphobilinogen synthase (EC 4.2.1.24) 1.44E‐01 3.39E+03 3.48E+04 2.24E+03 2.34E+04 9.73E‐02 ‐1.01E+00
methyl‐accepting/DNA response regulator, 
putative 1.58E‐01 4.28E+04 7.92E+04 1.87E+04 2.95E+04 5.40E‐01 ‐2.68E‐01
hypothetical protein 1.74E‐01 7.61E+04 4.72E+03 5.98E+04 3.20E+03 1.61E+01 1.21E+00
DNA gyrase subunit A (EC 5.99.1.3) 1.84E‐01 6.58E+03 5.43E+04 5.79E+03 4.18E+04 1.21E‐01 ‐9.17E‐01
hypothetical protein 3.15E‐01 5.46E+03 1.15E+04 7.15E+03 5.65E+03 4.73E‐01 ‐3.25E‐01
NLP/P60 family protein 3.19E‐01 1.28E+04 2.24E+04 1.22E+04 7.27E+03 5.71E‐01 ‐2.44E‐01
Nicotinate‐nucleotide adenylyltransferase 
(EC 2.7.7.18) 3.29E‐01 3.36E+03 1.18E+02 4.39E+03 3.80E+01 2.85E+01 1.45E+00
hypothetical protein 3.36E‐01 4.00E+04 8.36E+03 4.36E+04 4.59E+03 4.78E+00 6.80E‐01
Oligopeptide ABC transporter, periplasmic 
oligopeptide‐binding protein OppA (TC 
3.A.1.5.1) 3.67E‐01 2.56E+04 4.90E+03 3.10E+04 8.92E+02 5.23E+00 7.18E‐01
Phage lysin; N‐acetylmuramoyl‐L‐alanine
amidase, family 3 (EC:3.5.1.28) 3.96E‐01 2.15E+03 8.74E+01 3.33E+03 7.88E+01 2.46E+01 1.39E+00
N‐acetylmuramoyl‐L‐alanine amidase (EC
3.5.1.28) 4.22E‐01 1.51E+04 8.99E+02 2.45E+04 1.43E+02 1.68E+01 1.22E+00
Shared proteins of the Bt isolate E‐SE10.2 with the Bt isolate O‐V84.2
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hypothetical protein 4.26E‐01 5.27E+03 2.07E+02 8.85E+03 6.57E+01 2.55E+01 1.41E+00
hypothetical protein 4.59E‐01 4.36E+04 6.65E+03 7.04E+04 3.81E+03 6.56E+00 8.17E‐01
FIG01226217: hypothetical protein 4.69E‐01 7.97E+03 1.50E+03 1.26E+04 8.99E+02 5.33E+00 7.26E‐01
#¡REF! 4.89E‐01 4.62E+03 8.45E+03 2.16E+03 7.80E+03 5.47E‐01 ‐2.62E‐01
hypothetical protein 5.12E‐01 1.09E+05 2.75E+05 1.31E+05 3.55E+05 3.96E‐01 ‐4.03E‐01
NAD‐dependent malic enzyme (EC 1.1.1.38) 5.26E‐01 4.11E+03 1.07E+04 1.28E+03 1.50E+04 3.84E‐01 ‐4.16E‐01
enterotoxin / cell‐wall binding protein 5.33E‐01 2.57E+04 7.88E+03 4.12E+04 8.23E+03 3.27E+00 5.14E‐01
Fe‐S oxidoreductase 5.50E‐01 2.28E+03 3.33E+03 7.11E+02 2.54E+03 6.83E‐01 ‐1.66E‐01
FIG01231653: hypothetical protein 6.49E‐01 1.61E+04 2.51E+04 8.72E+03 2.89E+04 6.42E‐01 ‐1.93E‐01
Spore cortex‐lytic enzyme, N‐
acetylglucosaminidase SleL (EC 3.2.1.‐) 7.05E‐01 1.29E+03 2.03E+03 1.92E+03 2.48E+03 6.34E‐01 ‐1.98E‐01
Electron transfer flavoprotein, alpha subunit 7.49E‐01 1.64E+05 1.42E+05 5.55E+04 9.37E+04 1.15E+00 6.22E‐02
Glutamine ABC transporter, periplasmic 
glutamine‐binding protein (TC 3.A.1.3.2) 7.81E‐01 3.03E+03 3.96E+03 4.38E+03 3.19E+03 7.64E‐01 ‐1.17E‐01
Translation elongation factor Tu 8.31E‐01 5.52E+04 4.50E+04 7.08E+04 2.35E+04 1.23E+00 8.90E‐02
2,3,4,5‐tetrahydropyridine‐2,6‐dicarboxylate 
N‐acetyltransferase (EC 2.3.1.89) 8.64E‐01 1.28E+04 1.10E+04 6.67E+03 1.52E+04 1.16E+00 6.58E‐02
Succinate dehydrogenase flavoprotein 
subunit (EC 1.3.99.1) 9.34E‐01 2.37E+04 2.19E+04 3.29E+04 2.78E+03 1.08E+00 3.41E‐02














Analysis of cross-resistance to Vip3 proteins in eight insect colonies, 
from four insect species, selected for resistance to Bacillus thuringiensis 
insecticidal proteins 
Joaquín Gomis-Cebolla, Yuequin Wang, Yudong Quan, Kanglai He, Tom Walsh, Bill 
James, Sharon Downes, Wendy Kain, Ping Wang, Kathy Leonard, Tom Morgan, 
Brenda Oppert, Juan Ferré 
Table S1. Confirmation of resistance in the susceptible and Cry1Ac, Cry2Ab, Vip3Aa, 
and Vip3Aa/Cry2Ab-resistant H. armigera insect colonies. 
Toxins Dose (µg/cm2) 








Buffer3 - 0 ± 0 6.3 ± 4.6 1.0 ± 1.5 2.1 ± 2.1 0 ± 0 
Cry1Ac 0.25 100 ± 0 11.7 ± 7.9 94.8 ± 7.4 100 ± 0 95.8 ± 4.2 
Cry2Ab 0.25 100 ± 0 72.4 ± 8.0 1.4 ± 2.0 100 ± 0 4.2 ± 4.2 
Vip3Aa 20 100 ± 0 96.9 ± 5.4 86.2 ± 6.8 6.3 ± 6.3 10.6 ± 6.1 
1 Mortality: Number of death larvae in each treatment, expressed as percentage 
2 SE: Standard error of the mean 
3 Buffer: 20 mM Tris, 150 mM NaCl, pH 9 
Table S2.  Comparison of LC50 values of Cry and VIP3Aa protoxins  for Dipel-
susceptible and -resistant Plodia interpunctella strains. 
Toxin Susceptible1 Dipel-Resistant2 
Cry1Ab 0.02 2.37 
Cry1Ac 0.08 >250
Cry1F 15.3 280 
Dipel 4.80 UD 
ViP3Aa 15.9 78.7 
Vip3Ca 67.5 13.7 
1Data in g applied to a 15 mg diet disk; from Oppert et al., 2010 and this study 
2UD – unable to determine  
351
2 
Table S3. Confirmation of resistance in the susceptible and Cry1Ab-resistant O. 
furnacalis insect colonies 
O. furnacalis strains LC50 (FL95) Resistance Ratio1 Slope ± SE2 
μg/g diet 
Susceptible 0.23 (0.17 - 0.30) - 1.16 ± 0.11
Cry1Ab-resistant 183 (155 - 213) 794 2.41 ± 0.26
1 Resistance Ratio was calculated divided the LC50 value of the resistant strain by the LC50 value 
of the susceptible strain respectively.   











































Changes in gene expression and apoptotic response in 
Spodoptera exigua larvae exposed to sublethal 
concentrations of Vip3 insecticidal proteins 
Patricia Hernández-Martínez, Joaquín Gomis-Cebolla, Juan Ferré and Baltasar Escriche*  
ERI de Biotecnología y Biomedicina (BIOTECMED), Department of Genetics, Universitat 
de València. Dr Moliner, 50, Burjassot (46100), Spain. 
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Supplementary Information: 
Supplementary Figure 1. Venn diagram showing up-regulated genes (panel a) and down-
regulated genes (panel b) after 24 h challenged at 100, 1000, and 10000 ng/cm2 of Vip3Ca. 
Supplementary Figure 2. Correlation analysis between larval growth inhibition and the 
APN activity in the luminal fluid after exposure to four different concentrations of Vip3Ca 
protein for 24 h. Pearson r and p-value are shown in the graph. 
Supplementary Figure 3. Midgut tissue sections of S. exigua exposed for 24 h to Vip3Aa 
and Vip3Ca proteins were stained with hematoxylin and eosin. As controls, larvae fed with 
the empty vector (WK6) were used. Magnification was 100. BM, basal membrane; AM, 
apical membrane and L, lumen.  
Supplementary Table S1. List of primers for RT-qPCR used in this study and gene 
expression of each transcript after Vip3Ca challenged at 100, 1000, and 10000 ng/cm2, 
respectively. 
Supplementary Table S2. List of primers designed for the analysis of the expression 

















Supplementary Figure 3. 
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Supplementary Table S1: List of primers for RT-qPCR used in this study and gene expression of each transcript after Vip3Ca challenged at 100, 1000, and 10000 ng/cm 2, respectively.
Forward (5’ → 3’) Reverse (5’ → 3’)  expose 100 ng/cm2  expose 1000 ng/cm2  expose 10 000 ng/cm2
1 ATP synthase GTTGCTGGTCTGGTGGGATT AGGCCTCAGACACCATTGAAA Herrero et al., 2007 - - -
2 Beta-glucan recognition protein AATTGGAAGCCATCTATCCTAAAGG TGAGGTTTCCGTGGAATGC Jakubowska et al., 2013 0.8 ± 0.6 5.0 ± 3.9* 2.7 ± 2.8
3 Peptidoglycan recogniztion protein GTAGTACCGGAGTGTGTTAGTGATGAG TTGTCCTATATCAGTGAATCCACGTT Jakubowska et al., 2013 1.1 ± 0.8 1.7 ± 1.7 3.5 ± 4.4
4 Prophenoloxidase activating enzyme AGCTGTGCGGCCCAGAT TCGACACCGCAACATTCACT Jakubowska et al., 2013 1.1 ± 0.7 3.0 ± 2.6 3.5 ± 3.6
5 G-protein receptor GGCCGTCAGTGTGAAGAATATTAAGT ACGGGAACAGCAAATTGTTGT Jakubowska et al., 2013 1.3 ± 0.6 0.8  ± 0.9 1.0 ± 0.8
6 TIN-ag-RP CGATGACTGTTGCCCAGACTAC TGCAGCCCATGGTGTTATATTC Jakubowska et al., 2013 0.8 ± 0.4 1.9 ± 1.7 2.6 ± 1.7
7 Toll receptor TTCTTTAGTCTTTTCCAGAACATTGG ACCTGATGCTGACAAAGACCTACA Jakubowska et al., 2013 1.3 ± 0.7 0.3 ± 0.4 0.8 ± 0.5
8 Imd GCTCCAAGGCCATCTACAGAGA TCCTGATCTTCATTTTGATCTTGATT Jakubowska et al., 2013 1.1 ± 1.1 0.06  ± 0.2 0.5 ± 0.3
9 JAK-STAT CGCCCTTACAGGATCATCTCA AGGCCGGATTCTAGGAGCTT Jakubowska et al., 2013 0.7 ± 0.4 0.4 ± 0.2 * 0.5 ± 0.3
10 SE_U12696 (REVIP) GGTCCAATTCCAACATGCACT TGTAGGTCTTGTGAACGTGGTGT Bel et al., 2013 0.1 ± 0.1 * 0.0015 ± 0.0014 * 0.006 ± 0.0033 *
11 SE_U12832 ACTGGTGCAGTTCCGAGCAT AGCCCCAATACTGTGTCCCA Bel et al., 2013 0.4 ± 0.3 * 0.07 ± 0.04 * 0.09 ± 0.06 *
12 SE_U59986 GCCATTGCCTTACCTTCTGG GCTTCCAACAAAGTTCTCGTTGA Bel et al., 2013 0.7 ± 0.4 0.07 ± 0.05 * 0.06 ± 0.03 *
13 SE_U10224 CGAAGGGAATGTTTGCGAAG AGTTCGCTGACCAGAGAGTGC Bel et al., 2013 0.6 ± 0.4 0.08 ± 0.04 * 0.2 ± 0.1 *
14 SE_U08180 ATTCGCCCGACCTCTTCAAT TGTTTAGGATGAACTGGAACCATAAC Bel et al., 2013 0.6 ± 0.4 0.06 ± 0.04 * 0.2 ± 0.1 *
15 SE_U08346 AGGTCATCTCCAGCTACGACG CGTTGCACGATTCAAATTCG Bel et al., 2013 0.6 ± 0.4 0.06 ± 0.04 * 0.1 ± 0.07 *
16 SE_U56776 Bel et al., 2013 5.9 ± 3.6 * 11.0 ± 36.0 29.3 ± 34.6 *
17 SE_U20473 CGGCCAAGAATTAGTTTCCAAA AGACCGGGTACTCTGGCGTA Bel et al., 2013 9.3 ± 6.9 6.4 ± 3.5 * 6.9 ± 6.1 *
18 SE_U33476 CAGTACAATGGCCGCTCTCAA AAGGCAATGAGGAGCAGCAC Bel et al., 2013 0.8 ± 0.9 9.8 ± 12.9 19.3 ± 11.6 *
19 SE_17986 CGAGTGCACCATGAACACCT ATGACGGCGAGGAAAGAGAG Bel et al., 2013 1.8 ± 1.3 19.2 ± 11.6 * 10.4 ± 8.9 *
20 SE_U08322 GCCGCTAAGAATGCAGCTAAA TGATGCCCGTGGAAGCTT Bel et al., 2013 8.8 ± 5.9 * 11.3 ± 5.6 * 6.7 ± 5.7 *
21 SE_U08997 CTCCCCGAAGCTGAGACCT TGGTCTCCGGCTTTATTGGA Bel et al., 2013 1.4 ± 0.4 1.4 ± 0.6 2.3 ± 1.2 *
22 SE_13239 TTGGGCATCAAGTCGCTAGA GTCCCCCTTGATCTCGTCAA Bel et al., 2013 2.9 ± 2.3 20.9 ± 23.0 * 7.8 ± 5.6 *
23 SE_U09334 CAGTCGCCGGCCAAATAC CGGGCTCGGCTTTATAGACC Bel et al., 2013 5.2 ± 3.6 * 3.2 ± 3.6 1.8 ± 1.6
24 SE_U06544 TCAATTTCCAATAAAGCCGGA TCTCGTGCTCAGCAATGTGC Bel et al., 2013 1.1 ± 1.0 1.2 ± 1.1 1.1 ± 1.0
25 Gloverin CGAGGTGGCTACAAACAAGAC CATATGCCTGGCCTTGAAG Crava et al., 2015 1.1 ± 1.0 4.2 ± 3.6 31.7 ± 5.0 *
26 Attacin 1 CGTTCTTAGACCGCAAGGAC CACGGAAGTGGTCGGGCT Crava et al., 2015 1.5 ± 2.3 1.6 ± 2.6 2.2 ± 2.0
27 Attacin 3 CGGTTTATCAGCACCATTCGGT CGCCTGGCAGCATCAAAG Crava et al., 2015 1.3 ± 1.6 0.5 ± 0.7 2.9 ± 2.6
28 Lebocin 1 CACTACACCTGCCTGACTACA GGCGAGGGTTGAAGGGA Crava et al., 2015 1.2 ± 1.6 35.6 ± 19.5 * 14.7 ± 10.5 *
29 Cecropin A1 GTCATCGTAATCATCACATCAACTAC ACGGCAGGCAGTTGCTCAG Crava et al., 2015 0.2 ± 0.4 1.9 ± 2.1 1.2 ± 1.1
30 Cecropin B GGATAAGCTGGTCTCCAAACAC GTGTGCCAACTTATTCGAGAAC Crava et al., 2015 1.3 ± 1.1 5.2 ± 8.9 2.5 ± 2.3 *
31 Cecropin C CAGTGAGGAAGACTAGACGGC ATGGAGCGTATACAAATGAACG Crava et al., 2015 1.1 ± 0.9 4.5 ± 7.0 3,05 ± 2.8 *
32 Cecropin D GCCAAAGCGCTAGGAAAGTAG TCTGTTGCTGACTATTGAAGTAGG Crava et al., 2015 0.6 ± 0.5 3.2 ± 5.3 2.7 ± 2.3
33 Cecropin E TGGCCGTTGTGGGATCAG GTATGTGTCAGGTCATAGGGACT Crava et al., 2015 1.3 ± 1.1 1.2 ± 1.9 8,1 ± 8.3 *
34 Cecropin F CCAAGGCGCTAGGATAAAC GGCGGAATGAGTATTATGAGGT Crava et al., 2015 1.1 ± 0.8 0.9 ± 3.2 -2.2 ± 0.2
35 Spodoptericn TCGTGCGATTTCGAAGAAGC GCAGATGCCGTAAGTGTAACCT Crava et al., 2015 3.4 ± 3.7 10.2 ± 4.6 * 21,9 ± 28.4 *
36 LYZ 1 GAATCATGCAAAAGCTAACGGT TGCCTCGCAATGCAAGCA Crava et al., 2015 0.8 ± 0.7 3.0 ± 4.9 2.2 ± 1.9 *
37 LYZ 2 GACGAATTGCGATTTAGTTCAC GAGCACTCTCACTGTTTACCAGAC Crava et al., 2015 1.2 ± 0.9 3.7 ± 6.5 2.8 ± 2.1 *
38 LYZ 3 CCTAATTGAAGCGGAGGGTT GTGGGAACCGTCTGAATTCG Crava et al., 2015 1.4 ± 1.2 2.4 ± 4.7 11.1 ± 7.3 *
39 LLP 1 GCCTGATATTGAGAAATGTCCA CTTGCCGTTCTCTTGTCTCTAGG Crava et al., 2015 0.5 ± 0.4 0.5 ± 0.4 0.5 ± 0.3 * 
40 LLP 2 CGCGGTCCAGCACTAAGAC CGCCTAGATCTTCTCAACCTGG Crava et al., 2015 1.1 ± 0.5 0.8 ± 0.7 -2.0 ± 0.5
41 Diapausin A1 GCGGTAGAATGGACTGTTACTGATG CAAGAAGGTTATCACGAATACG Crava et al., 2015 1.8 ± 1.4 2.8 ± 2.8* 21.6 ± 15.3 *
42 Diapausin A2 GCGGTAGAATGGACTGTTACTGATG GCAAGTCAGGAATACTAAAGGGC Crava et al., 2015 1.1 ± 0.6 0.6 ± 0.6 4.6 ± 4.0 *
43 Diapausin A3 GCGGTAGAATGGACTGTTACTGATG CTAGAGAGCTGCGTTGTTCAC Crava et al., 2015 2.2 ± 1.3 0.8 ± 0.7 29.0 ± 16.3 *
44 Diapausin A6 GCGGTAGAATGGACTGTTACTGATG ATTAGGTTTCTAGGCTTGTGTCAC Crava et al., 2015 3.1 ± 3.2 39.5 ± 49.0* 46.4 ± 38.8*
45 Diapausin A7 GCGGTAGAATGGACTGTTACTGATG TAAGAAGATCCTCCACTACAAGG Crava et al., 2015 3.9 ± 3.4 21.8 ± 16.4* 46.5 ± 40.8*
46 Cobatoxin 1 TCGAGGAGGTGGGAGATGTC CGAACGGCTGGAGACTCTTC Crava et al., 2015 0.8 ± 0.6 5.3 ± 3.4 * 4.7 ± 6.9 
47 Cobatoxin 2 GAAGCTCGTATTGTTTGTCGT CCTCAGCAAGTCGTCAATG Crava et al., 2015 0.4 ± 0.2 0.4 ± 0.2* 0.8 ± 0.8 
48 Moricin AAGCGGCTCCAGGAAAGATACC ATTGCCCGGAGACCTTTACCAA Crava et al., 2015 1.6 ± 1.6 4.3 ± 2.8* 6.2 ± 6.6 *
* Genes whose expression was significantly up-(box in red) or down-regulated (box in green) after Vip3Ca challenge
Target geneNumber of pair of primer Primers Source Fold change ± SD
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Supplementary Table S2: List of primers design for the analysis of the expression levels of five apoptosis-related genes.
Target gene Name Length Tm %GC 5'-3' sequence Amp Length
Se-Caspase-1 F 20 62 60 GCTTGAAGTCGCGTACTGGC
Se-Caspase-1 R 19 61 63 GTCTGCAGTCTGCTGGACG
Se-Caspase-2 F 20 59 55 ATCGATATCCCACCACGAGC
Se-Caspase-2 R 21 58 48 CAACACTAAATCCCAACGCTG
Se-Caspase-3 F 23 64 57 CACATGCTGACTTCCTCGTGCTG
Se-Caspase-3 R 25 63 52 CAGGTCCTCATGATGTTCCTCCA
Se-Caspase-4 F 22 60 55 CGAGGTACGAAGATCACCCAAG
Se-Caspase-4 R 21 60 57 GAGATCAGACTCCACTGGCAG
Se-Caspase-6 F 20 59 55 GAAGCTCTCCTTACCTGCCA
Se-Caspase-6 R 20 59 50 AGTACTTGCGTGCTGCATTG
137
82
122
111
76
Se-Caspase-1
Se-Caspase-2
Se-Caspase-3
Se-Caspase-4
Se-Caspase-6
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